```json
{
  "albuminocytologic_dissociation": {
    "title": "Albuminocytologic Dissociation",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Diagnostic Findings",
      "CSF Analysis"
    ],
    "content": {
      "definition": "<p><b>Albuminocytologic dissociation</b> is a specific cerebrospinal fluid (CSF) finding characterized by an <u>elevated protein level</u> in the presence of a normal (or near-normal) white blood cell count, classically associated with the inflammation and nerve root demyelination of [[guillain_barre_syndrome]].</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> Inflammation of the spinal nerve roots allows plasma proteins to leak into the CSF, but the blood-nerve barrier remains intact enough to prevent significant cellular infiltration.</li><li><b>Diagnostic Criteria:</b> Elevated CSF protein (>45 mg/dL) with normal WBC count (<10 cells/µL).</li><li><b>Associations:</b> The hallmark laboratory finding of [[guillain_barre_syndrome]] (Acute Inflammatory Demyelinating Polyneuropathy).</li><li><b>USMLE Tip:</b> If the vignette describes ascending paralysis and asks for the CSF finding, look for \"High protein, low cells.\"</li></ul>",
      "takeAway": "<p><b>Albuminocytologic dissociation</b> reflects the breakdown of the blood-nerve barrier at the level of the nerve roots, allowing protein leakage without pleocytosis, distinguishing [[guillain_barre_syndrome]] from infectious etiologies like [[meningitis]].</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_hallmark_finding_of",
        "to": "guillain_barre_syndrome"
      },
      {
        "type": "is_detected_in",
        "to": "cerebrospinal_fluid"
      },
      {
        "type": "indicates",
        "to": "blood_nerve_barrier_breakdown"
      }
    ]
  },
  "vesicular_monoamine_transporter": {
    "title": "Vesicular Monoamine Transporter (VMAT)",
    "primaryType": "structure",
    "tags": [
      "Pharmacology",
      "Neurology",
      "Neuroscience",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Neuropharmacology",
      "Transporters"
    ],
    "content": {
      "definition": "<p>The <b>Vesicular Monoamine Transporter (VMAT)</b> is an integral membrane protein responsible for packaging monoamines (such as [[dopamine]], [[norepinephrine]], and [[serotonin]]) from the cytosol into synaptic vesicles, thereby enabling their subsequent release into the synaptic cleft and protecting them from degradation by [[monoamine_oxidase]].</p>",
      "atAGlance": "<ul><li><b>Function:</b> Transports monoamines into presynaptic vesicles against a concentration gradient using a proton gradient.</li><li><b>Pharmacology:</b> Inhibited by drugs like [[tetrabenazine]], [[deutetrabenazine]], and [[reserpine]].</li><li><b>Clinical Use:</b> Inhibition of VMAT2 depletes dopamine stores, which is therapeutic for hyperkinetic movement disorders like [[huntington_disease]] (chorea) and [[tardive_dyskinesia]].</li><li><b>Adverse Effects of Inhibition:</b> Depression, sedation, and parkinsonism due to monoamine depletion.</li><li><b>USMLE Tip:</b> Remember that <b>Reserpine</b> irreversibly blocks VMAT, while <b>Tetrabenazine</b> is a reversible inhibitor used for Huntington's chorea.</li></ul>",
      "takeAway": "<p><b>VMAT</b> is the gatekeeper for neurotransmitter storage; its inhibition leads to the depletion of presynaptic monoamines (dopamine, norepinephrine), making it a target for treating hyperkinetic disorders at the risk of causing depression or parkinsonism.</p>",
      "mermaid": "graph TD; A[Cytosolic Dopamine] -->|VMAT2| B[Synaptic Vesicle]; B -->|Release| C[Synaptic Cleft]; D[Tetrabenazine] --x|Inhibits| A;"
    },
    "connections": [
      {
        "type": "is_inhibited_by",
        "to": "tetrabenazine"
      },
      {
        "type": "is_inhibited_by",
        "to": "reserpine"
      },
      {
        "type": "transports",
        "to": "dopamine"
      },
      {
        "type": "transports",
        "to": "norepinephrine"
      }
    ]
  },
  "lateral_geniculate_nucleus": {
    "title": "Lateral Geniculate Nucleus (LGN)",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Anatomy",
      "Neuro-Ophthalmology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Brain Anatomy",
      "Thalamus",
      "Visual Pathway"
    ],
    "content": {
      "definition": "<p>The <b>Lateral Geniculate Nucleus (LGN)</b> is a specific sensory relay nucleus within the [[thalamus]] that receives visual information from the [[optic_tract]] and projects it via the optic radiations to the [[primary_visual_cortex]] (calcarine sulcus) in the occipital lobe.</p>",
      "atAGlance": "<ul><li><b>Input:</b> [[optic_tract]] (carrying fibers from the ipsilateral temporal retina and contralateral nasal retina).</li><li><b>Output:</b> Optic radiations (Geniculocalcarine tract) to the [[primary_visual_cortex]] (V1).</li><li><b>Function:</b> Processing and relaying visual data (Vision).</li><li><b>Structure:</b> 6 layers; Layers 1, 4, 6 receive contralateral input; Layers 2, 3, 5 receive ipsilateral input.</li><li><b>USMLE Tip:</b> Mnemonic: <b>L</b> is for <b>L</b>ight (Vision) = <b>L</b>GN.</li></ul>",
      "takeAway": "<p>The <b>Lateral Geniculate Nucleus</b> is the primary thalamic processing center for the visual system, acting as the gateway between the retina and the [[visual_cortex]].</p>",
      "mermaid": "graph LR; A[Retina] --> B[Optic Nerve]; B --> C[Optic Chiasm]; C --> D[Optic Tract]; D --> E[Lateral Geniculate Nucleus]; E --> F[Optic Radiations]; F --> G[Primary Visual Cortex];"
    },
    "connections": [
      {
        "type": "is_part_of",
        "to": "thalamus"
      },
      {
        "type": "receives_input_from",
        "to": "optic_tract"
      },
      {
        "type": "projects_to",
        "to": "primary_visual_cortex"
      },
      {
        "type": "relays_information_for",
        "to": "vision"
      }
    ]
  },
  "medial_geniculate_nucleus": {
    "title": "Medial Geniculate Nucleus (MGN)",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Anatomy",
      "Hearing",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Brain Anatomy",
      "Thalamus",
      "Auditory Pathway"
    ],
    "content": {
      "definition": "<p>The <b>Medial Geniculate Nucleus (MGN)</b> is a specific sensory relay nucleus within the [[thalamus]] that receives auditory information from the [[inferior_colliculus]] and projects it via the auditory radiations to the [[primary_auditory_cortex]] in the temporal lobe.</p>",
      "atAGlance": "<ul><li><b>Input:</b> [[inferior_colliculus]] (via the brachium of the inferior colliculus).</li><li><b>Output:</b> Auditory radiations to the [[primary_auditory_cortex]] (Transverse temporal gyri of Heschl).</li><li><b>Function:</b> Relaying auditory information (Hearing).</li><li><b>USMLE Tip:</b> Mnemonic: <b>M</b> is for <b>M</b>usic (Hearing) = <b>M</b>GN.</li></ul>",
      "takeAway": "<p>The <b>Medial Geniculate Nucleus</b> serves as the mandatory thalamic relay station for all ascending auditory information en route to the cortex.</p>",
      "mermaid": "graph LR; A[Cochlea] --> B[Brainstem Nuclei]; B --> C[Inferior Colliculus]; C --> D[Medial Geniculate Nucleus]; D --> E[Primary Auditory Cortex];"
    },
    "connections": [
      {
        "type": "is_part_of",
        "to": "thalamus"
      },
      {
        "type": "receives_input_from",
        "to": "inferior_colliculus"
      },
      {
        "type": "projects_to",
        "to": "primary_auditory_cortex"
      },
      {
        "type": "relays_information_for",
        "to": "hearing"
      }
    ]
  },
  "ventral_posterolateral_nucleus": {
    "title": "Ventral Posterolateral Nucleus (VPL)",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Anatomy",
      "Sensory Pathways",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Brain Anatomy",
      "Thalamus",
      "Somatosensory Pathway"
    ],
    "content": {
      "definition": "<p>The <b>Ventral Posterolateral Nucleus (VPL)</b> is the major somatosensory relay nucleus of the [[thalamus]] responsible for transmitting sensation from the <u>body</u> (vibration, pain, pressure, proprioception, temperature) to the primary somatosensory cortex.</p>",
      "atAGlance": "<ul><li><b>Input:</b> [[spinothalamic_tract]] (pain/temp) and [[dorsal_column_medial_lemniscus]] (touch/proprioception).</li><li><b>Output:</b> Primary [[somatosensory_cortex]] (Postcentral gyrus).</li><li><b>Information Type:</b> Somatosensory input from the <b>Body</b> (neck down).</li><li><b>USMLE Tip:</b> Differentiate from VPM (Face). Remember: V<b>P</b>L is for the <b>P</b>eriphery (Body).</li></ul>",
      "takeAway": "<p>The <b>Ventral Posterolateral Nucleus</b> integrates all somatosensory modalities from the <b>body</b> and relays them to the cortex; lesions here result in contralateral hemianesthesia of the body.</p>",
      "mermaid": "graph TD; A[Spinothalamic Tract] --> B[VPL]; C[Medial Lemniscus] --> B; B --> D[Somatosensory Cortex];"
    },
    "connections": [
      {
        "type": "is_part_of",
        "to": "thalamus"
      },
      {
        "type": "receives_input_from",
        "to": "spinothalamic_tract"
      },
      {
        "type": "receives_input_from",
        "to": "dorsal_column_medial_lemniscus"
      },
      {
        "type": "projects_to",
        "to": "somatosensory_cortex"
      }
    ]
  },
  "ventral_posteromedial_nucleus": {
    "title": "Ventral Posteromedial Nucleus (VPM)",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Anatomy",
      "Sensory Pathways",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Brain Anatomy",
      "Thalamus",
      "Somatosensory Pathway"
    ],
    "content": {
      "definition": "<p>The <b>Ventral Posteromedial Nucleus (VPM)</b> is the sensory relay nucleus of the [[thalamus]] responsible for transmitting sensation from the <u>face</u> and taste input to the primary somatosensory cortex.</p>",
      "atAGlance": "<ul><li><b>Input:</b> [[trigeminal_nerve]] (via trigeminothalamic tract) and Gustatory pathway.</li><li><b>Output:</b> Primary [[somatosensory_cortex]].</li><li><b>Information Type:</b> Somatosensory input from the <b>Face</b> and <b>Taste</b>.</li><li><b>USMLE Tip:</b> Mnemonic: V<b>P</b>M = <b>M</b>akeup goes on the <b>Face</b> (or <b>M</b>outh for taste).</li></ul>",
      "takeAway": "<p>The <b>Ventral Posteromedial Nucleus</b> serves as the exclusive thalamic relay for facial sensation and taste, funneling trigeminal and gustatory inputs to the cortex.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_part_of",
        "to": "thalamus"
      },
      {
        "type": "receives_input_from",
        "to": "trigeminal_nerve"
      },
      {
        "type": "relays_information_for",
        "to": "taste"
      },
      {
        "type": "projects_to",
        "to": "somatosensory_cortex"
      }
    ]
  },
  "charcot_bouchard_microaneurysm": {
    "title": "Charcot-Bouchard Microaneurysm",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Pathology",
      "Vascular",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Cerebrovascular Disease",
      "Intracranial Hemorrhage"
    ],
    "content": {
      "definition": "<p><b>Charcot-Bouchard microaneurysms</b> are minute aneurysms that form in the small, penetrating vessels of the brain (specifically the [[lenticulostriate_arteries]]) due to <u>chronic uncontrolled hypertension</u>, serving as the primary cause of spontaneous deep [[intraparenchymal_hemorrhage]].</p>",
      "atAGlance": "<ul><li><b>Pathophysiology:</b> Chronic [[hypertension]] leads to lipohyalinosis and fibrinoid necrosis of small vessel walls, weakening them and causing micro-dilations.</li><li><b>Location:</b> Deep brain structures: [[basal_ganglia]] (putamen), [[thalamus]], pons, and cerebellum.</li><li><b>Clinical Consequence:</b> Rupture leads to hypertensive intraparenchymal hemorrhage (hemorrhagic stroke), causing contralateral hemiparesis or sensory loss depending on location.</li><li><b>Imaging:</b> Too small to be seen on angiography (unlike [[saccular_aneurysm]]); diagnosis is inferred by the presence of deep hemorrhage on CT.</li><li><b>USMLE Tip:</b> Contrast with Saccular (Berry) aneurysms: Charcot-Bouchard = <b>Chronic Hypertension</b> (small vessels, intraparenchymal bleed); Berry = <b>Structural defect</b> (Circle of Willis, Subarachnoid bleed).</li></ul>",
      "takeAway": "<p><b>Charcot-Bouchard microaneurysms</b> are the pathological link between chronic hypertension and deep hemorrhagic strokes, specifically affecting the lenticulostriate arteries supplying the basal ganglia.</p>",
      "mermaid": "graph TD; A[Chronic Hypertension] --> B[Lipohyalinosis]; B --> C[Vessel Wall Weakening]; C --> D[Charcot-Bouchard Aneurysm]; D --> E[Rupture]; E --> F[Intraparenchymal Hemorrhage];"
    },
    "connections": [
      {
        "type": "is_caused_by",
        "to": "hypertension"
      },
      {
        "type": "affects_vessel",
        "to": "lenticulostriate_arteries"
      },
      {
        "type": "causes",
        "to": "intraparenchymal_hemorrhage"
      },
      {
        "type": "is_distinct_from",
        "to": "saccular_aneurysm"
      }
    ]
  },
  "noncommunicating_hydrocephalus": {
    "title": "Noncommunicating Hydrocephalus",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Pathology",
      "Pediatrics",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "CSF Disorders",
      "Hydrocephalus"
    ],
    "content": {
      "definition": "<p><b>Noncommunicating (Obstructive) Hydrocephalus</b> is a form of hydrocephalus caused by a <u>structural blockage</u> of cerebrospinal fluid (CSF) flow within the ventricular system, preventing CSF from communicating with the subarachnoid space and leading to dilation of the ventricles upstream of the obstruction.</p>",
      "atAGlance": "<ul><li><b>Etiologies:</b> [[aqueductal_stenosis]], colloid cysts (foramen of Monro), tumors (e.g., [[ependymoma]], [[medulloblastoma]]), or congenital malformations ([[dandy_walker_malformation]], [[chiari_malformation]]).</li><li><b>Pathophysiology:</b> Physical obstruction prevents CSF egress &rarr; Accumulation &rarr; Increased [[intracranial_pressure]] (ICP).</li><li><b>Imaging:</b> CT/MRI shows dilation of ventricles proximal to the block (e.g., dilated lateral/3rd ventricles with a normal 4th ventricle suggests aqueductal stenosis).</li><li><b>Clinical Presentation:</b> Headache, papilledema, nausea/vomiting, macrocephaly (in infants).</li><li><b>USMLE Tip:</b> Differentiate from [[communicating_hydrocephalus]] (decreased absorption, all ventricles dilated). Look for \"triventricular\" dilation as a sign of aqueductal blockage.</li></ul>",
      "takeAway": "<p><b>Noncommunicating Hydrocephalus</b> implies a physical blockade within the ventricular system (often the cerebral aqueduct), resulting in disparate dilation of ventricles upstream versus downstream of the lesion.</p>",
      "mermaid": "graph TD; A[Structural Blockage] --> B[CSF Accumulation Upstream]; B --> C[Ventricular Dilation]; C --> D[Increased ICP]; D --> E[Brain Compression];"
    },
    "connections": [
      {
        "type": "is_caused_by",
        "to": "aqueductal_stenosis"
      },
      {
        "type": "is_caused_by",
        "to": "medulloblastoma"
      },
      {
        "type": "causes",
        "to": "increased_intracranial_pressure"
      },
      {
        "type": "is_contrasted_with",
        "to": "communicating_hydrocephalus"
      }
    ]
  },
  "subacute_combined_degeneration": {
    "title": "Subacute Combined Degeneration",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Hematology",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Spinal Cord Disorders",
      "Nutritional Deficiencies"
    ],
    "content": {
      "definition": "<p><b>Subacute Combined Degeneration (SCD)</b> is a progressive degeneration of the spinal cord caused by [[vitamin_b12_deficiency]], characterized by the demyelination of the <u>dorsal columns</u>, <u>lateral corticospinal tracts</u>, and <u>spinocerebellar tracts</u>.</p>",
      "atAGlance": "<ul><li><b>Pathophysiology:</b> Vitamin B12 deficiency leads to accumulation of methylmalonic acid, which impairs myelin synthesis, causing vacuolar degeneration of spinal tracts.</li><li><b>Affected Tracts:</b><br> 1. <b>Dorsal Columns:</b> Loss of proprioception/vibration (sensory ataxia, +Romberg).<br> 2. <b>Lateral Corticospinal:</b> Spastic paresis, hyperreflexia, +Babinski (Upper Motor Neuron signs).<br> 3. <b>Spinocerebellar:</b> Ataxia.</li><li><b>Clinical Presentation:</b> Paresthesias, gait ataxia, weakness, and eventual spastic paralysis.</li><li><b>Associations:</b> Pernicious anemia, gastric bypass, vegan diet, diphyllobothrium latum infection.</li><li><b>USMLE Tip:</b> \"Combined\" refers to the combination of Sensory (Dorsal column) and Motor (Corticospinal) deficits. Always check B12 in patients with neuropathy/ataxia.</li></ul>",
      "takeAway": "<p><b>Subacute Combined Degeneration</b> is the classic neurological manifestation of B12 deficiency, presenting as a unique mix of <b>UMN signs</b> (spasticity) and <b>loss of proprioception/vibration</b> due to specific white matter tract demyelination.</p>",
      "mermaid": "graph TD; A[Vitamin B12 Deficiency] --> B[Elevated Methylmalonic Acid]; B --> C[Abnormal Myelin Synthesis]; C --> D[Demyelination]; D --> E[Dorsal Column Loss]; D --> F[Corticospinal Tract Loss];"
    },
    "connections": [
      {
        "type": "is_caused_by",
        "to": "vitamin_b12_deficiency"
      },
      {
        "type": "damages_structure",
        "to": "dorsal_column_medial_lemniscus"
      },
      {
        "type": "damages_structure",
        "to": "corticospinal_tract"
      },
      {
        "type": "presents_with",
        "to": "ataxia"
      }
    ]
  },
  "abducens_nerve": {
    "title": "Abducens Nerve (CN VI)",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Anatomy",
      "Cranial Nerves",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Cranial Nerves",
      "CN VI"
    ],
    "content": {
      "definition": "<p>The <b>Abducens Nerve (CN VI)</b> is a purely motor cranial nerve that originates from the <u>pons</u> and innervates the ipsilateral [[lateral_rectus]] muscle, responsible for <b>abducting</b> the eye (moving it laterally).</p>",
      "atAGlance": "<ul><li><b>Origin:</b> Abducens nucleus in the dorsal pons (facial nerve fibers loop around it).</li><li><b>Course:</b> Exits at the pontomedullary junction, travels through the cavernous sinus (most susceptible to injury here), and enters the orbit via the superior orbital fissure.</li><li><b>Function:</b> Motor innervation of the Lateral Rectus.</li><li><b>Clinical:</b> Lesion causes medial strabismus (eye turns in) and horizontal diplopia that worsens when looking toward the affected side.</li><li><b>USMLE Tip:</b> Because of its long intracranial course, CN VI is highly susceptible to stretching from <b>elevated intracranial pressure</b> (causing a \"false localizing sign\").</li></ul>",
      "takeAway": "<p>The <b>Abducens Nerve</b> is the sole innovator of the lateral rectus muscle; its palsy results in the inability to look laterally and is a common sign of raised intracranial pressure due to its long, vulnerable path.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "innervates",
        "to": "lateral_rectus_muscle"
      },
      {
        "type": "originates_in",
        "to": "pons"
      },
      {
        "type": "passes_through",
        "to": "cavernous_sinus"
      },
      {
        "type": "palsy_causes",
        "to": "diplopia"
      }
    ]
  }
}
``````json
{
  "abnormal_motor_posturing": {
    "title": "Abnormal Motor Posturing",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Physical Exam",
      "Trauma",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Neurologic Examination",
      "Motor Signs"
    ],
    "content": {
      "definition": "<p><b>Abnormal motor posturing</b> refers to involuntary, reflexive flexion or extension of the limbs in comatose patients, indicating severe brain injury and serving as a clinical marker for the <u>level of brainstem damage</u> (above or below the red nucleus).</p>",
      "atAGlance": "<ul><li><b>Decorticate (Flexor):</b> Arms flexed/adducted (hands like 'C's moving toward the 'Cord'), legs extended. Indicates lesion <u>above</u> the [[red_nucleus]] (e.g., cerebral hemispheres, internal capsule).</li><li><b>Decerebrate (Extensor):</b> Arms extended/pronated, legs extended. Indicates lesion <u>at or below</u> the [[red_nucleus]] (e.g., midbrain, upper pons).</li><li><b>Prognosis:</b> Decerebrate posturing generally indicates more severe brainstem damage and a worse prognosis than decorticate.</li><li><b>Pathophysiology:</b> Disinhibition of the [[rubrospinal_tract]] (flexion) vs. dominance of the [[vestibulospinal_tract]] (extension).</li><li><b>USMLE Tip:</b> Remember: De<b>cor</b>ticate = Hands near the <b>Cor</b> (Heart).</li></ul>",
      "takeAway": "<p><b>Abnormal motor posturing</b> distinguishes the level of brain injury: <b>Decorticate</b> (flexor) implies hemispheric damage sparing the red nucleus, while <b>Decerebrate</b> (extensor) implies deeper brainstem damage affecting the red nucleus.</p>",
      "mermaid": "graph TD; A[Brain Injury] --> B{Lesion Location?}; B -->|Above Red Nucleus| C[Decorticate Posturing]; B -->|At/Below Red Nucleus| D[Decerebrate Posturing]; C --> E[Flexor Tone Dominates]; D --> F[Extensor Tone Dominates];"
    },
    "connections": [
      {
        "type": "indicates_lesion_at",
        "to": "red_nucleus"
      },
      {
        "type": "involves_pathway",
        "to": "rubrospinal_tract"
      },
      {
        "type": "involves_pathway",
        "to": "vestibulospinal_tract"
      }
    ]
  },
  "absence_seizure": {
    "title": "Absence Seizure",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Pediatrics",
      "Epilepsy",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Epilepsy",
      "Generalized Seizures"
    ],
    "content": {
      "definition": "<p><b>Absence seizures</b> (formerly petit mal) are a type of <i>generalized seizure</i> primarily affecting children, characterized by sudden, brief lapses of consciousness (\"staring spells\") without loss of postural tone or postictal confusion, associated with a distinct <u>3 Hz spike-and-wave</u> EEG pattern.</p>",
      "atAGlance": "<ul><li><b>Clinical Presentation:</b> Sudden behavioral arrest (staring), eyelid fluttering, or automatisms (lip smacking); lasts ~10 seconds; immediate return to baseline (no postictal state).</li><li><b>Triggers:</b> Often provoked by <mark>hyperventilation</mark>.</li><li><b>EEG:</b> Classic generalized <b>3 Hz spike-and-wave</b> discharges.</li><li><b>Treatment:</b> First-line is [[ethosuximide]] (blocks T-type Ca<sup>2+</sup> channels); [[valproate]] is second-line (especially if co-occurring tonic-clonic seizures).</li><li><b>USMLE Tip:</b> Differentiate from [[focal_impaired_awareness_seizure]] (complex partial) which <i>does</i> have a postictal state and lasts longer.</li></ul>",
      "takeAway": "<p><b>Absence seizures</b> are pediatric generalized seizures defined by brief staring spells and a pathognomonic <mark>3 Hz spike-and-wave</mark> EEG, uniquely treated with [[ethosuximide]].</p>",
      "mermaid": "graph TD; A[Thalamocortical Circuitry] --> B[Abnormal Oscillation]; B --> C[3 Hz Spike-and-Wave]; C --> D[Brief Loss of Awareness]; D --> E[No Postictal Confusion];"
    },
    "connections": [
      {
        "type": "treated_by",
        "to": "ethosuximide"
      },
      {
        "type": "treated_by",
        "to": "valproate"
      },
      {
        "type": "is_distinguished_from",
        "to": "focal_impaired_awareness_seizure"
      },
      {
        "type": "manifests_as",
        "to": "staring_spell"
      }
    ]
  },
  "ethosuximide": {
    "title": "Ethosuximide",
    "primaryType": "substance",
    "tags": [
      "Pharmacology",
      "Neurology",
      "Anticonvulsants",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Neurology Drugs",
      "Anticonvulsants"
    ],
    "content": {
      "definition": "<p><b>Ethosuximide</b> is a narrow-spectrum <i>anticonvulsant</i> that acts by blocking <u>T-type calcium channels</u> in thalamic neurons, specifically indicated for the treatment of [[absence_seizure]].</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> Blocks voltage-gated <b>T-type Ca<sup>2+</sup> channels</b> in the [[thalamus]], disrupting the thalamocortical oscillations responsible for absence seizures.</li><li><b>Clinical Use:</b> First-line monotherapy for [[absence_seizure]].</li><li><b>Adverse Effects:</b> GI distress (nausea/vomiting), fatigue, headache, itching, and rarely [[stevens_johnson_syndrome]].</li><li><b>USMLE Tip:</b> Remember \"<b>E</b>thosuximide for <b>E</b>veryone's <b>F</b>avorite <b>G</b>eneralized <b>H</b>eart-throb\" (EFGH: <b>E</b>thosuximide, <b>F</b>atigue, <b>G</b>I distress, <b>H</b>eadache). Or simply: It SUCKS (Etho<b>sux</b>imide) to have Silent Seizures.</li></ul>",
      "takeAway": "<p><b>Ethosuximide</b> is the drug of choice for [[absence_seizure]] because it specifically targets the <mark>T-type calcium channels</mark> in the thalamus that generate the characteristic 3 Hz spike-and-wave rhythm.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "treats",
        "to": "absence_seizure"
      },
      {
        "type": "blocks_channel",
        "to": "t_type_calcium_channel"
      },
      {
        "type": "acts_on_structure",
        "to": "thalamus"
      },
      {
        "type": "can_cause",
        "to": "stevens_johnson_syndrome"
      }
    ]
  },
  "acalculia": {
    "title": "Acalculia",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Signs & Symptoms",
      "Cognition",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Cognitive Disorders",
      "Agnosias"
    ],
    "content": {
      "definition": "<p><b>Acalculia</b> is an acquired neurological deficit characterized by the <u>inability to perform simple mathematical calculations</u>, classically associated with lesions to the <b>dominant parietal lobe</b> (specifically the angular gyrus).</p>",
      "atAGlance": "<ul><li><b>Localization:</b> Dominant (usually Left) [[parietal_lobe]] (Angular Gyrus).</li><li><b>Associations:</b> A core component of [[gerstmann_syndrome]] (along with agraphia, finger agnosia, and left-right disorientation).</li><li><b>Etiology:</b> Stroke (e.g., [[middle_cerebral_artery]] infarct), tumor, or neurodegeneration.</li><li><b>USMLE Tip:</b> If a patient cannot subtract 7 from 100 serially and has right-left confusion, suspect a dominant parietal lesion.</li></ul>",
      "takeAway": "<p><b>Acalculia</b> is a localizing sign for <b>dominant parietal lobe</b> dysfunction, most famously as part of the tetrad of [[gerstmann_syndrome]].</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_part_of",
        "to": "gerstmann_syndrome"
      },
      {
        "type": "localizes_to",
        "to": "parietal_lobe"
      },
      {
        "type": "caused_by_infarct_of",
        "to": "middle_cerebral_artery"
      }
    ]
  },
  "accessory_nerve": {
    "title": "Accessory Nerve (CN XI)",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Anatomy",
      "Cranial Nerves",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Cranial Nerves",
      "CN XI"
    ],
    "content": {
      "definition": "<p>The <b>Accessory Nerve (CN XI)</b> is a purely motor cranial nerve that originates from the upper cervical spinal cord, enters the skull via the foramen magnum, and exits via the [[jugular_foramen]] to innervate the <b>sternocleidomastoid</b> (SCM) and <b>trapezius</b> muscles.</p>",
      "atAGlance": "<ul><li><b>Function:</b> Head turning (SCM) and shoulder shrugging (Trapezius).</li><li><b>Course:</b> Spinal roots C1-C5 &rarr; Foramen Magnum &rarr; Jugular Foramen &rarr; Muscles.</li><li><b>Lesion Findings:</b> <br> - <b>LMN Lesion:</b> Ipsilateral shoulder droop (weak trapezius), difficulty turning head to the <u>contralateral</u> side (weak ipsilateral SCM).<br> - <b>Winged Scapula:</b> Can occur (lateral winging) but distinct from Long Thoracic Nerve injury (medial winging).</li><li><b>USMLE Tip:</b> To test the <b>Right</b> SCM, the patient turns their head to the <b>Left</b>. A Right CN XI lesion causes weakness turning head to the Left.</li></ul>",
      "takeAway": "<p><b>CN XI</b> is unique for its spinal origin and cranial exit; damage results in ipsilateral shoulder weakness and difficulty turning the head away from the lesion.</p>",
      "mermaid": "graph TD; A[C1-C5 Spinal Roots] --> B[Foramen Magnum]; B --> C[Jugular Foramen]; C --> D[Sternocleidomastoid]; C --> E[Trapezius];"
    },
    "connections": [
      {
        "type": "innervates",
        "to": "sternocleidomastoid_muscle"
      },
      {
        "type": "innervates",
        "to": "trapezius_muscle"
      },
      {
        "type": "exits_via",
        "to": "jugular_foramen"
      },
      {
        "type": "lesion_causes",
        "to": "shoulder_droop"
      }
    ]
  },
  "accommodation_reflex": {
    "title": "Accommodation Reflex",
    "primaryType": "process",
    "tags": [
      "Neurology",
      "Ophthalmology",
      "Physiology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Neuro-Ophthalmology",
      "Reflexes"
    ],
    "content": {
      "definition": "<p>The <b>Accommodation Reflex</b> is the visual response to focusing on a near object, characterized by the triad of <b>convergence</b>, <b>miosis</b> (pupillary constriction), and <b>lens thickening</b> (accommodation), mediated by the parasympathetic fibers of [[oculomotor_nerve]].</p>",
      "atAGlance": "<ul><li><b>Triad:</b><br> 1. <b>Convergence:</b> Medial recti contraction (CN III).<br> 2. <b>Miosis:</b> Sphincter pupillae contraction (CN III parasympathetics) to increase depth of field.<br> 3. <b>Accommodation:</b> Ciliary muscle contraction &rarr; Zonules relax &rarr; Lens rounds up (increases refractive power).</li><li><b>Pathway:</b> Retina &rarr; Optic Nerve &rarr; LGN &rarr; Visual Cortex &rarr; Superior Colliculus/Pretectum &rarr; Edinger-Westphal Nucleus &rarr; Ciliary Ganglion &rarr; Eye.</li><li><b>Clinical Relevance:</b> <b>Argyll Robertson Pupil</b> (Neurosyphilis) shows \"Light-Near Dissociation\" (pupils accommodate but do not react to light).</li><li><b>USMLE Tip:</b> Ciliary muscle <u>contraction</u> leads to zonule <u>relaxation</u>. This is counterintuitive but critical.</li></ul>",
      "takeAway": "<p><b>Accommodation</b> allows for near vision through a coordinated parasympathetic response that rounds the lens, constricts the pupil, and converges the eyes; this reflex can be spared in pathways affecting the light reflex (Light-Near Dissociation).</p>",
      "mermaid": "graph TD; A[Visual Cortex] --> B[Edinger-Westphal Nucleus]; B -->|CN III Parasympathetic| C[Ciliary Ganglion]; C --> D[Sphincter Pupillae (Miosis)]; C --> E[Ciliary Muscle (Lens Rounding)];"
    },
    "connections": [
      {
        "type": "mediated_by",
        "to": "oculomotor_nerve"
      },
      {
        "type": "involves_structure",
        "to": "ciliary_muscle"
      },
      {
        "type": "is_spared_in",
        "to": "argyll_robertson_pupil"
      },
      {
        "type": "results_in",
        "to": "miosis"
      }
    ]
  },
  "acetazolamide": {
    "title": "Acetazolamide",
    "primaryType": "substance",
    "tags": [
      "Pharmacology",
      "Nephrology",
      "Ophthalmology",
      "Neurology",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Diuretics",
      "Carbonic Anhydrase Inhibitors"
    ],
    "content": {
      "definition": "<p><b>Acetazolamide</b> is a <i>carbonic anhydrase inhibitor</i> that acts primarily in the <u>proximal convoluted tubule</u> of the kidney to inhibit HCO<sub>3</sub><sup>-</sup> reabsorption, causing a metabolic acidosis and diuresis, while also reducing aqueous humor and CSF production.</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> Inhibits carbonic anhydrase &rarr; Decreased H<sup>+</sup> secretion &rarr; Increased Na<sup>+</sup>/K<sup>+</sup>/HCO<sub>3</sub><sup>-</sup> excretion.</li><li><b>Clinical Uses:</b> [[glaucoma]] (decreases aqueous humor), [[idiopathic_intracranial_hypertension]] (decreases CSF), [[altitude_sickness]] (metabolic acidosis stimulates respiration), metabolic alkalosis.</li><li><b>Adverse Effects:</b> <b>Proximal Renal Tubular Acidosis (Type 2)</b>, paresthesias, NH<sub>3</sub> toxicity, sulfa allergy, hypokalemia, kidney stones (calcium phosphate).</li><li><b>USMLE Tip:</b> \"ACID-azolamide\" causes <b>Acidosis</b>. Useful for alkalinizing urine (e.g., to excrete uric acid/cystine) but contraindicated in cirrhosis (traps ammonia).</li></ul>",
      "takeAway": "<p><b>Acetazolamide</b> is a diuretic that uniquely causes <mark>metabolic acidosis</mark> by dumping bicarbonate, making it useful for altitude sickness and glaucoma, but risking Type 2 RTA.</p>",
      "mermaid": "graph TD; A[Acetazolamide] --|Inhibits| B[Carbonic Anhydrase]; B --> C[Decreased H+ Formation]; C --> D[Decreased Na+/H+ Exchange]; D --> E[Increased HCO3- Excretion]; E --> F[Metabolic Acidosis];"
    },
    "connections": [
      {
        "type": "treats",
        "to": "glaucoma"
      },
      {
        "type": "treats",
        "to": "idiopathic_intracranial_hypertension"
      },
      {
        "type": "treats",
        "to": "altitude_sickness"
      },
      {
        "type": "causes",
        "to": "renal_tubular_acidosis"
      }
    ]
  },
  "acetylcholine": {
    "title": "Acetylcholine (ACh)",
    "primaryType": "substance",
    "tags": [
      "Neuroscience",
      "Physiology",
      "Pharmacology",
      "USMLE"
    ],
    "classificationPath": [
      "Neuroscience",
      "Neurotransmitters",
      "Cholinergics"
    ],
    "content": {
      "definition": "<p><b>Acetylcholine (ACh)</b> is a major neurotransmitter synthesized from choline and acetyl-CoA that acts on <u>nicotinic</u> (ligand-gated ion channels) and <u>muscarinic</u> (G-protein coupled) receptors to mediate motor control, autonomic functions, and cognition.</p>",
      "atAGlance": "<ul><li><b>Sites of Action:</b><br> 1. <b>NMJ:</b> Somatic motor neurons (Nicotinic).<br> 2. <b>Autonomic Ganglia:</b> Both Sympathetic and Parasympathetic (Nicotinic).<br> 3. <b>Parasympathetic Effectors:</b> Smooth muscle, glands, heart (Muscarinic).<br> 4. <b>CNS:</b> Basal nucleus of Meynert (Cognition/Memory).</li><li><b>Synthesis/Degradation:</b> Made by Choline Acetyltransferase (ChAT); degraded by [[acetylcholinesterase]] (AChE).</li><li><b>Pathology:</b> Decreased in [[alzheimer_disease]] and [[huntington_disease]]; Increased in [[parkinson_disease]] (relative to dopamine).</li><li><b>USMLE Tip:</b> In the Sympathetic NS, ACh is the neurotransmitter at the ganglion AND at the <b>Sweat Glands</b> (muscarinic) and <b>Adrenal Medulla</b> (nicotinic).</li></ul>",
      "takeAway": "<p><b>Acetylcholine</b> is the primary neurotransmitter of the parasympathetic nervous system and the neuromuscular junction; its levels are critically reduced in [[alzheimer_disease]] and targeted by AChE inhibitors.</p>",
      "mermaid": "graph TD; A[Choline + Acetyl-CoA] -->|ChAT| B[Acetylcholine]; B -->|Release| C[Synaptic Cleft]; C -->|AChE| D[Choline + Acetate]; C --> E[Nicotinic/Muscarinic Receptors];"
    },
    "connections": [
      {
        "type": "binds_to",
        "to": "nicotinic_acetylcholine_receptor"
      },
      {
        "type": "binds_to",
        "to": "muscarinic_acetylcholine_receptor"
      },
      {
        "type": "is_degraded_by",
        "to": "acetylcholinesterase"
      },
      {
        "type": "is_deficient_in",
        "to": "alzheimer_disease"
      }
    ]
  },
  "achilles_reflex": {
    "title": "Achilles Reflex",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Physical Exam",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Neurologic Examination",
      "Deep Tendon Reflexes"
    ],
    "content": {
      "definition": "<p>The <b>Achilles Reflex</b> (Ankle Jerk) is a deep tendon reflex mediated by the <u>S1 and S2</u> nerve roots (primarily S1), where striking the Achilles tendon causes plantar flexion of the foot.</p>",
      "atAGlance": "<ul><li><b>Nerve Roots:</b> <b>S1</b>, S2.</li><li><b>Nerve:</b> [[tibial_nerve]].</li><li><b>Action:</b> Plantar flexion of the foot via the gastrocnemius/soleus muscles.</li><li><b>Clinical Significance:</b><br> - <i>Decreased/Absent:</i> S1 radiculopathy (e.g., herniated disc), peripheral neuropathy (e.g., diabetes), [[guillain_barre_syndrome]].<br> - <i>Delayed Relaxation:</i> Classic sign of [[hypothyroidism]].</li><li><b>USMLE Tip:</b> Mnemonic: \"S1, S2, buckle my shoe\" (Achilles reflex).</li></ul>",
      "takeAway": "<p>The <b>Achilles Reflex</b> primarily tests the integrity of the <b>S1</b> nerve root and the tibial nerve; loss suggests pathology at this level or peripheral neuropathy.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "tests_nerve_root",
        "to": "s1_nerve_root"
      },
      {
        "type": "mediated_by",
        "to": "tibial_nerve"
      },
      {
        "type": "is_delayed_in",
        "to": "hypothyroidism"
      }
    ]
  },
  "action_potential": {
    "title": "Action Potential",
    "primaryType": "process",
    "tags": [
      "Physiology",
      "Neuroscience",
      "USMLE"
    ],
    "classificationPath": [
      "Physiology",
      "Cell Physiology",
      "Electrophysiology"
    ],
    "content": {
      "definition": "<p>An <b>Action Potential</b> is a rapid, transient, and regenerative <i>change in membrane potential</i> that propagates along an excitable membrane (neuron or muscle), driven by the sequential opening and closing of voltage-gated <u>sodium</u> and <u>potassium</u> channels.</p>",
      "atAGlance": "<ul><li><b>Phases:</b><br> 0. <b>Depolarization:</b> Voltage-gated Na<sup>+</sup> channels open (Na<sup>+</sup> influx).<br> 1. <b>Repolarization:</b> Na<sup>+</sup> channels inactivate, Voltage-gated K<sup>+</sup> channels open (K<sup>+</sup> efflux).<br> 2. <b>Hyperpolarization:</b> K<sup>+</sup> channels remain open, membrane potential dips below resting.</li><li><b>Threshold:</b> All-or-none principle (usually -55 mV).</li><li><b>Refractory Periods:</b><br> - <i>Absolute:</i> Na<sup>+</sup> channels inactivated (no new AP possible).<br> - <i>Relative:</i> Na<sup>+</sup> channels reset but K<sup>+</sup> efflux continues (requires stronger stimulus).</li><li><b>USMLE Tip:</b> [[tetrodotoxin]] (Pufferfish) blocks Na<sup>+</sup> channels (prevents depolarization). [[tetraethylammonium]] blocks K<sup>+</sup> channels (prolongs repolarization).</li></ul>",
      "takeAway": "<p>The <b>Action Potential</b> is the fundamental unit of neural communication, driven by Na<sup>+</sup> influx (depolarization) followed by K<sup>+</sup> efflux (repolarization), a sequence targeted by numerous toxins and anesthetics.</p>",
      "mermaid": "graph TD; A[Resting Potential] -->|Stimulus| B[Threshold Reached]; B -->|Na+ Channels Open| C[Depolarization]; C -->|Na+ Inactivate / K+ Open| D[Repolarization]; D -->|K+ Slow Close| E[Hyperpolarization]; E -->|Na+/K+ Pump| A;"
    },
    "connections": [
      {
        "type": "driven_by",
        "to": "voltage_gated_sodium_channel"
      },
      {
        "type": "driven_by",
        "to": "voltage_gated_potassium_channel"
      },
      {
        "type": "inhibited_by",
        "to": "tetrodotoxin"
      },
      {
        "type": "inhibited_by",
        "to": "local_anesthetics"
      }
    ]
  },
  "acute_disseminated_encephalomyelitis": {
    "title": "Acute Disseminated Encephalomyelitis (ADEM)",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Immunology",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Demyelinating Diseases",
      "Post-Infectious"
    ],
    "content": {
      "definition": "<p><b>Acute Disseminated Encephalomyelitis (ADEM)</b> is an acute, monophasic <i>inflammatory demyelinating disorder</i> of the CNS that typically occurs <u>following a viral infection or vaccination</u>, characterized by multifocal neurologic deficits and altered mental status.</p>",
      "atAGlance": "<ul><li><b>Pathophysiology:</b> Molecular mimicry leads to autoimmune demyelination.</li><li><b>Clinical Presentation:</b> Rapid onset of multifocal deficits (e.g., ataxia, weakness, vision loss) + <b>Encephalopathy</b> (confusion/coma) occurring 1-2 weeks post-infection (e.g., Measles, VZV) or vaccination.</li><li><b>Imaging:</b> MRI shows multiple, asymmetric, hyperintense white matter lesions.</li><li><b>Differentiation:</b> Unlike [[multiple_sclerosis]], ADEM is typically <b>monophasic</b> (one-time event) and involves encephalopathy.</li><li><b>USMLE Tip:</b> Look for a child with neurologic symptoms weeks after a viral illness or vaccine (e.g., Rabies vaccine).</li></ul>",
      "takeAway": "<p><b>ADEM</b> is a post-infectious autoimmune attack on CNS myelin, distinguished from MS by its monophasic course and the presence of altered mental status (encephalopathy).</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_triggered_by",
        "to": "viral_infection"
      },
      {
        "type": "is_contrasted_with",
        "to": "multiple_sclerosis"
      },
      {
        "type": "causes",
        "to": "demyelination"
      }
    ]
  },
  "acute_inflammatory_demyelinating_polyneuropathy": {
    "title": "Acute Inflammatory Demyelinating Polyneuropathy (AIDP)",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Immunology",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Peripheral Neuropathy",
      "Guillain-Barre Syndrome"
    ],
    "content": {
      "definition": "<p><b>Acute Inflammatory Demyelinating Polyneuropathy (AIDP)</b> is the most common subtype of [[guillain_barre_syndrome]], characterized by an acute, ascending, symmetrical <i>autoimmune demyelination</i> of peripheral nerves and roots, often triggered by a preceding infection.</p>",
      "atAGlance": "<ul><li><b>Pathophysiology:</b> Molecular mimicry (e.g., anti-ganglioside antibodies) following infection (classically [[campylobacter_jejuni]], Zika, CMV) leads to immune attack on Schwann cells/myelin.</li><li><b>Clinical Presentation:</b> Symmetric <b>ascending muscle weakness</b>/paralysis, absent deep tendon reflexes (areflexia), and potential autonomic dysregulation or respiratory failure.</li><li><b>Diagnosis:</b> CSF shows <mark>albuminocytologic dissociation</mark> (high protein, normal WBC). Nerve conduction studies show slowed conduction (demyelination).</li><li><b>Treatment:</b> IVIG or Plasmapheresis. <u>Steroids are NOT effective.</u></li><li><b>USMLE Tip:</b> \"Ascending paralysis\" after bloody diarrhea ([[campylobacter_jejuni]]) is the classic vignette. Watch for respiratory failure (measure Vital Capacity).</li></ul>",
      "takeAway": "<p><b>AIDP</b> is the classic form of Guillain-Barré, presenting as an ascending paralysis with areflexia and albuminocytologic dissociation, requiring urgent monitoring for respiratory compromise.</p>",
      "mermaid": "graph TD; A[Infection e.g. Campylobacter] --> B[Antibody Production]; B --> C[Cross-reactivity with Gangliosides]; C --> D[Attack on Schwann Cells]; D --> E[Peripheral Demyelination]; E --> F[Ascending Paralysis];"
    },
    "connections": [
      {
        "type": "is_synonymous_with",
        "to": "guillain_barre_syndrome"
      },
      {
        "type": "triggered_by",
        "to": "campylobacter_jejuni"
      },
      {
        "type": "diagnosed_by",
        "to": "albuminocytologic_dissociation"
      },
      {
        "type": "damages_cell_type",
        "to": "schwann_cells"
      }
    ]
  },
  "adenohypophysis": {
    "title": "Adenohypophysis (Anterior Pituitary)",
    "primaryType": "structure",
    "tags": [
      "Endocrinology",
      "Anatomy",
      "Embryology",
      "USMLE"
    ],
    "classificationPath": [
      "Endocrinology",
      "Pituitary Gland",
      "Anterior Lobe"
    ],
    "content": {
      "definition": "<p>The <b>Adenohypophysis</b> is the glandular anterior lobe of the [[pituitary_gland]], derived from oral ectoderm ([[rathke_pouch]]), which synthesizes and secretes six major hormones in response to hypothalamic releasing factors delivered via the hypophyseal portal system.</p>",
      "atAGlance": "<ul><li><b>Embryology:</b> Derived from <b>Rathke's Pouch</b> (surface ectoderm), unlike the neurohypophysis (neuroectoderm).</li><li><b>Hormones (FLAT PiG):</b> <b>F</b>SH, <b>L</b>H, <b>A</b>CTH, <b>T</b>SH (Basophils); <b>P</b>rolactin, <b>G</b>H (Acidophils).</li><li><b>Regulation:</b> Controlled by the [[hypothalamus]] via the hypophyseal portal system (blood), not direct neural connection.</li><li><b>Pathology:</b> [[pituitary_adenoma]] (e.g., Prolactinoma), [[sheehan_syndrome]] (ischemic necrosis post-partum), [[craniopharyngioma]] (Rathke's pouch remnant).</li><li><b>USMLE Tip:</b> Acidophils (GH, Prolactin) stain pink; Basophils (FSH, LH, ACTH, TSH) stain blue. \"B-FLAT\".</li></ul>",
      "takeAway": "<p>The <b>Adenohypophysis</b> is the master glandular center derived from oral ectoderm, regulating growth, metabolism, and reproduction through the secretion of tropic hormones under hypothalamic vascular control.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "derived_from",
        "to": "rathke_pouch"
      },
      {
        "type": "secretes",
        "to": "prolactin"
      },
      {
        "type": "secretes",
        "to": "growth_hormone"
      },
      {
        "type": "regulated_by",
        "to": "hypothalamus"
      }
    ]
  },
  "adenovirus": {
    "title": "Adenovirus",
    "primaryType": "organism",
    "tags": [
      "Microbiology",
      "Virology",
      "Infectious Disease",
      "USMLE"
    ],
    "classificationPath": [
      "Microbiology",
      "Viruses",
      "DNA Viruses",
      "Non-enveloped"
    ],
    "content": {
      "definition": "<p><b>Adenovirus</b> is a non-enveloped, double-stranded linear DNA virus responsible for a wide range of clinical syndromes, most notably pharyngoconjunctival fever, pneumonia, and hemorrhagic cystitis.</p>",
      "atAGlance": "<ul><li><b>Transmission:</b> Respiratory droplets, fecal-oral, direct contact (fomites). Highly stable in the environment.</li><li><b>Clinical Syndromes:</b><br> - <b>Pharyngoconjunctival Fever:</b> Fever + Sore throat + [[conjunctivitis]] (\"Pink eye\").<br> - <b>Pneumonia:</b> Especially in military recruits (vaccine available for military).<br> - <b>Hemorrhagic Cystitis:</b> Hematuria and dysuria in children.<br> - <b>Gastroenteritis:</b> Watery diarrhea.</li><li><b>Histology:</b> Intranuclear inclusions.</li><li><b>USMLE Tip:</b> Look for a child with \"Pink eye\" after swimming (swimming pool conjunctivitis) or a military recruit with pneumonia.</li></ul>",
      "takeAway": "<p><b>Adenovirus</b> is a hardy DNA virus that causes outbreaks of conjunctivitis, respiratory illness (military recruits), and hemorrhagic cystitis in children.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "causes",
        "to": "conjunctivitis"
      },
      {
        "type": "causes",
        "to": "hemorrhagic_cystitis"
      },
      {
        "type": "causes",
        "to": "pneumonia"
      }
    ]
  },
  "adrenoleukodystrophy": {
    "title": "Adrenoleukodystrophy",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Genetics",
      "Metabolism",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Demyelinating Diseases",
      "Leukodystrophies"
    ],
    "content": {
      "definition": "<p><b>Adrenoleukodystrophy</b> is an X-linked recessive <i>peroxisomal disorder</i> caused by a mutation in the <i>ABCD1</i> gene, leading to impaired <u>beta-oxidation of very-long-chain fatty acids (VLCFAs)</u>, which accumulate in and damage the adrenal glands and CNS myelin.</p>",
      "atAGlance": "<ul><li><b>Pathophysiology:</b> Defective transport of VLCFAs into peroxisomes &rarr; Accumulation of VLCFAs &rarr; Toxicity to adrenal cortex and white matter.</li><li><b>Clinical Presentation:</b> Progressive neurologic deterioration (dementia, vision loss, ataxia) + [[adrenal_insufficiency]] (skin hyperpigmentation, hypotension) in young boys.</li><li><b>Genetics:</b> X-linked recessive.</li><li><b>Diagnosis:</b> Elevated VLCFAs in plasma.</li><li><b>USMLE Tip:</b> Think of this when a young boy presents with behavioral changes/school failure AND signs of Addison disease (tan skin, low Na, high K).</li></ul>",
      "takeAway": "<p><b>Adrenoleukodystrophy</b> is a peroxisomal disease of VLCFA accumulation that uniquely combines progressive CNS demyelination with primary adrenal insufficiency.</p>",
      "mermaid": "graph TD; A[ABCD1 Mutation] --> B[Impaired Peroxisomal Entry]; B --> C[Accumulation of VLCFAs]; C --> D[Adrenal Gland Damage]; C --> E[CNS Demyelination]; D --> F[Adrenal Insufficiency]; E --> G[Neurologic Deterioration];"
    },
    "connections": [
      {
        "type": "causes",
        "to": "adrenal_insufficiency"
      },
      {
        "type": "involves_organelle",
        "to": "peroxisome"
      },
      {
        "type": "accumulates",
        "to": "very_long_chain_fatty_acids"
      }
    ]
  },
  "age_related_macular_degeneration": {
    "title": "Age-Related Macular Degeneration (AMD)",
    "primaryType": "disease",
    "tags": [
      "Ophthalmology",
      "Pathology",
      "Aging",
      "USMLE"
    ],
    "classificationPath": [
      "Ophthalmology",
      "Retinal Disorders",
      "Macular Degeneration"
    ],
    "content": {
      "definition": "<p><b>Age-Related Macular Degeneration (AMD)</b> is the leading cause of irreversible <u>central vision loss</u> in the elderly, characterized by the degeneration of the macula due to oxidative stress and the accumulation of extracellular deposits called <b>drusen</b>.</p>",
      "atAGlance": "<ul><li><b>Types:</b><br> - <b>Dry (Non-exudative):</b> Gradual vision loss; characterized by subretinal <mark>drusen</mark> (yellow deposits) and pigmentary changes. Most common (85%).<br> - <b>Wet (Exudative):</b> Rapid vision loss; characterized by <u>choroidal neovascularization</u> (VEGF-driven) leading to bleeding/leakage.</li><li><b>Clinical:</b> Central scotoma (loss of central vision), metamorphopsia (distortion of straight lines).</li><li><b>Treatment:</b><br> - Dry: Antioxidant vitamins (AREDS), smoking cessation.<br> - Wet: Anti-VEGF injections (e.g., [[ranibizumab]], [[bevacizumab]]).</li><li><b>USMLE Tip:</b> \"Metamorphopsia\" (wavy lines on Amsler grid) suggests Wet AMD. Peripheral vision is preserved (unlike [[glaucoma]]).</li></ul>",
      "takeAway": "<p><b>AMD</b> destroys central vision (macula) while sparing peripheral vision; Dry AMD involves <b>drusen</b>, while Wet AMD involves <b>neovascularization</b> treatable with anti-VEGF therapy.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "causes",
        "to": "central_scotoma"
      },
      {
        "type": "characterized_by",
        "to": "drusen"
      },
      {
        "type": "treated_by",
        "to": "anti_vegf_therapy"
      },
      {
        "type": "is_contrasted_with",
        "to": "glaucoma"
      }
    ]
  },
  "agraphia": {
    "title": "Agraphia",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Signs & Symptoms",
      "Language",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Cognitive Disorders",
      "Aphasias"
    ],
    "content": {
      "definition": "<p><b>Agraphia</b> is an acquired neurological deficit characterized by the <u>inability to write</u> or communicate through writing, often resulting from lesions in the dominant parietal lobe or frontal lobe language centers.</p>",
      "atAGlance": "<ul><li><b>Localization:</b> Dominant [[parietal_lobe]] (Angular Gyrus) or Frontal Lobe (Exner's area).</li><li><b>Associations:</b> A core component of [[gerstmann_syndrome]] (Agraphia + Acalculia + Finger Agnosia + Left-Right Disorientation).</li><li><b>Context:</b> Can occur in isolation or with aphasia (e.g., [[broca_aphasia]] patients have agraphia matching their speech deficits).</li><li><b>USMLE Tip:</b> Agraphia without aphasia points strongly to the dominant angular gyrus (Gerstmann Syndrome).</li></ul>",
      "takeAway": "<p><b>Agraphia</b> is the loss of writing ability, serving as a key localizing sign for dominant parietal lobe pathology, particularly when grouped with the other elements of [[gerstmann_syndrome]].</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_part_of",
        "to": "gerstmann_syndrome"
      },
      {
        "type": "localizes_to",
        "to": "parietal_lobe"
      },
      {
        "type": "is_associated_with",
        "to": "aphasia"
      }
    ]
  },
  "akathisia": {
    "title": "Akathisia",
    "primaryType": "finding",
    "tags": [
      "Psychiatry",
      "Neurology",
      "Pharmacology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Movement Disorders",
      "Drug-Induced"
    ],
    "content": {
      "definition": "<p><b>Akathisia</b> is an extrapyramidal symptom characterized by a subjective feeling of inner restlessness and an objective <u>inability to sit still</u> (e.g., pacing, tapping feet), most commonly caused by [[antipsychotics]] blocking dopamine receptors.</p>",
      "atAGlance": "<ul><li><b>Etiology:</b> High-potency typical [[antipsychotics]] (e.g., [[haloperidol]]) or antiemetics (e.g., [[metoclopramide]]).</li><li><b>Timeline:</b> Days to weeks after starting medication.</li><li><b>Differentiation:</b> Often mistaken for worsening agitation/psychosis (leading to increased drug dose, worsening the akathisia).</li><li><b>Treatment:</b> Decrease dose, switch to atypical, or treat with <b>Beta-blockers</b> ([[propranolol]]) or Benzodiazepines. Benztropine is less effective here than for dystonia.</li><li><b>USMLE Tip:</b> Patient on Haloperidol feels \"jumping out of their skin\" and keeps pacing the room. Treat with Propranolol.</li></ul>",
      "takeAway": "<p><b>Akathisia</b> is a drug-induced motor restlessness often misdiagnosed as anxiety; unlike other EPS, it responds best to beta-blockers ([[propranolol]]) rather than anticholinergics.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "caused_by",
        "to": "antipsychotics"
      },
      {
        "type": "treated_by",
        "to": "propranolol"
      },
      {
        "type": "is_a_type_of",
        "to": "extrapyramidal_symptoms"
      }
    ]
  }
}
```{
  "alar_plate": {
    "title": "Alar Plate",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Embryology",
      "Anatomy",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Neuroembryology",
      "Neural Tube Development"
    ],
    "content": {
      "definition": "<p>The <b>Alar Plate</b> is the <i>dorsal</i> region of the developing neural tube, induced by <u>Bone Morphogenetic Proteins (BMPs)</u>, which differentiates into sensory neurons and interneurons of the spinal cord and brainstem.</p>",
      "atAGlance": "<ul><li><b>Location:</b> Dorsal (posterior) portion of the neural tube.</li><li><b>Signaling Factor:</b> Induced by <b>BMPs</b> (Bone Morphogenetic Proteins) from the roof plate/overlying ectoderm.</li><li><b>Derivatives:</b> Sensory nuclei of the [[spinal_cord]] (dorsal horn) and brainstem (e.g., [[nucleus_tractus_solitarius]]).</li><li><b>Orientation:</b> Dorsal = Sensory (Alar); Ventral = Motor (Basal).</li><li><b>USMLE Tip:</b> Remember <b>A</b>lar = <b>A</b>fferent (Sensory); Basal = Efferent (Motor).</li></ul>",
      "takeAway": "<p>The <b>Alar Plate</b> is the dorsal, sensory division of the developing nervous system, regulated by BMP signaling, standing in contrast to the ventral, motor Basal Plate.</p>",
      "mermaid": "graph TD; A[Neural Tube] --> B[Alar Plate (Dorsal)]; A --> C[Basal Plate (Ventral)]; B --> D[Sensory Neurons]; C --> E[Motor Neurons];"
    },
    "connections": [
      {
        "type": "differentiates_into",
        "to": "sensory_neurons"
      },
      {
        "type": "is_induced_by",
        "to": "bone_morphogenetic_proteins"
      },
      {
        "type": "is_contrasted_with",
        "to": "basal_plate"
      }
    ]
  },
  "albuminocytologic_dissociation": {
    "title": "Albuminocytologic Dissociation",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Pathology",
      "Diagnostics",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Diagnostic Tests",
      "CSF Analysis"
    ],
    "content": {
      "definition": "<p><b>Albuminocytologic Dissociation</b> is a pathognomonic cerebrospinal fluid (CSF) finding characterized by <u>elevated protein levels</u> in the absence of significant white blood cell elevation (pleocytosis), classically reflecting the nerve root inflammation seen in [[guillain_barre_syndrome]].</p>",
      "atAGlance": "<ul><li><b>Key Findings:</b> High CSF protein (>45 mg/dL) + Normal/Low WBC count.</li><li><b>Mechanism:</b> Inflammation increases permeability of the blood-nerve barrier at the nerve roots, allowing protein leakage without frank infection.</li><li><b>Clinical Association:</b> Hallmark of <b>[[guillain_barre_syndrome]]</b> (Acute Inflammatory Demyelinating Polyneuropathy).</li><li><b>Differential:</b> Can also be seen in chronic inflammatory demyelinating polyneuropathy (CIDP) and spinal block (Froin syndrome).</li><li><b>USMLE Tip:</b> If a vignette mentions \"ascending paralysis\" and asks for CSF findings, look for \"High protein, normal cells.\"</li></ul>",
      "takeAway": "<p><b>Albuminocytologic Dissociation</b> identifies non-infectious inflammatory processes like [[guillain_barre_syndrome]] where protein leaks into the CSF but immune cells do not follow.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_hallmark_of",
        "to": "guillain_barre_syndrome"
      },
      {
        "type": "is_detected_in",
        "to": "cerebrospinal_fluid"
      },
      {
        "type": "indicates",
        "to": "blood_nerve_barrier_breakdown"
      }
    ]
  },
  "alexia": {
    "title": "Alexia",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Cognition",
      "Stroke",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Cognitive Disorders",
      "Aphasias and Agnosias"
    ],
    "content": {
      "definition": "<p><b>Alexia</b> is an acquired neurological deficit characterized by the <u>inability to read</u> or comprehend written language, often resulting from a disconnection between the visual cortex and the language centers in the dominant hemisphere.</p>",
      "atAGlance": "<ul><li><b>Alexia without Agraphia (Pure Alexia):</b> Patient <u>cannot read</u> but <b>can write</b>.</li><li><b>Lesion Location:</b> Dominant (usually Left) [[posterior_cerebral_artery]] (PCA) infarct affecting the occipital lobe and the <b>splenium</b> of the [[corpus_callosum]].</li><li><b>Mechanism:</b> Visual information from the right occipital lobe cannot cross the corpus callosum to reach the language center (Wernicke's) in the left hemisphere.</li><li><b>USMLE Tip:</b> Look for a patient with a right homonymous hemianopsia who can write a sentence but cannot read it back to you.</li></ul>",
      "takeAway": "<p><b>Alexia</b> specifically refers to acquired reading blindness; <b>Alexia without Agraphia</b> is a classic disconnection syndrome caused by a PCA stroke damaging the splenium and left visual cortex.</p>",
      "mermaid": "graph TD; A[Left PCA Stroke] --> B[Left Visual Cortex Damage]; A --> C[Splenium Damage]; B --> D[Right Visual Field Blindness]; C --> E[Right Visual Cortex Isolated from Language Center]; E --> F[Inability to Read (Alexia)];"
    },
    "connections": [
      {
        "type": "caused_by_infarct_of",
        "to": "posterior_cerebral_artery"
      },
      {
        "type": "involves_structure",
        "to": "corpus_callosum"
      },
      {
        "type": "often_presents_with",
        "to": "homonymous_hemianopsia"
      }
    ]
  },
  "alprazolam": {
    "title": "Alprazolam",
    "primaryType": "substance",
    "tags": [
      "Pharmacology",
      "Psychiatry",
      "Neurology",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Psychotropic Drugs",
      "Benzodiazepines"
    ],
    "content": {
      "definition": "<p><b>Alprazolam</b> (Xanax) is a short-acting, high-potency <i>benzodiazepine</i> that acts as a positive allosteric modulator of the [[gaba_a_receptor]], primarily used for the acute management of <u>panic disorder</u> and anxiety.</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> Increases the <b>frequency</b> of Cl<sup>-</sup> channel opening at the GABA<sub>A</sub> receptor.</li><li><b>Pharmacokinetics:</b> Short half-life; belongs to the \"ATOM\" group (<b>A</b>lprazolam, <b>T</b>riazolam, <b>O</b>xazepam, <b>M</b>idazolam).</li><li><b>Clinical Use:</b> Panic attacks, generalized anxiety (short-term).</li><li><b>Adverse Effects:</b> Sedation, dependence, <b>high risk of withdrawal seizures</b> due to short half-life.</li><li><b>USMLE Tip:</b> Short-acting benzos like Alprazolam have higher addictive potential and more severe rebound anxiety/withdrawal than long-acting ones like Diazepam.</li></ul>",
      "takeAway": "<p><b>Alprazolam</b> is a short-acting benzodiazepine ideal for acute panic but carries a high risk of dependence and withdrawal symptoms due to its rapid elimination.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "modulates",
        "to": "gaba_a_receptor"
      },
      {
        "type": "treats",
        "to": "panic_disorder"
      },
      {
        "type": "risk_of",
        "to": "withdrawal_seizure"
      }
    ]
  },
  "alzheimer_disease": {
    "title": "Alzheimer Disease",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Pathology",
      "Geriatrics",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Neurodegenerative Diseases",
      "Dementia"
    ],
    "content": {
      "definition": "<p><b>Alzheimer Disease</b> is the most common cause of dementia in older adults, defined by a progressive, chronic neurodegenerative process involving the accumulation of extracellular <u>amyloid-beta plaques</u> and intracellular <u>neurofibrillary tangles</u> (hyperphosphorylated tau), leading to cortical atrophy and cholinergic deficit.</p>",
      "atAGlance": "<ul><li><b>Pathology:</b><br> - <b>Senile Plaques:</b> Extracellular A&beta; amyloid (from APP cleavage).<br> - <b>Neurofibrillary Tangles:</b> Intracellular hyperphosphorylated <b>tau</b> protein.<br> - <b>Atrophy:</b> Widespread cortical atrophy (narrow gyri, wide sulci), especially in the <b>hippocampus</b>.</li><li><b>Neurotransmitters:</b> Significant decrease in <b>Acetylcholine</b> (degeneration of [[basal_nucleus_of_meynert]]).</li><li><b>Genetics:</b><br> - <i>Early Onset:</i> APP (Chr 21), Presenilin 1 (Chr 14), Presenilin 2 (Chr 1).<br> - <i>Late Onset Risk:</i> <b>ApoE4</b> (risk), <b>ApoE2</b> (protective).</li><li><b>Clinical:</b> Slow, insidious memory loss (anterograde amnesia), getting lost, aphasia, apraxia.</li><li><b>USMLE Tip:</b> Down syndrome patients have increased risk (APP is on Chr 21).</li></ul>",
      "takeAway": "<p><b>Alzheimer Disease</b> is characterized by <b>Amyloid</b> plaques and <b>Tau</b> tangles causing cortical atrophy and acetylcholine deficiency, with <b>ApoE4</b> being a major genetic risk factor for the sporadic form.</p>",
      "mermaid": "graph TD; A[APP Precursor] -->|Abnormal Cleavage| B[Beta-Amyloid]; B --> C[Extracellular Plaques]; D[Tau Protein] -->|Hyperphosphorylation| E[Intracellular Tangles]; C & E --> F[Neuronal Death]; F --> G[Cortical Atrophy/Dementia];"
    },
    "connections": [
      {
        "type": "accumulates",
        "to": "amyloid_beta"
      },
      {
        "type": "accumulates",
        "to": "tau_protein"
      },
      {
        "type": "involves_degeneration_of",
        "to": "basal_nucleus_of_meynert"
      },
      {
        "type": "associated_with_gene",
        "to": "apolipoprotein_e"
      }
    ]
  },
  "amantadine": {
    "title": "Amantadine",
    "primaryType": "substance",
    "tags": [
      "Pharmacology",
      "Neurology",
      "Infectious Disease",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Neurology Drugs",
      "Antiparkinsonian Agents"
    ],
    "content": {
      "definition": "<p><b>Amantadine</b> is a pharmacological agent that acts as both an <u>antiviral</u> (inhibiting influenza A uncoating) and an <u>antiparkinsonian</u> drug (enhancing dopamine release and blocking reuptake), noted for its side effect of livedo reticularis.</p>",
      "atAGlance": "<ul><li><b>Mechanism (Parkinson's):</b> Increases <b>dopamine release</b> and decreases dopamine reuptake; also has weak NMDA receptor antagonist properties.</li><li><b>Mechanism (Antiviral):</b> Blocks M2 proton channel of <b>Influenza A</b> (prevents uncoating). <i>Note: High resistance, rarely used for flu now.</i></li><li><b>Clinical Use:</b> [[parkinson_disease]] (helps with bradykinesia and dyskinesias from L-Dopa), Influenza A prophylaxis.</li><li><b>Adverse Effects:</b> <b>Livedo reticularis</b> (mottled, lace-like purple discoloration of skin), edema, ataxia, confusion.</li><li><b>USMLE Tip:</b> \"<b>A man to dine</b>\" (Amantadine) takes you out to dinner but gives you <b>Livedo Reticularis</b>.</li></ul>",
      "takeAway": "<p><b>Amantadine</b> enhances dopaminergic transmission for Parkinson's and targets Influenza A, but is board-famous for causing <mark>livedo reticularis</mark>.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "treats",
        "to": "parkinson_disease"
      },
      {
        "type": "increases_availability_of",
        "to": "dopamine"
      },
      {
        "type": "causes_adverse_effect",
        "to": "livedo_reticularis"
      }
    ]
  },
  "amaurosis_fugax": {
    "title": "Amaurosis Fugax",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Ophthalmology",
      "Vascular",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Cerebrovascular Disease",
      "TIA"
    ],
    "content": {
      "definition": "<p><b>Amaurosis Fugax</b> is a form of <i>transient ischemic attack (TIA)</i> characterized by painless, temporary monocular vision loss (often described as a \"curtain coming down\"), typically caused by an embolus from the ipsilateral <u>internal carotid artery</u> to the ophthalmic/retinal artery.</p>",
      "atAGlance": "<ul><li><b>Pathophysiology:</b> Embolus (platelet-fibrin or cholesterol/Hollenhorst plaque) from the carotid bifurcation travels to the [[central_retinal_artery]].</li><li><b>Clinical Presentation:</b> Sudden, painless vision loss in one eye that resolves within minutes; \"curtain descending\" sensation.</li><li><b>Workup:</b> Carotid ultrasound (evaluate for stenosis), echocardiogram.</li><li><b>Risk Factors:</b> Atherosclerosis, hypertension, diabetes.</li><li><b>USMLE Tip:</b> This is a TIA of the eye. It is a warning sign for impending [[stroke]].</li></ul>",
      "takeAway": "<p><b>Amaurosis Fugax</b> is \"fleeting blindness\" caused by retinal ischemia from carotid emboli, signaling severe carotid disease and high stroke risk.</p>",
      "mermaid": "graph TD; A[Carotid Atherosclerosis] --> B[Embolus Breaks Off]; B --> C[Ophthalmic Artery]; C --> D[Central Retinal Artery]; D --> E[Retinal Ischemia]; E --> F[Transient Vision Loss];"
    },
    "connections": [
      {
        "type": "caused_by_stenosis_of",
        "to": "internal_carotid_artery"
      },
      {
        "type": "is_a_type_of",
        "to": "transient_ischemic_attack"
      },
      {
        "type": "involves_vessel",
        "to": "central_retinal_artery"
      }
    ]
  },
  "amblyopia": {
    "title": "Amblyopia",
    "primaryType": "disease",
    "tags": [
      "Ophthalmology",
      "Pediatrics",
      "Neurology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Neuro-Ophthalmology",
      "Developmental Disorders"
    ],
    "content": {
      "definition": "<p><b>Amblyopia</b>, colloquially known as \"lazy eye,\" is a functional reduction in visual acuity in one or both eyes caused by <u>abnormal visual experience</u> (e.g., strabismus, anisometropia) during early childhood development, leading to cortical suppression of the sensory input from the affected eye.</p>",
      "atAGlance": "<ul><li><b>Pathophysiology:</b> The [[visual_cortex]] suppresses input from one eye to avoid diplopia or blur, preventing proper synaptic development for that eye.</li><li><b>Causes:</b> [[strabismus]] (misalignment), anisometropia (unequal refractive error), or deprivation (e.g., congenital [[cataract]]).</li><li><b>Treatment:</b> Must treat early (plasticity window). Patch the <b>good</b> eye to force the brain to use the amblyopic eye.</li><li><b>USMLE Tip:</b> This is a problem of <b>brain development</b>, not just eye structure. The eye looks normal, but the brain ignores it.</li></ul>",
      "takeAway": "<p><b>Amblyopia</b> is cortical blindness driven by disuse during the critical period of visual development, often secondary to [[strabismus]] or refractive errors.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "caused_by",
        "to": "strabismus"
      },
      {
        "type": "involves_dysfunction_of",
        "to": "visual_cortex"
      },
      {
        "type": "is_contrasted_with",
        "to": "strabismus"
      }
    ]
  },
  "amino_acids_neuro": {
    "title": "Amino Acids (Neuroscience Context)",
    "primaryType": "concept",
    "tags": [
      "Biochemistry",
      "Neurology",
      "Metabolism",
      "USMLE"
    ],
    "classificationPath": [
      "Biochemistry",
      "Metabolism",
      "Amino Acids"
    ],
    "content": {
      "definition": "<p><b>Amino Acids</b> serve critical roles in the nervous system as <u>neurotransmitters</u> (e.g., Glutamate, GABA, Glycine) and precursors for catecholamines and serotonin, while their metabolic derangements can lead to severe neurological deficits (e.g., PKU, MSUD).</p>",
      "atAGlance": "<ul><li><b>Neurotransmitters:</b><br> - <b>Glutamate:</b> Main excitatory neurotransmitter.<br> - <b>GABA:</b> Main inhibitory neurotransmitter (from Glutamate).<br> - <b>Glycine:</b> Inhibitory (spinal cord).</li><li><b>Precursors:</b><br> - <b>Tyrosine</b> &rarr; L-Dopa &rarr; [[dopamine]] &rarr; [[norepinephrine]] &rarr; Epinephrine.<br> - <b>Tryptophan</b> &rarr; [[serotonin]] &rarr; Melatonin.</li><li><b>Pathology:</b><br> - <b>Phenylketonuria (PKU):</b> Phenylalanine hydroxylase def. &rarr; Intellectual disability, seizures.<br> - <b>Maple Syrup Urine Disease:</b> Branched-chain AA accumulation &rarr; Neurotoxicity.</li><li><b>Transport:</b> Large neutral amino acids compete for transport across the [[blood_brain_barrier]].</li></ul>",
      "takeAway": "<p><b>Amino acids</b> are the building blocks of neural signaling; their precise metabolism is required for neurotransmitter synthesis, and metabolic errors often manifest with profound neurological sequelae.</p>",
      "mermaid": "graph LR; A[Tyrosine] --> B[L-Dopa]; B --> C[Dopamine]; C --> D[Norepinephrine]; E[Glutamate] --> F[GABA]; G[Tryptophan] --> H[Serotonin];"
    },
    "connections": [
      {
        "type": "is_precursor_to",
        "to": "dopamine"
      },
      {
        "type": "is_precursor_to",
        "to": "gaba"
      },
      {
        "type": "is_precursor_to",
        "to": "serotonin"
      },
      {
        "type": "transported_across",
        "to": "blood_brain_barrier"
      }
    ]
  },
  "amitriptyline": {
    "title": "Amitriptyline",
    "primaryType": "substance",
    "tags": [
      "Pharmacology",
      "Neurology",
      "Psychiatry",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Psychotropic Drugs",
      "Tricyclic Antidepressants"
    ],
    "content": {
      "definition": "<p><b>Amitriptyline</b> is a tertiary amine <i>Tricyclic Antidepressant (TCA)</i> that inhibits the reuptake of <u>serotonin and norepinephrine</u>, commonly used for migraine prophylaxis, neuropathic pain, and depression.</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> Blocks reuptake of <b>NE</b> and <b>5-HT</b>. Also blocks &alpha;1-adrenergic, H1-histamine, and muscarinic receptors (dirty drug).</li><li><b>Clinical Uses:</b> Neuropathic pain, [[migraine]] prophylaxis, Fibromyalgia, Major Depressive Disorder (rarely first-line).</li><li><b>Adverse Effects (The 3 Cs of Toxicity):</b><br> 1. <b>C</b>ardiotoxicity (Na<sup>+</sup> channel blockade &rarr; Arrhythmias/Wide QRS).<br> 2. <b>C</b>onvulsions (Seizures).<br> 3. <b>C</b>oma.<br> - <i>Anticholinergic:</i> Dry mouth, urinary retention.<br> - <i>Anti-&alpha;1:</i> Orthostatic hypotension.</li><li><b>Treatment of Overdose:</b> NaHCO<sub>3</sub> (Sodium Bicarbonate) to overcome Na<sup>+</sup> channel blockade.</li><li><b>USMLE Tip:</b> In elderly patients, avoid TCAs due to severe anticholinergic effects (delirium, falls) - \"Beers Criteria\".</li></ul>",
      "takeAway": "<p><b>Amitriptyline</b> is a potent TCA used primarily for pain and migraine prevention today; its utility is limited by a wide side-effect profile, particularly <b>anticholinergic</b> effects and fatal <b>cardiotoxicity</b> in overdose.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "treats",
        "to": "migraine"
      },
      {
        "type": "treats",
        "to": "neuropathic_pain"
      },
      {
        "type": "toxicity_treated_with",
        "to": "sodium_bicarbonate"
      }
    ]
  }
}
``````json
{
  "amnesia": {
    "title": "Amnesia",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Psychiatry",
      "Cognition",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Cognitive Disorders",
      "Memory Disorders"
    ],
    "content": {
      "definition": "<p><b>Amnesia</b> is the pathological loss of memory, which can be classified by the timeline of memory loss relative to the inciting event (anterograde vs. retrograde) or by etiology (organic vs. dissociative).</p>",
      "atAGlance": "<ul><li><b>Anterograde Amnesia:</b> Inability to form <i>new</i> memories; classically caused by bilateral lesions to the [[hippocampus]] (e.g., medial temporal lobe damage).</li><li><b>Retrograde Amnesia:</b> Inability to recall <i>past</i> memories formed before the event.</li><li><b>Wernicke-Korsakoff Syndrome:</b> Caused by [[thiamine]] deficiency (alcoholism); involves both anterograde and retrograde amnesia with confabulation.</li><li><b>Dissociative Amnesia:</b> Psychogenic inability to recall important personal information, usually traumatic/stressful, inconsistent with ordinary forgetting.</li><li><b>USMLE Tip:</b> Bilateral hippocampal damage (e.g., hypoxia, infarction) = Anterograde Amnesia. Mammillary body damage = Wernicke-Korsakoff.</li></ul>",
      "takeAway": "<p><b>Amnesia</b> manifests as either the failure to encode new memories (anterograde, linked to the [[hippocampus]]) or retrieve old ones (retrograde), with specific patterns aiding in localization (e.g., Korsakoff syndrome).</p>",
      "mermaid": "graph TD; A[Memory Loss] --> B{Type?}; B -->|New Memories| C[Anterograde (Hippocampus)]; B -->|Old Memories| D[Retrograde]; B -->|Psychogenic| E[Dissociative];"
    },
    "connections": [
      {
        "type": "localized_to",
        "to": "hippocampus"
      },
      {
        "type": "associated_with",
        "to": "wernicke_korsakoff_syndrome"
      },
      {
        "type": "is_symptom_of",
        "to": "alzheimer_disease"
      }
    ]
  },
  "amygdala": {
    "title": "Amygdala",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Anatomy",
      "Limbic System",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Brain Anatomy",
      "Limbic System"
    ],
    "content": {
      "definition": "<p>The <b>Amygdala</b> is a set of nuclei located deep within the medial temporal lobes, part of the [[limbic_system]], responsible for processing emotions such as fear, aggression, and sexual behavior.</p>",
      "atAGlance": "<ul><li><b>Function:</b> Emotion processing (Fear, Aggression), memory consolidation of emotional events, feeding, and sexual behavior.</li><li><b>Lesions:</b> <b>Bilateral</b> lesions lead to [[kluver_bucy_syndrome]].</li><li><b>Klüver-Bucy Syndrome:</b> Characterized by <i>Hyperphagia</i>, <i>Hypersexuality</i>, <i>Hyperorality</i>, and Docility (loss of fear/aggression).</li><li><b>Etiology of Damage:</b> HSV-1 [[encephalitis]] (has a predilection for the temporal lobes).</li><li><b>USMLE Tip:</b> Think of the Amygdala as the \"Fear and Rage\" center; without it (bilaterally), patients become inappropriately fearless and hypersexual (Klüver-Bucy).</li></ul>",
      "takeAway": "<p>The <b>Amygdala</b> governs primal emotions like fear and aggression; its bilateral destruction results in the disinhibited behaviors of [[kluver_bucy_syndrome]].</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_part_of",
        "to": "limbic_system"
      },
      {
        "type": "bilateral_lesion_causes",
        "to": "kluver_bucy_syndrome"
      },
      {
        "type": "is_damaged_by",
        "to": "herpes_simplex_virus"
      }
    ]
  },
  "cerebral_amyloid_angiopathy": {
    "title": "Cerebral Amyloid Angiopathy",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Pathology",
      "Vascular",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Cerebrovascular Disease",
      "Intracranial Hemorrhage"
    ],
    "content": {
      "definition": "<p><b>Cerebral Amyloid Angiopathy (CAA)</b> is a condition characterized by the deposition of beta-amyloid proteins in the walls of small- to medium-sized cortical and leptomeningeal arteries, weakening the vessels and predisposing elderly patients to <u>recurrent lobar</u> [[intraparenchymal_hemorrhage]].</p>",
      "atAGlance": "<ul><li><b>Pathophysiology:</b> Beta-amyloid deposition makes vessel walls fragile and prone to rupture.</li><li><b>Clinical Presentation:</b> Spontaneous, often <b>recurrent</b> hemorrhagic strokes in the elderly.</li><li><b>Location:</b> Typically <b>Lobar</b> (cortical/subcortical) hemorrhages (e.g., occipital, parietal), unlike hypertensive hemorrhages which are deep (basal ganglia/thalamus).</li><li><b>Associations:</b> Strong association with [[alzheimer_disease]].</li><li><b>USMLE Tip:</b> If an elderly patient has a \"lobar\" bleed (not deep), suspect Amyloid Angiopathy. If it's deep (basal ganglia), suspect Hypertension.</li></ul>",
      "takeAway": "<p><b>Cerebral Amyloid Angiopathy</b> is the most common cause of spontaneous lobar hemorrhage in the elderly, driven by amyloid deposition in cortical vessels.</p>",
      "mermaid": "graph TD; A[Beta-Amyloid Deposition] --> B[Vessel Wall Fragility]; B --> C[Rupture]; C --> D[Lobar Intracerebral Hemorrhage];"
    },
    "connections": [
      {
        "type": "causes",
        "to": "intraparenchymal_hemorrhage"
      },
      {
        "type": "is_associated_with",
        "to": "alzheimer_disease"
      },
      {
        "type": "accumulates",
        "to": "amyloid_beta"
      }
    ]
  },
  "amyotrophic_lateral_sclerosis": {
    "title": "Amyotrophic Lateral Sclerosis (ALS)",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Pathology",
      "Degenerative",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Motor Neuron Diseases",
      "ALS"
    ],
    "content": {
      "definition": "<p><b>Amyotrophic Lateral Sclerosis (ALS)</b>, also known as Lou Gehrig's disease, is a progressive, fatal neurodegenerative disorder characterized by the combined destruction of both <u>upper motor neurons</u> (corticospinal tract) and <u>lower motor neurons</u> (anterior horn cells), sparing sensory and autonomic functions.</p>",
      "atAGlance": "<ul><li><b>Clinical Signs:</b><br> - <b>LMN Signs:</b> Muscle atrophy, weakness, <b>fasciculations</b> (tongue/limbs), hyporeflexia.<br> - <b>UMN Signs:</b> Spasticity, hyperreflexia, Babinski sign.<br> - <i>Bulbar Onset:</i> Dysphagia, dysarthria.</li><li><b>Sparing:</b> No sensory, bowel/bladder, or oculomotor deficits (Stephen Hawking could drive his wheelchair with eye movements).</li><li><b>Genetics:</b> Most sporadic; familial cases associated with <b>SOD1</b> (Superoxide Dismutase 1) mutation.</li><li><b>Treatment:</b> [[riluzole]] (decreases glutamate excitotoxicity) extends survival modestly; Edaravone.</li><li><b>USMLE Tip:</b> Look for a patient with <b>fasciculations</b> (LMN) + <b>Hyperreflexia</b> (UMN) in the same limb.</li></ul>",
      "takeAway": "<p><b>ALS</b> is defined by the unique combination of UMN and LMN signs without sensory loss, caused by motor neuron apoptosis potentially linked to superoxide dismutase dysfunction.</p>",
      "mermaid": "graph TD; A[Motor Neuron Degeneration] --> B[Anterior Horn Cells (LMN)]; A --> C[Corticospinal Tract (UMN)]; B --> D[Weakness, Atrophy, Fasciculations]; C --> E[Spasticity, Hyperreflexia];"
    },
    "connections": [
      {
        "type": "treated_by",
        "to": "riluzole"
      },
      {
        "type": "associated_with_mutation_in",
        "to": "superoxide_dismutase"
      },
      {
        "type": "destroys",
        "to": "upper_motor_neuron"
      },
      {
        "type": "destroys",
        "to": "lower_motor_neuron"
      }
    ]
  },
  "anal_wink_reflex": {
    "title": "Anal Wink Reflex",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Physical Exam",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Neurologic Examination",
      "Reflexes"
    ],
    "content": {
      "definition": "<p>The <b>Anal Wink Reflex</b> (Anocutaneous Reflex) is a superficial reflex elicited by stroking the perianal skin, which normally causes contraction of the external anal sphincter, testing the integrity of the <u>S3 and S4</u> nerve roots.</p>",
      "atAGlance": "<ul><li><b>Afferent/Efferent Limbs:</b> [[pudendal_nerve]] (S2-S4).</li><li><b>Integration Center:</b> Conus medullaris (S3-S4).</li><li><b>Clinical Significance:</b> Absence suggests a lesion of the sacral spinal cord (conus medullaris) or cauda equina nerve roots.</li><li><b>USMLE Tip:</b> \"<b>S3, S4</b> winks galore\" (Anal wink).</li></ul>",
      "takeAway": "<p>The <b>Anal Wink Reflex</b> tests the S3-S4 spinal levels and the pudendal nerve, serving as a critical assessment for conus medullaris or cauda equina syndrome.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "tests_nerve_root",
        "to": "s3_nerve_root"
      },
      {
        "type": "tests_nerve_root",
        "to": "s4_nerve_root"
      },
      {
        "type": "mediated_by",
        "to": "pudendal_nerve"
      }
    ]
  },
  "anencephaly": {
    "title": "Anencephaly",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Embryology",
      "Pediatrics",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Congenital Malformations",
      "Neural Tube Defects"
    ],
    "content": {
      "definition": "<p><b>Anencephaly</b> is a severe, lethal <i>neural tube defect</i> resulting from the failure of the <u>rostral neuropore</u> to close during the 4th week of development, leading to the absence of the forebrain and an open calvarium.</p>",
      "atAGlance": "<ul><li><b>Pathophysiology:</b> Failed closure of the rostral neural tube &rarr; Amniotic fluid damages exposed neural tissue &rarr; Degeneration of forebrain.</li><li><b>Clinical Presentation:</b> Newborn with absent brain/calvarium (\"frog-like\" appearance); incompatible with life.</li><li><b>Prenatal Diagnosis:</b> Increased <b>Alpha-fetoprotein (AFP)</b> and <b>Acetylcholinesterase (AChE)</b> in amniotic fluid/maternal serum. Ultrasound shows absent cranial vault.</li><li><b>Associations:</b> [[polyhydramnios]] (fetus cannot swallow amniotic fluid due to lack of swallowing reflex/neural control).</li><li><b>Prevention:</b> Maternal [[folic_acid]] supplementation.</li></ul>",
      "takeAway": "<p><b>Anencephaly</b> is a lethal failure of rostral neural tube closure, diagnosable prenatally by elevated AFP/AChE and polyhydramnios.</p>",
      "mermaid": "graph TD; A[Folate Deficiency] --> B[Failure of Rostral Neuropore Closure]; B --> C[Exposed Neural Tissue]; C --> D[Degeneration]; D --> E[Anencephaly]; E --> F[Polyhydramnios];"
    },
    "connections": [
      {
        "type": "caused_by_failure_of",
        "to": "neural_tube"
      },
      {
        "type": "associated_with",
        "to": "polyhydramnios"
      },
      {
        "type": "prevented_by",
        "to": "folic_acid"
      }
    ]
  },
  "general_anesthetics": {
    "title": "General Anesthetics",
    "primaryType": "substance",
    "tags": [
      "Pharmacology",
      "Anesthesiology",
      "Neurology",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Anesthetics",
      "General"
    ],
    "content": {
      "definition": "<p><b>General Anesthetics</b> are a class of CNS depressants used to induce a state of reversible unconsciousness, amnesia, analgesia, and immobility, divided into <u>Inhaled</u> (e.g., Sevoflurane) and <u>Intravenous</u> (e.g., Propofol) agents.</p>",
      "atAGlance": "<ul><li><b>Inhaled Anesthetics:</b> (e.g., [[halothane]], [[sevoflurane]]). Potency defined by <b>MAC</b> (Minimum Alveolar Concentration); lower MAC = higher potency (lipid solubility). Induction speed defined by Blood/Gas partition coefficient (lower solubility = faster onset).</li><li><b>IV Anesthetics:</b> (e.g., [[propofol]], [[etomidate]], [[ketamine]], Barbiturates). Used for rapid induction.</li><li><b>Mechanism:</b> Generally potentiate GABA<sub>A</sub> receptors (inhibitory) or inhibit NMDA receptors (excitatory, e.g., Ketamine).</li><li><b>Adverse Effects:</b> Respiratory depression, cardiovascular depression. <b>Malignant Hyperthermia</b> (especially inhaled agents + succinylcholine).</li><li><b>USMLE Tip:</b> <b>M</b>AC = <b>M</b>inimum concentration to prevent <b>M</b>ovement in 50% of patients. Inversely related to lipid solubility (Meyer-Overton rule).</li></ul>",
      "takeAway": "<p><b>General Anesthetics</b> suppress CNS activity via GABA/NMDA modulation; Inhaled kinetics are governed by solubility (Blood/Gas = Speed; Oil/Gas = Potency), while IV agents provide rapid induction.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "includes",
        "to": "propofol"
      },
      {
        "type": "includes",
        "to": "sevoflurane"
      },
      {
        "type": "can_cause",
        "to": "malignant_hyperthermia"
      },
      {
        "type": "modulates",
        "to": "gaba_a_receptor"
      }
    ]
  },
  "saccular_aneurysm": {
    "title": "Saccular Aneurysm (Berry Aneurysm)",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Vascular",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Cerebrovascular Disease",
      "Aneurysms"
    ],
    "content": {
      "definition": "<p>A <b>Saccular (Berry) Aneurysm</b> is a rounded outpouching of cerebral vessels, typically occurring at bifurcations in the [[circle_of_willis]] due to congenital weakness in the media, serving as the most common cause of spontaneous [[subarachnoid_hemorrhage]].</p>",
      "atAGlance": "<ul><li><b>Locations:</b><br> - <b>ACom (Anterior Communicating):</b> Most common. Compresses optic chiasm &rarr; Bitemporal hemianopsia.<br> - <b>PCom (Posterior Communicating):</b> Compresses [[oculomotor_nerve]] &rarr; Down-and-out eye + <b>Dilated pupil</b> (surgical emergency).<br> - <b>MCA (Middle Cerebral):</b> Rupture &rarr; Contralateral deficits.</li><li><b>Risk Factors:</b> [[autosomal_dominant_polycystic_kidney_disease]] (ADPKD), [[ehlers_danlos_syndrome]], [[marfan_syndrome]], Hypertension, Smoking.</li><li><b>Rupture:</b> Causes [[subarachnoid_hemorrhage]] (\"Worst headache of my life\").</li><li><b>USMLE Tip:</b> A \"blown pupil\" (CN III palsy) with a headache suggests a <b>PCom</b> aneurysm until proven otherwise.</li></ul>",
      "takeAway": "<p><b>Saccular Aneurysms</b> are thin-walled outpouchings at Circle of Willis branch points (especially ACom/PCom) that can rupture to cause subarachnoid hemorrhage or compress cranial nerves (CN III with PCom).</p>",
      "mermaid": "graph TD; A[Vessel Bifurcation] --> B[Hemodynamic Stress]; B --> C[Weakened Media]; C --> D[Saccular Aneurysm Formation]; D --> E[Rupture]; E --> F[Subarachnoid Hemorrhage];"
    },
    "connections": [
      {
        "type": "occurs_in",
        "to": "circle_of_willis"
      },
      {
        "type": "associated_with",
        "to": "autosomal_dominant_polycystic_kidney_disease"
      },
      {
        "type": "causes",
        "to": "subarachnoid_hemorrhage"
      },
      {
        "type": "compresses",
        "to": "oculomotor_nerve"
      }
    ]
  },
  "angle_closure_glaucoma": {
    "title": "Angle-Closure Glaucoma",
    "primaryType": "disease",
    "tags": [
      "Ophthalmology",
      "Neurology",
      "Emergency Medicine",
      "USMLE"
    ],
    "classificationPath": [
      "Ophthalmology",
      "Glaucoma",
      "Angle-Closure"
    ],
    "content": {
      "definition": "<p><b>Angle-Closure Glaucoma</b> is an ophthalmic emergency caused by the physical obstruction of the anterior chamber angle (specifically the trabecular meshwork) by the iris, preventing aqueous humor drainage and leading to a rapid spike in [[intraocular_pressure]].</p>",
      "atAGlance": "<ul><li><b>Pathophysiology:</b> Pupillary block (lens pushes against iris) &rarr; Iris pushed forward &rarr; Occlusion of trabecular meshwork.</li><li><b>Clinical Presentation:</b> Severe eye pain, headache, nausea/vomiting, <b>halos around lights</b>, \"rock-hard\" eye, dilated/fixed pupil.</li><li><b>Triggers:</b> Mydriasis (dilation) e.g., entering a dark room, anticholinergic drugs, sympathomimetics.</li><li><b>Treatment:</b> <u>Emergency:</u> [[acetazolamide]], Mannitol, Pilocarpine (constricts pupil to pull iris away), Beta-blockers (Timolol). Definitive: Laser Iridotomy.</li><li><b>USMLE Tip:</b> DO NOT give Epinephrine (causes mydriasis). Look for a patient with eye pain after watching a movie (dark room).</li></ul>",
      "takeAway": "<p><b>Angle-Closure Glaucoma</b> is a painful emergency of raised intraocular pressure due to mechanical blockage of outflow, triggered by pupil dilation and requiring immediate pressure reduction and pupillary constriction.</p>",
      "mermaid": "graph TD; A[Pupil Dilation] --> B[Iris blocks Trabecular Meshwork]; B --> C[Aqueous Humor Trapped]; C --> D[Rapid Increase in IOP]; D --> E[Optic Nerve Damage/Pain];"
    },
    "connections": [
      {
        "type": "characterized_by",
        "to": "increased_intraocular_pressure"
      },
      {
        "type": "treated_by",
        "to": "pilocarpine"
      },
      {
        "type": "treated_by",
        "to": "acetazolamide"
      },
      {
        "type": "contraindication_for",
        "to": "epinephrine"
      }
    ]
  }
}
``````json
{
  "antidiuretic_hormone": {
    "title": "Antidiuretic Hormone (ADH)",
    "primaryType": "substance",
    "tags": [
      "Endocrinology",
      "Neurology",
      "Physiology",
      "USMLE"
    ],
    "classificationPath": [
      "Endocrinology",
      "Hypothalamic-Pituitary Axis",
      "Posterior Pituitary Hormones"
    ],
    "content": {
      "definition": "<p><b>Antidiuretic Hormone (ADH)</b>, also known as <b>Vasopressin</b>, is a peptide hormone synthesized in the [[hypothalamus]] (supraoptic and paraventricular nuclei) and secreted by the [[posterior_pituitary]], which regulates water balance and blood pressure.</p>",
      "atAGlance": "<ul><li><b>Synthesis & Secretion:</b> Made in Hypothalamus, stored/released by Posterior Pituitary (Neurohypophysis).</li><li><b>Receptors:</b><br> - <b>V<sub>1</sub>:</b> Vasoconstriction (G<sub>q</sub> pathway).<br> - <b>V<sub>2</sub>:</b> Water reabsorption in renal collecting ducts (G<sub>s</sub> pathway, insertion of Aquaporin-2).</li><li><b>Regulation:</b> Stimulated by increased plasma osmolality and hypovolemia.</li><li><b>Pathology:</b><br> - <i>Deficiency:</i> [[diabetes_insipidus]] (Polyuria, Polydipsia).<br> - <i>Excess:</i> [[siadh]] (Euvolemic hyponatremia).</li><li><b>USMLE Tip:</b> ADH acts on the <b>Medullary Collecting Duct</b> to concentrate urine. Alcohol inhibits ADH release &rarr; diuresis.</li></ul>",
      "takeAway": "<p><b>ADH</b> is the primary regulator of free water retention via V2 receptors in the kidney and contributes to blood pressure maintenance via V1 receptors; dysfunction leads to water balance disorders like DI or SIADH.</p>",
      "mermaid": "graph TD; A[Hypothalamus] -->|Synthesis| B[Posterior Pituitary]; B -->|Secretion| C[ADH]; C -->|V1 Receptor| D[Vasoconstriction]; C -->|V2 Receptor| E[Renal Water Reabsorption];"
    },
    "connections": [
      {
        "type": "secreted_by",
        "to": "posterior_pituitary"
      },
      {
        "type": "synthesized_in",
        "to": "hypothalamus"
      },
      {
        "type": "deficiency_causes",
        "to": "diabetes_insipidus"
      },
      {
        "type": "excess_causes",
        "to": "siadh"
      }
    ]
  },
  "antimuscarinic_drugs": {
    "title": "Antimuscarinic Drugs",
    "primaryType": "substance",
    "tags": [
      "Pharmacology",
      "Neurology",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Autonomic Drugs",
      "Anticholinergics"
    ],
    "content": {
      "definition": "<p><b>Antimuscarinic Drugs</b> are competitive antagonists at muscarinic acetylcholine receptors, used in neurology primarily to treat drug-induced [[extrapyramidal_symptoms]] and tremor in [[parkinson_disease]] by restoring the striatal dopamine-acetylcholine balance.</p>",
      "atAGlance": "<ul><li><b>Key Agents:</b> [[benztropine]], [[trihexyphenidyl]].</li><li><b>Mechanism:</b> Block central M1 muscarinic receptors in the [[striatum]], countering relative cholinergic excess caused by dopamine depletion or blockade.</li><li><b>Clinical Uses:</b><br> - <b>Parkinson Disease:</b> Treats <b>Tremor</b> and <b>Rigidity</b> (less effective for bradykinesia).<br> - <b>EPS:</b> Acute [[dystonia]] and drug-induced parkinsonism.</li><li><b>Adverse Effects (Anti-SLUDGE):</b> Dry mouth, urinary retention, constipation, mydriasis (glaucoma risk), delirium (especially in elderly).</li><li><b>USMLE Tip:</b> \"Park my Benz\" (Benztropine for Parkinson's). Avoid in elderly patients due to delirium risk (Beers criteria).</li></ul>",
      "takeAway": "<p><b>Antimuscarinics</b> like [[benztropine]] are centrally acting agents used to manage tremor in Parkinson's and acute dystonia, limited by significant anticholinergic side effects.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "includes",
        "to": "benztropine"
      },
      {
        "type": "includes",
        "to": "trihexyphenidyl"
      },
      {
        "type": "treats",
        "to": "parkinson_disease"
      },
      {
        "type": "treats",
        "to": "dystonia"
      }
    ]
  },
  "skeletal_muscle_relaxants": {
    "title": "Skeletal Muscle Relaxants (Antispasmodics)",
    "primaryType": "substance",
    "tags": [
      "Pharmacology",
      "Neurology",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Neurology Drugs",
      "Muscle Relaxants"
    ],
    "content": {
      "definition": "<p><b>Skeletal Muscle Relaxants</b> are a diverse group of centrally and peripherally acting drugs used to treat muscle spasticity and spasms resulting from upper motor neuron lesions or musculoskeletal conditions.</p>",
      "atAGlance": "<ul><li><b>Agents & Mechanisms:</b><br> - <b>[[baclofen]]:</b> GABA<sub>B</sub> agonist (spinal cord level).<br> - <b>[[cyclobenzaprine]]:</b> Centrally acting (brainstem); structurally related to TCAs.<br> - <b>[[tizanidine]]:</b> Central &alpha;<sub>2</sub> agonist.<br> - <b>[[dantrolene]]:</b> Inhibits Ryanodine receptor (Ca<sup>2+</sup> release) in muscle (Peripheral).</li><li><b>Clinical Uses:</b> Spasticity (MS, Cerebral Palsy), Malignant Hyperthermia (Dantrolene).</li><li><b>Adverse Effects:</b> Significant <b>sedation</b>, muscle weakness, anticholinergic effects (Cyclobenzaprine).</li><li><b>USMLE Tip:</b> Dantrolene is the specific antidote for [[malignant_hyperthermia]] and [[neuroleptic_malignant_syndrome]].</li></ul>",
      "takeAway": "<p><b>Muscle Relaxants</b> reduce spasticity through various mechanisms: Baclofen acts on GABA-B, Tizanidine on alpha-2, and Dantrolene directly on the muscle's calcium release.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "includes",
        "to": "baclofen"
      },
      {
        "type": "includes",
        "to": "dantrolene"
      },
      {
        "type": "includes",
        "to": "tizanidine"
      },
      {
        "type": "treats",
        "to": "spasticity"
      }
    ]
  },
  "anxiety_disorders": {
    "title": "Anxiety Disorders",
    "primaryType": "disease",
    "tags": [
      "Psychiatry",
      "Neurology",
      "USMLE"
    ],
    "classificationPath": [
      "Psychiatry",
      "Anxiety Disorders"
    ],
    "content": {
      "definition": "<p><b>Anxiety Disorders</b> are a group of psychiatric conditions characterized by excessive, persistent fear and worry, mediated by dysregulation of neurotransmitters including GABA, norepinephrine, and serotonin.</p>",
      "atAGlance": "<ul><li><b>Neurobiology:</b> Decreased <b>GABA</b> and <b>Serotonin</b>; Increased <b>Norepinephrine</b>.</li><li><b>Types:</b> Generalized Anxiety Disorder (GAD), Panic Disorder, Phobias.</li><li><b>Treatment:</b><br> - <i>Acute:</i> [[benzodiazepines]] (GABA<sub>A</sub> modulation).<br> - <i>Chronic/Maintenance:</i> [[ssris]] (e.g., Paroxetine, Sertraline), SNRIs (e.g., Venlafaxine), [[buspirone]] (for GAD).</li><li><b>USMLE Tip:</b> Benzodiazepines provide immediate relief but have abuse potential; SSRIs take weeks to work but are first-line for long-term management.</li></ul>",
      "takeAway": "<p><b>Anxiety Disorders</b> involve a failure of inhibitory (GABA) and serotonergic regulation of fear circuits, managed acutely with benzodiazepines and chronically with serotonergic antidepressants.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "treated_by",
        "to": "benzodiazepines"
      },
      {
        "type": "treated_by",
        "to": "ssris"
      },
      {
        "type": "involves_dysregulation_of",
        "to": "gaba"
      }
    ]
  },
  "aphasia": {
    "title": "Aphasia",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Pathology",
      "Language",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Cognitive Disorders",
      "Aphasias"
    ],
    "content": {
      "definition": "<p><b>Aphasia</b> is an impairment of language modalities (speaking, writing, reading, listening) caused by damage to the dominant cerebral hemisphere (usually Left), classified by fluency, comprehension, and repetition.</p>",
      "atAGlance": "<ul><li><b>[[broca_aphasia]]:</b> Non-fluent, intact comprehension, impaired repetition. Lesion: Inferior Frontal Gyrus.</li><li><b>[[wernicke_aphasia]]:</b> Fluent (word salad), impaired comprehension, impaired repetition. Lesion: Superior Temporal Gyrus.</li><li><b>Conduction Aphasia:</b> Fluent, intact comprehension, <b>impaired repetition</b>. Lesion: [[arcuate_fasciculus]].</li><li><b>Global Aphasia:</b> Non-fluent, impaired comprehension, impaired repetition. Large MCA infarct.</li><li><b>USMLE Tip:</b> If repetition is <u>intact</u>, it is a transcortical aphasia (Motor or Sensory).</li></ul>",
      "takeAway": "<p><b>Aphasia</b> localization depends on fluency (Frontal vs. Posterior) and repetition (Perisylvian vs. Transcortical); Broca's is \"Broken\" speech, Wernicke's is \"Wordy\" but meaningless.</p>",
      "mermaid": "graph TD; A[Language Deficit] --> B{Fluent?}; B -->|No| C{Comprehension?}; B -->|Yes| D{Comprehension?}; C -->|Intact| E[Broca's]; C -->|Impaired| F[Global]; D -->|Intact| G[Conduction]; D -->|Impaired| H[Wernicke's];"
    },
    "connections": [
      {
        "type": "includes",
        "to": "broca_aphasia"
      },
      {
        "type": "includes",
        "to": "wernicke_aphasia"
      },
      {
        "type": "caused_by_lesion_in",
        "to": "arcuate_fasciculus"
      },
      {
        "type": "caused_by_infarct_of",
        "to": "middle_cerebral_artery"
      }
    ]
  },
  "apoptosis": {
    "title": "Apoptosis",
    "primaryType": "process",
    "tags": [
      "Pathology",
      "Cell Biology",
      "Neurology",
      "USMLE"
    ],
    "classificationPath": [
      "Pathology",
      "Cell Death",
      "Programmed Cell Death"
    ],
    "content": {
      "definition": "<p><b>Apoptosis</b> is a highly regulated, ATP-dependent form of <i>programmed cell death</i> characterized by cell shrinkage, chromatin condensation, and membrane blebbing without significant inflammation, playing a key role in neurodegenerative diseases like [[amyotrophic_lateral_sclerosis]].</p>",
      "atAGlance": "<ul><li><b>Morphology:</b> Cell shrinkage, nuclear fragmentation (karyorrhexis), apoptotic bodies. <b>No Inflammation.</b></li><li><b>Pathways:</b><br> - <i>Intrinsic (Mitochondrial):</i> Regulated by BCL-2 family; release of Cytochrome C.<br> - <i>Extrinsic (Death Receptor):</i> FasL binding to Fas (CD95) or TNF binding.</li><li><b>Neurodegeneration:</b> Mechanism of neuronal death in [[als]], [[huntington_disease]], and [[alzheimer_disease]].</li><li><b>USMLE Tip:</b> Differentiate from <b>Necrosis</b> (swelling, membrane rupture, significant inflammation). Apoptosis is \"suicide\"; Necrosis is \"homicide\".</li></ul>",
      "takeAway": "<p><b>Apoptosis</b> is clean, programmed cell suicide involving caspase activation, essential for development and implicated in chronic neurodegeneration, distinct from inflammatory necrosis.</p>",
      "mermaid": "graph TD; A[Trigger] --> B{Pathway?}; B -->|Intrinsic| C[Mitochondrial Leak]; B -->|Extrinsic| D[Death Receptor]; C & D --> E[Caspase Activation]; E --> F[Cellular Dismantling];"
    },
    "connections": [
      {
        "type": "occurs_in",
        "to": "amyotrophic_lateral_sclerosis"
      },
      {
        "type": "is_contrasted_with",
        "to": "necrosis"
      },
      {
        "type": "involves",
        "to": "caspases"
      }
    ]
  },
  "apraclonidine": {
    "title": "Apraclonidine",
    "primaryType": "substance",
    "tags": [
      "Pharmacology",
      "Ophthalmology",
      "Neurology",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Ophthalmic Drugs",
      "Alpha Agonists"
    ],
    "content": {
      "definition": "<p><b>Apraclonidine</b> is an &alpha;<sub>2</sub>-adrenergic agonist (with weak &alpha;<sub>1</sub> activity) used clinically to lower intraocular pressure in [[glaucoma]] and diagnostically to confirm [[horner_syndrome]].</p>",
      "atAGlance": "<ul><li><b>Mechanism (Glaucoma):</b> Stimulates &alpha;<sub>2</sub> receptors &rarr; Decreases aqueous humor production.</li><li><b>Diagnostic Use (Horner Syndrome):</b> Weak &alpha;<sub>1</sub> activity causes pupil dilation in a Horner pupil due to <b>denervation supersensitivity</b>, but has no effect on a normal pupil.</li><li><b>Result:</b> Reversal of anisocoria (Horner pupil becomes larger than normal pupil).</li><li><b>USMLE Tip:</b> In Horner syndrome diagnosis: Cocaine (no dilation in Horner's), Apraclonidine (dilation in Horner's).</li></ul>",
      "takeAway": "<p><b>Apraclonidine</b> treats glaucoma by reducing aqueous production and diagnoses Horner syndrome by exploiting denervation supersensitivity to cause paradoxical dilation.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "treats",
        "to": "glaucoma"
      },
      {
        "type": "diagnoses",
        "to": "horner_syndrome"
      },
      {
        "type": "acts_on_receptor",
        "to": "alpha_2_adrenergic_receptor"
      }
    ]
  },
  "gait_apraxia": {
    "title": "Gait Apraxia",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Signs & Symptoms",
      "Gait Disorders",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Movement Disorders",
      "Apraxia"
    ],
    "content": {
      "definition": "<p><b>Gait Apraxia</b> (Frontal Gait) is a higher-level motor planning deficit characterized by difficulty initiating walking and a \"magnetic\" quality (feet appear stuck to the floor), despite intact motor strength and sensation, classically associated with [[normal_pressure_hydrocephalus]].</p>",
      "atAGlance": "<ul><li><b>Description:</b> Short, shuffling steps; difficulty lifting feet off the floor (\"magnetic gait\"); difficulty turning.</li><li><b>Pathophysiology:</b> Disruption of frontal lobe connections (corona radiata) to the basal ganglia/brainstem, often due to ventricular expansion.</li><li><b>Associations:</b> The \"Wobbly\" component of the <b>Wet, Wobbly, Wacky</b> triad of [[normal_pressure_hydrocephalus]]. Also seen in frontal lobe lesions.</li><li><b>Differentiation:</b> Unlike Parkinsonian gait, arm swing may be preserved, and cues (visual/auditory) don't help as much.</li><li><b>USMLE Tip:</b> \"Feet stuck to the floor\" + Urinary Incontinence + Dementia = NPH.</li></ul>",
      "takeAway": "<p><b>Gait Apraxia</b> is a frontal lobe release sign often described as a \"magnetic gait,\" serving as the most responsive symptom to shunting in [[normal_pressure_hydrocephalus]].</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_characteristic_of",
        "to": "normal_pressure_hydrocephalus"
      },
      {
        "type": "associated_with_lesion_in",
        "to": "frontal_lobe"
      },
      {
        "type": "is_a_type_of",
        "to": "apraxia"
      }
    ]
  },
  "aqueous_humor_pathway": {
    "title": "Aqueous Humor Pathway",
    "primaryType": "process",
    "tags": [
      "Ophthalmology",
      "Physiology",
      "Anatomy",
      "USMLE"
    ],
    "classificationPath": [
      "Ophthalmology",
      "Physiology",
      "Fluid Dynamics"
    ],
    "content": {
      "definition": "<p>The <b>Aqueous Humor Pathway</b> describes the circulation of intraocular fluid, which is produced by the <u>ciliary body</u>, flows from the posterior to the anterior chamber, and drains primarily through the <u>trabecular meshwork</u>, maintaining intraocular pressure.</p>",
      "atAGlance": "<ul><li><b>Production:</b> Ciliary processes of the [[ciliary_body]] (Active secretion dependent on Carbonic Anhydrase).</li><li><b>Flow:</b> Posterior Chamber &rarr; Through Pupil &rarr; Anterior Chamber.</li><li><b>Drainage:</b><br> 1. <b>Trabecular Outflow (90%):</b> Trabecular Meshwork &rarr; Canal of Schlemm &rarr; Episcleral veins. (Target of [[pilocarpine]]).<br> 2. <b>Uveoscleral Outflow (10%):</b> Directly through ciliary muscle into suprachoroidal space. (Target of [[prostaglandins]]).</li><li><b>Pathology:</b> Blockage leads to [[glaucoma]].</li><li><b>USMLE Tip:</b> [[acetazolamide]] decreases production; Prostaglandins increase uveoscleral outflow; Pilocarpine increases trabecular outflow.</li></ul>",
      "takeAway": "<p><b>Aqueous Humor</b> circulates from the ciliary body to the anterior chamber angle; the balance between production and trabecular/uveoscleral outflow determines intraocular pressure, the key target in [[glaucoma]] therapy.</p>",
      "mermaid": "graph TD; A[Ciliary Body] -->|Secretion| B[Posterior Chamber]; B -->|Through Pupil| C[Anterior Chamber]; C -->|90%| D[Trabecular Meshwork]; C -->|10%| E[Uveoscleral Outflow]; D --> F[Canal of Schlemm];"
    },
    "connections": [
      {
        "type": "produced_by",
        "to": "ciliary_body"
      },
      {
        "type": "drains_via",
        "to": "trabecular_meshwork"
      },
      {
        "type": "dysfunction_causes",
        "to": "glaucoma"
      }
    ]
  },
  "arachnoid_granulations": {
    "title": "Arachnoid Granulations",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Anatomy",
      "Physiology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Brain Anatomy",
      "Meninges"
    ],
    "content": {
      "definition": "<p><b>Arachnoid Granulations</b> are bulbous projections of the arachnoid mater that protrude into the dural venous sinuses (primarily the [[superior_sagittal_sinus]]), serving as the primary site for the <u>resorption of cerebrospinal fluid (CSF)</u> into the venous circulation.</p>",
      "atAGlance": "<ul><li><b>Function:</b> One-way valves allowing CSF to flow from the subarachnoid space into venous blood, driven by a pressure gradient.</li><li><b>Location:</b> Protrude into the <b>Superior Sagittal Sinus</b>.</li><li><b>Pathology:</b><br> - <i>Scarring/Fibrosis:</i> (e.g., post-meningitis, subarachnoid hemorrhage) leads to decreased resorption &rarr; [[communicating_hydrocephalus]].<br> - <i>Hypertrophy:</i> Can cause \"pitting\" on the inner skull table (foveolae granulares).</li><li><b>USMLE Tip:</b> If CSF production (choroid plexus) exceeds resorption (arachnoid granulations), [[communicating_hydrocephalus]] ensues.</li></ul>",
      "takeAway": "<p><b>Arachnoid Granulations</b> are the drainage points for CSF; their dysfunction (e.g., scarring) is the primary mechanism behind [[communicating_hydrocephalus]].</p>",
      "mermaid": "graph TD; A[Subarachnoid Space] -->|CSF| B[Arachnoid Granulations]; B -->|Resorption| C[Superior Sagittal Sinus]; C --> D[Venous Circulation];"
    },
    "connections": [
      {
        "type": "resorbs",
        "to": "cerebrospinal_fluid"
      },
      {
        "type": "drains_into",
        "to": "superior_sagittal_sinus"
      },
      {
        "type": "dysfunction_causes",
        "to": "communicating_hydrocephalus"
      }
    ]
  }
}
``````json
{
  "arachnoid_mater": {
    "title": "Arachnoid Mater",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Anatomy",
      "Meninges",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Brain Anatomy",
      "Meninges"
    ],
    "content": {
      "definition": "<p>The <b>Arachnoid Mater</b> is the delicate, avascular, spider-web-like middle layer of the [[meninges]], situated between the outer [[dura_mater]] and the inner [[pia_mater]], which facilitates cerebrospinal fluid (CSF) reabsorption via [[arachnoid_granulations]].</p>",
      "atAGlance": "<ul><li><b>Location:</b> Middle meningeal layer; separated from the dura by the potential subdural space and from the pia by the <b>subarachnoid space</b> (contains CSF).</li><li><b>Structure:</b> Avascular connective tissue with trabeculae extending to the pia mater.</li><li><b>Function:</b> CSF containment and reabsorption via [[arachnoid_granulations]] into the dural venous sinuses (e.g., [[superior_sagittal_sinus]]).</li><li><b>Pathology:</b><br> - <b>Meningioma:</b> Tumor arising from arachnoid cap cells.<br> - <b>Subarachnoid Hemorrhage:</b> Bleeding between arachnoid and pia (e.g., ruptured aneurysm).</li><li><b>USMLE Tip:</b> Unlike the dura, the arachnoid does <u>not</u> dive into the sulci (except for the longitudinal fissure), but bridges over them.</li></ul>",
      "takeAway": "<p>The <b>Arachnoid Mater</b> acts as a physiologic barrier and CSF resorption site; pathology here includes [[meningioma]] (from cap cells) and containment of subarachnoid hemorrhage.</p>",
      "mermaid": "graph TD; A[Dura Mater] -->|Potential Subdural Space| B[Arachnoid Mater]; B -->|Subarachnoid Space (CSF)| C[Pia Mater]; B -->|Arachnoid Granulations| D[Venous Sinuses];"
    },
    "connections": [
      {
        "type": "contains",
        "to": "arachnoid_granulations"
      },
      {
        "type": "is_site_of_origin_for",
        "to": "meningioma"
      },
      {
        "type": "defines_boundary_of",
        "to": "subarachnoid_space"
      }
    ]
  },
  "area_postrema": {
    "title": "Area Postrema",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Physiology",
      "Pharmacology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Brainstem",
      "Circumventricular Organs"
    ],
    "content": {
      "definition": "<p>The <b>Area Postrema</b> is a paired [[circumventricular_organ]] located on the floor of the <u>fourth ventricle</u> in the dorsal medulla that lacks a [[blood_brain_barrier]], allowing it to sense circulating toxins and trigger vomiting via the [[vomiting_center]].</p>",
      "atAGlance": "<ul><li><b>Location:</b> Dorsal medulla, caudal end of the 4th ventricle.</li><li><b>Function:</b> Chemoreceptor Trigger Zone (CTZ). Senses emetics in blood/CSF.</li><li><b>Mechanism:</b> Lacks tight junctions (no BBB) &rarr; detects toxins/drugs &rarr; projects to the <b>Nucleus Tractus Solitarius</b> (vomiting center).</li><li><b>Receptors:</b> Rich in Dopamine (D2), Serotonin (5-HT3), and Neurokinin (NK1) receptors.</li><li><b>Clinical Relevance:</b> Target for antiemetics (e.g., [[ondansetron]], [[metoclopramide]]) and site of action for chemotherapy-induced vomiting.</li><li><b>USMLE Tip:</b> This is the \"vomit button\" that gets pushed by systemic drugs because it sits <i>outside</i> the blood-brain barrier.</li></ul>",
      "takeAway": "<p>The <b>Area Postrema</b> is the medullary chemoreceptor trigger zone that monitors blood for toxins due to its absent [[blood_brain_barrier]], initiating the vomiting reflex via D2 and 5-HT3 receptors.</p>",
      "mermaid": "graph TD; A[Systemic Toxins/Drugs] -->|Cross Permeable Capillaries| B[Area Postrema]; B -->|Signaling| C[Nucleus Tractus Solitarius]; C -->|Vomiting Reflex| D[Emesis];"
    },
    "connections": [
      {
        "type": "lacks",
        "to": "blood_brain_barrier"
      },
      {
        "type": "initiates",
        "to": "vomiting"
      },
      {
        "type": "located_in",
        "to": "medulla_oblongata"
      },
      {
        "type": "contains_receptors_for",
        "to": "dopamine"
      }
    ]
  },
  "argyll_robertson_pupil": {
    "title": "Argyll Robertson Pupil",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Ophthalmology",
      "Infectious Disease",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Neuro-Ophthalmology",
      "Pupillary Disorders"
    ],
    "content": {
      "definition": "<p>The <b>Argyll Robertson Pupil</b> is a bilateral pupillary defect characterized by small, irregular pupils that <u>accommodate but do not react to light</u> (Light-Near Dissociation), classically associated with late-stage [[syphilis]] (neurosyphilis).</p>",
      "atAGlance": "<ul><li><b>Classic Sign:</b> \"Prostitute's Pupil\" – accommodates but doesn't react.</li><li><b>Pathophysiology:</b> Lesion in the <b>pretectal area</b> of the dorsal midbrain, disrupting the afferent light reflex fibers while sparing the ventral accommodation pathway.</li><li><b>Etiology:</b> <b>Tertiary Syphilis</b> ([[tabes_dorsalis]]). Rare causes include diabetes or pinealoma ([[parinaud_syndrome]]).</li><li><b>Associated Findings:</b> Tabes dorsalis (loss of proprioception, ataxia, Charcot joints).</li><li><b>USMLE Tip:</b> Contrast with <b>Adie's Tonic Pupil</b> (dilated, reacts poorly to light/accommodation) and <b>Marcus Gunn Pupil</b> (RAPD, optic nerve lesion).</li></ul>",
      "takeAway": "<p><b>Argyll Robertson Pupil</b> is the hallmark of [[neurosyphilis]], defined by light-near dissociation due to damage in the dorsal midbrain pretectal region.</p>",
      "mermaid": "graph TD; A[Light Stimulus] --x|Lesion in Pretectum| B[Edinger-Westphal Nucleus]; C[Near Stimulus/Accommodation] -->|Bypasses Pretectum| B; B --> D[Pupillary Constriction];"
    },
    "connections": [
      {
        "type": "is_caused_by",
        "to": "neurosyphilis"
      },
      {
        "type": "demonstrates",
        "to": "light_near_dissociation"
      },
      {
        "type": "associated_with",
        "to": "tabes_dorsalis"
      }
    ]
  },
  "aspirin": {
    "title": "Aspirin (Acetylsalicylic Acid)",
    "primaryType": "substance",
    "tags": [
      "Pharmacology",
      "Cardiology",
      "Hematology",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Analgesics",
      "NSAIDs"
    ],
    "content": {
      "definition": "<p><b>Aspirin</b> is a non-steroidal anti-inflammatory drug (NSAID) that acts as an <u>irreversible</u> inhibitor of [[cyclooxygenase]] (COX-1 and COX-2), reducing the synthesis of thromboxane A2 (platelet aggregation) and prostaglandins (inflammation/pain).</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> <b>Irreversible</b> acetylation of COX-1 and COX-2 serine residues. <br> - <i>Low Dose:</i> Predominantly blocks COX-1 &rarr; Decreased Thromboxane A2 (Antiplatelet).<br> - <i>High Dose:</i> Blocks COX-1 and COX-2 &rarr; Anti-inflammatory/Analgesic.</li><li><b>Clinical Use:</b> Acute Coronary Syndromes ( STEMI/NSTEMI), Stroke prevention, Kawasaki disease (exception for kids).</li><li><b>Adverse Effects:</b> GI bleeding/ulcers, <b>Tinnitus</b> (early toxicity), Renal ischemia, [[reye_syndrome]] (in children with viral illness).</li><li><b>Toxicity (Salicylism):</b> Mixed respiratory alkalosis (early) + metabolic acidosis (late). Treat with NaHCO<sub>3</sub> (alkalinize urine).</li><li><b>USMLE Tip:</b> Unlike other NSAIDs, Aspirin's effect lasts the life of the platelet (7-10 days) because platelets lack DNA to resynthesize COX.</li></ul>",
      "takeAway": "<p><b>Aspirin</b> is unique among NSAIDs for its <b>irreversible</b> inhibition of COX enzymes, making it a potent cardioprotective agent; watch out for <b>Reye Syndrome</b> in kids and <b>Tinnitus</b> in overdose.</p>",
      "mermaid": "graph TD; A[Arachidonic Acid]; B[Cyclooxygenase] --x|Irreversible Inhibition| A; B --> C[Prostaglandins/Thromboxanes]; D[Aspirin] -->|Acetylation| B;"
    },
    "connections": [
      {
        "type": "irreversibly_inhibits",
        "to": "cyclooxygenase"
      },
      {
        "type": "inhibits_synthesis_of",
        "to": "thromboxane_a2"
      },
      {
        "type": "can_cause",
        "to": "reye_syndrome"
      },
      {
        "type": "can_cause",
        "to": "tinnitus"
      }
    ]
  },
  "asterixis": {
    "title": "Asterixis",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Gastroenterology",
      "Metabolic",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Movement Disorders",
      "Tremors"
    ],
    "content": {
      "definition": "<p><b>Asterixis</b>, also known as \"flapping tremor,\" is a negative myoclonus characterized by momentary loss of muscle tone upon extension of the wrists, classically seen in <u>metabolic encephalopathies</u>.</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> Intermittent failure of the parietal lobe/motor centers to sustain posture (negative myoclonus).</li><li><b>Etiologies:</b><br> - <b>Hepatic Encephalopathy:</b> Hyperammonemia (classic).<br> - <b>Uremia:</b> Renal failure.<br> - <b>Hypercapnia:</b> CO<sub>2</sub> narcosis.<br> - <b>Wilson Disease:</b> Copper accumulation.</li><li><b>Testing:</b> Patient extends arms with wrists dorsiflexed (\"stop traffic\" pose); look for rhythmic flapping/lapsing of the hand.</li><li><b>USMLE Tip:</b> While classic for liver failure, remember it is a general sign of metabolic brain dysfunction (uremia, CO2 retention).</li></ul>",
      "takeAway": "<p><b>Asterixis</b> is a sign of metabolic encephalopathy (e.g., liver or kidney failure) caused by the inability to maintain sustained muscle contraction (negative myoclonus).</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_sign_of",
        "to": "hepatic_encephalopathy"
      },
      {
        "type": "is_sign_of",
        "to": "uremia"
      },
      {
        "type": "caused_by_accumulation_of",
        "to": "ammonia"
      },
      {
        "type": "associated_with",
        "to": "wilson_disease"
      }
    ]
  },
  "astigmatism": {
    "title": "Astigmatism",
    "primaryType": "disease",
    "tags": [
      "Ophthalmology",
      "Physics",
      "USMLE"
    ],
    "classificationPath": [
      "Ophthalmology",
      "Refractive Errors"
    ],
    "content": {
      "definition": "<p><b>Astigmatism</b> is a refractive error caused by an <u>irregular curvature</u> of the cornea (or lens), leading to light focusing on multiple points rather than a single focal point on the retina, resulting in blurred vision at all distances.</p>",
      "atAGlance": "<ul><li><b>Pathophysiology:</b> The cornea is shaped like a <b>football</b> (elliptical) rather than a basketball (spherical). Light rays in different planes focus at different points.</li><li><b>Clinical Presentation:</b> Blurry vision at both near and far distances, eye strain, headaches.</li><li><b>Treatment:</b> <b>Cylindrical lenses</b> (corrects curvature in one axis) or surgery (LASIK).</li><li><b>USMLE Tip:</b> Differentiate from Myopia (eye too long, focal point anterior to retina) and Hyperopia (eye too short, focal point posterior).</li></ul>",
      "takeAway": "<p><b>Astigmatism</b> arises from corneal asymmetry preventing a single point of focus, corrected with cylindrical lenses.</p>",
      "mermaid": "graph TD; A[Light Rays] --> B[Irregular Cornea]; B --> C[Multiple Focal Points]; C --> D[Blurred Image on Retina];"
    },
    "connections": [
      {
        "type": "involves_structure",
        "to": "cornea"
      },
      {
        "type": "treated_with",
        "to": "cylindrical_lens"
      },
      {
        "type": "is_a_type_of",
        "to": "refractive_error"
      }
    ]
  },
  "astrocytes": {
    "title": "Astrocytes",
    "primaryType": "cell",
    "tags": [
      "Neurology",
      "Histology",
      "Cell Biology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Neurohistology",
      "Glial Cells"
    ],
    "content": {
      "definition": "<p><b>Astrocytes</b> are the most abundant macroglial cells in the CNS, derived from neuroectoderm, responsible for physical support, maintenance of the <u>Blood-Brain Barrier (BBB)</u>, electrolyte balance (K+ buffering), and repair/scar formation (gliosis).</p>",
      "atAGlance": "<ul><li><b>Marker:</b> <b>GFAP</b> (Glial Fibrillary Acidic Protein) positive.</li><li><b>Functions:</b><br> - <b>Support:</b> Structural framework.<br> - <b>Metabolic:</b> Glycogen reserve, lactate shuttling to neurons, K+ buffering, neurotransmitter (glutamate) uptake.<br> - <b>Protection:</b> Foot processes contribute to the <b>Blood-Brain Barrier</b>.<br> - <b>Repair:</b> Form the <i>glial scar</i> (reactive gliosis) after injury.</li><li><b>Pathology:</b> Source of [[glioblastoma]] (GFAP+). Damaged in hyperammonemia (Alzheimer Type II astrocytes).</li><li><b>USMLE Tip:</b> If a brain lesion shows \"pseudopalisading necrosis\" or is GFAP+, it's of astrocytic origin.</li></ul>",
      "takeAway": "<p><b>Astrocytes</b> are the metabolic and structural support cells of the CNS, crucial for the blood-brain barrier and responding to injury via reactive gliosis (GFAP+).</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "expresses_marker",
        "to": "gfap"
      },
      {
        "type": "forms",
        "to": "blood_brain_barrier"
      },
      {
        "type": "performs",
        "to": "reactive_gliosis"
      },
      {
        "type": "gives_rise_to",
        "to": "glioblastoma"
      }
    ]
  },
  "ataxia": {
    "title": "Ataxia",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Physical Exam",
      "Cerebellum",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Neurologic Examination",
      "Coordination"
    ],
    "content": {
      "definition": "<p><b>Ataxia</b> is a lack of voluntary muscle coordination (gait, speech, limb movements) typically caused by dysfunction of the [[cerebellum]], vestibular system, or dorsal columns (sensory ataxia).</p>",
      "atAGlance": "<ul><li><b>Cerebellar Ataxia:</b><br> - <b>Vermis Lesion:</b> Truncal ataxia (drunken sailor gait), affects medial motor systems.<br> - <b>Hemisphere Lesion:</b> Limb ataxia (dysmetria, intention tremor), fall toward <i>ipsilateral</i> side.<br> - <b>Findings:</b> Negative Romberg (sways with eyes open AND closed).</li><li><b>Sensory Ataxia:</b> Loss of proprioception (Dorsal Columns).<br> - <b>Findings:</b> Positive Romberg (stable with eyes open, falls with eyes closed).</li><li><b>Etiologies:</b> Alcohol (vermis atrophy), [[friedreich_ataxia]], Vitamin B12/E deficiency, Stroke (AICA/PICA).</li><li><b>USMLE Tip:</b> Romberg test distinguishes Sensory (Dorsal Column) from Cerebellar ataxia. Cerebellar patients fall even with eyes open.</li></ul>",
      "takeAway": "<p><b>Ataxia</b> signifies incoordination; localize by testing balance with visual cues removed (Romberg) to differentiate sensory loss from primary cerebellar pathology.</p>",
      "mermaid": "graph TD; A[Ataxia] --> B{Romberg Test?}; B -->|Positive (Falls w/ eyes closed)| C[Sensory Ataxia (Dorsal Columns)]; B -->|Negative (Falls w/ eyes open)| D[Cerebellar Ataxia]; D -->|Truncal| E[Vermis Lesion]; D -->|Limb| F[Hemisphere Lesion];"
    },
    "connections": [
      {
        "type": "localizes_to",
        "to": "cerebellum"
      },
      {
        "type": "localizes_to",
        "to": "dorsal_column_medial_lemniscus"
      },
      {
        "type": "associated_with",
        "to": "friedreich_ataxia"
      },
      {
        "type": "associated_with",
        "to": "alcohol_use_disorder"
      }
    ]
  },
  "athetosis": {
    "title": "Athetosis",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Movement Disorders",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Movement Disorders",
      "Hyperkinetic"
    ],
    "content": {
      "definition": "<p><b>Athetosis</b> refers to slow, involuntary, writhing, \"snake-like\" movements, typically affecting the distal extremities (fingers/toes), caused by lesions to the [[basal_ganglia]] (striatum).</p>",
      "atAGlance": "<ul><li><b>Appearance:</b> Slow, twisting, convoluted movements; \"worm-like\".</li><li><b>Localization:</b> Basal Ganglia ([[striatum]]).</li><li><b>Associations:</b><br> - [[huntington_disease]] (often mixed with chorea = choreoathetosis).<br> - Cerebral Palsy.<br> - Wilson Disease.</li><li><b>Differentiation:</b><br> - <b>Chorea:</b> Rapid, jerky, dance-like.<br> - <b>Athetosis:</b> Slow, writhing.<br> - <b>Ballismus:</b> Violent, flinging (Subthalamic nucleus).</li><li><b>USMLE Tip:</b> If the fingers look like they are playing a slow, invisible piano or holding a tea cup, think Athetosis.</li></ul>",
      "takeAway": "<p><b>Athetosis</b> is a slow, writhing hyperkinetic movement disorder indicative of basal ganglia dysfunction, often co-occurring with chorea in conditions like Huntington disease.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "localizes_to",
        "to": "basal_ganglia"
      },
      {
        "type": "localizes_to",
        "to": "striatum"
      },
      {
        "type": "is_associated_with",
        "to": "huntington_disease"
      },
      {
        "type": "is_contrasted_with",
        "to": "chorea"
      }
    ]
  },
  "atonic_seizure": {
    "title": "Atonic Seizure",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Epilepsy",
      "Pediatrics",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Epilepsy",
      "Generalized Seizures"
    ],
    "content": {
      "definition": "<p><b>Atonic Seizures</b> (Drop Attacks) are a type of <i>generalized seizure</i> characterized by the sudden, transient loss of muscle tone, leading to a sudden collapse or fall to the floor.</p>",
      "atAGlance": "<ul><li><b>Clinical Presentation:</b> Sudden loss of postural tone. Patient collapses (\"drops\") like a puppet with strings cut. Head may drop forward.</li><li><b>Duration:</b> Brief (seconds).</li><li><b>Risks:</b> High risk of trauma (facial/head injury). Patients often wear helmets.</li><li><b>Associations:</b> Often seen in <b>Lennox-Gastaut Syndrome</b> (severe childhood epilepsy).</li><li><b>Differentiation:</b> Distinguish from syncope (usually has prodrome) and tonic seizures (stiffening).</li><li><b>USMLE Tip:</b> \"Drop seizure\" = Atonic. Often confused with cataplexy (triggered by emotion) or syncope.</li></ul>",
      "takeAway": "<p><b>Atonic Seizures</b> involve sudden loss of tone causing falls; they are a dangerous form of generalized epilepsy often associated with severe syndromic epilepsy in children.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_a_type_of",
        "to": "generalized_seizure"
      },
      {
        "type": "associated_with",
        "to": "lennox_gastaut_syndrome"
      },
      {
        "type": "is_distinguished_from",
        "to": "syncope"
      },
      {
        "type": "is_distinguished_from",
        "to": "cataplexy"
      }
    ]
  }
}
``````json
{
  "atracurium": {
    "title": "Atracurium",
    "primaryType": "substance",
    "tags": [
      "Pharmacology",
      "Anesthesiology",
      "Neurology",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Neuromuscular Blockers",
      "Nondepolarizing"
    ],
    "content": {
      "definition": "<p><b>Atracurium</b> is an intermediate-acting <i>nondepolarizing neuromuscular blocker</i> that acts as a competitive antagonist at nicotinic acetylcholine receptors (nAChR) at the neuromuscular junction, notable for its degradation via <u>Hoffmann elimination</u>.</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> Competes with ACh for binding sites on the nAChR, preventing depolarization and causing flaccid paralysis.</li><li><b>Metabolism:</b> Spontaneous degradation in plasma via <b>Hoffmann elimination</b> (temperature and pH dependent) and ester hydrolysis. <u>Independent of renal or hepatic function.</u></li><li><b>Adverse Effects:</b> Moderate <b>histamine release</b> (hypotension, flushing, bronchospasm). Metabolite <b>Laudanosine</b> can accumulate and cause seizures (low risk clinically).</li><li><b>Reversal:</b> [[neostigmine]] or other AChE inhibitors (with atropine).</li><li><b>USMLE Tip:</b> Ideal for patients with <b>renal or liver failure</b> because it doesn't need those organs to be cleared.</li></ul>",
      "takeAway": "<p><b>Atracurium</b> is a nondepolarizing paralytic safe for renal/hepatic failure due to spontaneous Hoffmann elimination, though it carries a risk of histamine release and laudanosine toxicity.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "antagonizes",
        "to": "nicotinic_acetylcholine_receptor"
      },
      {
        "type": "metabolite_is",
        "to": "laudanosine"
      },
      {
        "type": "reversed_by",
        "to": "neostigmine"
      }
    ]
  },
  "atrophy": {
    "title": "Atrophy (Muscle)",
    "primaryType": "finding",
    "tags": [
      "Pathology",
      "Neurology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Neurologic Examination",
      "Motor Signs"
    ],
    "content": {
      "definition": "<p><b>Atrophy</b> refers to the decrease in size and metabolic activity of cells or tissues; in neurology, <i>neurogenic atrophy</i> occurs rapidly following damage to the <u>lower motor neuron</u> (LMN) or its axon, leading to loss of trophic support to the muscle.</p>",
      "atAGlance": "<ul><li><b>Pathophysiology:</b> Loss of innervation leads to downregulation of protein synthesis and increased degradation (Ubiquitin-Proteasome pathway).</li><li><b>Clinical Sign:</b> Visible wasting of muscle bulk.</li><li><b>Localization:</b> A hallmark of <b>[[lower_motor_neuron]]</b> lesions (along with fasciculations and hyporeflexia). <u>Absent</u> or mild (disuse) in Upper Motor Neuron lesions.</li><li><b>Examples:</b> [[amyotrophic_lateral_sclerosis]] (LMN component), [[polio]], peripheral nerve entrapment.</li><li><b>USMLE Tip:</b> Severe wasting + Fasciculations = LMN lesion.</li></ul>",
      "takeAway": "<p><b>Atrophy</b> is a cardinal sign of <b>lower motor neuron</b> dysfunction, resulting from the loss of trophic signals required to maintain muscle mass.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_sign_of",
        "to": "lower_motor_neuron_lesion"
      },
      {
        "type": "is_contrasted_with",
        "to": "hypertrophy"
      },
      {
        "type": "seen_in",
        "to": "amyotrophic_lateral_sclerosis"
      }
    ]
  },
  "auditory_system": {
    "title": "Auditory System",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Anatomy",
      "Physiology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Sensory Systems",
      "Hearing"
    ],
    "content": {
      "definition": "<p>The <b>Auditory System</b> transduces sound waves into neural signals via the <u>Cochlea</u> and transmits them through the [[vestibulocochlear_nerve]] (CN VIII) to the brainstem and eventually the <u>Primary Auditory Cortex</u> for perception.</p>",
      "atAGlance": "<ul><li><b>Peripheral Anatomy:</b><br> - <i>Outer Ear:</i> Pinna, Auditory Canal, Tympanic Membrane.<br> - <i>Middle Ear:</i> Ossicles (Malleus, Incus, Stapes) amplify force.<br> - <i>Inner Ear:</i> <b>Cochlea</b> (Organ of Corti) performs mechanotransduction.</li><li><b>Central Pathway:</b> <b>C</b>ochlear nerve &rarr; <b>C</b>ochlear nuclei &rarr; <b>S</b>uperior Olivary Complex (Localization) &rarr; <b>L</b>ateral Lemniscus &rarr; <b>I</b>nferior Colliculus &rarr; <b>M</b>edial Geniculate Nucleus (Thalamus) &rarr; <b>A</b>uditory Cortex.</li><li><b>Tonotopy:</b> High frequencies at the <b>base</b> (stiff/narrow); Low frequencies at the <b>apex</b> (floppy/wide).</li><li><b>USMLE Tip:</b> Mnemonic for pathway: <b>C S L I M A</b> (Cochlear nuclei, Superior olive, Lateral lemniscus, Inferior colliculus, MGN, Auditory cortex).</li></ul>",
      "takeAway": "<p>The <b>Auditory System</b> converts mechanical sound energy into electrical signals in the cochlea (tonotopically organized) and relays them via a complex brainstem pathway involving the <b>Superior Olive</b> (localization) and <b>Inferior Colliculus</b> to the cortex.</p>",
      "mermaid": "graph TD; A[Sound Waves] --> B[Tympanic Membrane]; B --> C[Ossicles]; C --> D[Oval Window]; D --> E[Cochlea/Organ of Corti]; E --> F[CN VIII]; F --> G[Brainstem Pathway]; G --> H[Primary Auditory Cortex];"
    },
    "connections": [
      {
        "type": "includes",
        "to": "cochlea"
      },
      {
        "type": "includes",
        "to": "vestibulocochlear_nerve"
      },
      {
        "type": "projects_to",
        "to": "primary_auditory_cortex"
      },
      {
        "type": "synapses_in",
        "to": "medial_geniculate_nucleus"
      }
    ]
  },
  "auditory_cortex": {
    "title": "Primary Auditory Cortex",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Anatomy",
      "Hearing",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Brain Anatomy",
      "Cerebral Cortex",
      "Temporal Lobe"
    ],
    "content": {
      "definition": "<p>The <b>Primary Auditory Cortex</b> (A1, Brodmann areas 41, 42) is located on the <u>Transverse Temporal Gyri of Heschl</u> within the superior temporal lobe and is responsible for the conscious perception and processing of auditory information relayed from the [[medial_geniculate_nucleus]].</p>",
      "atAGlance": "<ul><li><b>Location:</b> Superior Temporal Gyrus (buried in the Sylvian fissure).</li><li><b>Input:</b> Auditory radiations from the <b>Medial Geniculate Nucleus (MGN)</b> of the thalamus.</li><li><b>Organization:</b> Tonotopic map (preserves frequency arrangement from the cochlea).</li><li><b>Lesions:</b><br> - <i>Unilateral:</i> Difficulty localizing sound (because auditory input is bilateral/decussates at multiple levels).<br> - <i>Bilateral:</i> Cortical deafness.</li><li><b>USMLE Tip:</b> Located adjacent to [[wernicke_area]] (posterior superior temporal gyrus), linking hearing to language comprehension.</li></ul>",
      "takeAway": "<p>The <b>Primary Auditory Cortex</b> is the final destination for the auditory pathway, located on Heschl's gyri; unilateral lesions cause localization deficits rather than deafness due to bilateral brainstem input.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "receives_input_from",
        "to": "medial_geniculate_nucleus"
      },
      {
        "type": "located_in",
        "to": "temporal_lobe"
      },
      {
        "type": "adjacent_to",
        "to": "wernicke_area"
      }
    ]
  },
  "autonomic_nervous_system": {
    "title": "Autonomic Nervous System (ANS)",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Physiology",
      "Anatomy",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Peripheral Nervous System",
      "ANS"
    ],
    "content": {
      "definition": "<p>The <b>Autonomic Nervous System (ANS)</b> is the division of the peripheral nervous system responsible for regulating involuntary physiologic processes, divided into the <u>Sympathetic</u> (\"Fight or Flight\") and <u>Parasympathetic</u> (\"Rest and Digest\") systems.</p>",
      "atAGlance": "<ul><li><b>Sympathetic (Thoracolumbar):</b><br> - Origin: T1-L2 lateral horn.<br> - Pre-ganglionic: Short, release ACh (Nicotinic).<br> - Post-ganglionic: Long, release <b>Norepinephrine</b> (Adrenergic) [Except Sweat glands: ACh].</li><li><b>Parasympathetic (Craniosacral):</b><br> - Origin: Cranial Nerves (III, VII, IX, X) & S2-S4.<br> - Pre-ganglionic: Long, release ACh (Nicotinic).<br> - Post-ganglionic: Short, release <b>ACh</b> (Muscarinic).</li><li><b>Functions:</b> Balance between arousal/catabolism (Sympathetic) and conservation/anabolism (Parasympathetic).</li><li><b>USMLE Tip:</b> The <b>Adrenal Medulla</b> is essentially a modified sympathetic ganglion directly innervated by pre-ganglionic fibers (ACh).</li></ul>",
      "takeAway": "<p>The <b>ANS</b> maintains homeostasis through opposing Sympathetic and Parasympathetic divisions, utilizing specific neurotransmitters (ACh, NE) at ganglionic and effector sites.</p>",
      "mermaid": "graph TD; A[CNS Output] --> B{Division?}; B -->|Sympathetic| C[Short Pre-ganglionic (ACh)]; C --> D[Sympathetic Chain/Ganglia]; D --> E[Long Post-ganglionic (NE)]; B -->|Parasympathetic| F[Long Pre-ganglionic (ACh)]; F --> G[Terminal Ganglia]; G --> H[Short Post-ganglionic (ACh)];"
    },
    "connections": [
      {
        "type": "utilizes",
        "to": "acetylcholine"
      },
      {
        "type": "utilizes",
        "to": "norepinephrine"
      },
      {
        "type": "regulates",
        "to": "heart_rate"
      },
      {
        "type": "includes",
        "to": "vagus_nerve"
      }
    ]
  },
  "autosomal_dominant_inheritance": {
    "title": "Autosomal Dominant Inheritance",
    "primaryType": "concept",
    "tags": [
      "Genetics",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Genetics",
      "Inheritance Patterns"
    ],
    "content": {
      "definition": "<p><b>Autosomal Dominant</b> is a pattern of inheritance where a single copy of a mutated gene on a non-sex chromosome is sufficient to cause the phenotype, typically involving <u>structural proteins</u> or receptors.</p>",
      "atAGlance": "<ul><li><b>Risk:</b> 50% chance of passing to offspring if one parent is affected (heterozygous).</li><li><b>Features:</b><br> - <b>Vertical Transmission:</b> Seen in every generation.<br> - <b>Structural Defects:</b> Often involves structural proteins (e.g., Collagen, Fibrillin, Spectrin).<br> - <b>Variable Expressivity:</b> Severity varies among affected individuals (e.g., [[neurofibromatosis_type_1]] (NF1)).<br> - <b>Incomplete Penetrance:</b> Not everyone with the gene shows the phenotype (e.g., BRCA1).</li><li><b>Examples:</b> [[marfan_syndrome]], [[huntington_disease]], [[achondroplasia]], [[autosomal_dominant_polycystic_kidney_disease]], [[familial_hypercholesterolemia]].</li><li><b>USMLE Tip:</b> Male-to-male transmission can occur (rules out X-linked).</li></ul>",
      "takeAway": "<p><b>Autosomal Dominant</b> diseases typically involve structural proteins, appear in every generation, and carry a 50% recurrence risk for offspring of an affected parent.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_pattern_of",
        "to": "marfan_syndrome"
      },
      {
        "type": "is_pattern_of",
        "to": "neurofibromatosis_type_1"
      },
      {
        "type": "is_pattern_of",
        "to": "huntington_disease"
      },
      {
        "type": "is_pattern_of",
        "to": "autosomal_dominant_polycystic_kidney_disease"
      }
    ]
  },
  "autosomal_dominant_polycystic_kidney_disease": {
    "title": "Autosomal Dominant Polycystic Kidney Disease (ADPKD)",
    "primaryType": "disease",
    "tags": [
      "Nephrology",
      "Genetics",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Nephrology",
      "Cystic Diseases",
      "ADPKD"
    ],
    "content": {
      "definition": "<p><b>Autosomal Dominant Polycystic Kidney Disease (ADPKD)</b> is the most common inherited kidney disease, caused by mutations in <i>PKD1</i> (Chr 16) or <i>PKD2</i> (Chr 4), leading to the formation of multiple fluid-filled cysts that progressively destroy renal parenchyma.</p>",
      "atAGlance": "<ul><li><b>Genetics:</b> <b>PKD1</b> (85%, Ch 16, more severe) or <b>PKD2</b> (15%, Ch 4). \"PKD1 on 16 letters (Polycystic Kidney)\".</li><li><b>Pathophysiology:</b> Defective polycystin proteins &rarr; Ciliopathy &rarr; Fluid secretion/cyst growth in cortex and medulla.</li><li><b>Clinical Presentation:</b> Flank pain, hematuria, hypertension, progressive renal failure (ESRD) in adulthood (40s-50s).</li><li><b>Extra-renal Manifestations:</b> <b>Berry Aneurysms</b> (Subarachnoid hemorrhage risk), Hepatic cysts, Mitral Valve Prolapse.</li><li><b>USMLE Tip:</b> A patient with bilateral flank masses + hypertension + family history of sudden death (aneurysm rupture) = ADPKD.</li></ul>",
      "takeAway": "<p><b>ADPKD</b> is an adult-onset cystic kidney disease associated with <b>PKD1/2</b> mutations, hypertension, and a critical risk of <b>Berry Aneurysms</b>.</p>",
      "mermaid": "graph TD; A[PKD1/PKD2 Mutation] --> B[Defective Polycystin]; B --> C[Tubular Epithelial Proliferation]; C --> D[Cyst Formation]; D --> E[Renal Parenchymal Compression]; E --> F[End Stage Renal Disease];"
    },
    "connections": [
      {
        "type": "associated_with",
        "to": "saccular_aneurysm"
      },
      {
        "type": "associated_with",
        "to": "mitral_valve_prolapse"
      },
      {
        "type": "causes",
        "to": "hypertension"
      },
      {
        "type": "is_contrasted_with",
        "to": "autosomal_recessive_polycystic_kidney_disease"
      }
    ]
  },
  "autosomal_recessive_inheritance": {
    "title": "Autosomal Recessive Inheritance",
    "primaryType": "concept",
    "tags": [
      "Genetics",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Genetics",
      "Inheritance Patterns"
    ],
    "content": {
      "definition": "<p><b>Autosomal Recessive</b> is a pattern of inheritance where two copies of a mutated gene are required to cause the phenotype, typically involving <u>enzyme deficiencies</u>.</p>",
      "atAGlance": "<ul><li><b>Risk:</b> 25% chance of affected offspring if both parents are carriers (heterozygous).</li><li><b>Features:</b><br> - <b>Horizontal Transmission:</b> Often seen in only one generation (siblings).<br> - <b>Enzyme Defects:</b> Heterozygotes usually produce enough functional enzyme to be asymptomatic (carriers).<br> - <b>Consanguinity:</b> Increases risk.</li><li><b>Examples:</b> [[cystic_fibrosis]], [[phenylketonuria]], [[sickle_cell_anemia]], [[tay_sachs_disease]], [[autosomal_recessive_polycystic_kidney_disease]].</li><li><b>USMLE Tip:</b> Most metabolic disorders (enzyme deficiencies) are Autosomal Recessive. Exception: Hunter syndrome, OTC deficiency (X-linked).</li></ul>",
      "takeAway": "<p><b>Autosomal Recessive</b> diseases typically involve enzyme deficiencies, require two carrier parents, and carry a 25% recurrence risk.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_pattern_of",
        "to": "cystic_fibrosis"
      },
      {
        "type": "is_pattern_of",
        "to": "sickle_cell_anemia"
      },
      {
        "type": "is_pattern_of",
        "to": "phenylketonuria"
      },
      {
        "type": "is_pattern_of",
        "to": "autosomal_recessive_polycystic_kidney_disease"
      }
    ]
  },
  "axonal_injury": {
    "title": "Axonal Injury (Reaction)",
    "primaryType": "process",
    "tags": [
      "Neurology",
      "Pathology",
      "Histology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Neuronal Pathology",
      "Cellular Response"
    ],
    "content": {
      "definition": "<p><b>Axonal Injury</b> triggers specific cellular responses: <u>Wallerian Degeneration</u> occurs distal to the lesion (axonal breakdown), while the cell body undergoes the <u>Axonal Reaction</u> (central chromatolysis) to support regeneration.</p>",
      "atAGlance": "<ul><li><b>Wallerian Degeneration (Distal):</b><br> - Degeneration of axon and myelin sheath distal to injury.<br> - Macrophages remove debris.<br> - <i>PNS:</i> Schwann cells promote regeneration.<br> - <i>CNS:</i> Oligodendrocytes/Astrocytes inhibit regeneration (glial scar).</li><li><b>Axonal Reaction (Proximal/Soma):</b><br> - <b>Central Chromatolysis:</b> Cell body swells, nucleus moves to periphery, Nissl substance disperses.<br> - <i>Purpose:</i> Increased protein synthesis for repair.</li><li><b>Diffuse Axonal Injury (DAI):</b> Traumatic shearing of white matter tracts (e.g., rapid deceleration). MRI shows punctate hemorrhages (gray-white junction). Major cause of coma/PVS.</li><li><b>USMLE Tip:</b> \"Chromatolysis\" looks like the cell is falling apart, but it's actually revving up for repair.</li></ul>",
      "takeAway": "<p><b>Axonal Injury</b> leads to distal Wallerian degeneration and proximal central chromatolysis; regeneration is possible in the PNS (Schwann cells) but inhibited in the CNS (glial scar).</p>",
      "mermaid": "graph TD; A[Axonal Transsection] --> B[Distal Segment]; A --> C[Proximal Soma]; B --> D[Wallerian Degeneration]; D --> E[Myelin/Axon Clearance]; C --> F[Central Chromatolysis]; F --> G[Protein Synthesis/Repair Attempt];"
    },
    "connections": [
      {
        "type": "involves_process",
        "to": "wallerian_degeneration"
      },
      {
        "type": "manifests_as",
        "to": "central_chromatolysis"
      },
      {
        "type": "is_inhibited_by",
        "to": "reactive_gliosis"
      },
      {
        "type": "includes_type",
        "to": "diffuse_axonal_injury"
      }
    ]
  },
  "babinski_reflex": {
    "title": "Babinski Reflex (Plantar Reflex)",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Physical Exam",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Neurologic Examination",
      "Reflexes"
    ],
    "content": {
      "definition": "<p>The <b>Babinski Reflex</b> is a primitive reflex elicited by stroking the lateral sole of the foot; a \"positive\" sign (dorsiflexion/extension of the big toe and fanning of other toes) indicates <u>Upper Motor Neuron (UMN)</u> dysfunction in adults.</p>",
      "atAGlance": "<ul><li><b>Normal Response (Adult):</b> Plantar flexion (down-going toes).</li><li><b>Positive Sign (Pathologic):</b> <b>Dorsiflexion</b> (up-going) of the great toe + fanning of toes.</li><li><b>Significance:</b> Specific sign of <b>Upper Motor Neuron</b> (corticospinal tract) lesion.</li><li><b>Infants:</b> Positive Babinski is <b>normal</b> in infants up to ~12 months due to incomplete myelination of the corticospinal tracts.</li><li><b>USMLE Tip:</b> Presence of Babinski sign rules out LMN lesion (which would cause flaccid paralysis/areflexia).</li></ul>",
      "takeAway": "<p>The <b>Babinski Sign</b> is the quintessential sign of corticospinal tract (UMN) dysfunction in adults, though it is physiologic in infants prior to myelination.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "indicates_dysfunction_of",
        "to": "upper_motor_neuron"
      },
      {
        "type": "indicates_dysfunction_of",
        "to": "corticospinal_tract"
      },
      {
        "type": "is_distinguished_from",
        "to": "lower_motor_neuron_lesion"
      }
    ]
  }
}
``````json
{
  "upper_motor_neuron_lesion": {
    "title": "Upper Motor Neuron (UMN) Lesion",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Motor Neuron Diseases",
      "Upper Motor Neuron"
    ],
    "content": {
      "definition": "<p>An <b>Upper Motor Neuron (UMN) Lesion</b> involves damage to the neural pathways above the anterior horn cells (e.g., cortex, internal capsule, corticospinal tract), resulting in a loss of inhibitory modulation over lower motor neurons.</p>",
      "atAGlance": "<ul><li><b>Muscle Tone:</b> Increased (Spasticity), \"Clasp-knife\" rigidity.</li><li><b>Reflexes:</b> Hyperreflexia (3+), Clonus.</li><li><b>Babinski Sign:</b> Positive (Up-going toes) in adults; normal in infants <1 year.</li><li><b>Muscle Bulk:</b> Preserved (no significant atrophy initially; disuse atrophy may occur late).</li><li><b>Fasciculations:</b> Absent.</li><li><b>Distribution:</b> Often affects groups of muscles (e.g., hemiparesis).</li><li><b>USMLE Tip:</b> \"Everything goes <b>UP</b> in an <b>U</b>pper Motor Neuron lesion\" (Tone, Reflexes, Toes).</li></ul>",
      "takeAway": "<p><b>UMN lesions</b> result in spastic paralysis, hyperreflexia, and a positive Babinski sign due to the loss of descending inhibitory control, contrasting with the flaccid paralysis of LMN lesions.</p>",
      "mermaid": "graph TD; A[Corticospinal Tract Damage] --> B[Loss of Inhibition]; B --> C[Anterior Horn Cell Hyperactivity]; C --> D[Spasticity]; C --> E[Hyperreflexia]; A --> F[Primitive Reflex Release]; F --> G[Positive Babinski];"
    },
    "connections": [
      {
        "type": "manifests_as",
        "to": "babinski_reflex"
      },
      {
        "type": "causes",
        "to": "spasticity"
      },
      {
        "type": "is_contrasted_with",
        "to": "lower_motor_neuron_lesion"
      }
    ]
  },
  "baclofen": {
    "title": "Baclofen",
    "primaryType": "substance",
    "tags": [
      "Pharmacology",
      "Neurology",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Muscle Relaxants",
      "Centrally Acting"
    ],
    "content": {
      "definition": "<p><b>Baclofen</b> is a centrally acting skeletal muscle relaxant that functions as a <b>GABA<sub>B</sub></b> receptor agonist within the spinal cord, leading to hyperpolarization of neurons and inhibition of monosynaptic and polysynaptic reflexes.</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> Agonist at <b>GABA<sub>B</sub></b> receptors (metabotropic, G<sub>i</sub>-coupled) &rarr; Increases K<sup>+</sup> efflux &rarr; Hyperpolarization &rarr; Decreased release of excitatory neurotransmitters (Glutamate/Aspartate).</li><li><b>Clinical Use:</b> Chronic spasticity (e.g., [[multiple_sclerosis]], cerebral palsy, spinal cord injury), Dystonia.</li><li><b>Adverse Effects:</b> Sedation, drowsiness, muscle weakness.</li><li><b>Withdrawal:</b> Abrupt cessation can cause severe rebound spasticity, rhabdomyolysis, and seizures.</li><li><b>USMLE Tip:</b> Acts on the <b>Back</b> (Spinal Cord) = <b>Bac</b>lofen.</li></ul>",
      "takeAway": "<p><b>Baclofen</b> targets GABA<sub>B</sub> receptors in the spinal cord to treat spasticity associated with UMN disorders like [[multiple_sclerosis]].</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "agonizes",
        "to": "gaba_b_receptor"
      },
      {
        "type": "treats",
        "to": "spasticity"
      },
      {
        "type": "treats",
        "to": "multiple_sclerosis"
      }
    ]
  },
  "barbiturates": {
    "title": "Barbiturates",
    "primaryType": "substance",
    "tags": [
      "Pharmacology",
      "Neurology",
      "Psychiatry",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Sedative-Hypnotics",
      "Barbiturates"
    ],
    "content": {
      "definition": "<p><b>Barbiturates</b> (e.g., [[phenobarbital]], [[thiopental]]) are sedative-hypnotic drugs that potentiate the effect of GABA at the GABA<sub>A</sub> receptor by increasing the <u>duration</u> of chloride channel opening.</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> Bind to allosteric site on GABA<sub>A</sub> receptor &rarr; Increase <b>Duration</b> of Cl<sup>-</sup> channel opening (\"Barbi<b>durat</b>es\"). At high doses, can mimic GABA directly (narrow therapeutic index).</li><li><b>Clinical Uses:</b><br> - <i>Thiopental:</i> Anesthesia induction (rapid redistribution to fat).<br> - <i>Phenobarbital:</i> Seizures (infants), Gilbert syndrome (induces glucuronidation).<br> - <i>Primidone:</i> Essential tremor.</li><li><b>Adverse Effects:</b> Severe respiratory/CV depression, CNS depression, dependence, <b>P450 Induction</b> (decreases levels of warfarin, etc.). Contraindicated in [[porphyria]].</li><li><b>USMLE Tip:</b> <b>Barbi</b>durates increase <b>Duration</b>; <b>Frenz</b>odiazepines increase <b>Frequency</b>. No antidote for overdose (unlike flumazenil for benzos).</li></ul>",
      "takeAway": "<p><b>Barbiturates</b> are potent GABA<sub>A</sub> modulators increasing channel opening duration, notable for P450 induction, lack of a reversal agent, and contraindication in porphyria.</p>",
      "mermaid": "graph TD; A[Barbiturate Binding] --> B[GABA-A Receptor]; B --> C[Increased Duration of Cl- Opening]; C --> D[Hyperpolarization]; D --> E[CNS Depression];"
    },
    "connections": [
      {
        "type": "modulates",
        "to": "gaba_a_receptor"
      },
      {
        "type": "includes",
        "to": "phenobarbital"
      },
      {
        "type": "includes",
        "to": "thiopental"
      },
      {
        "type": "induces",
        "to": "cytochrome_p450"
      },
      {
        "type": "contraindicated_in",
        "to": "acute_intermittent_porphyria"
      }
    ]
  },
  "basal_ganglia": {
    "title": "Basal Ganglia",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Anatomy",
      "Motor Control",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Brain Anatomy",
      "Subcortical Structures"
    ],
    "content": {
      "definition": "<p>The <b>Basal Ganglia</b> are a group of subcortical nuclei (Striatum, Globus Pallidus, Subthalamic Nucleus, Substantia Nigra) that regulate voluntary motor control, procedural learning, and emotion via the <u>Direct</u> (excitatory) and <u>Indirect</u> (inhibitory) pathways.</p>",
      "atAGlance": "<ul><li><b>Components:</b><br> - <i>Striatum:</i> [[caudate_nucleus]] + [[putamen]] (Input).<br> - <i>Lentiform Nucleus:</i> Putamen + [[globus_pallidus]].<br> - <i>Output:</i> GPi / SNr inhibit the Thalamus.</li><li><b>Pathways:</b><br> - <b>Direct (D1):</b> Disinhibits Thalamus &rarr; Facilitates movement.<br> - <b>Indirect (D2):</b> Inhibits Thalamus &rarr; Suppresses movement.</li><li><b>Pathology:</b><br> - <i>Parkinson's:</i> Loss of Dopamine (SNc) &rarr; Loss of Direct/Disinhibition of Indirect &rarr; Bradykinesia.<br> - <i>Huntington's:</i> Loss of Indirect pathway (Caudate) &rarr; Hyperkinesia (Chorea).<br> - <i>Hemiballismus:</i> Lesion of [[subthalamic_nucleus]].</li></ul>",
      "takeAway": "<p>The <b>Basal Ganglia</b> modulate motor output; the Direct pathway says \"Go\" (D1), the Indirect pathway says \"No\" (D2), and dopamine from the substantia nigra stimulates \"Go\" and inhibits \"No\".</p>",
      "mermaid": "graph TD; A[Cortex] --> B[Striatum]; B -->|Direct D1| C[GPi/SNr]; B -->|Indirect D2| D[GPe]; D --> E[Subthalamic Nucleus]; E --> C; C -->|Inhibits| F[Thalamus]; F -->|Excites| A;"
    },
    "connections": [
      {
        "type": "includes",
        "to": "striatum"
      },
      {
        "type": "includes",
        "to": "substantia_nigra"
      },
      {
        "type": "includes",
        "to": "subthalamic_nucleus"
      },
      {
        "type": "dysfunction_causes",
        "to": "parkinson_disease"
      },
      {
        "type": "dysfunction_causes",
        "to": "huntington_disease"
      }
    ]
  },
  "basal_nucleus_of_meynert": {
    "title": "Basal Nucleus of Meynert",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Anatomy",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Brain Anatomy",
      "Forebrain"
    ],
    "content": {
      "definition": "<p>The <b>Basal Nucleus of Meynert</b> is a group of neurons in the substantia innominata of the basal forebrain that serves as the major source of <u>cholinergic innervation</u> to the cerebral cortex.</p>",
      "atAGlance": "<ul><li><b>Function:</b> Synthesis and projection of [[acetylcholine]] to the neocortex; critical for arousal, attention, and memory.</li><li><b>Pathology:</b> Degeneration of cholinergic neurons in this nucleus is a hallmark of <b>[[alzheimer_disease]]</b>.</li><li><b>Pharmacology:</b> Targeted by AChE inhibitors (e.g., [[donepezil]], [[rivastigmine]]) to treat Alzheimer symptoms.</li><li><b>USMLE Tip:</b> Decreased ACh in Alzheimer's is due to loss of the Basal Nucleus of Meynert. Decreased GABA in Huntington's is due to Caudate atrophy.</li></ul>",
      "takeAway": "<p>The <b>Basal Nucleus of Meynert</b> is the brain's cholinergic hub; its degeneration drives the cognitive decline in [[alzheimer_disease]].</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "synthesizes",
        "to": "acetylcholine"
      },
      {
        "type": "degenerates_in",
        "to": "alzheimer_disease"
      }
    ]
  },
  "basal_plate": {
    "title": "Basal Plate",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Embryology",
      "Anatomy",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Neuroembryology",
      "Neural Tube Development"
    ],
    "content": {
      "definition": "<p>The <b>Basal Plate</b> is the <i>ventral</i> region of the developing neural tube, induced by <u>Sonic Hedgehog (SHH)</u> signaling from the notochord, which differentiates into motor neurons and interneurons of the spinal cord and brainstem.</p>",
      "atAGlance": "<ul><li><b>Location:</b> Ventral (anterior) portion of the neural tube.</li><li><b>Signaling Factor:</b> Induced by <b>Sonic Hedgehog (SHH)</b> from the [[notochord]]/floor plate.</li><li><b>Derivatives:</b> Motor nuclei of the [[spinal_cord]] (ventral horn) and brainstem motor nuclei (e.g., Hypoglossal nucleus).</li><li><b>Orientation:</b> Ventral = Motor (Basal); Dorsal = Sensory (Alar).</li><li><b>USMLE Tip:</b> Remember <b>B</b>asal = <b>B</b>elly (Ventral) = Motor.</li></ul>",
      "takeAway": "<p>The <b>Basal Plate</b> is the ventral, motor division of the developing nervous system, regulated by SHH signaling, standing in contrast to the dorsal, sensory [[alar_plate]].</p>",
      "mermaid": "graph TD; A[Neural Tube] --> B[Basal Plate (Ventral)]; A --> C[Alar Plate (Dorsal)]; B --> D[Motor Neurons]; C --> E[Sensory Neurons];"
    },
    "connections": [
      {
        "type": "differentiates_into",
        "to": "motor_neurons"
      },
      {
        "type": "is_induced_by",
        "to": "sonic_hedgehog"
      },
      {
        "type": "is_contrasted_with",
        "to": "alar_plate"
      }
    ]
  },
  "basement_membrane": {
    "title": "Basement Membrane",
    "primaryType": "structure",
    "tags": [
      "Histology",
      "Pathology",
      "Nephrology",
      "USMLE"
    ],
    "classificationPath": [
      "Histology",
      "Extracellular Matrix"
    ],
    "content": {
      "definition": "<p>The <b>Basement Membrane</b> is a specialized extracellular matrix sheet composed primarily of <u>Type IV collagen</u>, laminin, and proteoglycans, anchoring epithelium to connective tissue and functioning as a selective filtration barrier.</p>",
      "atAGlance": "<ul><li><b>Components:</b> Type <b>IV</b> Collagen (floor), Laminin, Fibronectin, Entactin.</li><li><b>Functions:</b> Cell anchorage, filtration (Kidney), scaffold for regeneration.</li><li><b>Pathology:</b><br> - <b>[[alport_syndrome]]:</b> Defect in Type IV collagen (splitting of GBM) &rarr; Hematuria, Deafness.<br> - <b>[[goodpasture_syndrome]]:</b> Autoantibodies against Type IV collagen (Anti-GBM) &rarr; Hematuria, Hemoptysis.</li><li><b>Blood-Brain Barrier:</b> Fused basement membrane of endothelial cells and astrocyte foot processes.</li><li><b>USMLE Tip:</b> Type <b>IV</b> collagen is under the <b>Floor</b> (Basement membrane).</li></ul>",
      "takeAway": "<p>The <b>Basement Membrane</b> relies on Type IV collagen for structural integrity; defects lead to Alport syndrome, while autoimmune attack causes Goodpasture syndrome.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "contains",
        "to": "type_iv_collagen"
      },
      {
        "type": "is_damaged_in",
        "to": "alport_syndrome"
      },
      {
        "type": "is_targeted_in",
        "to": "goodpasture_syndrome"
      },
      {
        "type": "is_part_of",
        "to": "blood_brain_barrier"
      }
    ]
  },
  "basilar_artery": {
    "title": "Basilar Artery",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Vascular",
      "Anatomy",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Cerebrovascular System",
      "Vertebrobasilar System"
    ],
    "content": {
      "definition": "<p>The <b>Basilar Artery</b> is a major midline vessel formed by the confluence of the two [[vertebral_artery|vertebral arteries]], supplying the brainstem, cerebellum, and posterior cerebrum before bifurcating into the posterior cerebral arteries (PCA).</p>",
      "atAGlance": "<ul><li><b>Formation:</b> Junction of vertebral arteries at the pontomedullary junction.</li><li><b>Branches:</b> [[anterior_inferior_cerebellar_artery]] (AICA), Pontine arteries, [[superior_cerebellar_artery]] (SCA), [[posterior_cerebral_artery]] (PCA).</li><li><b>Stroke Syndromes:</b><br> - <b>Locked-in Syndrome:</b> Basilar artery thrombosis affecting the ventral pons (bilateral corticospinal/bulbar tracts). Preserves vertical eye movements (CN III) and consciousness (RAS).<br> - <b>Top of the Basilar Syndrome:</b> Embolus to top of basilar &rarr; Ischemia of midbrain/thalamus/temporal/occipital lobes (hallucinations, blindness, consciousness issues).</li><li><b>USMLE Tip:</b> Patient is paralyzed but can blink and look up? Think <b>Basilar</b> thrombosis (Locked-in).</li></ul>",
      "takeAway": "<p>The <b>Basilar Artery</b> is the lifeline of the brainstem; occlusion can lead to the catastrophic Locked-in Syndrome, sparing only vertical gaze and consciousness.</p>",
      "mermaid": "graph TD; A[Vertebral Arteries] --> B[Basilar Artery]; B --> C[AICA]; B --> D[Pontine Arteries]; B --> E[Superior Cerebellar Arteries]; B --> F[Posterior Cerebral Arteries];"
    },
    "connections": [
      {
        "type": "is_formed_by",
        "to": "vertebral_artery"
      },
      {
        "type": "gives_rise_to",
        "to": "posterior_cerebral_artery"
      },
      {
        "type": "occlusion_causes",
        "to": "locked_in_syndrome"
      }
    ]
  },
  "rem_sleep_behavior_disorder": {
    "title": "REM Sleep Behavior Disorder",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Psychiatry",
      "Sleep Medicine",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Sleep Disorders",
      "Parasomnias"
    ],
    "content": {
      "definition": "<p><b>REM Sleep Behavior Disorder (RBD)</b> is a parasomnia characterized by the <u>loss of normal muscle atonia</u> during REM sleep, resulting in the physical enactment of vivid, often unpleasant dreams.</p>",
      "atAGlance": "<ul><li><b>Pathophysiology:</b> Dysfunction of brainstem nuclei (e.g., perilocus coeruleus) that normally inhibit spinal motor neurons during REM.</li><li><b>Clinical Presentation:</b> Punching, kicking, yelling during sleep; patient recalls the dream if awakened.</li><li><b>Associations:</b> Strong predictor of <b>Synucleinopathies</b>: [[parkinson_disease]], [[lewy_body_dementia]], Multiple System Atrophy (MSA). Can precede motor symptoms by decades.</li><li><b>Treatment:</b> Clonazepam, Melatonin.</li><li><b>USMLE Tip:</b> An elderly man \"acting out dreams\" is a harbinger of Lewy Body Dementia or Parkinson's.</li></ul>",
      "takeAway": "<p><b>REM Sleep Behavior Disorder</b> involves the failure of REM atonia and is a specific prodromal marker for alpha-synuclein neurodegenerative diseases like Parkinson's and Lewy Body Dementia.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_associated_with",
        "to": "lewy_body_dementia"
      },
      {
        "type": "is_associated_with",
        "to": "parkinson_disease"
      },
      {
        "type": "treated_by",
        "to": "clonazepam"
      }
    ]
  },
  "limbic_system": {
    "title": "Limbic System",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Anatomy",
      "Behavior",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Brain Anatomy",
      "Functional Systems"
    ],
    "content": {
      "definition": "<p>The <b>Limbic System</b> is a complex set of brain structures (including the [[hippocampus]], [[amygdala]], [[hypothalamus]], and cingulate gyrus) responsible for regulating <u>emotion, behavior, motivation, long-term memory</u>, and olfaction.</p>",
      "atAGlance": "<ul><li><b>Key Structures:</b><br> - <b>Hippocampus:</b> Memory formation.<br> - <b>Amygdala:</b> Emotion (Fear/Aggression).<br> - <b>Mammillary Bodies:</b> Memory (damaged in Wernicke-Korsakoff).<br> - <b>Nucleus Accumbens:</b> Reward/Addiction.<br> - <b>Cingulate Gyrus:</b> Emotion/Pain processing.</li><li><b>Function (The 5 F's):</b> <b>F</b>eeding, <b>F</b>leeing, <b>F</b>ighting, <b>F</b>eeling, and <b>S</b>ex.</li><li><b>Circuitry:</b> Papez Circuit (Hippocampus &rarr; Fornix &rarr; Mammillary Bodies &rarr; Thalamus &rarr; Cingulate &rarr; Hippocampus).</li><li><b>Pathology:</b> [[kluver_bucy_syndrome]] (HSV-1 damage to amygdala), Wernicke-Korsakoff (Mammillary bodies).</li></ul>",
      "takeAway": "<p>The <b>Limbic System</b> integrates primitive drives (Feeding, Fighting, Sex) with higher cognitive functions (Memory, Emotion); its dysfunction leads to profound behavioral and amnestic syndromes.</p>",
      "mermaid": "graph TD; A[Hippocampus] -->|Fornix| B[Mammillary Bodies]; B -->|Mammillothalamic Tract| C[Anterior Thalamic Nucleus]; C --> D[Cingulate Gyrus]; D --> A;"
    },
    "connections": [
      {
        "type": "includes",
        "to": "amygdala"
      },
      {
        "type": "includes",
        "to": "hippocampus"
      },
      {
        "type": "includes",
        "to": "hypothalamus"
      },
      {
        "type": "dysfunction_causes",
        "to": "kluver_bucy_syndrome"
      }
    ]
  },
  "benzocaine": {
    "title": "Benzocaine",
    "primaryType": "substance",
    "tags": [
      "Pharmacology",
      "Anesthesiology",
      "Hematology",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Local Anesthetics",
      "Esters"
    ],
    "content": {
      "definition": "<p><b>Benzocaine</b> is an ester local anesthetic commonly used topically (e.g., for sunburns or throat pain) that is notable for its ability to oxidize hemoglobin, causing [[methemoglobinemia]].</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> Blocks voltage-gated [[sodium_channel]]s &rarr; blocks nerve conduction.</li><li><b>Adverse Effect:</b> <b>Methemoglobinemia</b> (Oxidizes Fe<sup>2+</sup> to Fe<sup>3+</sup>).</li><li><b>Clinical Presentation:</b> Cyanosis, \"Chocolate-colored blood\", shortness of breath, normal PaO<sub>2</sub> but low SaO<sub>2</sub>.</li><li><b>Treatment of Toxicity:</b> [[methylene_blue]] (reduces Fe<sup>3+</sup> back to Fe<sup>2+</sup>).</li><li><b>USMLE Tip:</b> Look for a patient using throat spray or topical analgesic who suddenly turns blue.</li></ul>",
      "takeAway": "<p><b>Benzocaine</b> is a topical ester anesthetic with the specific board-relevant side effect of inducing <mark>methemoglobinemia</mark>, treated with Methylene Blue.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_a_type_of",
        "to": "local_anesthetics"
      },
      {
        "type": "causes",
        "to": "methemoglobinemia"
      },
      {
        "type": "toxicity_treated_by",
        "to": "methylene_blue"
      }
    ]
  },
  "benzodiazepines": {
    "title": "Benzodiazepines",
    "primaryType": "substance",
    "tags": [
      "Pharmacology",
      "Neurology",
      "Psychiatry",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Psychotropic Drugs",
      "GABA Modulators"
    ],
    "content": {
      "definition": "<p><b>Benzodiazepines</b> (e.g., Diazepam, Lorazepam, Midazolam) are CNS depressants that act as positive allosteric modulators of the <u>GABA<sub>A</sub> receptor</u>, increasing the <b>frequency</b> of chloride channel opening.</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> Bind to allosteric site on GABA<sub>A</sub> &rarr; Increase <b>Frequency</b> of Cl<sup>-</sup> channel opening (\"Frenzodiazepines\").</li><li><b>Uses:</b> Anxiety, Spasticity, [[status_epilepticus]] (Lorazepam), Alcohol withdrawal, Anesthesia (Midazolam), Night terrors.</li><li><b>Metabolism:</b> Most hepatic. \"LOT\" drugs (<b>L</b>orazepam, <b>O</b>xazepam, <b>T</b>emazepam) bypass Phase I metabolism (Safe in Liver failure).</li><li><b>Adverse Effects:</b> Sedation, dependence, respiratory depression (esp. with alcohol).</li><li><b>Overdose Reversal:</b> [[flumazenil]] (Competitive antagonist). Warning: Can precipitate seizures in chronic users.</li><li><b>USMLE Tip:</b> Barbiturates increase <b>Duration</b>; Benzodiazepines increase <b>Frequency</b>.</li></ul>",
      "takeAway": "<p><b>Benzodiazepines</b> facilitate GABAergic inhibition by increasing channel opening frequency; they are first-line for status epilepticus and alcohol withdrawal, with overdose reversed by Flumazenil.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "modulates",
        "to": "gaba_a_receptor"
      },
      {
        "type": "treats",
        "to": "status_epilepticus"
      },
      {
        "type": "treats",
        "to": "alcohol_withdrawal"
      },
      {
        "type": "reversed_by",
        "to": "flumazenil"
      },
      {
        "type": "includes",
        "to": "alprazolam"
      }
    ]
  },
  "benztropine": {
    "title": "Benztropine",
    "primaryType": "substance",
    "tags": [
      "Pharmacology",
      "Neurology",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Neurology Drugs",
      "Antimuscarinics"
    ],
    "content": {
      "definition": "<p><b>Benztropine</b> is a centrally acting <i>antimuscarinic</i> agent used to treat tremor and rigidity in [[parkinson_disease]] and to reverse drug-induced [[extrapyramidal_symptoms]] (specifically acute dystonia).</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> Blocks muscarinic (M1) receptors in the striatum, restoring the balance between Dopamine (low) and Acetylcholine (high).</li><li><b>Clinical Use:</b><br> - <b>Parkinson's:</b> Treats <u>Tremor</u> and <u>Rigidity</u> (little effect on bradykinesia).<br> - <b>EPS:</b> Drug of choice for acute <b>Dystonia</b> (e.g., from Haloperidol).</li><li><b>Adverse Effects:</b> Anticholinergic toxicity (Dry mouth, Urinary retention, Confusion/Delirium).</li><li><b>USMLE Tip:</b> \"<b>Park</b> my <b>Benz</b>\" (Benztropine for Parkinson's). Avoid in elderly (delirium risk).</li></ul>",
      "takeAway": "<p><b>Benztropine</b> targets the cholinergic excess in the striatum, making it effective for Parkinsonian tremor and antipsychotic-induced dystonia.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_a_type_of",
        "to": "antimuscarinic_drugs"
      },
      {
        "type": "treats",
        "to": "parkinson_disease"
      },
      {
        "type": "treats",
        "to": "dystonia"
      },
      {
        "type": "treats_side_effect_of",
        "to": "antipsychotics"
      }
    ]
  },
  "betaxolol": {
    "title": "Betaxolol",
    "primaryType": "substance",
    "tags": [
      "Pharmacology",
      "Ophthalmology",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Ophthalmic Drugs",
      "Beta Blockers"
    ],
    "content": {
      "definition": "<p><b>Betaxolol</b> is a cardioselective (&beta;<sub>1</sub>) <i>beta-blocker</i> commonly used as ophthalmic drops to treat [[glaucoma]] by decreasing the secretion of aqueous humor.</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> Blocks &beta; receptors on the ciliary epithelium &rarr; Decreases cAMP &rarr; Decreases <b>production</b> of aqueous humor.</li><li><b>Selectivity:</b> &beta;<sub>1</sub> selective (unlike Timolol, which is non-selective). Theoretically less risk of bronchospasm in asthmatics, but caution is still advised.</li><li><b>Clinical Use:</b> Open-angle [[glaucoma]].</li><li><b>USMLE Tip:</b> Beta-blockers decrease <b>production</b> (ciliary epithelium). Prostaglandins increase <b>outflow</b>.</li></ul>",
      "takeAway": "<p><b>Betaxolol</b> reduces intraocular pressure in glaucoma by inhibiting aqueous humor synthesis, offering a &beta;1-selective alternative to Timolol.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "treats",
        "to": "glaucoma"
      },
      {
        "type": "decreases_production_of",
        "to": "aqueous_humor"
      },
      {
        "type": "is_a_type_of",
        "to": "beta_blocker"
      }
    ]
  }
}
``````json
{
  "biceps_reflex": {
    "title": "Biceps Reflex",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Physical Exam",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Neurologic Examination",
      "Deep Tendon Reflexes"
    ],
    "content": {
      "definition": "<p>The <b>Biceps Reflex</b> is a deep tendon reflex mediated by the <u>C5 and C6</u> nerve roots, testing the integrity of the [[musculocutaneous_nerve]] and the C5/C6 spinal segments.</p>",
      "atAGlance": "<ul><li><b>Nerve Roots:</b> <b>C5</b>, C6.</li><li><b>Nerve:</b> [[musculocutaneous_nerve]].</li><li><b>Action:</b> Flexion of the elbow when the biceps tendon is struck.</li><li><b>Clinical Significance:</b><br> - <i>Decreased:</i> Lower motor neuron lesion (e.g., C5/C6 radiculopathy, peripheral neuropathy).<br> - <i>Hyperactive:</i> Upper motor neuron lesion.</li><li><b>USMLE Tip:</b> Mnemonic: \"C5, C6, pick up sticks\" (Biceps/Brachioradialis).</li></ul>",
      "takeAway": "<p>The <b>Biceps Reflex</b> assesses the C5-C6 spinal levels and the musculocutaneous nerve.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "tests_nerve_root",
        "to": "c5_nerve_root"
      },
      {
        "type": "tests_nerve_root",
        "to": "c6_nerve_root"
      },
      {
        "type": "mediated_by",
        "to": "musculocutaneous_nerve"
      }
    ]
  },
  "bimatoprost": {
    "title": "Bimatoprost",
    "primaryType": "substance",
    "tags": [
      "Pharmacology",
      "Ophthalmology",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Ophthalmic Drugs",
      "Prostaglandin Analogs"
    ],
    "content": {
      "definition": "<p><b>Bimatoprost</b> is a prostaglandin F2&alpha; analog used topically to treat [[glaucoma]] by <u>increasing the uveoscleral outflow</u> of aqueous humor, thereby reducing intraocular pressure.</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> Agonist at prostaglandin receptors &rarr; Relaxes ciliary muscle &rarr; Increases <b>uveoscleral outflow</b> (drainage through the ciliary body tissue).</li><li><b>Clinical Use:</b> Open-angle [[glaucoma]], Ocular hypertension. Also used cosmetically (Latisse) for hypotrichosis of eyelashes.</li><li><b>Adverse Effects:</b> <b>Darkening of the iris</b> (permanent heterochromia), increased eyelash length/thickness (hypertrichosis), conjunctival hyperemia.</li><li><b>USMLE Tip:</b> Remember: Prostaglandins increase <b>Outflow</b>; Beta-blockers decrease <b>Production</b>.</li></ul>",
      "takeAway": "<p><b>Bimatoprost</b> lowers intraocular pressure by enhancing uveoscleral outflow and is notable for the side effect of irreversible iris darkening.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "treats",
        "to": "glaucoma"
      },
      {
        "type": "increases_outflow_of",
        "to": "aqueous_humor"
      },
      {
        "type": "causes_side_effect",
        "to": "iris_hyperpigmentation"
      }
    ]
  },
  "bitemporal_hemianopia": {
    "title": "Bitemporal Hemianopia",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Ophthalmology",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Neuro-Ophthalmology",
      "Visual Fields"
    ],
    "content": {
      "definition": "<p><b>Bitemporal Hemianopia</b> is a visual field defect characterized by the loss of vision in the <u>temporal (outer) halves</u> of both visual fields (\"tunnel vision\"), caused by compression of the decussating nasal fibers at the <b>[[optic_chiasm]]</b>.</p>",
      "atAGlance": "<ul><li><b>Pathophysiology:</b> Lesion at the <b>Optic Chiasm</b> compresses the crossing fibers from the <i>nasal retinas</i> (which see the temporal fields).</li><li><b>Etiologies:</b><br> - <b>[[pituitary_adenoma]]:</b> Compresses chiasm from below.<br> - <b>[[craniopharyngioma]]:</b> Compresses chiasm from above (typically children).<br> - <b>[[saccular_aneurysm]]:</b> Anterior Communicating Artery (ACom) aneurysm.</li><li><b>Clinical:</b> Patient bumps into door frames; loss of peripheral vision.</li><li><b>USMLE Tip:</b> \"Tunnel Vision\" = Optic Chiasm Lesion.</li></ul>",
      "takeAway": "<p><b>Bitemporal Hemianopia</b> is the classic sign of chiasmal compression, most commonly due to a [[pituitary_adenoma]] pushing upwards on the crossing nasal fibers.</p>",
      "mermaid": "graph TD; A[Pituitary Adenoma] --> B[Compression of Optic Chiasm]; B --> C[Damage to Crossing Nasal Fibers]; C --> D[Loss of Temporal Visual Fields];"
    },
    "connections": [
      {
        "type": "caused_by_lesion_at",
        "to": "optic_chiasm"
      },
      {
        "type": "is_symptom_of",
        "to": "pituitary_adenoma"
      },
      {
        "type": "is_symptom_of",
        "to": "craniopharyngioma"
      }
    ]
  },
  "blepharitis": {
    "title": "Blepharitis",
    "primaryType": "disease",
    "tags": [
      "Ophthalmology",
      "Pathology",
      "Infectious Disease",
      "USMLE"
    ],
    "classificationPath": [
      "Ophthalmology",
      "Eyelid Disorders"
    ],
    "content": {
      "definition": "<p><b>Blepharitis</b> is a chronic inflammation of the <u>eyelid margins</u>, often involving the meibomian glands or eyelash follicles, characterized by irritation, burning, and crusting.</p>",
      "atAGlance": "<ul><li><b>Etiology:</b> [[staphylococcus_aureus]], seborrheic dermatitis, or rosacea.</li><li><b>Clinical Presentation:</b> Red, swollen eyelids with <b>crusting</b> (collarettes) at the lash base; \"gritty\" sensation.</li><li><b>Complications:</b> Can lead to [[hordeolum]] (stye) or [[chalazion]].</li><li><b>Treatment:</b> Warm compresses, lid hygiene (baby shampoo), topical antibiotics.</li></ul>",
      "takeAway": "<p><b>Blepharitis</b> is a common inflammatory condition of the eyelid margin involving crusting and irritation, often associated with Staph colonization or seborrhea.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "associated_with",
        "to": "staphylococcus_aureus"
      },
      {
        "type": "can_progress_to",
        "to": "hordeolum"
      },
      {
        "type": "can_progress_to",
        "to": "chalazion"
      }
    ]
  },
  "blood_brain_barrier": {
    "title": "Blood-Brain Barrier (BBB)",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Histology",
      "Physiology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Neuroanatomy",
      "Barriers"
    ],
    "content": {
      "definition": "<p>The <b>Blood-Brain Barrier (BBB)</b> is a highly selective semipermeable border that separates the circulating blood from the brain extracellular fluid, formed primarily by endothelial <u>tight junctions</u> and supported by <u>astrocyte foot processes</u>.</p>",
      "atAGlance": "<ul><li><b>Components:</b><br> 1. <b>Tight Junctions:</b> Between non-fenestrated capillary endothelial cells (prevent paracellular diffusion).<br> 2. <b>Basement Membrane.</b><br> 3. <b>Astrocyte Foot Processes:</b> Induce and maintain tight junctions.</li><li><b>Function:</b> Protects CNS from toxins/pathogens; maintains homeostasis. Allows diffusion of lipid-soluble substances (O2, CO2, ethanol) and carrier-mediated transport of glucose/amino acids.</li><li><b>Disruption:</b> Inflammation (vasogenic edema), Infarction, Osmotic injury.</li><li><b>Exceptions (Circumventricular Organs):</b> Area Postrema (vomiting), OVLT (osmolarity), Neurohypophysis (ADH release) lack a strict BBB.</li></ul>",
      "takeAway": "<p>The <b>BBB</b> strictly regulates CNS entry via endothelial tight junctions and astrocyte foot processes; breakdown leads to vasogenic edema.</p>",
      "mermaid": "graph TD; A[Capillary Endothelium] -->|Tight Junctions| B[Barrier Function]; C[Astrocytes] -->|Foot Processes| B; D[Lipid Soluble Molecules] -->|Diffuse| E[Brain Parenchyma]; F[Polar Molecules] --x|Blocked| E;"
    },
    "connections": [
      {
        "type": "formed_by",
        "to": "astrocytes"
      },
      {
        "type": "contains",
        "to": "tight_junctions"
      },
      {
        "type": "is_absent_in",
        "to": "area_postrema"
      }
    ]
  },
  "blood_nerve_permeability_barrier": {
    "title": "Blood-Nerve Permeability Barrier",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Histology",
      "Pathology"
    ],
    "classificationPath": [
      "Neurology",
      "Peripheral Nervous System",
      "Barriers"
    ],
    "content": {
      "definition": "<p>The <b>Blood-Nerve Permeability Barrier</b> is a physiologic barrier within the peripheral nervous system, formed by tight junctions in the endoneurial capillaries and the <u>perineurium</u>, protecting axons from plasma constituents.</p>",
      "atAGlance": "<ul><li><b>Location:</b> Endoneurial microvessels and the inner layers of the [[perineurium]].</li><li><b>Function:</b> Maintains a stable endoneurial microenvironment for nerve conduction.</li><li><b>Pathology:</b> Breakdown leads to leakage of plasma proteins into the endoneurium.</li><li><b>Clinical Relevance:</b> In [[guillain_barre_syndrome]], inflammation disrupts this barrier at the nerve roots, leading to high CSF protein without cells ([[albuminocytologic_dissociation]]).</li></ul>",
      "takeAway": "<p>The <b>Blood-Nerve Barrier</b> protects peripheral nerves; its disruption contributes to the high protein levels seen in inflammatory neuropathies like GBS.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "located_in",
        "to": "perineurium"
      },
      {
        "type": "disrupted_in",
        "to": "guillain_barre_syndrome"
      },
      {
        "type": "dysfunction_results_in",
        "to": "albuminocytologic_dissociation"
      }
    ]
  },
  "blown_pupil": {
    "title": "Blown Pupil",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Ophthalmology",
      "Emergency Medicine",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Neuro-Ophthalmology",
      "Pupillary Findings"
    ],
    "content": {
      "definition": "<p>A <b>Blown Pupil</b> (Fixed and Dilated Pupil) represents a loss of parasympathetic innervation to the sphincter pupillae muscle, resulting in unopposed sympathetic tone and mydriasis, classically caused by compression of the <u>Oculomotor Nerve (CN III)</u>.</p>",
      "atAGlance": "<ul><li><b>Pathophysiology:</b> Parasympathetic fibers run superficially on CN III. External compression affects these fibers first.</li><li><b>Etiologies:</b><br> - <b>Uncal Herniation:</b> Medial temporal lobe pushes against the tentorium, compressing CN III.<br> - <b>PCom Aneurysm:</b> [[posterior_communicating_artery]] aneurysm compresses CN III.</li><li><b>Clinical Context:</b> \"Down-and-out\" eye with a dilated, non-reactive pupil.</li><li><b>USMLE Tip:</b> <br> - <i>Surgical Rule:</i> Pupil-involving CN III palsy = Aneurysm/Herniation (Compression).<br> - <i>Medical Rule:</i> Pupil-sparing CN III palsy = Diabetes (Ischemia of deep motor fibers).</li></ul>",
      "takeAway": "<p>A <b>Blown Pupil</b> indicates compression of the superficial parasympathetic fibers of CN III, a neurosurgical emergency often signaling uncal herniation or a PCom aneurysm.</p>",
      "mermaid": "graph TD; A[Mass Effect / Aneurysm] --> B[External Compression of CN III]; B --> C[Damage to Superficial Parasympathetics]; C --> D[Loss of Constriction]; D --> E[Unopposed Dilation (Blown Pupil)];"
    },
    "connections": [
      {
        "type": "caused_by_compression_of",
        "to": "oculomotor_nerve"
      },
      {
        "type": "is_sign_of",
        "to": "uncal_herniation"
      },
      {
        "type": "is_sign_of",
        "to": "saccular_aneurysm"
      }
    ]
  },
  "blowout_fracture": {
    "title": "Blowout Fracture",
    "primaryType": "disease",
    "tags": [
      "Ophthalmology",
      "Trauma",
      "Surgery",
      "USMLE"
    ],
    "classificationPath": [
      "Ophthalmology",
      "Orbital Trauma"
    ],
    "content": {
      "definition": "<p>A <b>Blowout Fracture</b> is a fracture of the orbital floor (maxillary bone) or medial wall (ethmoid bone) caused by blunt trauma to the globe, leading to herniation of orbital contents into the maxillary sinus.</p>",
      "atAGlance": "<ul><li><b>Pathophysiology:</b> Sudden increase in intraorbital pressure \"blows out\" the thin orbital floor.</li><li><b>Clinical Features:</b><br> - <b>Diplopia:</b> Due to entrapment of the [[inferior_rectus_muscle]] (restriction of upward gaze).<br> - <b>Enophthalmos:</b> Sunken eye.<br> - <b>Infraorbital Anesthesia:</b> Damage to the [[infraorbital_nerve]] (numbness of cheek/upper lip).</li><li><b>Imaging:</b> CT Scan shows \"teardrop sign\" (herniated fat/muscle in sinus).</li><li><b>USMLE Tip:</b> Look for a patient punched in the eye who cannot look up and has a numb cheek.</li></ul>",
      "takeAway": "<p><b>Blowout Fractures</b> typically involve the orbital floor, causing entrapment of the inferior rectus (diplopia on upgaze) and injury to the infraorbital nerve (cheek numbness).</p>",
      "mermaid": "graph TD; A[Blunt Trauma to Globe] --> B[Increased Intraorbital Pressure]; B --> C[Fracture of Orbital Floor]; C --> D[Herniation of Contents]; D --> E[Inferior Rectus Entrapment]; E --> F[Diplopia / Gaze Restriction];"
    },
    "connections": [
      {
        "type": "entraps",
        "to": "inferior_rectus_muscle"
      },
      {
        "type": "damages",
        "to": "infraorbital_nerve"
      },
      {
        "type": "causes",
        "to": "diplopia"
      }
    ]
  },
  "bone_morphogenetic_protein": {
    "title": "Bone Morphogenetic Protein (BMP)",
    "primaryType": "substance",
    "tags": [
      "Embryology",
      "Neurology",
      "Signaling",
      "USMLE"
    ],
    "classificationPath": [
      "Embryology",
      "Signaling Molecules",
      "TGF-beta Superfamily"
    ],
    "content": {
      "definition": "<p><b>Bone Morphogenetic Proteins (BMPs)</b> are signaling molecules (TGF-&beta; superfamily) secreted by the overlying ectoderm/roof plate during neural tube development, which induce the differentiation of the <u>dorsal</u> aspect of the neural tube ([[alar_plate]]). </p>",
      "atAGlance": "<ul><li><b>Function in Neuroembryology:</b> BMP signaling induces the <b>Alar Plate</b> (Sensory).</li><li><b>Opposing Signal:</b> <b>Sonic Hedgehog (SHH)</b> from the notochord induces the Basal Plate (Motor).</li><li><b>General Function:</b> Bone and cartilage formation, dorsal-ventral patterning.</li><li><b>USMLE Tip:</b> <b>B</b>MP = <b>B</b>ack (Dorsal/Sensory). SHH = Stomach side (Ventral/Motor).</li></ul>",
      "takeAway": "<p><b>BMPs</b> provide the dorsalizing signal for the neural tube, establishing the sensory [[alar_plate]], in opposition to the ventralizing SHH signal.</p>",
      "mermaid": "graph TD; A[Ectoderm] -->|Secretes BMP| B[Dorsal Neural Tube]; B --> C[Alar Plate Differentiation]; C --> D[Sensory Neurons];"
    },
    "connections": [
      {
        "type": "induces",
        "to": "alar_plate"
      },
      {
        "type": "opposes",
        "to": "sonic_hedgehog"
      }
    ]
  },
  "botulinum_toxin": {
    "title": "Botulinum Toxin",
    "primaryType": "substance",
    "tags": [
      "Microbiology",
      "Pharmacology",
      "Neurology",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Neuromuscular Blockers",
      "Toxins"
    ],
    "content": {
      "definition": "<p><b>Botulinum Toxin</b> is a neurotoxin produced by <i>Clostridium botulinum</i> that acts as a protease, cleaving <u>SNARE proteins</u> (e.g., SNAP-25, synaptobrevin) to prevent the presynaptic release of [[acetylcholine]], causing flaccid paralysis.</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> Cleaves SNARE complex &rarr; prevents fusion of ACh vesicles with presynaptic membrane &rarr; No ACh release.</li><li><b>Clinical Findings:</b> Descending flaccid paralysis, diplopia, dysphagia, respiratory failure (\"Floppy Baby\" from honey spores).</li><li><b>Therapeutic Uses:</b><br> - Focal Dystonia (e.g., Blepharospasm, Torticollis).<br> - Spasticity (e.g., Cerebral Palsy).<br> - Achalasia (relaxes LES).<br> - Migraine prophylaxis.</li><li><b>USMLE Tip:</b> <b>Bot</b>ulinum = <b>Bot</b>tles up ACh (Flaccid). Tetanus = Tetanic (Spastic, blocks GABA/Glycine release).</li></ul>",
      "takeAway": "<p><b>Botulinum Toxin</b> inhibits acetylcholine release by cleaving SNARE proteins, causing flaccid paralysis; it is therapeutically used to treat focal dystonias, spasticity, and achalasia.</p>",
      "mermaid": "graph TD; A[Botulinum Toxin] -->|Endocytosis| B[Motor Neuron]; B -->|Cleaves SNAREs| C[Inhibits Vesicle Fusion]; C -->|No ACh Release| D[Flaccid Paralysis];"
    },
    "connections": [
      {
        "type": "inhibits_release_of",
        "to": "acetylcholine"
      },
      {
        "type": "cleaves",
        "to": "snare_proteins"
      },
      {
        "type": "causes",
        "to": "flaccid_paralysis"
      },
      {
        "type": "treats",
        "to": "dystonia"
      },
      {
        "type": "treats",
        "to": "achalasia"
      }
    ]
  },
  "brachioradialis_reflex": {
    "title": "Brachioradialis Reflex",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Physical Exam",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Neurologic Examination",
      "Deep Tendon Reflexes"
    ],
    "content": {
      "definition": "<p>The <b>Brachioradialis Reflex</b> is a deep tendon reflex mediated by the <u>C5 and C6</u> nerve roots (primarily C6), where striking the brachioradialis tendon causes flexion and supination of the forearm.</p>",
      "atAGlance": "<ul><li><b>Nerve Roots:</b> C5, <b>C6</b>.</li><li><b>Nerve:</b> [[radial_nerve]].</li><li><b>Action:</b> Elbow flexion and forearm supination.</li><li><b>Clinical Significance:</b> Used to assess the integrity of the C5/C6 segments and the Radial nerve.</li><li><b>USMLE Tip:</b> Mnemonic: \"C5, C6, pick up sticks\" applies to both Biceps and Brachioradialis reflexes.</li></ul>",
      "takeAway": "<p>The <b>Brachioradialis Reflex</b> tests the C5-C6 spinal levels and the radial nerve.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "tests_nerve_root",
        "to": "c5_nerve_root"
      },
      {
        "type": "tests_nerve_root",
        "to": "c6_nerve_root"
      },
      {
        "type": "mediated_by",
        "to": "radial_nerve"
      }
    ]
  },
  "brain": {
    "title": "Brain",
    "primaryType": "concept",
    "tags": [
      "Index Stub"
    ],
    "classificationPath": [
      "Neurology",
      "Brain"
    ],
    "content": {
      "definition": "<p><i>(Placeholder)</i> The central organ of the nervous system, comprising the cerebrum, cerebellum, and brainstem, referenced in the graph awaiting detailed population of specific sub-structures.</p>",
      "atAGlance": "<ul><li>See [[cerebral_cortex]], [[brainstem]], [[cerebellum]], [[thalamus]], [[basal_ganglia]], [[limbic_system]].</li></ul>",
      "takeAway": "",
      "mermaid": ""
    },
    "connections": []
  },
  "brain_death": {
    "title": "Brain Death",
    "primaryType": "concept",
    "tags": [
      "Neurology",
      "Ethics",
      "Critical Care",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Coma and Disorders of Consciousness",
      "Brain Death"
    ],
    "content": {
      "definition": "<p><b>Brain Death</b> is the irreversible cessation of all functions of the entire brain, including the brainstem, characterized clinically by <u>coma</u>, <u>absent brainstem reflexes</u>, and <u>apnea</u>.</p>",
      "atAGlance": "<ul><li><b>Pathophysiology:</b> Complete loss of cerebral perfusion (Cerebral Perfusion Pressure = MAP - ICP = 0).</li><li><b>Clinical Criteria:</b><br> 1. Coma (unresponsive).<br> 2. Absence of Brainstem Reflexes (Pupillary, Corneal, Oculocephalic, Gag/Cough).<br> 3. Apnea Test (No respiratory drive despite hypercapnia).</li><li><b>Ethical/Legal:</b> Legally equivalent to death. Artificial support can be withdrawn.</li><li><b>USMLE Tip:</b> Spinal reflexes (e.g., DTRs) may remain intact because they are mediated by the spinal cord, not the brain.</li></ul>",
      "takeAway": "<p><b>Brain Death</b> is a clinical diagnosis of irreversible total brain failure defined by coma, apnea, and absent brainstem reflexes, often resulting from zero cerebral perfusion pressure.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "requires_absence_of",
        "to": "brainstem_reflexes"
      },
      {
        "type": "caused_by_loss_of",
        "to": "cerebral_perfusion"
      }
    ]
  },
  "brain_injury": {
    "title": "Brain Injury",
    "primaryType": "concept",
    "tags": [
      "Index Stub"
    ],
    "classificationPath": [
      "Neurology",
      "Trauma"
    ],
    "content": {
      "definition": "<p><i>(Placeholder)</i> A broad category of insults to the brain, including traumatic brain injury (TBI), diffuse axonal injury, and hypoxic-ischemic injury.</p>",
      "atAGlance": "<ul><li>See [[diffuse_axonal_injury]], [[epidural_hematoma]], [[subdural_hematoma]], [[concussion]].</li></ul>",
      "takeAway": "",
      "mermaid": ""
    },
    "connections": []
  },
  "brainstem": {
    "title": "Brainstem",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Anatomy",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Brain Anatomy",
      "Brainstem"
    ],
    "content": {
      "definition": "<p>The <b>Brainstem</b> is the caudal part of the brain, connecting the cerebrum, cerebellum, and spinal cord, composed of the <u>Midbrain</u>, <u>Pons</u>, and <u>Medulla Oblongata</u>; it houses cranial nerve nuclei and vital respiratory/cardiovascular centers.</p>",
      "atAGlance": "<ul><li><b>Components:</b><br> - <b>Midbrain (Mesencephalon):</b> CN III, IV. Vertical gaze, auditory/visual relays.<br> - <b>Pons (Metencephalon):</b> CN V, VI, VII, VIII. Horizontal gaze center (PPRF).<br> - <b>Medulla (Myelencephalon):</b> CN IX, X, XII. Respiratory/Cardiac centers.</li><li><b>Rule of 4s:</b><br> - 4 CNs in Medulla, 4 in Pons, 4 above (2 in midbrain).<br> - Midline structures (Motor) start with <b>M</b> (Motor pathway, Medial Lemniscus, MLF, Motor nuclei 3,4,6,12).<br> - Side structures (Sensory) start with <b>S</b> (Spinothalamic, Spinocerebellar, Sensory V, Sympathetic).</li><li><b>Vascular Supply:</b> Vertebrobasilar system.</li></ul>",
      "takeAway": "<p>The <b>Brainstem</b> is the vital conduit for all ascending/descending tracts and the origin of CN III-XII, organized such that medial lesions cause motor deficits and lateral lesions cause sensory/autonomic deficits (Rule of 4s).</p>",
      "mermaid": "graph TD; A[Brainstem] --> B[Midbrain]; A --> C[Pons]; A --> D[Medulla]; B --> E[CN III, IV]; C --> F[CN V, VI, VII, VIII]; D --> G[CN IX, X, XII];"
    },
    "connections": [
      {
        "type": "includes",
        "to": "midbrain"
      },
      {
        "type": "includes",
        "to": "pons"
      },
      {
        "type": "includes",
        "to": "medulla_oblongata"
      },
      {
        "type": "supplied_by",
        "to": "basilar_artery"
      }
    ]
  }
}
``````json
{
  "brainstem_cerebellar_syndromes_ms": {
    "title": "Brainstem and Cerebellar Syndromes (Multiple Sclerosis)",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Pathology",
      "Multiple Sclerosis",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Demyelinating Diseases",
      "Clinical Presentation"
    ],
    "content": {
      "definition": "<p><b>Brainstem and Cerebellar Syndromes</b> in the context of [[multiple_sclerosis]] refer to a constellation of neurologic deficits resulting from demyelinating plaques in the brainstem or cerebellum, characterized by [[diplopia]], [[ataxia]], scanning speech, and [[internuclear_ophthalmoplegia]].</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> Demyelination disrupts conduction in the [[brainstem]] (cranial nerve nuclei, MLF) and [[cerebellum]] (peduncles).</li><li><b>Key Findings:</b><br> - <b>Charcot Triad:</b> Scanning speech, Intention tremor, [[nystagmus]].<br> - <b>Eye Movements:</b> [[internuclear_ophthalmoplegia]] (MLF lesion), diplopia.<br> - <b>Bulbar/Motor:</b> Dysarthria, dysphagia, vertigo.</li><li><b>USMLE Tip:</b> Bilateral INO in a young patient is pathognomonic for MS.</li></ul>",
      "takeAway": "<p>Brainstem and cerebellar involvement in MS produces the classic Charcot Triad and oculomotor deficits like INO, reflecting the spatial dissemination of demyelination.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_manifestation_of",
        "to": "multiple_sclerosis"
      },
      {
        "type": "includes",
        "to": "internuclear_ophthalmoplegia"
      },
      {
        "type": "includes",
        "to": "charcot_triad_ms"
      }
    ]
  },
  "brain_tumors": {
    "title": "Brain Tumors",
    "primaryType": "concept",
    "tags": [
      "Index Stub"
    ],
    "classificationPath": [
      "Neurology",
      "Oncology",
      "CNS Tumors"
    ],
    "content": {
      "definition": "<p><i>(Placeholder)</i> A broad category of neoplasms affecting the central nervous system, including primary tumors (gliomas, meningiomas) and metastatic lesions.</p>",
      "atAGlance": "<ul><li>See [[glioblastoma]], [[meningioma]], [[medulloblastoma]], [[ependymoma]], [[pilocytic_astrocytoma]], [[oligodendroglioma]].</li></ul>",
      "takeAway": "",
      "mermaid": ""
    },
    "connections": []
  },
  "branch_retinal_vein_occlusion": {
    "title": "Branch Retinal Vein Occlusion (BRVO)",
    "primaryType": "disease",
    "tags": [
      "Ophthalmology",
      "Vascular",
      "USMLE"
    ],
    "classificationPath": [
      "Ophthalmology",
      "Retinal Vascular Disease",
      "Venous Occlusion"
    ],
    "content": {
      "definition": "<p><b>Branch Retinal Vein Occlusion (BRVO)</b> is a vascular disorder of the retina caused by the compression of a retinal vein by an overlying sclerotic arteriole at an <u>arteriovenous (AV) crossing point</u>, leading to venous engorgement, hemorrhage, and edema in the drained quadrant.</p>",
      "atAGlance": "<ul><li><b>Pathophysiology:</b> Arteriolar sclerosis (due to [[hypertension]]) compresses the vein at a shared adventitial crossing (AV nicking) &rarr; turbulent flow/thrombosis.</li><li><b>Fundoscopy:</b> Sectoral retinal hemorrhages, cotton-wool spots, and macular edema confined to the distribution of the occluded branch.</li><li><b>Risk Factors:</b> Hypertension, Diabetes, Hyperlipidemia.</li><li><b>USMLE Tip:</b> Look for hemorrhages in <b>one quadrant</b> of the retina, unlike Central Retinal Vein Occlusion (CRVO) which is diffuse (\"blood and thunder\").</li></ul>",
      "takeAway": "<p><b>BRVO</b> is a compression of a retinal vein by a hardened artery at an AV crossing, resulting in sectoral retinal hemorrhage and vision loss.</p>",
      "mermaid": "graph TD; A[Chronic Hypertension] --> B[Arteriolar Sclerosis]; B --> C[Compression of Vein at AV Crossing]; C --> D[Venous Stasis/Thrombosis]; D --> E[Sectoral Retinal Hemorrhage/Edema];"
    },
    "connections": [
      {
        "type": "caused_by",
        "to": "arteriolosclerosis"
      },
      {
        "type": "is_a_type_of",
        "to": "retinal_vein_occlusion"
      },
      {
        "type": "manifests_as",
        "to": "retinal_hemorrhage"
      }
    ]
  },
  "brimonidine": {
    "title": "Brimonidine",
    "primaryType": "substance",
    "tags": [
      "Pharmacology",
      "Ophthalmology",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Ophthalmic Drugs",
      "Alpha Agonists"
    ],
    "content": {
      "definition": "<p><b>Brimonidine</b> is a highly selective <u>&alpha;<sub>2</sub>-adrenergic agonist</u> used topically to treat [[glaucoma]] by a dual mechanism: decreasing aqueous humor production and increasing uveoscleral outflow.</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> Activates &alpha;<sub>2</sub> receptors on ciliary epithelium &rarr; <b>Decreases cAMP</b> &rarr; Decreases aqueous production. Also enhances uveoscleral outflow.</li><li><b>Clinical Use:</b> Open-angle [[glaucoma]], Ocular hypertension.</li><li><b>Adverse Effects:</b> Foreign body sensation, ocular hyperemia, dry mouth, fatigue, hypotension (systemic absorption).</li><li><b>USMLE Tip:</b> Do not use in <b>closed-angle glaucoma</b> (sympathomimetics can cause mydriasis, worsening the block).</li></ul>",
      "takeAway": "<p><b>Brimonidine</b> lowers intraocular pressure by inhibiting aqueous production via &alpha;<sub>2</sub> agonism, similar to [[apraclonidine]].</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "agonizes",
        "to": "alpha_2_adrenergic_receptor"
      },
      {
        "type": "treats",
        "to": "glaucoma"
      },
      {
        "type": "decreases_production_of",
        "to": "aqueous_humor"
      }
    ]
  },
  "broad_spectrum_anticonvulsants": {
    "title": "Broad Spectrum Anticonvulsants",
    "primaryType": "group",
    "tags": [
      "Pharmacology",
      "Neurology",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Neurology Drugs",
      "Anticonvulsants"
    ],
    "content": {
      "definition": "<p><b>Broad Spectrum Anticonvulsants</b> are a class of antiepileptic drugs effective against both focal (partial) and generalized seizures (including absence), typically acting via multiple mechanisms of action (e.g., Na<sup>+</sup> channel blockade + GABA enhancement).</p>",
      "atAGlance": "<ul><li><b>Key Agents:</b> [[valproate]], [[lamotrigine]], [[levetiracetam]], [[topiramate]].</li><li><b>Mechanisms:</b><br> - <i>Valproate:</i> Na<sup>+</sup> block, Ca<sup>2+</sup> block, GABA transaminase inhibition.<br> - <i>Lamotrigine:</i> Na<sup>+</sup> block, glutamate inhibition.<br> - <i>Levetiracetam:</i> SV2A vesicle protein binding.<br> - <i>Topiramate:</i> Na<sup>+</sup> block, GABA potentiation.</li><li><b>Clinical Use:</b> First-line for generalized tonic-clonic, myoclonic, and absence seizures (Valproate).</li><li><b>USMLE Tip:</b> If a patient has mixed seizure types (e.g., Absence + Tonic-Clonic), use a broad spectrum agent like <b>Valproate</b>. Narrow spectrum agents (e.g., [[carbamazepine]], [[phenytoin]]) can worsen absence seizures.</li></ul>",
      "takeAway": "<p><b>Broad Spectrum Anticonvulsants</b> like Valproate and Levetiracetam cover multiple seizure types by targeting diverse neural pathways, unlike narrow spectrum agents which target focal seizures.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "includes",
        "to": "valproate"
      },
      {
        "type": "includes",
        "to": "levetiracetam"
      },
      {
        "type": "includes",
        "to": "lamotrigine"
      },
      {
        "type": "includes",
        "to": "topiramate"
      }
    ]
  },
  "broca_aphasia": {
    "title": "Broca Aphasia (Expressive Aphasia)",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Pathology",
      "Language",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Cognitive Disorders",
      "Aphasias"
    ],
    "content": {
      "definition": "<p><b>Broca Aphasia</b> is a non-fluent aphasia characterized by <u>impaired speech production</u> with preserved comprehension, caused by a lesion to the <b>inferior frontal gyrus</b> of the dominant hemisphere.</p>",
      "atAGlance": "<ul><li><b>Lesion:</b> [[broca_area]] (Inferior Frontal Gyrus, Brodmann 44/45). usually Left [[middle_cerebral_artery]] superior division infarct.</li><li><b>Characteristics:</b><br> - <b>Fluency:</b> Non-fluent, halting, telegraphic speech (nouns/verbs only).<br> - <b>Comprehension:</b> Intact (Patient is frustrated/aware of deficit).<br> - <b>Repetition:</b> Impaired.</li><li><b>Associated Signs:</b> Contralateral face/arm weakness (due to proximity to motor cortex).</li><li><b>USMLE Tip:</b> \"Broca = Broken Boca\" (Broken mouth). Patient appears frustrated.</li></ul>",
      "takeAway": "<p><b>Broca Aphasia</b> is a motor aphasia of the inferior frontal gyrus resulting in non-fluent, effortful speech with intact comprehension and impaired repetition.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "caused_by_lesion_in",
        "to": "broca_area"
      },
      {
        "type": "caused_by_infarct_of",
        "to": "middle_cerebral_artery"
      },
      {
        "type": "is_contrasted_with",
        "to": "wernicke_aphasia"
      }
    ]
  },
  "broca_area": {
    "title": "Broca Area",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Anatomy",
      "Language",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Brain Anatomy",
      "Cerebral Cortex",
      "Frontal Lobe"
    ],
    "content": {
      "definition": "<p><b>Broca Area</b> is the motor speech area located in the posterior <u>inferior frontal gyrus</u> of the dominant hemisphere (usually left), responsible for speech production and articulation.</p>",
      "atAGlance": "<ul><li><b>Location:</b> Inferior Frontal Gyrus (Pars opercularis/triangularis). Brodmann 44, 45.</li><li><b>Blood Supply:</b> Superior division of the [[middle_cerebral_artery]].</li><li><b>Function:</b> Planning and execution of speech movements; grammatical structure.</li><li><b>Connections:</b> Connected to [[wernicke_area]] via the [[arcuate_fasciculus]].</li><li><b>Pathology:</b> Lesion causes [[broca_aphasia]] (Expressive).</li></ul>",
      "takeAway": "<p><b>Broca Area</b> resides in the frontal lobe and drives language output; damage destroys fluency but spares comprehension.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "located_in",
        "to": "frontal_lobe"
      },
      {
        "type": "connected_to",
        "to": "wernicke_area"
      },
      {
        "type": "supplied_by",
        "to": "middle_cerebral_artery"
      }
    ]
  },
  "bromocriptine": {
    "title": "Bromocriptine",
    "primaryType": "substance",
    "tags": [
      "Pharmacology",
      "Endocrinology",
      "Neurology",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Neurology Drugs",
      "Dopamine Agonists"
    ],
    "content": {
      "definition": "<p><b>Bromocriptine</b> is an <u>ergot derivative</u> dopamine agonist (D2) used to treat [[parkinson_disease]], [[prolactinoma]], and acromegaly, though less commonly used now due to side effects.</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> Directly stimulates dopamine D2 receptors.</li><li><b>Clinical Uses:</b><br> - <b>Prolactinoma:</b> Inhibits prolactin secretion (Dopamine is PIH).<br> - <b>Parkinson Disease:</b> Stimulates striatal receptors (adjunct to L-Dopa).<br> - <b>Acromegaly:</b> Suppresses GH secretion (paradoxical effect in acromegaly).</li><li><b>Adverse Effects:</b> Nausea, orthostatic hypotension, impulse control disorders. <b>Pulmonary/Retroperitoneal Fibrosis</b> (specific to ergot derivatives).</li><li><b>USMLE Tip:</b> Differentiate from non-ergots ([[pramipexole]], [[ropinirole]]) which are preferred for Parkinson's due to better side effect profile (no fibrosis).</li></ul>",
      "takeAway": "<p><b>Bromocriptine</b> is an ergot dopamine agonist effective for hyperprolactinemia and Parkinson's, but limited by fibrosis risk compared to non-ergot alternatives.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "agonizes",
        "to": "dopamine_receptor"
      },
      {
        "type": "treats",
        "to": "prolactinoma"
      },
      {
        "type": "treats",
        "to": "parkinson_disease"
      },
      {
        "type": "is_contrasted_with",
        "to": "pramipexole"
      }
    ]
  },
  "brown_sequard_syndrome": {
    "title": "Brown-Séquard Syndrome",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Spinal Cord",
      "Trauma",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Spinal Cord Disorders",
      "Hemisection"
    ],
    "content": {
      "definition": "<p><b>Brown-Séquard Syndrome</b> is a neurological condition caused by <u>hemisection</u> (damage to one half) of the spinal cord, resulting in a characteristic pattern of ipsilateral motor/proprioceptive loss and contralateral pain/temperature loss.</p>",
      "atAGlance": "<ul><li><b>Pathophysiology & Findings:</b><br> 1. <b>Ipsilateral Corticospinal Tract:</b> UMN signs (weakness, Babinski) <i>below</i> lesion.<br> 2. <b>Ipsilateral Dorsal Column:</b> Loss of vibration/proprioception/touch <i>below</i> lesion.<br> 3. <b>Contralateral Spinothalamic Tract:</b> Loss of pain/temperature <i>1-2 segments below</i> lesion (due to decussation delay).<br> 4. <b>Ipsilateral LMN Signs:</b> At the <i>level</i> of the lesion (anterior horn damage).<br> 5. <b>Ipsilateral Horner Syndrome:</b> If lesion is above T1 (disrupts oculosympathetic pathway).</li><li><b>Etiology:</b> Penetrating trauma (knife/bullet), tumor compression, MS plaque.</li><li><b>USMLE Tip:</b> If a patient has weak Left leg + no vibration Left leg + no pain Right leg, think <b>Left</b> Hemisection.</li></ul>",
      "takeAway": "<p><b>Brown-Séquard Syndrome</b> creates a crossed sensory deficit: <b>Ipsilateral</b> loss of Motor/Vibration/Proprioception and <b>Contralateral</b> loss of Pain/Temperature.</p>",
      "mermaid": "graph TD; A[Spinal Cord Hemisection] --> B[Damage to Dorsal Column]; A --> C[Damage to Corticospinal Tract]; A --> D[Damage to Spinothalamic Tract]; B --> E[Ipsilateral Loss of Vib/Prop]; C --> F[Ipsilateral UMN Weakness]; D --> G[Contralateral Loss of Pain/Temp];"
    },
    "connections": [
      {
        "type": "involves_damage_to",
        "to": "corticospinal_tract"
      },
      {
        "type": "involves_damage_to",
        "to": "dorsal_column_medial_lemniscus"
      },
      {
        "type": "involves_damage_to",
        "to": "spinothalamic_tract"
      },
      {
        "type": "can_cause",
        "to": "horner_syndrome"
      }
    ]
  }
}
``````json
{
  "spinothalamic_tract": {
    "title": "Spinothalamic Tract",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Anatomy",
      "Sensory Pathways",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Spinal Cord",
      "Ascending Tracts"
    ],
    "content": {
      "definition": "<p>The <b>Spinothalamic Tract</b> is the ascending sensory pathway responsible for transmitting <u>pain</u>, <u>temperature</u>, and crude touch sensation from the contralateral side of the body to the thalamus.</p>",
      "atAGlance": "<ul><li><b>Function:</b> Pain, Temperature, Crude Touch.</li><li><b>Pathway:</b><br> 1. <b>1st Order:</b> Sensory neuron in Dorsal Root Ganglion &rarr; enters spinal cord (Lissauer tract).<br> 2. <b>Synapse:</b> Ipsilateral Dorsal Horn (Substantia Gelatinosa).<br> 3. <b>2nd Order:</b> Decussates (crosses) immediately via <b>Anterior White Commissure</b> &rarr; Ascends in anterolateral cord.<br> 4. <b>Synapse:</b> VPL of Thalamus.<br> 5. <b>3rd Order:</b> Sensory Cortex.</li><li><b>Lesions:</b><br> - <i>Syringomyelia:</i> Compresses Anterior White Commissure &rarr; Bilateral loss of pain/temp (cape-like).<br> - <i>Brown-Séquard:</i> Hemisection &rarr; Contralateral loss of pain/temp 1-2 segments below lesion.</li><li><b>USMLE Tip:</b> Crosses <b>immediately</b> (unlike Dorsal Columns).</li></ul>",
      "takeAway": "<p>The <b>Spinothalamic Tract</b> mediates pain and temperature sensation, decussating at the level of entry in the spinal cord, making it key for localizing spinal cord lesions like [[syringomyelia]] and [[brown_sequard_syndrome]].</p>",
      "mermaid": "graph TD; A[Free Nerve Endings] --> B[Dorsal Root Ganglion]; B --> C[Dorsal Horn Synapse]; C -->|Decussation via Ant. White Commissure| D[Contralateral Anterolateral Cord]; D --> E[VPL of Thalamus]; E --> F[Somatosensory Cortex];"
    },
    "connections": [
      {
        "type": "transmits_sensation_of",
        "to": "pain"
      },
      {
        "type": "transmits_sensation_of",
        "to": "temperature_sensation"
      },
      {
        "type": "decussates_at",
        "to": "anterior_white_commissure"
      },
      {
        "type": "is_disrupted_in",
        "to": "syringomyelia"
      },
      {
        "type": "is_disrupted_in",
        "to": "brown_sequard_syndrome"
      }
    ]
  },
  "bulbar_palsy": {
    "title": "Bulbar Palsy",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Pathology",
      "Cranial Nerves",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Cranial Nerve Disorders",
      "Brainstem Lesions"
    ],
    "content": {
      "definition": "<p><b>Bulbar Palsy</b> is a constellation of signs and symptoms resulting from dysfunction of the <u>lower motor neurons</u> of the lower cranial nerves (CN IX, X, XI, XII), typically localized to the medulla (the \"bulb\").</p>",
      "atAGlance": "<ul><li><b>Affected Nerves:</b> Glossopharyngeal (IX), Vagus (X), Accessory (XI), Hypoglossal (XII).</li><li><b>Clinical Features:</b><br> - <b>Dysphagia</b> (difficulty swallowing).<br> - <b>Dysarthria</b> (nasal speech).<br> - <b>Tongue:</b> Atrophy, fasciculations, flaccid weakness.<br> - <b>Reflexes:</b> Absent gag reflex, absent jaw jerk.</li><li><b>Etiologies:</b> [[amyotrophic_lateral_sclerosis]] (LMN component), [[polio]], Myasthenia Gravis, Brainstem infarction (Medullary).</li><li><b>Differentiation:</b> Contrast with <b>Pseudobulbar Palsy</b> (UMN lesion: spastic tongue, hyperactive gag, emotional lability).</li></ul>",
      "takeAway": "<p><b>Bulbar Palsy</b> is an LMN lesion of the lower cranial nerves characterized by a wasted, fasciculating tongue and absent gag reflex, distinguishing it from the spasticity of pseudobulbar palsy.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "involves_dysfunction_of",
        "to": "lower_motor_neuron"
      },
      {
        "type": "affects",
        "to": "hypoglossal_nerve"
      },
      {
        "type": "affects",
        "to": "vagus_nerve"
      },
      {
        "type": "is_contrasted_with",
        "to": "pseudobulbar_palsy"
      }
    ]
  },
  "bupivacaine": {
    "title": "Bupivacaine",
    "primaryType": "substance",
    "tags": [
      "Pharmacology",
      "Anesthesiology",
      "Cardiology",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Local Anesthetics",
      "Amides"
    ],
    "content": {
      "definition": "<p><b>Bupivacaine</b> is a potent, long-acting <i>amide local anesthetic</i> commonly used for spinal and epidural anesthesia, notable for its significant risk of severe <u>cardiotoxicity</u>.</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> Blocks voltage-gated Na<sup>+</sup> channels, preventing nerve impulse conduction.</li><li><b>Structure:</b> Amide (has two 'i's in the name). Metabolized by liver.</li><li><b>Clinical Use:</b> Regional anesthesia (epidural, spinal), infiltration.</li><li><b>Adverse Effects:</b> <b>Severe Cardiotoxicity</b> (refractory arrhythmias, hypotension) if injected intravascularly. More cardiotoxic than lidocaine due to slower dissociation from Na<sup>+</sup> channels.</li><li><b>USMLE Tip:</b> If a patient seizes or arrests after a nerve block, suspect lipid-soluble local anesthetic toxicity (LAST). Treat with <b>Lipid Emulsion</b>.</li></ul>",
      "takeAway": "<p><b>Bupivacaine</b> is the most cardiotoxic local anesthetic, capable of causing fatal arrhythmias upon accidental intravascular injection.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_a_type_of",
        "to": "local_anesthetics"
      },
      {
        "type": "causes_toxicity",
        "to": "cardiotoxicity"
      },
      {
        "type": "blocks_channel",
        "to": "voltage_gated_sodium_channel"
      }
    ]
  },
  "buprenorphine": {
    "title": "Buprenorphine",
    "primaryType": "substance",
    "tags": [
      "Pharmacology",
      "Psychiatry",
      "Addiction Medicine",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Analgesics",
      "Opioids"
    ],
    "content": {
      "definition": "<p><b>Buprenorphine</b> is a <u>partial agonist</u> at mu-opioid receptors and an antagonist at kappa-receptors, used for pain management and medication-assisted treatment (MAT) of [[opioid_use_disorder]].</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> <b>Partial Mu Agonist</b> (High affinity, low intrinsic activity).</li><li><b>Pharmacology:</b> Has a \"ceiling effect\" for respiratory depression (safer than methadone). High affinity means it can displace other opioids.</li><li><b>Clinical Use:</b> Opioid detoxification and maintenance.</li><li><b>Adverse Effect:</b> Can precipitate <b>withdrawal</b> if given to a patient with a full agonist (e.g., heroin, methadone) in their system due to displacement.</li><li><b>Combination:</b> Often combined with [[naloxone]] (Suboxone) to prevent abuse via injection.</li></ul>",
      "takeAway": "<p><b>Buprenorphine</b> is a high-affinity partial opioid agonist that treats addiction but can precipitate withdrawal in dependent patients currently using full agonists.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "acts_as",
        "to": "partial_agonist"
      },
      {
        "type": "treats",
        "to": "opioid_use_disorder"
      },
      {
        "type": "can_precipitate",
        "to": "opioid_withdrawal"
      }
    ]
  },
  "butorphanol": {
    "title": "Butorphanol",
    "primaryType": "substance",
    "tags": [
      "Pharmacology",
      "Anesthesiology",
      "Pain Management",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Analgesics",
      "Opioids"
    ],
    "content": {
      "definition": "<p><b>Butorphanol</b> is a synthetic opioid analgesic that acts as a <u>kappa-opioid receptor agonist</u> and a <u>mu-opioid receptor partial agonist</u> (or antagonist), typically used for moderate-to-severe pain, such as in labor.</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> &kappa;-agonist and &mu;-partial agonist.</li><li><b>Clinical Use:</b> Severe pain (e.g., migraine, <b>labor</b>).</li><li><b>Advantages:</b> Less respiratory depression than full mu-agonists.</li><li><b>Adverse Effects:</b> Can cause <b>opioid withdrawal</b> symptoms if administered to a patient dependent on full mu-agonists (due to competitive antagonism at mu receptor). Psychotomimetic effects (hallucinations) via kappa activation.</li><li><b>USMLE Tip:</b> Beware giving this to a heroin addict in labor; it will send them into withdrawal.</li></ul>",
      "takeAway": "<p><b>Butorphanol</b> is a mixed opioid agonist/antagonist useful for labor analgesia but contraindicated in opioid-dependent patients due to the risk of precipitating withdrawal.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "agonizes",
        "to": "kappa_opioid_receptor"
      },
      {
        "type": "antagonizes",
        "to": "mu_opioid_receptor"
      },
      {
        "type": "can_precipitate",
        "to": "opioid_withdrawal"
      }
    ]
  },
  "oculomotor_nerve": {
    "title": "Oculomotor Nerve (CN III)",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Anatomy",
      "Cranial Nerves",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Cranial Nerves",
      "CN III"
    ],
    "content": {
      "definition": "<p>The <b>Oculomotor Nerve (CN III)</b> is a cranial nerve originating in the midbrain that provides <u>somatic motor</u> innervation to most extraocular muscles and <u>parasympathetic</u> innervation for pupillary constriction and lens accommodation.</p>",
      "atAGlance": "<ul><li><b>Motor Innervation:</b> Superior Rectus, Inferior Rectus, Medial Rectus, Inferior Oblique, [[levator_palpebrae_superioris]] (eyelid opening).</li><li><b>Parasympathetic Innervation:</b> Sphincter pupillae (Miosis), Ciliary muscle (Accommodation). Fibers run on the <b>surface</b> of the nerve.</li><li><b>Origin:</b> Midbrain (Oculomotor nucleus + Edinger-Westphal nucleus). Passes through cavernous sinus and Superior Orbital Fissure.</li><li><b>Palsy Presentation:</b> Eye is \"<b>Down and Out</b>\" (unopposed SO and LR). Ptosis (drooping eyelid).</li><li><b>Clinical Rules:</b><br> - <b>Pupil-Sparing:</b> Suggests microvascular ischemia (e.g., Diabetes) affecting deep motor fibers.<br> - <b>Pupil-Involving (Blown Pupil):</b> Suggests compression (e.g., <b>PCom Aneurysm</b>, Uncal Herniation) affecting superficial parasympathetic fibers.</li></ul>",
      "takeAway": "<p><b>CN III</b> controls most eye movements and pupil constriction; a \"down-and-out\" eye with a dilated pupil is a surgical emergency (aneurysm) until proven otherwise, while a pupil-sparing palsy is typically ischemic.</p>",
      "mermaid": "graph TD; A[Midbrain Nuclei] --> B[CN III]; B --> C{Fibers}; C -->|Deep Motor| D[Extraocular Muscles]; C -->|Superficial Parasympathetic| E[Pupil/Lens]; D --> F[Eye Movement/Lid Lift]; E --> G[Constriction/Accommodation];"
    },
    "connections": [
      {
        "type": "innervates",
        "to": "medial_rectus_muscle"
      },
      {
        "type": "innervates",
        "to": "sphincter_pupillae"
      },
      {
        "type": "originates_in",
        "to": "midbrain"
      },
      {
        "type": "compression_caused_by",
        "to": "posterior_communicating_artery_aneurysm"
      },
      {
        "type": "ischemia_caused_by",
        "to": "diabetes_mellitus"
      }
    ]
  },
  "trochlear_nerve": {
    "title": "Trochlear Nerve (CN IV)",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Anatomy",
      "Cranial Nerves",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Cranial Nerves",
      "CN IV"
    ],
    "content": {
      "definition": "<p>The <b>Trochlear Nerve (CN IV)</b> is a somatic motor cranial nerve that originates in the dorsal midbrain (the only CN to exit dorsally) and innervates the <u>Superior Oblique</u> muscle, responsible for intorsion and depression of the eye.</p>",
      "atAGlance": "<ul><li><b>Function:</b> Innervates the <b>Superior Oblique</b> muscle. Action: Intorsion, Depression (especially when adducted), Abduction.</li><li><b>Course:</b> Exits dorsal midbrain &rarr; Decussates &rarr; Cavernous Sinus &rarr; Superior Orbital Fissure.</li><li><b>Palsy Presentation:</b> Eye drifts <b>upward</b> and <b>outward</b> (hypertropia/extorsion). Vertical diplopia.</li><li><b>Compensatory Behavior:</b> Patient tilts head <b>toward the contralateral shoulder</b> (away from the lesion) to compensate for lack of intorsion.</li><li><b>USMLE Tip:</b> Difficulty going down stairs or reading (activities requiring looking down/in). Head tilt is the key clue.</li></ul>",
      "takeAway": "<p><b>CN IV</b> controls the Superior Oblique; palsy causes vertical diplopia resolved by tilting the head away from the affected side, often complaining of trouble navigating stairs.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "innervates",
        "to": "superior_oblique_muscle"
      },
      {
        "type": "originates_in",
        "to": "midbrain"
      },
      {
        "type": "palsy_causes",
        "to": "vertical_diplopia"
      }
    ]
  },
  "cabergoline": {
    "title": "Cabergoline",
    "primaryType": "substance",
    "tags": [
      "Pharmacology",
      "Endocrinology",
      "Neurology",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Neurology Drugs",
      "Dopamine Agonists"
    ],
    "content": {
      "definition": "<p><b>Cabergoline</b> is a potent, long-acting <u>dopamine D2 receptor agonist</u> used primarily as the first-line treatment for [[prolactinoma]] and hyperprolactinemia.</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> Stimulates dopamine receptors on lactotrophs in the anterior pituitary &rarr; Inhibits Prolactin secretion (Dopamine is Prolactin-Inhibiting Factor).</li><li><b>Clinical Use:</b><br> - <b>Prolactinoma:</b> Shrinks tumor and lowers prolactin levels.<br> - <b>Acromegaly:</b> Adjunct therapy (less effective than somatostatin analogs).<br> - <b>Parkinson Disease:</b> Occasionally used.</li><li><b>Comparison:</b> More effective and better tolerated than [[bromocriptine]].</li><li><b>Adverse Effects:</b> Nausea, headache, dizziness. Risk of valvular heart disease (rare, high dose).</li></ul>",
      "takeAway": "<p><b>Cabergoline</b> is the preferred dopamine agonist for treating prolactinomas, working by mimicking the tonic inhibition of prolactin by hypothalamic dopamine.</p>",
      "mermaid": "graph TD; A[Cabergoline] -->|Agonizes| B[D2 Receptors]; B -->|Inhibits| C[Lactotrophs]; C -->|Decreased| D[Prolactin Secretion];"
    },
    "connections": [
      {
        "type": "agonizes",
        "to": "dopamine_receptor"
      },
      {
        "type": "treats",
        "to": "prolactinoma"
      },
      {
        "type": "is_contrasted_with",
        "to": "bromocriptine"
      }
    ]
  }
}
``````json
{
  "cafe_au_lait_spots": {
    "title": "Café-au-lait Spots",
    "primaryType": "finding",
    "tags": [
      "Dermatology",
      "Neurology",
      "Genetics",
      "USMLE"
    ],
    "classificationPath": [
      "Dermatology",
      "Pigmentary Disorders",
      "Hyperpigmentation"
    ],
    "content": {
      "definition": "<p><b>Café-au-lait spots</b> are flat, hyperpigmented (coffee-colored) skin macules caused by increased melanin deposition, serving as a hallmark cutaneous finding in several neurocutaneous syndromes, most notably [[neurofibromatosis_type_1]].</p>",
      "atAGlance": "<ul><li><b>Appearance:</b> Light brown, flat macules with smooth (NF1) or irregular (McCune-Albright) borders.</li><li><b>Differential Diagnosis:</b><br> - <b>[[neurofibromatosis_type_1]] (NF1):</b> typically >6 spots, smooth \"coast of California\" borders.<br> - <b>McCune-Albright Syndrome:</b> Large, unilateral, irregular \"coast of Maine\" borders.</li><li><b>Genetics:</b> NF1 mutation (Chromosome 17) affects neurofibromin (Ras-GTPase activating protein).</li><li><b>USMLE Tip:</b> Presence of axillary or inguinal freckling (Crowe sign) along with Café-au-lait spots strongly suggests NF1.</li></ul>",
      "takeAway": "<p><b>Café-au-lait spots</b> are key diagnostic markers for neurocutaneous disorders; multiple smooth-bordered spots suggest [[neurofibromatosis_type_1]], while large irregular spots suggest McCune-Albright syndrome.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_characteristic_of",
        "to": "neurofibromatosis_type_1"
      },
      {
        "type": "is_characteristic_of",
        "to": "mccune_albright_syndrome"
      },
      {
        "type": "associated_with_mutation_in",
        "to": "nf1_gene"
      }
    ]
  },
  "calcitonin_gene_related_peptide": {
    "title": "Calcitonin Gene-Related Peptide (CGRP)",
    "primaryType": "substance",
    "tags": [
      "Neurology",
      "Physiology",
      "Pharmacology",
      "USMLE"
    ],
    "classificationPath": [
      "Neuroscience",
      "Neuropeptides",
      "Vasoactive Peptides"
    ],
    "content": {
      "definition": "<p><b>Calcitonin Gene-Related Peptide (CGRP)</b> is a potent neuropeptide vasodilator released from trigeminal nerve endings that plays a central role in the pathophysiology of <u>migraine pain</u> transmission and neurogenic inflammation.</p>",
      "atAGlance": "<ul><li><b>Function:</b> Potent vasodilation of intracranial blood vessels; transmission of nociceptive signals in the trigeminovascular system.</li><li><b>Migraine Pathophysiology:</b> Stimulation of the [[trigeminal_nerve]] releases CGRP &rarr; vasodilation & plasma protein extravasation &rarr; mast cell degranulation &rarr; sensitization of pain receptors.</li><li><b>Pharmacology:</b><br> - <b>Triptans (e.g., [[sumatriptan]]):</b> 5-HT<sub>1B/1D</sub> agonists inhibit CGRP release.<br> - <b>CGRP Antagonists (Gepants/mAbs):</b> E.g., Erenumab, Ubrogepant block CGRP or its receptor for migraine prophylaxis/treatment.</li><li><b>USMLE Tip:</b> Migraine pain correlates with <u>elevated</u> CGRP levels in the jugular venous blood.</li></ul>",
      "takeAway": "<p><b>CGRP</b> is the key vasoactive mediator in migraine pathogenesis, released by the trigeminal nerve to cause vasodilation and pain, making it a prime target for modern migraine therapies.</p>",
      "mermaid": "graph TD; A[Trigeminal Nerve Stimulation] --> B[Release of CGRP]; B --> C[Intracranial Vasodilation]; B --> D[Neurogenic Inflammation]; C & D --> E[Migraine Pain]; F[Triptans] --x|Inhibit| B;"
    },
    "connections": [
      {
        "type": "released_by",
        "to": "trigeminal_nerve"
      },
      {
        "type": "mediates",
        "to": "migraine"
      },
      {
        "type": "inhibited_by",
        "to": "sumatriptan"
      }
    ]
  },
  "capsaicin": {
    "title": "Capsaicin",
    "primaryType": "substance",
    "tags": [
      "Pharmacology",
      "Pain Management",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Analgesics",
      "Topical Agents"
    ],
    "content": {
      "definition": "<p><b>Capsaicin</b> is a topical analgesic derived from chili peppers that initially stimulates and subsequently desensitizes nociceptive fibers by depleting <u>Substance P</u>.</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> Agonist at <b>TRPV1</b> (Transient Receptor Potential Vanilloid 1) cation channels.</li><li><b>Action:</b> Causes initial burning/stinging (excitation) followed by depletion of <b>[[substance_p]]</b> from sensory nerve terminals, leading to desensitization and analgesia.</li><li><b>Clinical Use:</b> [[postherpetic_neuralgia]], Diabetic neuropathy, Osteoarthritis.</li><li><b>Adverse Effects:</b> Local burning, erythema.</li><li><b>USMLE Tip:</b> Mechanism is <b>Substance P depletion</b> via excessive stimulation.</li></ul>",
      "takeAway": "<p><b>Capsaicin</b> relieves neuropathic pain by activating TRPV1 channels to deplete the neurotransmitter <b>Substance P</b> from nociceptive nerve endings.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "depletes",
        "to": "substance_p"
      },
      {
        "type": "activates",
        "to": "trpv1_receptor"
      },
      {
        "type": "treats",
        "to": "neuropathic_pain"
      }
    ]
  },
  "caput_succedaneum": {
    "title": "Caput Succedaneum",
    "primaryType": "disease",
    "tags": [
      "Pediatrics",
      "Neonatology",
      "Trauma",
      "USMLE"
    ],
    "classificationPath": [
      "Pediatrics",
      "Neonatal Birth Injuries",
      "Scalp Swelling"
    ],
    "content": {
      "definition": "<p><b>Caput Succedaneum</b> is a diffuse, edematous swelling of the soft tissues of the scalp in a newborn caused by pressure during delivery, characterized by its ability to <u>cross suture lines</u>.</p>",
      "atAGlance": "<ul><li><b>Location:</b> Subcutaneous/supragaleal (above the periosteum).</li><li><b>Characteristics:</b> Soft, boggy, poorly defined margins. <b>Crosses suture lines</b>.</li><li><b>Etiology:</b> Venous congestion/edema due to head compression against the cervix.</li><li><b>Prognosis:</b> Benign; resolves spontaneously within days.</li><li><b>USMLE Tip:</b> Differentiate from [[cephalohematoma]] (Subperiosteal, does <b>NOT</b> cross sutures) and [[subgaleal_hemorrhage]] (Mobile, crosses sutures, life-threatening). Mnemonic: <b>C</b>aput <b>C</b>rosses (sutures).</li></ul>",
      "takeAway": "<p><b>Caput Succedaneum</b> is benign neonatal scalp edema that <u>crosses suture lines</u>, distinguishing it from the suture-bound cephalohematoma.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_contrasted_with",
        "to": "cephalohematoma"
      },
      {
        "type": "is_contrasted_with",
        "to": "subgaleal_hemorrhage"
      },
      {
        "type": "affects_structure",
        "to": "scalp"
      }
    ]
  },
  "carbachol": {
    "title": "Carbachol",
    "primaryType": "substance",
    "tags": [
      "Pharmacology",
      "Ophthalmology",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Autonomic Drugs",
      "Cholinomimetics"
    ],
    "content": {
      "definition": "<p><b>Carbachol</b> is a direct-acting <i>cholinomimetic agonist</i> that binds to both muscarinic and nicotinic receptors, primarily used topically to induce miosis and lower intraocular pressure in [[glaucoma]].</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> Direct agonist at Muscarinic (M3) and Nicotinic receptors.Resistant to acetylcholinesterase (Carbon copy of Acetylcholine).</li><li><b>Ophthalmic Action:</b> Contracts ciliary muscle (opens trabecular meshwork &rarr; increased aqueous outflow) and sphincter pupillae (miosis).</li><li><b>Clinical Use:</b> [[glaucoma]] (Open-angle and Angle-closure), inducing miosis during surgery.</li><li><b>USMLE Tip:</b> Like [[pilocarpine]] but also has nicotinic activity. <b>CARB</b>achol has <b>CARB</b>on copy resistance to AChE.</li></ul>",
      "takeAway": "<p><b>Carbachol</b> is a potent cholinergic agonist resistant to degradation, used in ophthalmology to constrict the pupil and treat glaucoma.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "treats",
        "to": "glaucoma"
      },
      {
        "type": "agonizes",
        "to": "muscarinic_acetylcholine_receptor"
      },
      {
        "type": "causes",
        "to": "miosis"
      }
    ]
  },
  "carbamazepine": {
    "title": "Carbamazepine",
    "primaryType": "substance",
    "tags": [
      "Pharmacology",
      "Neurology",
      "Psychiatry",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Neurology Drugs",
      "Anticonvulsants"
    ],
    "content": {
      "definition": "<p><b>Carbamazepine</b> is an anticonvulsant and mood stabilizer that acts by blocking voltage-gated <u>sodium channels</u>, serving as the first-line treatment for [[trigeminal_neuralgia]].</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> Blocks Na<sup>+</sup> channels (increases refractory period), inhibiting high-frequency neuronal firing.</li><li><b>Clinical Uses:</b> [[focal_seizures]], [[generalized_tonic_clonic_seizures]], <b>[[trigeminal_neuralgia]]</b> (1st line), Bipolar disorder.</li><li><b>Pharmacokinetics:</b> Potent <b>Inducer</b> of CYP450 (induces its own metabolism - autoinduction).</li><li><b>Adverse Effects:</b> <br> - <b>Blood:</b> [[agranulocytosis]], aplastic anemia (monitor CBC).<br> - <b>Skin:</b> [[stevens_johnson_syndrome]] (HLA-B*1502 screening in Asians).<br> - <b>Endocrine:</b> [[siadh]] (Hyponatremia).<br> - <b>Neuro:</b> Diplopia, ataxia.</li><li><b>Teratogenicity:</b> Neural tube defects.</li></ul>",
      "takeAway": "<p><b>Carbamazepine</b> is the drug of choice for trigeminal neuralgia; watch out for <b>SIADH</b>, <b>agranulocytosis</b>, and <b>SJS</b>, and remember it is a potent <b>CYP450 inducer</b>.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "treats",
        "to": "trigeminal_neuralgia"
      },
      {
        "type": "blocks_channel",
        "to": "voltage_gated_sodium_channel"
      },
      {
        "type": "induces",
        "to": "cytochrome_p450"
      },
      {
        "type": "can_cause",
        "to": "siadh"
      },
      {
        "type": "can_cause",
        "to": "stevens_johnson_syndrome"
      }
    ]
  },
  "carbidopa_levodopa": {
    "title": "Carbidopa-Levodopa",
    "primaryType": "substance",
    "tags": [
      "Pharmacology",
      "Neurology",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Neurology Drugs",
      "Antiparkinsonian Agents"
    ],
    "content": {
      "definition": "<p><b>Carbidopa-Levodopa</b> (Sinemet) is the gold-standard combination therapy for [[parkinson_disease]], consisting of the dopamine precursor <b>Levodopa</b> (which crosses the BBB) and the peripheral DOPA decarboxylase inhibitor <b>Carbidopa</b>.</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b><br> - <b>Levodopa (L-DOPA):</b> Crosses [[blood_brain_barrier]] and is converted to [[dopamine]] by DOPA decarboxylase in the CNS.<br> - <b>Carbidopa:</b> Inhibits <i>peripheral</i> DOPA decarboxylase. It does <u>not</u> cross the BBB.</li><li><b>Benefit of Carbidopa:</b> Increases CNS bioavailability of L-DOPA and reduces peripheral side effects (nausea, vomiting, orthostatic hypotension) caused by peripheral dopamine.</li><li><b>Adverse Effects:</b><br> - <i>Central:</i> Hallucinations, anxiety/agitation, insomnia.<br> - <i>Long-term:</i> Dyskinesias, \"On-off\" phenomenon.</li><li><b>USMLE Tip:</b> Carbidopa reduces peripheral side effects but can <i>worsen</i> central side effects (e.g., hallucinations) by increasing brain dopamine levels.</li></ul>",
      "takeAway": "<p><b>Levodopa</b> treats Parkinson's by replenishing CNS dopamine; <b>Carbidopa</b> is essential to prevent its peripheral breakdown, maximizing efficacy and minimizing peripheral toxicity.</p>",
      "mermaid": "graph TD; A[L-DOPA Oral] --> B{Peripheral Circulation}; B -->|DOPA Decarboxylase| C[Peripheral Dopamine (Side Effects)]; B -->|Carbidopa inhibits| C; B -->|Crosses BBB| D[CNS L-DOPA]; D -->|DOPA Decarboxylase| E[CNS Dopamine (Therapeutic)];"
    },
    "connections": [
      {
        "type": "treats",
        "to": "parkinson_disease"
      },
      {
        "type": "increases_levels_of",
        "to": "dopamine"
      },
      {
        "type": "transported_across",
        "to": "blood_brain_barrier"
      }
    ]
  },
  "carotid_cavernous_fistula": {
    "title": "Carotid-Cavernous Fistula (CCF)",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Vascular",
      "Ophthalmology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Cerebrovascular Disease",
      "Vascular Malformations"
    ],
    "content": {
      "definition": "<p>A <b>Carotid-Cavernous Fistula (CCF)</b> is an abnormal communication between the [[internal_carotid_artery]] (or its branches) and the [[cavernous_sinus]], leading to high-pressure arterial blood entering the venous sinus.</p>",
      "atAGlance": "<ul><li><b>Etiology:</b> Trauma (basal skull fracture), aneurysm rupture, or spontaneous (in Ehlers-Danlos).</li><li><b>Pathophysiology:</b> Arterial pressure creates venous congestion in the ophthalmic veins and cavernous sinus.</li><li><b>Clinical Triad:</b><br> 1. <b>Pulsatile Proptosis:</b> Eye bulges and pulses with heartbeat.<br> 2. <b>Chemosis:</b> Severe conjunctival edema.<br> 3. <b>Bruit:</b> Whooshing sound heard over the eye/temple.</li><li><b>Associated Findings:</b> [[ophthalmoplegia]] (CN III, IV, VI traverse the sinus) and [[horner_syndrome]] (sympathetics run on the ICA).</li><li><b>USMLE Tip:</b> Look for a patient with a \"red, bulging, pulsing eye\" after head trauma.</li></ul>",
      "takeAway": "<p><b>Carotid-Cavernous Fistula</b> results in high-pressure venous engorgement of the orbit, presenting with pulsatile proptosis, bruit, and cranial nerve palsies.</p>",
      "mermaid": "graph TD; A[Trauma/Rupture] --> B[Fistula between ICA and Cavernous Sinus]; B --> C[Arterial Pressure in Venous System]; C --> D[Retrograde Flow in Ophthalmic Veins]; D --> E[Pulsatile Proptosis / Chemosis]; B --> F[Compression of CN III, IV, VI];"
    },
    "connections": [
      {
        "type": "involves_vessel",
        "to": "internal_carotid_artery"
      },
      {
        "type": "occurs_in",
        "to": "cavernous_sinus"
      },
      {
        "type": "causes",
        "to": "pulsatile_proptosis"
      }
    ]
  },
  "carteolol": {
    "title": "Carteolol",
    "primaryType": "substance",
    "tags": [
      "Pharmacology",
      "Ophthalmology",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Ophthalmic Drugs",
      "Beta Blockers"
    ],
    "content": {
      "definition": "<p><b>Carteolol</b> is a non-selective <i>beta-blocker</i> used as ophthalmic drops to treat [[glaucoma]] by decreasing the production of aqueous humor by the ciliary body.</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> Blocks &beta;<sub>1</sub> and &beta;<sub>2</sub> receptors on the ciliary epithelium &rarr; Decreases cAMP &rarr; Decreases <b>production</b> of aqueous humor.</li><li><b>Clinical Use:</b> Open-angle [[glaucoma]].</li><li><b>Adverse Effects:</b> Can cause systemic beta-blockade (bradycardia, bronchospasm) due to nasolacrimal absorption. </li><li><b>Differentiation:</b> Similar to [[timolol]] but has intrinsic sympathomimetic activity (ISA), theoretically causing less resting bradycardia.</li></ul>",
      "takeAway": "<p><b>Carteolol</b> is a non-selective beta-blocker that lowers intraocular pressure by reducing aqueous humor synthesis.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "treats",
        "to": "glaucoma"
      },
      {
        "type": "decreases_production_of",
        "to": "aqueous_humor"
      },
      {
        "type": "is_a_type_of",
        "to": "beta_blocker"
      }
    ]
  },
  "cataract": {
    "title": "Cataract",
    "primaryType": "disease",
    "tags": [
      "Ophthalmology",
      "Pathology",
      "Aging",
      "USMLE"
    ],
    "classificationPath": [
      "Ophthalmology",
      "Lens Disorders"
    ],
    "content": {
      "definition": "<p>A <b>Cataract</b> is a painless clouding or opacification of the crystalline <u>lens</u> of the eye, leading to decreased visual acuity, glare, and loss of the red reflex.</p>",
      "atAGlance": "<ul><li><b>Etiologies:</b><br> - <b>Acquired:</b> Aging (most common), [[diabetes_mellitus]] (sorbitol accumulation), [[corticosteroids]], Smoking, UV light, Trauma.<br> - <b>Congenital:</b> [[rubella]] (Classic Triad), [[galactosemia]] (Galactitol accumulation), Trisomies, Marfan syndrome.</li><li><b>Clinical Presentation:</b> Progressive blurring, glare at night (halos), leukocoria (white pupil) in severe cases.</li><li><b>Pathophysiology:</b> Oxidative damage, protein aggregation (crystallins), or osmotic swelling (polyol pathway).</li><li><b>Treatment:</b> Surgical lens replacement.</li><li><b>USMLE Tip:</b> <b>Galactosemia</b> cataracts appear in infancy; <b>Diabetes</b> cataracts (\"snowflake\") occur due to osmotic damage from Sorbitol.</li></ul>",
      "takeAway": "<p><b>Cataracts</b> are lens opacities caused by aging or metabolic insults (sugar alcohols); congenital forms are key indicators of metabolic or infectious diseases (Rubella, Galactosemia).</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "affects_structure",
        "to": "lens"
      },
      {
        "type": "associated_with",
        "to": "diabetes_mellitus"
      },
      {
        "type": "associated_with",
        "to": "rubella"
      },
      {
        "type": "caused_by_accumulation_of",
        "to": "sorbitol"
      }
    ]
  },
  "cauda_equina": {
    "title": "Cauda Equina",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Anatomy",
      "Spinal Cord",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Spinal Anatomy",
      "Nerve Roots"
    ],
    "content": {
      "definition": "<p>The <b>Cauda Equina</b> (\"Horse's Tail\") is a bundle of intradural spinal nerve roots (L2-S5, coccygeal) that travel inferiorly through the vertebral canal after the spinal cord terminates at the [[conus_medullaris]] (L1-L2).</p>",
      "atAGlance": "<ul><li><b>Components:</b> Ventral and dorsal roots of lumbar, sacral, and coccygeal nerves.</li><li><b>Location:</b> Subarachnoid space (cistern) below L2.</li><li><b>Clinical Relevance:</b> Target for [[lumbar_puncture]] (L3/L4 or L4/L5) to avoid cord damage. Site of [[cauda_equina_syndrome]].</li><li><b>Function:</b> Innervation of lower limbs, pelvic organs, and sphincters.</li></ul>",
      "takeAway": "<p>The <b>Cauda Equina</b> consists of floating nerve roots below the spinal cord proper, allowing for safe lumbar puncture access and serving as the substrate for Cauda Equina Syndrome.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "originates_from",
        "to": "conus_medullaris"
      },
      {
        "type": "is_site_of",
        "to": "lumbar_puncture"
      },
      {
        "type": "pathology_causes",
        "to": "cauda_equina_syndrome"
      }
    ]
  },
  "cauda_equina_syndrome": {
    "title": "Cauda Equina Syndrome",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Surgery",
      "Emergency Medicine",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Spinal Cord Disorders",
      "Radiculopathy"
    ],
    "content": {
      "definition": "<p><b>Cauda Equina Syndrome</b> is a neurosurgical emergency caused by compression of the [[cauda_equina]] nerve roots, characterized by <u>asymmetric</u> lower motor neuron signs, saddle anesthesia, and late-onset bowel/bladder dysfunction.</p>",
      "atAGlance": "<ul><li><b>Etiology:</b> Massive central disc herniation, tumor, trauma, epidural abscess.</li><li><b>Clinical Features:</b><br> - <b>Sensory:</b> Saddle anesthesia (perineum/inner thighs), severe radicular pain.<br> - <b>Motor:</b> Flaccid paresis, areflexia (LMN signs).<br> - <b>Autonomic:</b> Urinary retention (overflow incontinence), fecal incontinence (decreased anal tone).</li><li><b>Differentiation:</b> Contrast with [[conus_medullaris_syndrome]] (Symmetric, UMN+LMN signs, <i>early</i> autonomic dysfunction).</li><li><b>Treatment:</b> Emergent MRI + Surgical Decompression.</li><li><b>USMLE Tip:</b> \"Saddle anesthesia\" + \"New incontinence\" = Cauda Equina Syndrome.</li></ul>",
      "takeAway": "<p><b>Cauda Equina Syndrome</b> is an LMN lesion of multiple lumbosacral roots causing saddle anesthesia and incontinence, requiring immediate surgical intervention to prevent permanent paralysis.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "involves_compression_of",
        "to": "cauda_equina"
      },
      {
        "type": "is_contrasted_with",
        "to": "conus_medullaris_syndrome"
      },
      {
        "type": "manifests_as",
        "to": "saddle_anesthesia"
      },
      {
        "type": "manifests_as",
        "to": "lower_motor_neuron_lesion"
      }
    ]
  },
  "caudate_nucleus": {
    "title": "Caudate Nucleus",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Anatomy",
      "Basal Ganglia",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Brain Anatomy",
      "Basal Ganglia"
    ],
    "content": {
      "definition": "<p>The <b>Caudate Nucleus</b> is a C-shaped nucleus of the [[basal_ganglia]] located adjacent to the lateral ventricles, which, together with the [[putamen]], forms the <b>Striatum</b>, playing a key role in motor inhibition and cognition.</p>",
      "atAGlance": "<ul><li><b>Structure:</b> Head, body, and tail. Head bulges into the anterior horn of the lateral ventricle.</li><li><b>Neurotransmitters:</b> Rich in <b>GABA</b> and Acetylcholine neurons.</li><li><b>Function:</b> Part of the indirect pathway (inhibitory) and cognitive loops.</li><li><b>Pathology:</b><br> - <b>[[huntington_disease]]:</b> Atrophy of the Caudate (loss of GABA neurons) leads to <i>Chorea</i> and dilated lateral ventricles (Boxcar ventricles).<br> - <b>Hemiballismus:</b> Rare, usually Subthalamic Nucleus, but striatal lesions can contribute.</li><li><b>USMLE Tip:</b> \"<b>C</b>audate atrophy causes <b>C</b>horea (Huntington's).\"</li></ul>",
      "takeAway": "<p>The <b>Caudate Nucleus</b> is the cognitive/motor brake of the basal ganglia; its degeneration is the hallmark of [[huntington_disease]].</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_part_of",
        "to": "striatum"
      },
      {
        "type": "degenerates_in",
        "to": "huntington_disease"
      },
      {
        "type": "utilizes",
        "to": "gaba"
      }
    ]
  },
  "cavernous_sinus": {
    "title": "Cavernous Sinus",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Anatomy",
      "Vascular",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Cerebrovascular System",
      "Venous Sinuses"
    ],
    "content": {
      "definition": "<p>The <b>Cavernous Sinus</b> is a paired dural venous sinus located on either side of the sella turcica, containing the [[internal_carotid_artery]] and cranial nerves III, IV, V1, V2, and VI, making it a critical choke point for neurovascular pathology.</p>",
      "atAGlance": "<ul><li><b>Contents:</b><br> - <i>Running Through Center:</i> <b>[[internal_carotid_artery]]</b> (and sympathetic plexus), <b>[[abducens_nerve]] (CN VI)</b>.<br> - <i>In Lateral Wall (Sup to Inf):</i> <b>[[oculomotor_nerve]] (CN III)</b>, <b>[[trochlear_nerve]] (CN IV)</b>, <b>[[ophthalmic_nerve]] (CN V1)</b>, <b>[[maxillary_nerve]] (CN V2)</b>.</li><li><b>Inputs/Outputs:</b> Receives blood from ophthalmic veins (danger triangle of face); drains into petrosal sinuses.</li><li><b>Pathology:</b> [[cavernous_sinus_syndrome]] (Thrombosis, Fistula, Tumor, Aneurysm).</li><li><b>USMLE Tip:</b> <b>CN VI</b> is \"free-floating\" next to the ICA, making it the <b>first</b> nerve affected by an ICA aneurysm or cavernous pathology (Lateral Rectus palsy).</li></ul>",
      "takeAway": "<p>The <b>Cavernous Sinus</b> houses the ICA and CN III, IV, V1, V2, VI; CN VI is most vulnerable to intracavernous pathology due to its medial location.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "contains",
        "to": "internal_carotid_artery"
      },
      {
        "type": "contains",
        "to": "abducens_nerve"
      },
      {
        "type": "contains",
        "to": "oculomotor_nerve"
      },
      {
        "type": "contains",
        "to": "trochlear_nerve"
      },
      {
        "type": "pathology_causes",
        "to": "cavernous_sinus_syndrome"
      }
    ]
  },
  "cavernous_sinus_syndrome": {
    "title": "Cavernous Sinus Syndrome",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Ophthalmology",
      "Vascular",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Cerebrovascular Disease",
      "Venous Thrombosis"
    ],
    "content": {
      "definition": "<p><b>Cavernous Sinus Syndrome</b> is a clinical condition resulting from pathology (thrombosis, fistula, tumor, inflammation) within the [[cavernous_sinus]], characterized by multiple cranial nerve palsies (III, IV, V1, V2, VI) and venous congestion signs.</p>",
      "atAGlance": "<ul><li><b>Etiologies:</b><br> - <b>Thrombosis:</b> Often secondary to facial infection (<i>S. aureus</i>, <i>Mucor</i> in diabetics).<br> - <b>Fistula:</b> [[carotid_cavernous_fistula]] (Trauma).<br> - <b>Tolosa-Hunt Syndrome:</b> Idiopathic granulomatous inflammation.</li><li><b>Clinical Features:</b><br> - <b>Ophthalmoplegia:</b> CN III, IV, VI palsy (fixed eye).<br> - <b>Sensory Loss:</b> V1/V2 distribution (Corneal reflex loss).<br> - <b>Horner Syndrome:</b> Damage to sympathetic fibers on ICA.<br> - <b>Venous Signs:</b> Proptosis, chemosis, periorbital edema.</li><li><b>USMLE Tip:</b> A patient with a dangerous facial infection (\"pimple popping\") presenting with a \"frozen eye\" and numbness likely has Cavernous Sinus Thrombosis.</li></ul>",
      "takeAway": "<p><b>Cavernous Sinus Syndrome</b> presents with global ophthalmoplegia, facial numbness, and venous congestion, often triggered by spread of infection from the danger triangle of the face.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "involves_pathology_of",
        "to": "cavernous_sinus"
      },
      {
        "type": "can_be_caused_by",
        "to": "mucormycosis"
      },
      {
        "type": "includes",
        "to": "ophthalmoplegia"
      },
      {
        "type": "includes",
        "to": "carotid_cavernous_fistula"
      }
    ]
  }
}
``````json
{
  "cavernous_sinus_thrombosis": {
    "title": "Cavernous Sinus Thrombosis",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Infectious Disease",
      "Vascular",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Cerebrovascular Disease",
      "Venous Thrombosis"
    ],
    "content": {
      "definition": "<p><b>Cavernous Sinus Thrombosis</b> is a life-threatening septic thrombosis of the [[cavernous_sinus]], typically resulting from the retrograde spread of infection from the \"danger triangle\" of the face, sinuses, or teeth via valveless emissary veins.</p>",
      "atAGlance": "<ul><li><b>Etiology:</b> <i>Staphylococcus aureus</i> (most common), Streptococci, or fungi (<i>Mucor</i>/<i>Rhizopus</i> in diabetics).</li><li><b>Clinical Features:</b> Rapid onset of fever, severe headache, <b>chemosis</b> (conjunctival edema), proptosis, and <b>painful ophthalmoplegia</b> (CN III, IV, VI palsies).</li><li><b>Sensory Deficit:</b> Loss of sensation in V1/V2 distribution (ophthalmic/maxillary nerves).</li><li><b>Pathophysiology:</b> Compression of structures running through the sinus (ICA, CN III, IV, V1, V2, VI) due to clot and inflammation.</li><li><b>USMLE Tip:</b> Suspect in a patient with a nasal boil or sinusitis who develops bilateral eye swelling and fixed pupils.</li></ul>",
      "takeAway": "<p><b>Cavernous Sinus Thrombosis</b> is a septic occlusion of the cavernous sinus causing cranial nerve palsies (III, IV, V1, V2, VI) and venous engorgement, often spreading from facial infections.</p>",
      "mermaid": "graph TD; A[Facial/Sinus Infection] -->|Retrograde Spread| B[Cavernous Sinus]; B -->|Thrombosis/Inflammation| C[Venous Engorgement]; B -->|Compression| D[Cranial Nerve Palsies]; C --> E[Proptosis/Chemosis]; D --> F[Ophthalmoplegia];"
    },
    "connections": [
      {
        "type": "affects_structure",
        "to": "cavernous_sinus"
      },
      {
        "type": "often_caused_by",
        "to": "staphylococcus_aureus"
      },
      {
        "type": "causes",
        "to": "ophthalmoplegia"
      }
    ]
  },
  "cellular_injury": {
    "title": "Cellular Injury",
    "primaryType": "process",
    "tags": [
      "Pathology",
      "Cell Biology",
      "USMLE"
    ],
    "classificationPath": [
      "Pathology",
      "Cellular Adaptation and Injury",
      "Mechanisms"
    ],
    "content": {
      "definition": "<p><b>Cellular Injury</b> refers to the structural and functional alteration of cells in response to stress or noxious stimuli, classified as <u>reversible</u> (if the stimulus is removed) or <u>irreversible</u> (leading to cell death via [[necrosis]] or [[apoptosis]]).</p>",
      "atAGlance": "<ul><li><b>Mechanisms:</b> ATP depletion, mitochondrial damage, Ca<sup>2+</sup> influx, accumulation of Reactive Oxygen Species (ROS), membrane permeability defects.</li><li><b>Reversible Signs:</b> <b>Cellular swelling</b> (hydropic change) due to Na<sup>+</sup>/K<sup>+</sup> pump failure; fatty change; ribosomal detachment (decreased protein synthesis).</li><li><b>Irreversible Signs:</b> <b>Membrane damage</b> (plasma/lysosomal/mitochondrial); Nuclear changes (Pyknosis &rarr; Karyorrhexis &rarr; Karyolysis).</li><li><b>USMLE Tip:</b> The hallmark of <b>irreversible</b> injury is <u>membrane damage</u> (look for elevated serum enzymes like Troponin or AST/ALT). The hallmark of <b>reversible</b> injury is <u>cellular swelling</u>.</li></ul>",
      "takeAway": "<p><b>Cellular Injury</b> progresses from reversible swelling (ATP depletion) to irreversible membrane damage and nuclear dissolution, culminating in cell death.</p>",
      "mermaid": "graph TD; A[Injury/Hypoxia] --> B[Decreased ATP]; B --> C[Na+/K+ Pump Failure]; C --> D[Cellular Swelling (Reversible)]; A --> E[Membrane Damage]; E --> F[Ca2+ Influx/Enzyme Leakage]; F --> G[Cell Death (Irreversible)];"
    },
    "connections": [
      {
        "type": "results_in",
        "to": "necrosis"
      },
      {
        "type": "results_in",
        "to": "apoptosis"
      },
      {
        "type": "characterized_by",
        "to": "cellular_swelling"
      }
    ]
  },
  "central_nervous_system": {
    "title": "Central Nervous System (CNS)",
    "primaryType": "concept",
    "tags": [
      "Index Stub"
    ],
    "classificationPath": [
      "Neurology",
      "Anatomy"
    ],
    "content": {
      "definition": "<p><i>(Placeholder)</i> The division of the nervous system consisting of the brain and spinal cord, responsible for integrating sensory information and coordinating motor output.</p>",
      "atAGlance": "<ul><li>See [[brain]], [[spinal_cord]], [[brainstem]], [[cerebellum]].</li></ul>",
      "takeAway": "",
      "mermaid": ""
    },
    "connections": []
  },
  "central_poststroke_pain": {
    "title": "Central Poststroke Pain (Thalamic Syndrome)",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Pain Management",
      "Stroke",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Cerebrovascular Disease",
      "Stroke Complications"
    ],
    "content": {
      "definition": "<p><b>Central Poststroke Pain</b> (Dejerine-Roussy Syndrome) is a chronic neuropathic pain syndrome caused by a thalamic stroke (specifically the [[ventral_posterolateral_nucleus]]), characterized by contralateral hemianesthesia followed by severe, burning pain and <b>allodynia</b>.</p>",
      "atAGlance": "<ul><li><b>Etiology:</b> Ischemic or hemorrhagic stroke affecting the <b>Thalamus</b> (VPL/VPM nuclei).</li><li><b>Clinical Presentation:</b> Initially contralateral sensory loss (hemianesthesia); weeks to months later, development of dysesthesia (burning, shooting pain) and <mark>allodynia</mark> (pain from non-painful stimuli) in the same distribution.</li><li><b>Mechanism:</b> Aberrant rewiring and sensitization of central pain pathways following deafferentation.</li><li><b>Treatment:</b> Resistant to conventional analgesics. Use anticonvulsants ([[gabapentin]], [[pregabalin]]) or antidepressants ([[amitriptyline]]).</li><li><b>USMLE Tip:</b> Patient had a stroke months ago and now complains that \"even clothes touching my skin hurts\" on the affected side.</li></ul>",
      "takeAway": "<p><b>Central Poststroke Pain</b> is a delayed hyperpathic pain syndrome resulting from a thalamic infarct, characterized by severe contralateral burning pain and allodynia.</p>",
      "mermaid": "graph TD; A[Thalamic Stroke] --> B[Damage to VPL/VPM]; B --> C[Loss of Sensory Input]; C --> D[Central Sensitization]; D --> E[Allodynia/Hyperalgesia];"
    },
    "connections": [
      {
        "type": "caused_by_lesion_in",
        "to": "thalamus"
      },
      {
        "type": "involves_nucleus",
        "to": "ventral_posterolateral_nucleus"
      },
      {
        "type": "manifests_as",
        "to": "allodynia"
      },
      {
        "type": "treated_by",
        "to": "amitriptyline"
      }
    ]
  },
  "central_retinal_artery_occlusion": {
    "title": "Central Retinal Artery Occlusion (CRAO)",
    "primaryType": "disease",
    "tags": [
      "Ophthalmology",
      "Vascular",
      "Emergency Medicine",
      "USMLE"
    ],
    "classificationPath": [
      "Ophthalmology",
      "Retinal Vascular Disease",
      "Arterial Occlusion"
    ],
    "content": {
      "definition": "<p><b>Central Retinal Artery Occlusion (CRAO)</b> is an ophthalmic emergency caused by the blockage of the central retinal artery (usually embolic), leading to acute, profound, painless monocular vision loss and retinal infarction.</p>",
      "atAGlance": "<ul><li><b>Fundoscopy:</b> <b>Cherry-red spot</b> at the fovea (choroidal circulation supply is intact and shows through the pale, ischemic retina) and retinal pallor/edema.</li><li><b>Pathophysiology:</b> Embolism (cholesterol/Hollenhorst plaque from carotid, cardiac vegetation) occludes the CRA.</li><li><b>Clinical:</b> Sudden, painless loss of vision (count fingers or worse). Relative Afferent Pupillary Defect (RAPD).</li><li><b>Treatment:</b> Ocular massage, anterior chamber paracentesis, hyperbaric oxygen (poor prognosis).</li><li><b>USMLE Tip:</b> \"Cherry-red spot\" is also seen in [[tay_sachs_disease]] and [[niemann_pick_disease]], but CRAO is <b>unilateral</b> and acute in an adult.</li></ul>",
      "takeAway": "<p><b>CRAO</b> presents as sudden painless vision loss with a classic <b>cherry-red spot</b> on a pale retina, typically due to embolic disease.</p>",
      "mermaid": "graph TD; A[Embolus] --> B[Occludes Central Retinal Artery]; B --> C[Retinal Ischemia/Pallor]; C --> D[Fovea Sparing (Choroidal Supply)]; D --> E[Cherry-Red Spot];"
    },
    "connections": [
      {
        "type": "manifests_as",
        "to": "cherry_red_spot"
      },
      {
        "type": "caused_by",
        "to": "embolism"
      },
      {
        "type": "is_distinguished_from",
        "to": "tay_sachs_disease"
      }
    ]
  },
  "central_retinal_vein_occlusion": {
    "title": "Central Retinal Vein Occlusion (CRVO)",
    "primaryType": "disease",
    "tags": [
      "Ophthalmology",
      "Vascular",
      "USMLE"
    ],
    "classificationPath": [
      "Ophthalmology",
      "Retinal Vascular Disease",
      "Venous Occlusion"
    ],
    "content": {
      "definition": "<p><b>Central Retinal Vein Occlusion (CRVO)</b> is a blockage of the main vein draining the retina, leading to venous engorgement, stagnation, and diffuse hemorrhage, often described as a \"blood and thunder\" appearance.</p>",
      "atAGlance": "<ul><li><b>Fundoscopy:</b> Diffuse retinal hemorrhages in all four quadrants, dilated tortuous veins, cotton-wool spots, optic disc edema (\"Blood and Thunder\").</li><li><b>Pathophysiology:</b> Thrombosis of the central retinal vein, often due to compression by a sclerotic central retinal artery or hypercoagulability.</li><li><b>Clinical:</b> Sudden, painless monocular vision loss (variable severity).</li><li><b>Risk Factors:</b> Hypertension, Diabetes, Glaucoma, Hypercoagulable states.</li><li><b>Complications:</b> Neovascular glaucoma (VEGF release).</li><li><b>USMLE Tip:</b> Differentiate from CRAO (Pale retina) and BRVO (Sectoral hemorrhage). CRVO is messy and diffuse.</li></ul>",
      "takeAway": "<p><b>CRVO</b> causes acute painless vision loss with a dramatic \"blood and thunder\" fundus due to venous outflow obstruction.</p>",
      "mermaid": "graph TD; A[Venous Occlusion] --> B[Increased Venous Pressure]; B --> C[Capillary Rupture]; C --> D[Diffuse Retinal Hemorrhages]; D --> E[Retinal Edema/Ischemia];"
    },
    "connections": [
      {
        "type": "manifests_as",
        "to": "retinal_hemorrhage"
      },
      {
        "type": "associated_with",
        "to": "hypertension"
      },
      {
        "type": "can_cause",
        "to": "neovascular_glaucoma"
      }
    ]
  },
  "central_vertigo": {
    "title": "Central Vertigo",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Otology",
      "Diagnosis",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Vestibular Disorders",
      "Vertigo"
    ],
    "content": {
      "definition": "<p><b>Central Vertigo</b> is a type of vertigo caused by lesions in the brainstem (vestibular nuclei) or cerebellum, characterized by <u>purely vertical</u> or multidirectional nystagmus, absence of latency, and resistance to fatigue.</p>",
      "atAGlance": "<ul><li><b>Etiologies:</b> Stroke (PICA/AICA), Multiple Sclerosis, Tumors, Migraine.</li><li><b>Nystagmus:</b> Purely <b>vertical</b> (upbeat/downbeat) or direction-changing. <u>Not</u> suppressed by visual fixation.</li><li><b>Dix-Hallpike Test:</b> Immediate onset of nystagmus (no latency) that does not fatigue (persists).</li><li><b>Associated Symptoms:</b> Diplopia, Dysmetria, Dysarthria, Focal weakness/numbness (The \"D's\" of brainstem stroke).</li><li><b>USMLE Tip:</b> Purely vertical nystagmus is <b>always</b> central. Peripheral vertigo (inner ear) usually has a horizontal/rotary component and fatigues.</li></ul>",
      "takeAway": "<p><b>Central Vertigo</b> indicates brainstem or cerebellar pathology and is distinguished from peripheral vertigo by non-fatigable, vertical nystagmus and associated focal neurologic deficits.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "caused_by_lesion_in",
        "to": "brainstem"
      },
      {
        "type": "caused_by_lesion_in",
        "to": "cerebellum"
      },
      {
        "type": "manifests_as",
        "to": "vertical_nystagmus"
      },
      {
        "type": "is_distinguished_from",
        "to": "peripheral_vertigo"
      }
    ]
  },
  "central_herniation": {
    "title": "Central (Transtentorial) Herniation",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Pathology",
      "Trauma",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Intracranial Pressure Disorders",
      "Brain Herniation"
    ],
    "content": {
      "definition": "<p><b>Central Herniation</b> is the downward displacement of the diencephalon and midbrain through the tentorial notch due to supratentorial mass effect, leading to progressive brainstem compression.</p>",
      "atAGlance": "<ul><li><b>Pathophysiology:</b> Increased ICP pushes the brainstem downwards.</li><li><b>Clinical Progression (Rostral to Caudal):</b><br> 1. <b>Diencephalic:</b> Decreased consciousness, small reactive pupils, Cheyne-Stokes respiration.<br> 2. <b>Midbrain:</b> Fixed mid-position pupils, decorticate posturing.<br> 3. <b>Pons/Medulla:</b> Decerebrate posturing, apnea, death.</li><li><b>Vascular Complication:</b> Stretching of pontine perforating arteries causes <b>Duret Hemorrhages</b> (brainstem streaks).</li><li><b>USMLE Tip:</b> Duret hemorrhages are the fatal signature of central herniation.</li></ul>",
      "takeAway": "<p><b>Central Herniation</b> involves the downward shift of the brainstem causing sequential loss of consciousness, pupillary changes, and posturing, often culminating in fatal Duret hemorrhages.</p>",
      "mermaid": "graph TD; A[Supratentorial Mass] --> B[Downward Displacement]; B --> C[Brainstem Compression]; C --> D[Stretching of Pontine Arteries]; D --> E[Duret Hemorrhages]; C --> F[Coma/Death];"
    },
    "connections": [
      {
        "type": "causes",
        "to": "duret_hemorrhage"
      },
      {
        "type": "manifests_as",
        "to": "decorticate_posturing"
      },
      {
        "type": "manifests_as",
        "to": "decerebrate_posturing"
      }
    ]
  },
  "cephalohematoma": {
    "title": "Cephalohematoma",
    "primaryType": "disease",
    "tags": [
      "Pediatrics",
      "Neonatology",
      "Trauma",
      "USMLE"
    ],
    "classificationPath": [
      "Pediatrics",
      "Neonatal Birth Injuries",
      "Scalp Swelling"
    ],
    "content": {
      "definition": "<p><b>Cephalohematoma</b> is a traumatic subperiosteal collection of blood that occurs between the skull and the periosteum in a newborn, characterized by a firm swelling that <u>does not cross suture lines</u>.</p>",
      "atAGlance": "<ul><li><b>Location:</b> Subperiosteal.</li><li><b>Characteristics:</b> Firm, well-defined. <b>Does NOT cross suture lines</b> (bounded by periosteal attachment at sutures).</li><li><b>Timeline:</b> Appears hours to days after birth; resolves over weeks/months.</li><li><b>Complications:</b> Calcification, Hyperbilirubinemia (jaundice) as the RBCs break down.</li><li><b>Differentiation:</b> Contrast with [[caput_succedaneum]] (crosses sutures, superficial edema).</li><li><b>USMLE Tip:</b> \"Cephalohematoma is confined by the sutures.\"</li></ul>",
      "takeAway": "<p><b>Cephalohematoma</b> is a subperiosteal bleed bounded by suture lines, posing a risk for neonatal jaundice as the hematoma resolves.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_contrasted_with",
        "to": "caput_succedaneum"
      },
      {
        "type": "can_cause",
        "to": "neonatal_jaundice"
      },
      {
        "type": "located_in",
        "to": "subperiosteal_space"
      }
    ]
  },
  "cerebellar_tonsillar_herniation": {
    "title": "Cerebellar Tonsillar Herniation",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Pathology",
      "Emergency Medicine",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Intracranial Pressure Disorders",
      "Brain Herniation"
    ],
    "content": {
      "definition": "<p><b>Cerebellar Tonsillar Herniation</b> (\"Coning\") is the downward displacement of the cerebellar tonsils through the <u>foramen magnum</u>, compressing the medulla oblongata and leading to rapid cardiorespiratory arrest.</p>",
      "atAGlance": "<ul><li><b>Pathophysiology:</b> Increased posterior fossa pressure pushes tonsils down.</li><li><b>Clinical Consequences:</b> Compression of the <b>Medulla</b> (respiratory/cardiac centers).<br> - Respiratory arrest.<br> - Cardiovascular collapse.<br> - Coma.</li><li><b>Associations:</b> [[chiari_malformation]] (congenital tonsillar ectopia).</li><li><b>USMLE Tip:</b> Be cautious with lumbar puncture in patients with high ICP; sudden pressure drop can precipitate coning.</li></ul>",
      "takeAway": "<p><b>Tonsillar Herniation</b> is a lethal event where the cerebellum crushes the medulla against the foramen magnum, causing respiratory arrest.</p>",
      "mermaid": "graph TD; A[Increased ICP] --> B[Tonsils pushed through Foramen Magnum]; B --> C[Compression of Medulla]; C --> D[Depression of Respiratory Center]; D --> E[Respiratory Arrest/Death];"
    },
    "connections": [
      {
        "type": "compresses",
        "to": "medulla_oblongata"
      },
      {
        "type": "associated_with",
        "to": "chiari_malformation"
      },
      {
        "type": "causes",
        "to": "respiratory_arrest"
      }
    ]
  },
  "cerebellar_vermis_lesion": {
    "title": "Cerebellar Vermis Lesion",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Anatomy",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Cerebellar Disorders",
      "Localization"
    ],
    "content": {
      "definition": "<p>A <b>Cerebellar Vermis Lesion</b> affects the medial zone of the cerebellum, resulting in <u>truncal ataxia</u>, gait instability, and nystagmus, while typically sparing distal limb coordination.</p>",
      "atAGlance": "<ul><li><b>Functional Anatomy:</b> The Vermis controls medial motor systems (trunk, proximal muscles, head/neck).</li><li><b>Clinical Findings:</b><br> - <b>Truncal Ataxia:</b> Inability to sit or stand without swaying.<br> - <b>Gait Ataxia:</b> Wide-based, unsteady gait (\"Drunken Sailor\").<br> - <b>Nystagmus/Head Titubation.</b></li><li><b>Etiologies:</b> Chronic [[alcohol_use_disorder]] (selectively damages anterior vermis), Medulloblastoma (children).</li><li><b>USMLE Tip:</b> Medial lesion = Medial body (Trunk). Lateral lesion = Lateral body (Limbs).</li></ul>",
      "takeAway": "<p>Lesions of the <b>Cerebellar Vermis</b> cause central/truncal instability (truncal ataxia), classically seen in alcoholic cerebellar degeneration.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "causes",
        "to": "truncal_ataxia"
      },
      {
        "type": "associated_with",
        "to": "alcohol_use_disorder"
      },
      {
        "type": "associated_with",
        "to": "medulloblastoma"
      }
    ]
  },
  "cerebellum": {
    "title": "Cerebellum",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Anatomy",
      "Physiology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Brain Anatomy",
      "Cerebellum"
    ],
    "content": {
      "definition": "<p>The <b>Cerebellum</b> is a hindbrain structure responsible for the coordination of voluntary movement, maintenance of balance and posture, and motor learning, interacting with the cortex and brainstem via three pairs of peduncles.</p>",
      "atAGlance": "<ul><li><b>Functional Divisions:</b><br> - <b>Vestibulocerebellum (Flocculonodular):</b> Balance, eye movements.<br> - <b>Spinocerebellum (Vermis/Paravermis):</b> Trunk/Limb coordination.<br> - <b>Cerebrocerebellum (Hemispheres):</b> Motor planning, fine dexterity.</li><li><b>Deep Nuclei (Lateral to Medial):</b> <b>D</b>entate, <b>E</b>mboliform, <b>G</b>lobose, <b>F</b>astigial (\"<b>D</b>on't <b>E</b>at <b>G</b>reasy <b>F</b>oods\").</li><li><b>Input/Output:</b><br> - Inputs: Mossy/Climbing fibers via Middle/Inferior Peduncles.<br> - Output: Purkinje cells (inhibitory) &rarr; Deep Nuclei &rarr; Superior Peduncle.</li><li><b>Pathology:</b> Ataxia, Dysmetria, Intention Tremor, Dysdiadochokinesia. Lesions cause <u>ipsilateral</u> deficits.</li></ul>",
      "takeAway": "<p>The <b>Cerebellum</b> fine-tunes motor output; lesions produce ipsilateral incoordination (ataxia), with medial structures controlling the trunk and lateral structures controlling the limbs.</p>",
      "mermaid": "graph TD; A[Cortex/Spinal Cord] --> B[Mossy/Climbing Fibers]; B --> C[Cerebellar Cortex]; C --> D[Deep Nuclei]; D --> E[Thalamus/Brainstem]; E --> F[Motor Cortex/Spinal Cord];"
    },
    "connections": [
      {
        "type": "contains",
        "to": "dentate_nucleus"
      },
      {
        "type": "dysfunction_causes",
        "to": "ataxia"
      },
      {
        "type": "projects_to",
        "to": "thalamus"
      }
    ]
  },
  "cerebral_aqueduct": {
    "title": "Cerebral Aqueduct (Aqueduct of Sylvius)",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Anatomy",
      "CSF",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Brain Anatomy",
      "Ventricular System"
    ],
    "content": {
      "definition": "<p>The <b>Cerebral Aqueduct</b> is a narrow channel within the midbrain that connects the <u>third ventricle</u> to the <u>fourth ventricle</u>, serving as a critical bottleneck in the circulation of cerebrospinal fluid.</p>",
      "atAGlance": "<ul><li><b>Location:</b> Midbrain (surrounded by Periaqueductal Gray).</li><li><b>Connection:</b> 3rd Ventricle &rarr; 4th Ventricle.</li><li><b>Pathology:</b> <b>[[aqueductal_stenosis]]</b> (congenital or acquired) is a common cause of [[noncommunicating_hydrocephalus]].</li><li><b>Compression:</b> Susceptible to compression by pineal tumors ([[parinaud_syndrome]]) or midbrain lesions.</li><li><b>USMLE Tip:</b> Enlarged lateral/3rd ventricles with a <i>normal</i> 4th ventricle points to aqueductal stenosis.</li></ul>",
      "takeAway": "<p>The <b>Cerebral Aqueduct</b> is the narrowest point in the ventricular system, making it highly prone to obstruction (stenosis) and a frequent cause of obstructive hydrocephalus.</p>",
      "mermaid": "graph TD; A[Third Ventricle] --> B[Cerebral Aqueduct]; B --> C[Fourth Ventricle]; B -.->|Stenosis| D[Hydrocephalus (Triventricular)];"
    },
    "connections": [
      {
        "type": "connects",
        "to": "third_ventricle"
      },
      {
        "type": "connects",
        "to": "fourth_ventricle"
      },
      {
        "type": "stenosis_causes",
        "to": "noncommunicating_hydrocephalus"
      }
    ]
  },
  "cerebral_arteries": {
    "title": "Cerebral Arteries",
    "primaryType": "concept",
    "tags": [
      "Index Stub"
    ],
    "classificationPath": [
      "Neurology",
      "Cerebrovascular System"
    ],
    "content": {
      "definition": "<p><i>(Placeholder)</i> The vascular supply of the brain, including the Circle of Willis and major territories (ACA, MCA, PCA), referenced in the graph awaiting detailed population.</p>",
      "atAGlance": "<ul><li>See [[anterior_cerebral_artery]], [[middle_cerebral_artery]], [[posterior_cerebral_artery]], [[circle_of_willis]].</li></ul>",
      "takeAway": "",
      "mermaid": ""
    },
    "connections": []
  },
  "cerebral_cortex": {
    "title": "Cerebral Cortex",
    "primaryType": "concept",
    "tags": [
      "Index Stub"
    ],
    "classificationPath": [
      "Neurology",
      "Brain Anatomy"
    ],
    "content": {
      "definition": "<p><i>(Placeholder)</i> The outer layer of the cerebrum responsible for higher-level processes such as language, memory, reasoning, thought, learning, decision-making, emotion, intelligence and personality.</p>",
      "atAGlance": "<ul><li>See [[frontal_lobe]], [[parietal_lobe]], [[temporal_lobe]], [[occipital_lobe]].</li></ul>",
      "takeAway": "",
      "mermaid": ""
    },
    "connections": []
  }
}
``````json
{
  "cerebral_edema": {
    "title": "Cerebral Edema",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Intracranial Pressure Disorders",
      "Edema"
    ],
    "content": {
      "definition": "<p><b>Cerebral Edema</b> is the pathological accumulation of fluid within the brain parenchyma, leading to increased [[intracranial_pressure]], classified primarily into <u>cytotoxic</u> and <u>vasogenic</u> types based on the integrity of the blood-brain barrier.</p>",
      "atAGlance": "<ul><li><b>Cytotoxic Edema:</b> Intracellular swelling due to Na<sup>+</sup>/K<sup>+</sup> pump failure. Seen in <b>early ischemia</b>/stroke. BBB remains intact.</li><li><b>Vasogenic Edema:</b> Extracellular swelling due to <b>BBB disruption</b> and increased permeability. Seen in tumors, abscesses, and late ischemia.</li><li><b>Complications:</b> Increased ICP, [[brain_herniation]] (e.g., Uncal, Tonsillar), Cushing reflex.</li><li><b>Treatment:</b> Mannitol, Hyperventilation (vasoconstriction), Steroids (for vasogenic edema in tumors).</li><li><b>USMLE Tip:</b> Vasogenic edema \"tracks along white matter\" tracts; Cytotoxic edema affects gray and white matter (loss of gray-white differentiation).</li></ul>",
      "takeAway": "<p><b>Cerebral Edema</b> drives intracranial hypertension; <b>Cytotoxic</b> is cellular swelling from pump failure (ischemia), while <b>Vasogenic</b> is vascular leakage from BBB breakdown (tumors/trauma).</p>",
      "mermaid": "graph TD; A[Brain Insult] --> B{Type?}; B -->|Ischemia/Hypoxia| C[ATP Failure]; C --> D[Na+/K+ Pump Stop]; D --> E[Intracellular Na+ Accumulation]; E --> F[Cytotoxic Edema]; B -->|Tumor/Inflammation| G[BBB Disruption]; G --> H[Protein Leakage]; H --> I[Vasogenic Edema];"
    },
    "connections": [
      {
        "type": "causes",
        "to": "increased_intracranial_pressure"
      },
      {
        "type": "is_a_type_of",
        "to": "cytotoxic_edema"
      },
      {
        "type": "is_a_type_of",
        "to": "vasogenic_edema"
      },
      {
        "type": "treated_by",
        "to": "mannitol"
      }
    ]
  },
  "cerebral_palsy": {
    "title": "Cerebral Palsy",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Pediatrics",
      "Index Stub"
    ],
    "classificationPath": [
      "Neurology",
      "Movement Disorders",
      "Pediatric"
    ],
    "content": {
      "definition": "<p><b>Cerebral Palsy</b> is a group of permanent, non-progressive movement disorders causing physical disability in development, often attributed to disturbances in the developing fetal or infant brain.</p>",
      "atAGlance": "<ul><li><b>Clinical Features:</b> Spasticity, dystonia, muscle weakness, ataxia.</li><li><b>Treatment:</b> Muscle relaxants like [[baclofen]], [[tizanidine]], and [[botulinum_toxin]] for spasticity.</li><li><b>Note:</b> Detailed pathophysiology is awaiting further population from source text; currently referenced in pharmacology context.</li></ul>",
      "takeAway": "<p><b>Cerebral Palsy</b> manifests as chronic motor impairment (spasticity) treated with centrally acting muscle relaxants and botulinum toxin.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "treated_by",
        "to": "baclofen"
      },
      {
        "type": "treated_by",
        "to": "tizanidine"
      },
      {
        "type": "treated_by",
        "to": "botulinum_toxin"
      }
    ]
  },
  "cerebral_perfusion": {
    "title": "Cerebral Perfusion",
    "primaryType": "process",
    "tags": [
      "Neurology",
      "Physiology",
      "Hemodynamics",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Cerebrovascular Physiology"
    ],
    "content": {
      "definition": "<p><b>Cerebral Perfusion</b> is the delivery of blood to the brain tissue, strictly regulated by <u>autoregulation</u> to maintain constant flow across a range of pressures, primarily driven by arterial <b>PCO<sub>2</sub></b>.</p>",
      "atAGlance": "<ul><li><b>Regulation:</b><br> - <b>PCO<sub>2</sub>:</b> Potent vasodilator. &uarr; PCO<sub>2</sub> &rarr; &uarr; CBF. (Linear relationship).<br> - <b>PO<sub>2</sub>:</b> Minimal effect until severe hypoxia (<50 mmHg) &rarr; vasodilation.<br> - <b>Autoregulation:</b> Constant CBF between MAP 60-140 mmHg.</li><li><b>Therapeutic Hyperventilation:</b> Decreases PCO<sub>2</sub> &rarr; Vasoconstriction &rarr; Decreases Cerebral Blood Volume &rarr; Lowers [[intracranial_pressure]] (acute management).</li><li><b>Cushing Reflex:</b> Response to ischemia from high ICP: Hypertension, Bradycardia, Respiratory Irregularity.</li></ul>",
      "takeAway": "<p><b>Cerebral Perfusion</b> is exquisitely sensitive to <b>CO<sub>2</sub></b> (hypercapnia dilates, hypocapnia constricts); therapeutic hyperventilation exploits this to rapidly lower ICP.</p>",
      "mermaid": "graph TD; A[Increased PCO2] --> B[Cerebral Vasodilation]; B --> C[Increased Cerebral Blood Flow]; D[Decreased PCO2] --> E[Cerebral Vasoconstriction]; E --> F[Decreased Intracranial Pressure];"
    },
    "connections": [
      {
        "type": "regulated_by",
        "to": "carbon_dioxide"
      },
      {
        "type": "determines",
        "to": "intracranial_pressure"
      },
      {
        "type": "influenced_by",
        "to": "cushing_reflex"
      }
    ]
  },
  "cerebral_perfusion_pressure": {
    "title": "Cerebral Perfusion Pressure (CPP)",
    "primaryType": "concept",
    "tags": [
      "Neurology",
      "Physiology",
      "Critical Care",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Cerebrovascular Physiology",
      "Hemodynamics"
    ],
    "content": {
      "definition": "<p><b>Cerebral Perfusion Pressure (CPP)</b> is the net pressure gradient driving blood flow to the brain, calculated as the difference between <u>Mean Arterial Pressure (MAP)</u> and <u>Intracranial Pressure (ICP)</u>.</p>",
      "atAGlance": "<ul><li><b>Equation:</b> CPP = MAP - ICP.</li><li><b>Normal Range:</b> 70-90 mmHg.</li><li><b>Pathology:</b><br> - If <b>ICP</b> increases (e.g., hemorrhage, edema), CPP decreases.<br> - If <b>CPP = 0</b>, there is no perfusion &rarr; <b>Brain Death</b>.</li><li><b>Clinical Goal:</b> In TBI/High ICP, maintain MAP to ensure adequate CPP prevents ischemia.</li><li><b>Cushing Reflex:</b> Body increases MAP to preserve CPP in the face of rising ICP.</li></ul>",
      "takeAway": "<p><b>CPP</b> represents the driving force for brain blood flow; elevated ICP directly compromises CPP, necessitating systemic hypertension (Cushing reflex) to maintain perfusion.</p>",
      "mermaid": "graph LR; A[MAP] --Minus--> B[ICP]; B --> C[CPP]; C --> D[Cerebral Blood Flow];"
    },
    "connections": [
      {
        "type": "calculated_from",
        "to": "intracranial_pressure"
      },
      {
        "type": "determines",
        "to": "cerebral_perfusion"
      },
      {
        "type": "loss_results_in",
        "to": "brain_death"
      }
    ]
  },
  "cerebrospinal_fluid": {
    "title": "Cerebrospinal Fluid (CSF)",
    "primaryType": "substance",
    "tags": [
      "Neurology",
      "Anatomy",
      "Physiology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "CNS Fluids"
    ],
    "content": {
      "definition": "<p><b>Cerebrospinal Fluid (CSF)</b> is the clear fluid produced by the <u>choroid plexus</u> that circulates through the ventricles and subarachnoid space to cushion the brain, eventually being reabsorbed by [[arachnoid_granulations]].</p>",
      "atAGlance": "<ul><li><b>Production:</b> Ependymal cells of the <b>Choroid Plexus</b> (Lateral, 3rd, 4th ventricles).</li><li><b>Circulation:</b> Lateral Ventricles &rarr; Foramen of Monro &rarr; 3rd Ventricle &rarr; Aqueduct of Sylvius &rarr; 4th Ventricle &rarr; Foramina of Luschka/Magendie &rarr; Subarachnoid Space.</li><li><b>Reabsorption:</b> <b>Arachnoid Granulations</b> &rarr; Dural Venous Sinuses.</li><li><b>Pathology:</b><br> - <i>Hydrocephalus:</i> Excess CSF (Communicating vs. Non-communicating).<br> - <i>Meningitis:</i> CSF analysis shows WBCs, protein, low glucose.</li><li><b>USMLE Tip:</b> CSF is produced at a constant rate; blockage or decreased absorption leads to increased ICP.</li></ul>",
      "takeAway": "<p><b>CSF</b> flows from the choroid plexus to arachnoid granulations; obstruction of this flow causes [[noncommunicating_hydrocephalus]], while impaired resorption causes [[communicating_hydrocephalus]].</p>",
      "mermaid": "graph TD; A[Choroid Plexus] --> B[Ventricles]; B --> C[Subarachnoid Space]; C --> D[Arachnoid Granulations]; D --> E[Venous Sinuses];"
    },
    "connections": [
      {
        "type": "produced_by",
        "to": "choroid_plexus"
      },
      {
        "type": "reabsorbed_by",
        "to": "arachnoid_granulations"
      },
      {
        "type": "accumulation_causes",
        "to": "hydrocephalus"
      }
    ]
  },
  "chalazion": {
    "title": "Chalazion",
    "primaryType": "disease",
    "tags": [
      "Ophthalmology",
      "Pathology",
      "Inflammation",
      "USMLE"
    ],
    "classificationPath": [
      "Ophthalmology",
      "Eyelid Disorders"
    ],
    "content": {
      "definition": "<p>A <b>Chalazion</b> is a painless, chronic, granulomatous inflammation of the eyelid resulting from the obstruction of a <u>Meibomian gland</u> (or Zeis gland), distinct from an infectious stye.</p>",
      "atAGlance": "<ul><li><b>Pathophysiology:</b> Blocked oil gland &rarr; Lipid extrusion &rarr; Granulomatous reaction.</li><li><b>Clinical Presentation:</b> Firm, rubbery, <b>painless</b> nodule on the eyelid. (Contrast with [[hordeolum]]: painful, acute infection).</li><li><b>Treatment:</b> Warm compresses, incision and curettage if persistent.</li><li><b>USMLE Tip:</b> If it's <b>Painless</b>, it's a Chalazion. If it's <b>Painful</b>, it's a Stye (Hordeolum).</li></ul>",
      "takeAway": "<p><b>Chalazion</b> is a sterile lipogranuloma of the meibomian gland, presenting as a painless lid nodule, unlike the painful infectious [[hordeolum]].</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_contrasted_with",
        "to": "hordeolum"
      },
      {
        "type": "involves_structure",
        "to": "meibomian_gland"
      },
      {
        "type": "characterized_by",
        "to": "granulomatous_inflammation"
      }
    ]
  },
  "charcot_joint": {
    "title": "Charcot Joint (Neuropathic Arthropathy)",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Rheumatology",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Sensory Disorders",
      "Joint Pathology"
    ],
    "content": {
      "definition": "<p><b>Charcot Joint</b> (Neuropathic Arthropathy) is a progressive degeneration of a weight-bearing joint characterized by bone destruction and deformity, caused by loss of <u>sensation</u> (proprioception/pain) leading to unrecognized trauma.</p>",
      "atAGlance": "<ul><li><b>Etiologies:</b><br> - <b>Diabetes Mellitus:</b> (Foot/Ankle) - Most common cause.<br> - <b>[[tabes_dorsalis]] (Syphilis):</b> (Knee) - Classic historical cause.<br> - <b>[[syringomyelia]]:</b> (Shoulder/Elbow) - Upper extremity involvement.</li><li><b>Pathophysiology:</b> Loss of sensory feedback &rarr; repetitive microtrauma &rarr; joint destruction &rarr; \"Bag of bones\" deformity.</li><li><b>Clinical:</b> Swollen, deformed, unstable joint that is surprisingly <b>painless</b> relative to appearance.</li><li><b>USMLE Tip:</b> \"Painless destruction\" of a joint in a diabetic or syphilis patient.</li></ul>",
      "takeAway": "<p><b>Charcot Joint</b> results from the loss of protective sensation, leading to destructive arthropathy; location hints at etiology (Feet=Diabetes, Knees=Syphilis, Upper Extremity=[[syringomyelia]]).</p>",
      "mermaid": "graph TD; A[Loss of Proprioception/Pain] --> B[Repetitive Microtrauma]; B --> C[Joint Inflammation/Destruction]; C --> D[Deformity]; D --> E[Charcot Joint];"
    },
    "connections": [
      {
        "type": "caused_by",
        "to": "tabes_dorsalis"
      },
      {
        "type": "caused_by",
        "to": "syringomyelia"
      },
      {
        "type": "caused_by",
        "to": "diabetes_mellitus"
      }
    ]
  },
  "charcot_marie_tooth_disease": {
    "title": "Charcot-Marie-Tooth Disease",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Genetics",
      "Peripheral Neuropathy",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Hereditary Neuropathies"
    ],
    "content": {
      "definition": "<p><b>Charcot-Marie-Tooth Disease (CMT)</b> is a group of hereditary motor and sensory neuropathies, most commonly caused by a duplication of the <u>PMP22</u> gene (CMT1A), leading to defective myelin structure and function.</p>",
      "atAGlance": "<ul><li><b>Genetics:</b> Autosomal Dominant (most common); Duplication of <b>PMP22</b> gene (Peripheral Myelin Protein).</li><li><b>Pathophysiology:</b> Demyelination and remyelination (Onion bulb formation) &rarr; Axonal degeneration.</li><li><b>Clinical Presentation:</b> Progressive distal muscle weakness and atrophy (<b>\"Inverted champagne bottle\"</b> legs or \"Stork legs\"), <b>Pes Cavus</b> (high arches), Hammer toes, foot drop, sensory deficits.</li><li><b>Diagnosis:</b> Nerve conduction studies (slowed conduction), Genetic testing.</li><li><b>USMLE Tip:</b> Look for a patient with high arched feet (Pes Cavus) and lower extremity weakness/atrophy, often with a family history.</li></ul>",
      "takeAway": "<p><b>Charcot-Marie-Tooth</b> is the most common hereditary neuropathy, presenting with distal atrophy (\"stork legs\") and foot deformities (pes cavus) due to PMP22 duplication.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "caused_by_mutation_in",
        "to": "pmp22_gene"
      },
      {
        "type": "manifests_as",
        "to": "pes_cavus"
      },
      {
        "type": "causes",
        "to": "foot_drop"
      }
    ]
  },
  "chemoreceptor_trigger_zone": {
    "title": "Chemoreceptor Trigger Zone (CTZ)",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Physiology",
      "Pharmacology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Brainstem",
      "Circumventricular Organs"
    ],
    "content": {
      "definition": "<p>The <b>Chemoreceptor Trigger Zone (CTZ)</b> is a specialized area located in the [[area_postrema]] on the floor of the fourth ventricle that lacks a blood-brain barrier, allowing it to detect emetic toxins in the blood and CSF to initiate vomiting.</p>",
      "atAGlance": "<ul><li><b>Location:</b> Area Postrema (Dorsal Medulla).</li><li><b>Function:</b> Senses chemical emetics (drugs, toxins, ketoacidosis, uremia) &rarr; Activates the [[vomiting_center]] (Nucleus Tractus Solitarius).</li><li><b>Receptors:</b> Dopamine (D2), Serotonin (5-HT3), Neurokinin (NK1).</li><li><b>Pharmacology:</b> <br> - <i>Antiemetics:</i> [[ondansetron]] (5-HT3 antagonist), [[metoclopramide]] (D2 antagonist), [[aprepitant]] (NK1 antagonist).</li><li><b>USMLE Tip:</b> Dopamine agonists (e.g., for Parkinson's) stimulate the CTZ causing nausea.</li></ul>",
      "takeAway": "<p>The <b>CTZ</b> is the brain's chemical sensor for vomiting, accessible to systemic drugs due to the lack of a BBB, and is the primary target for antiemetic therapy.</p>",
      "mermaid": "graph TD; A[Systemic Toxins] --> B[Chemoreceptor Trigger Zone]; B -->|Signaling| C[Vomiting Center]; C --> D[Emesis];"
    },
    "connections": [
      {
        "type": "located_in",
        "to": "area_postrema"
      },
      {
        "type": "inputs_to",
        "to": "vomiting_center"
      },
      {
        "type": "contains_receptors_for",
        "to": "dopamine"
      },
      {
        "type": "contains_receptors_for",
        "to": "serotonin"
      }
    ]
  },
  "chemotherapy_induced_vomiting": {
    "title": "Chemotherapy-Induced Vomiting",
    "primaryType": "disease",
    "tags": [
      "Pharmacology",
      "Oncology",
      "Gastroenterology",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Toxicities",
      "Emesis"
    ],
    "content": {
      "definition": "<p><b>Chemotherapy-Induced Vomiting</b> is a common adverse effect of cytotoxic drugs (e.g., [[cisplatin]]), mediated by the release of serotonin and substance P which activate the [[chemoreceptor_trigger_zone]] and the vomiting center.</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> Chemo damages GI mucosa &rarr; 5-HT release &rarr; Vagal afferents &rarr; CTZ. Also direct central stimulation.</li><li><b>Phases:</b><br> - <i>Acute (<24h):</i> Serotonin (5-HT3) mediated.<br> - <i>Delayed (>24h):</i> Substance P (NK1) mediated.</li><li><b>Treatment:</b><br> - <b>5-HT3 Antagonists:</b> [[ondansetron]].<br> - <b>NK1 Antagonists:</b> [[aprepitant]].<br> - <b>D2 Antagonists:</b> [[metoclopramide]], Prochlorperazine.</li><li><b>USMLE Tip:</b> For highly emetogenic drugs like Cisplatin, use a combination (5-HT3 antagonist + NK1 antagonist + Dexamethasone).</li></ul>",
      "takeAway": "<p>Chemotherapy triggers vomiting via peripheral (GI) serotonin release and central CTZ stimulation; treatment targets 5-HT3 (Ondansetron) and NK1 (Aprepitant) receptors.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "mediated_by",
        "to": "chemoreceptor_trigger_zone"
      },
      {
        "type": "treated_by",
        "to": "ondansetron"
      },
      {
        "type": "treated_by",
        "to": "aprepitant"
      }
    ]
  },
  "cherry_red_spot": {
    "title": "Cherry-Red Spot",
    "primaryType": "finding",
    "tags": [
      "Ophthalmology",
      "Pathology",
      "Metabolic Diseases",
      "USMLE"
    ],
    "classificationPath": [
      "Ophthalmology",
      "Retinal Signs"
    ],
    "content": {
      "definition": "<p>A <b>Cherry-Red Spot</b> is a funduscopic finding characterized by a reddish fovea surrounded by a pale, white macula, caused by retinal opacity (edema or lipid storage) sparing the thin fovea where the underlying choroid remains visible.</p>",
      "atAGlance": "<ul><li><b>Appearance:</b> Bright red dot in the center of a white retina.</li><li><b>Etiologies:</b><br> 1. <b>[[central_retinal_artery_occlusion]] (CRAO):</b> Retinal infarction/edema makes retina pale; fovea stays red (choroidal supply). <u>Unilateral</u>, Acute.<br> 2. <b>Lysosomal Storage Diseases:</b> [[tay_sachs_disease]] (GM2 ganglioside), [[niemann_pick_disease]] (Sphingomyelin). Lipid accumulation opacifies retina. <u>Bilateral</u>, Chronic, Infants.</li><li><b>USMLE Tip:</b><br> - Cherry-red spot + Hepatosplenomegaly = Niemann-Pick.<br> - Cherry-red spot + <u>NO</u> HSM + Exaggerated Startle = Tay-Sachs.</li></ul>",
      "takeAway": "<p>The <b>Cherry-Red Spot</b> is a sign of retinal transparency contrast, seen acutely in CRAO (ischemia) or chronically in lipid storage diseases like Tay-Sachs and Niemann-Pick.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "seen_in",
        "to": "central_retinal_artery_occlusion"
      },
      {
        "type": "seen_in",
        "to": "tay_sachs_disease"
      },
      {
        "type": "seen_in",
        "to": "niemann_pick_disease"
      }
    ]
  },
  "chiari_malformation": {
    "title": "Chiari Malformation",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Pediatrics",
      "Congenital Malformations",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Congenital Malformations",
      "Posterior Fossa Defects"
    ],
    "content": {
      "definition": "<p><b>Chiari Malformations</b> are congenital defects involving the downward displacement of cerebellar structures through the foramen magnum, classified primarily into Type I and Type II.</p>",
      "atAGlance": "<ul><li><b>Chiari I:</b> Herniation of cerebellar <b>tonsils</b> (>5mm).<br> - <i>Clinical:</i> Often asymptomatic until adulthood. Headaches (worse with cough/strain), ataxia.<br> - <i>Association:</i> <b>[[syringomyelia]]</b> (cape-like sensory loss).</li><li><b>Chiari II (Arnold-Chiari):</b> Herniation of cerebellar <b>vermis</b> and tonsils + medulla.<br> - <i>Clinical:</i> Hydrocephalus (aqueductal stenosis), breathing/swallowing difficulties.<br> - <i>Association:</i> <b>[[myelomeningocele]]</b> (lumbosacral).</li><li><b>USMLE Tip:</b> Chiari <b>1</b> = <b>1</b> structure (tonsils), Adult. Chiari <b>2</b> = <b>2</b> structures (vermis + tonsils), Infant with Neural Tube Defect.</li></ul>",
      "takeAway": "<p><b>Chiari Malformations</b> involve cerebellar herniation; Type I is tonsillar (adults, syringomyelia), while Type II is vermian/brainstem (infants, myelomeningocele, hydrocephalus).</p>",
      "mermaid": "graph TD; A[Posterior Fossa Malformation] --> B{Type?}; B -->|Type I| C[Tonsillar Herniation]; C --> D[Syringomyelia]; B -->|Type II| E[Vermis + Tonsil Herniation]; E --> F[Myelomeningocele]; E --> G[Hydrocephalus];"
    },
    "connections": [
      {
        "type": "is_associated_with",
        "to": "syringomyelia"
      },
      {
        "type": "is_associated_with",
        "to": "myelomeningocele"
      },
      {
        "type": "causes",
        "to": "hydrocephalus"
      }
    ]
  },
  "chickenpox": {
    "title": "Chickenpox (Varicella)",
    "primaryType": "disease",
    "tags": [
      "Infectious Disease",
      "Dermatology",
      "Virology",
      "USMLE"
    ],
    "classificationPath": [
      "Microbiology",
      "Viruses",
      "Herpesviruses",
      "VZV"
    ],
    "content": {
      "definition": "<p><b>Chickenpox</b> is a highly contagious primary infection caused by the <u>Varicella-Zoster Virus (VZV)</u>, characterized by a pruritic, vesicular rash in various stages of healing (\"dewdrop on a rose petal\").</p>",
      "atAGlance": "<ul><li><b>Pathogen:</b> [[varicella_zoster_virus]] (HHV-3).</li><li><b>Clinical Presentation:</b> Fever, malaise, followed by generalized pruritic rash. Lesions progress: Macule &rarr; Papule &rarr; Vesicle &rarr; Crust. All stages present simultaneously.</li><li><b>Complications:</b> Bacterial superinfection (Staph/Strep), Pneumonia (Adults), Encephalitis, Reye Syndrome (if aspirin used).</li><li><b>Latency:</b> Virus remains latent in <b>Dorsal Root Ganglia</b>. Reactivation causes [[shingles]].</li><li><b>Prevention:</b> Live attenuated vaccine.</li><li><b>USMLE Tip:</b> \"Dewdrops on a rose petal\" description. Contrast with Smallpox (lesions all in same stage).</li></ul>",
      "takeAway": "<p><b>Chickenpox</b> is the primary VZV infection causing a polymorphic vesicular rash; the virus establishes latency in sensory ganglia, risking future reactivation as Shingles.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "caused_by",
        "to": "varicella_zoster_virus"
      },
      {
        "type": "establishes_latency_in",
        "to": "dorsal_root_ganglion"
      },
      {
        "type": "reactivates_as",
        "to": "shingles"
      }
    ]
  }
}
``````json
{
  "childhood_diseases": {
    "title": "Childhood Diseases/Disorders",
    "primaryType": "concept",
    "tags": [
      "Index Stub"
    ],
    "classificationPath": [
      "Pediatrics",
      "Pathology"
    ],
    "content": {
      "definition": "<p><i>(Placeholder)</i> A broad category of pathologies presenting primarily in the pediatric population, ranging from congenital malformations to infectious diseases and developmental disorders.</p>",
      "atAGlance": "<ul><li>See [[measles]], [[mumps]], [[rubella]], [[kawasaki_disease]], [[cystic_fibrosis]], [[croup]], [[epiglottitis]].</li></ul>",
      "takeAway": "",
      "mermaid": ""
    },
    "connections": []
  },
  "children": {
    "title": "Children (Pediatrics)",
    "primaryType": "concept",
    "tags": [
      "Index Stub"
    ],
    "classificationPath": [
      "Pediatrics",
      "Development"
    ],
    "content": {
      "definition": "<p><i>(Placeholder)</i> The patient population covering the developmental period from infancy through adolescence, characterized by unique physiological, pharmacokinetic, and pathological considerations.</p>",
      "atAGlance": "<ul><li>See [[infant_development]], [[toddler_development]], [[adolescent_development]], [[pediatric_immunization_schedule]].</li></ul>",
      "takeAway": "",
      "mermaid": ""
    },
    "connections": []
  },
  "chlordiazepoxide": {
    "title": "Chlordiazepoxide",
    "primaryType": "substance",
    "tags": [
      "Pharmacology",
      "Psychiatry",
      "Addiction Medicine",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Psychotropic Drugs",
      "Benzodiazepines"
    ],
    "content": {
      "definition": "<p><b>Chlordiazepoxide</b> is a long-acting <i>benzodiazepine</i> that acts as a positive allosteric modulator of the [[gaba_a_receptor]], primarily used for the management of <u>alcohol withdrawal syndrome</u> and anxiety.</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> Potentiates GABA<sub>A</sub> receptor activity &rarr; Increases chloride influx &rarr; CNS depression.</li><li><b>Pharmacokinetics:</b> Long half-life due to active metabolites. Hepatic metabolism.</li><li><b>Clinical Use:</b> First-line for preventing [[delirium_tremens]] and seizures in [[alcohol_withdrawal]].</li><li><b>Adverse Effects:</b> Sedation, ataxia, respiratory depression (especially with alcohol).</li><li><b>USMLE Tip:</b> Because of its long half-life, avoid in patients with severe hepatic failure; prefer \"LOT\" benzos ([[lorazepam]], [[oxazepam]], [[temazepam]]) instead.</li></ul>",
      "takeAway": "<p><b>Chlordiazepoxide</b> is a classic long-acting benzodiazepine used to taper patients off alcohol safely, preventing withdrawal seizures.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "treats",
        "to": "alcohol_withdrawal"
      },
      {
        "type": "modulates",
        "to": "gaba_a_receptor"
      },
      {
        "type": "is_distinguished_from",
        "to": "lorazepam"
      }
    ]
  },
  "chloroprocaine": {
    "title": "Chloroprocaine",
    "primaryType": "substance",
    "tags": [
      "Pharmacology",
      "Anesthesiology",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Local Anesthetics",
      "Esters"
    ],
    "content": {
      "definition": "<p><b>Chloroprocaine</b> is a short-acting <i>ester local anesthetic</i> that blocks voltage-gated <u>sodium channels</u>, used primarily for spinal and epidural anesthesia requiring rapid onset and short duration.</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> Blocks Na<sup>+</sup> channels, preventing nerve impulse conduction.</li><li><b>Class:</b> <b>Ester</b> (one 'i' in name). Metabolized rapidly by plasma pseudocholinesterases.</li><li><b>Clinical Use:</b> Short procedures, epidural anesthesia (e.g., labor).</li><li><b>Adverse Effects:</b> Allergic reactions (due to <b>PABA</b> metabolite), CNS toxicity (seizures) if injected intravascularly.</li><li><b>USMLE Tip:</b> Esters (Procaine, Chloroprocaine, Tetracaine, Cocaine) have a higher risk of allergy than Amides due to PABA formation.</li></ul>",
      "takeAway": "<p><b>Chloroprocaine</b> is a rapidly metabolized ester anesthetic useful for short procedures but carries a risk of allergic reaction.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_a_type_of",
        "to": "local_anesthetics"
      },
      {
        "type": "blocks_channel",
        "to": "voltage_gated_sodium_channel"
      },
      {
        "type": "metabolized_to",
        "to": "para_aminobenzoic_acid"
      }
    ]
  },
  "cholesteatoma": {
    "title": "Cholesteatoma",
    "primaryType": "disease",
    "tags": [
      "Otolaryngology",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Otolaryngology",
      "Middle Ear Pathology"
    ],
    "content": {
      "definition": "<p><b>Cholesteatoma</b> is a destructive, expanding growth of <u>keratinizing squamous epithelium</u> within the middle ear or mastoid, often resulting from chronic negative pressure and tympanic membrane retraction pockets.</p>",
      "atAGlance": "<ul><li><b>Pathophysiology:</b> \"Skin in the wrong place.\" Squamous epithelium trapped in the middle ear &rarr; Keratin accumulation &rarr; Enzymes (collagenases) erode bone.</li><li><b>Clinical Presentation:</b> <b>Painless otorrhea</b> (discharge), conductive hearing loss.</li><li><b>Complications:</b> Erosion of ossicles (hearing loss), damage to [[facial_nerve]], vertigo (labyrinthine fistula), intracranial spread (meningitis).</li><li><b>Otoscopy:</b> Pearly white mass behind the tympanic membrane (usually pars flaccida).</li><li><b>USMLE Tip:</b> Look for a patient with chronic ear drainage and hearing loss who has a white mass behind the eardrum.</li></ul>",
      "takeAway": "<p><b>Cholesteatoma</b> is a cyst of keratinizing squamous epithelium in the middle ear that can erode bone (ossicles) and cause conductive hearing loss and facial nerve palsy.</p>",
      "mermaid": "graph TD; A[Eustachian Tube Dysfunction] --> B[Negative Middle Ear Pressure]; B --> C[Retraction Pocket Formation]; C --> D[Squamous Epithelium Trapped]; D --> E[Keratin Accumulation]; E --> F[Bone Erosion/Cholesteatoma];"
    },
    "connections": [
      {
        "type": "causes",
        "to": "conductive_hearing_loss"
      },
      {
        "type": "can_damage",
        "to": "facial_nerve"
      },
      {
        "type": "located_in",
        "to": "middle_ear"
      }
    ]
  },
  "cholinesterase_inhibitors": {
    "title": "Cholinesterase Inhibitors",
    "primaryType": "group",
    "tags": [
      "Pharmacology",
      "Neurology",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Autonomic Drugs",
      "Indirect Cholinomimetics"
    ],
    "content": {
      "definition": "<p><b>Cholinesterase Inhibitors</b> (AChE Inhibitors) are a class of drugs that inhibit the enzyme [[acetylcholinesterase]], thereby increasing the concentration and duration of <u>acetylcholine</u> at the synaptic cleft to treat conditions like Myasthenia Gravis and Alzheimer's.</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> Prevents breakdown of ACh &rarr; Increased ACh at Nicotinic (NMJ) and Muscarinic receptors.</li><li><b>Agents:</b><br> - <i>CNS penetrating:</i> [[donepezil]], [[rivastigmine]], [[galantamine]] (Alzheimer's).<br> - <i>Peripheral only:</i> [[neostigmine]], [[pyridostigmine]] (Myasthenia Gravis, Ileus), [[edrophonium]] (Diagnosis).</li><li><b>Toxicity:</b> DUMBELS syndrome (Diarrhea, Urination, Miosis, Bronchospasm, Bradycardia, Emesis, Lacrimation, Salivation).</li><li><b>Antidote:</b> [[atropine]] (Muscarinic) + [[pralidoxime]] (Nicotinic/Enzyme regenerator).</li></ul>",
      "takeAway": "<p><b>Cholinesterase Inhibitors</b> amplify cholinergic signaling, useful for reversing neuromuscular blockade, treating Myasthenia Gravis, and slowing cognitive decline in Alzheimer's.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "inhibits",
        "to": "acetylcholinesterase"
      },
      {
        "type": "increases_level_of",
        "to": "acetylcholine"
      },
      {
        "type": "treats",
        "to": "myasthenia_gravis"
      },
      {
        "type": "treats",
        "to": "alzheimer_disease"
      }
    ]
  },
  "cholinomimetic_agents": {
    "title": "Cholinomimetic Agents",
    "primaryType": "group",
    "tags": [
      "Pharmacology",
      "Neurology",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Autonomic Drugs",
      "Cholinomimetics"
    ],
    "content": {
      "definition": "<p><b>Cholinomimetic Agents</b> are drugs that mimic the action of acetylcholine, either directly by binding to receptors (Direct Agonists) or indirectly by inhibiting acetylcholinesterase (Indirect Agonists).</p>",
      "atAGlance": "<ul><li><b>Direct Agonists:</b><br> - <b>[[bethanechol]]:</b> Muscarinic (Ileus, urinary retention).<br> - <b>[[pilocarpine]]:</b> Muscarinic (Glaucoma, Sjögren's).<br> - <b>[[carbachol]]:</b> Muscarinic/Nicotinic (Glaucoma).</li><li><b>Indirect Agonists (AChE Inhibitors):</b> [[neostigmine]], [[physostigmine]] (crosses BBB), [[donepezil]].</li><li><b>Effects:</b> Parasympathetic activation (DUMBELS: Diarrhea, Urination, Miosis, Bradycardia, Bronchoconstriction, Emesis, Lacrimation).</li><li><b>USMLE Tip:</b> <b>Physostigmine</b> crosses the BBB ("Phyxes" atropine overdose centrally); <b>Neostigmine</b> does not ("No CNS").</li></ul>",
      "takeAway": "<p><b>Cholinomimetics</b> increase cholinergic tone, useful for glaucoma, urinary retention, and reversing neuromuscular blockade, but carry risks of cholinergic toxicity (DUMBELS).</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "mimics",
        "to": "acetylcholine"
      },
      {
        "type": "includes",
        "to": "bethanechol"
      },
      {
        "type": "includes",
        "to": "pilocarpine"
      },
      {
        "type": "antagonized_by",
        "to": "atropine"
      }
    ]
  },
  "chorea": {
    "title": "Chorea",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Movement Disorders",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Movement Disorders",
      "Hyperkinetic"
    ],
    "content": {
      "definition": "<p><b>Chorea</b> refers to involuntary, rapid, irregular, and purposeless \"dance-like\" movements that flow from one body part to another, resulting from dysfunction in the [[basal_ganglia]].</p>",
      "atAGlance": "<ul><li><b>Localization:</b> Lesions of the <b>[[caudate_nucleus]]</b> or putamen.</li><li><b>Etiologies:</b><br> - <b>[[huntington_disease]]:</b> CAG repeats, atrophy of caudate, loss of GABAergic neurons.<br> - <b>[[sydenham_chorea]]:</b> Autoimmune reaction post-Group A Strep (Rheumatic Fever).<br> - <b>Acute:</b> Stroke, SLE, Drug-induced (L-Dopa).</li><li><b>Differentiation:</b> Faster than [[athetosis]] (writhing), less violent/amplitude than [[hemiballismus]] (flinging).</li><li><b>USMLE Tip:</b> Chorea + Dementia + Family History = Huntington's. Chorea + Sore Throat history = Sydenham's.</li></ul>",
      "takeAway": "<p><b>Chorea</b> is a hyperkinetic movement disorder indicative of basal ganglia (striatal) pathology, classically seen in Huntington Disease and Rheumatic Fever.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "caused_by_dysfunction_of",
        "to": "caudate_nucleus"
      },
      {
        "type": "is_characteristic_of",
        "to": "huntington_disease"
      },
      {
        "type": "is_characteristic_of",
        "to": "sydenham_chorea"
      }
    ]
  },
  "choroid_layer": {
    "title": "Choroid Layer",
    "primaryType": "structure",
    "tags": [
      "Ophthalmology",
      "Anatomy",
      "USMLE"
    ],
    "classificationPath": [
      "Ophthalmology",
      "Uvea"
    ],
    "content": {
      "definition": "<p>The <b>Choroid</b> is the highly vascular, pigmented middle layer of the eye (part of the uvea) located between the [[retina]] and the [[sclera]], responsible for supplying blood to the outer retina and absorbing excess light.</p>",
      "atAGlance": "<ul><li><b>Function:</b> Provides oxygen/nutrients to the photoreceptors (rods/cones) and retinal pigment epithelium (RPE). Pigmentation prevents light scattering.</li><li><b>Anatomy:</b> Part of the <b>Uvea</b> (Iris + Ciliary Body + Choroid).</li><li><b>Pathology:</b><br> - <b>Melanoma:</b> Most common primary intraocular malignancy in adults.<br> - <b>Choroiditis:</b> Inflammation (Posterior Uveitis).<br> - <b>Neovascularization:</b> Wet [[age_related_macular_degeneration]].</li><li><b>USMLE Tip:</b> In [[central_retinal_artery_occlusion]], the choroid remains perfused, creating the contrast for the \"Cherry-Red Spot\".</li></ul>",
      "takeAway": "<p>The <b>Choroid</b> is the vascular coat of the eye essential for outer retinal health; its perfusion visible through a pale retina creates the cherry-red spot in CRAO.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "supplies_blood_to",
        "to": "retina"
      },
      {
        "type": "is_part_of",
        "to": "uvea"
      },
      {
        "type": "remains_perfused_in",
        "to": "central_retinal_artery_occlusion"
      }
    ]
  },
  "choroid_plexus": {
    "title": "Choroid Plexus",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Anatomy",
      "Histology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Brain Anatomy",
      "Ventricular System"
    ],
    "content": {
      "definition": "<p>The <b>Choroid Plexus</b> is a specialized secretory tissue located within the brain ventricles, composed of fenestrated capillaries covered by <u>ependymal cells</u>, responsible for the production of [[cerebrospinal_fluid]].</p>",
      "atAGlance": "<ul><li><b>Location:</b> Lateral, Third, and Fourth ventricles.</li><li><b>Function:</b> Active secretion of <b>CSF</b> (Blood-CSF barrier).</li><li><b>Histology:</b> Cuboidal ependymal cells with microvilli surrounding a core of capillaries.</li><li><b>Pathology:</b><br> - <b>Choroid Plexus Papilloma:</b> Rare tumor causing CSF overproduction &rarr; Hydrocephalus (children).<br> - <b>Infection:</b> Can be a portal of entry for pathogens (e.g., Neisseria).</li><li><b>USMLE Tip:</b> CSF is produced here and reabsorbed at the [[arachnoid_granulations]]. Imbalance leads to hydrocephalus.</li></ul>",
      "takeAway": "<p>The <b>Choroid Plexus</b> is the CSF manufacturing plant of the CNS, utilizing specialized ependymal cells to filter plasma into cerebrospinal fluid.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "produces",
        "to": "cerebrospinal_fluid"
      },
      {
        "type": "contains_cell_type",
        "to": "ependymal_cells"
      },
      {
        "type": "tumor_causes",
        "to": "communicating_hydrocephalus"
      }
    ]
  },
  "ciliary_ganglion": {
    "title": "Ciliary Ganglion",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Anatomy",
      "Autonomic Nervous System",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Autonomic Nervous System",
      "Parasympathetic Ganglia"
    ],
    "content": {
      "definition": "<p>The <b>Ciliary Ganglion</b> is a parasympathetic ganglion located in the orbit posterior to the eye, serving as the relay station for preganglionic fibers from the [[edinger_westphal_nucleus]] (CN III) to the intraocular muscles.</p>",
      "atAGlance": "<ul><li><b>Input:</b> Preganglionic parasympathetic fibers from <b>CN III</b> (Edinger-Westphal).</li><li><b>Output:</b> Short Ciliary Nerves.</li><li><b>Target Organs:</b><br> 1. <b>Sphincter Pupillae:</b> Constricts pupil (Miosis).<br> 2. <b>Ciliary Muscle:</b> Accommodation (Lens rounding).</li><li><b>Pathology:</b> Damage leads to <b>Adie's Tonic Pupil</b> (dilated pupil with poor light reaction but preserved/slow accommodation).</li><li><b>USMLE Tip:</b> Involved in both the [[pupillary_light_reflex]] and [[accommodation_reflex]].</li></ul>",
      "takeAway": "<p>The <b>Ciliary Ganglion</b> mediates the parasympathetic control of the eye, executing pupillary constriction and accommodation via the short ciliary nerves.</p>",
      "mermaid": "graph TD; A[Edinger-Westphal Nucleus] -->|CN III| B[Ciliary Ganglion]; B -->|Short Ciliary Nerves| C[Sphincter Pupillae]; B -->|Short Ciliary Nerves| D[Ciliary Muscle];"
    },
    "connections": [
      {
        "type": "receives_input_from",
        "to": "oculomotor_nerve"
      },
      {
        "type": "innervates",
        "to": "sphincter_pupillae"
      },
      {
        "type": "innervates",
        "to": "ciliary_muscle"
      },
      {
        "type": "dysfunction_causes",
        "to": "adies_tonic_pupil"
      }
    ]
  },
  "ciliospinal_center_of_budge": {
    "title": "Ciliospinal Center of Budge",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Anatomy",
      "Autonomic Nervous System",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Spinal Cord",
      "Autonomic Nuclei"
    ],
    "content": {
      "definition": "<p>The <b>Ciliospinal Center of Budge</b> is the sympathetic column located in the intermediolateral cell column of the spinal cord at levels <u>C8-T2</u>, serving as the origin of preganglionic sympathetic fibers to the head and neck (oculosympathetic pathway).</p>",
      "atAGlance": "<ul><li><b>Location:</b> Lateral horn of spinal cord T1-T2 (sometimes C8).</li><li><b>Pathway Position:</b> 2nd order neuron in the 3-neuron oculosympathetic chain.</li><li><b>Connections:</b> Receives input from Hypothalamus (1st order) &rarr; Projects to Superior Cervical Ganglion (3rd order).</li><li><b>Pathology:</b> Lesions here (e.g., [[syringomyelia]], Pancoast tumor compression of roots) cause ipsilateral [[horner_syndrome]] (Ptosis, Miosis, Anhidrosis).</li><li><b>USMLE Tip:</b> This is the spinal synapse for the sympathetic chain to the eye. Damage = Horner's.</li></ul>",
      "takeAway": "<p>The <b>Ciliospinal Center</b> is the spinal origin (C8-T2) of the sympathetic supply to the face; lesions here interrupt the oculosympathetic pathway causing Horner syndrome.</p>",
      "mermaid": "graph TD; A[Hypothalamus] -->|1st Neuron| B[Ciliospinal Center C8-T2]; B -->|2nd Neuron| C[Superior Cervical Ganglion]; C -->|3rd Neuron| D[Eye/Face];"
    },
    "connections": [
      {
        "type": "located_at_level",
        "to": "t1_spinal_level"
      },
      {
        "type": "projects_to",
        "to": "superior_cervical_ganglion"
      },
      {
        "type": "lesion_causes",
        "to": "horner_syndrome"
      }
    ]
  },
  "cingulate_herniation": {
    "title": "Cingulate Herniation (Subfalcine Herniation)",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Pathology",
      "Neurosurgery",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Intracranial Pressure Disorders",
      "Brain Herniation"
    ],
    "content": {
      "definition": "<p><b>Cingulate (Subfalcine) Herniation</b> is the most common type of brain herniation, where the <u>cingulate gyrus</u> is displaced horizontally under the [[falx_cerebri]] due to a unilateral supratentorial mass effect.</p>",
      "atAGlance": "<ul><li><b>Pathophysiology:</b> Increased pressure in one hemisphere pushes the cingulate gyrus across the midline under the rigid falx cerebri.</li><li><b>Vascular Compromise:</b> Can compress the ipsilateral <b>[[anterior_cerebral_artery]] (ACA)</b>.</li><li><b>Clinical Presentation:</b> Contralateral leg weakness/paralysis (due to ACA territory infarction affecting the motor homunculus leg area).</li><li><b>Imaging:</b> Midline shift on CT/MRI.</li><li><b>USMLE Tip:</b> Look for a patient with a mass/bleed on one side who develops leg weakness on the opposite side.</li></ul>",
      "takeAway": "<p><b>Cingulate Herniation</b> involves the displacement of the cingulate gyrus under the falx, classically compressing the [[anterior_cerebral_artery]] and causing contralateral leg weakness.</p>",
      "mermaid": "graph TD; A[Unilateral Mass Effect] --> B[Cingulate Gyrus pushed medial]; B --> C[Herniation under Falx Cerebri]; C --> D[Compression of ACA]; D --> E[Frontal Lobe Ischemia]; E --> F[Contralateral Leg Weakness];"
    },
    "connections": [
      {
        "type": "compresses",
        "to": "anterior_cerebral_artery"
      },
      {
        "type": "involves_structure",
        "to": "cingulate_gyrus"
      },
      {
        "type": "herniates_under",
        "to": "falx_cerebri"
      },
      {
        "type": "causes",
        "to": "contralateral_leg_weakness"
      }
    ]
  },
  "cingulate_gyrus": {
    "title": "Cingulate Gyrus",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Anatomy",
      "Limbic System",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Brain Anatomy",
      "Limbic System"
    ],
    "content": {
      "definition": "<p>The <b>Cingulate Gyrus</b> is a medial cortical structure lying immediately above the [[corpus_callosum]], serving as a key component of the [[limbic_system]] involved in emotion formation, processing, learning, and memory.</p>",
      "atAGlance": "<ul><li><b>Location:</b> Medial aspect of the cerebral hemisphere, arching over the corpus callosum.</li><li><b>Function:</b> Emotion regulation, pain processing, cognitive control (error detection).</li><li><b>Circuitry:</b> Part of the <b>Papez Circuit</b> (Hippocampus &rarr; Mammillary Bodies &rarr; Anterior Thalamus &rarr; Cingulate &rarr; Hippocampus).</li><li><b>Pathology:</b> Involved in [[cingulate_herniation]] (Subfalcine). Implicated in depression and schizophrenia.</li></ul>",
      "takeAway": "<p>The <b>Cingulate Gyrus</b> is a limbic cortex essential for emotional processing and memory linkage via the Papez circuit, and is the structure displaced in subfalcine herniation.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_part_of",
        "to": "limbic_system"
      },
      {
        "type": "is_part_of",
        "to": "papez_circuit"
      },
      {
        "type": "displaced_in",
        "to": "cingulate_herniation"
      }
    ]
  },
  "circadian_rhythm": {
    "title": "Circadian Rhythm",
    "primaryType": "process",
    "tags": [
      "Neurology",
      "Physiology",
      "Sleep Medicine",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Sleep Physiology"
    ],
    "content": {
      "definition": "<p><b>Circadian Rhythm</b> is the endogenous 24-hour physiological cycle regulating sleep-wake patterns, hormone secretion (e.g., Cortisol, Melatonin), and body temperature, primarily controlled by the <u>Suprachiasmatic Nucleus (SCN)</u> of the hypothalamus.</p>",
      "atAGlance": "<ul><li><b>Master Clock:</b> [[suprachiasmatic_nucleus]] (SCN) in the hypothalamus.</li><li><b>Input:</b> Light enters retina &rarr; Retinohypothalamic tract &rarr; SCN.</li><li><b>Output:</b> SCN &rarr; Norepinephrine release to [[pineal_gland]] &rarr; Regulates <b>Melatonin</b> production.</li><li><b>Mechanism:</b> Light <i>inhibits</i> melatonin production; Darkness <i>stimulates</i> it.</li><li><b>Hormones:</b> Cortisol peaks in early morning (waking); Melatonin peaks at night (sleep).</li><li><b>USMLE Tip:</b> Lesion to the SCN results in loss of circadian periodicity (irregular sleep-wake cycles).</li></ul>",
      "takeAway": "<p>The <b>Circadian Rhythm</b> acts as the body's internal clock, driven by the [[suprachiasmatic_nucleus]] and synchronized by light to regulate melatonin secretion from the [[pineal_gland]].</p>",
      "mermaid": "graph TD; A[Light] --> B[Retina]; B --> C[Suprachiasmatic Nucleus]; C --Inhibits--> D[Pineal Gland]; D --> E[Decreased Melatonin]; A2[Darkness] --> B2[Retina]; B2 --> C; C --Stimulates--> D; D --> E2[Increased Melatonin];"
    },
    "connections": [
      {
        "type": "controlled_by",
        "to": "suprachiasmatic_nucleus"
      },
      {
        "type": "regulates_secretion_of",
        "to": "melatonin"
      },
      {
        "type": "involves_gland",
        "to": "pineal_gland"
      }
    ]
  }
}
``````json
{
  "circle_of_willis": {
    "title": "Circle of Willis",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Anatomy",
      "Vascular",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Cerebrovascular System",
      "Arterial Supply"
    ],
    "content": {
      "definition": "<p>The <b>Circle of Willis</b> is an anastomotic arterial ring at the base of the brain connecting the <u>anterior circulation</u> (Internal Carotid) and <u>posterior circulation</u> (Vertebrobasilar), providing collateral blood flow.</p>",
      "atAGlance": "<ul><li><b>Components:</b><br> - <b>Anterior:</b> [[anterior_communicating_artery]] (ACom), [[anterior_cerebral_artery]] (ACA).<br> - <b>Posterior:</b> [[posterior_communicating_artery]] (PCom), [[posterior_cerebral_artery]] (PCA).<br> - <b>Lateral:</b> [[internal_carotid_artery]] (ICA).</li><li><b>Function:</b> Collateral circulation; safety net against ischemia if one vessel is stenosed.</li><li><b>Pathology:</b> Most common site for <b>[[saccular_aneurysm]]</b> (Berry aneurysm), particularly at the ACom (visual field defects) or PCom (CN III palsy).</li><li><b>USMLE Tip:</b> ACom aneurysm compression &rarr; Bitemporal Hemianopia. PCom aneurysm compression &rarr; Blown Pupil (CN III).</li></ul>",
      "takeAway": "<p>The <b>Circle of Willis</b> is the critical anastomotic loop supplying the brain, serving as a common site for aneurysm formation (ACom, PCom) and collateral flow.</p>",
      "mermaid": "graph TD; A[Internal Carotid] --> B[ACA]; A --> C[MCA]; B --> D[Anterior Communicating]; E[Basilar Artery] --> F[PCA]; F --> G[Posterior Communicating]; G --> A;"
    },
    "connections": [
      {
        "type": "contains",
        "to": "anterior_communicating_artery"
      },
      {
        "type": "contains",
        "to": "posterior_communicating_artery"
      },
      {
        "type": "site_of",
        "to": "saccular_aneurysm"
      }
    ]
  },
  "cisatracurium": {
    "title": "Cisatracurium",
    "primaryType": "substance",
    "tags": [
      "Pharmacology",
      "Anesthesiology",
      "Neurology",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Neuromuscular Blockers",
      "Nondepolarizing"
    ],
    "content": {
      "definition": "<p><b>Cisatracurium</b> is an intermediate-acting <i>nondepolarizing neuromuscular blocker</i> (isoquinoline derivative) that undergoes spontaneous degradation via <u>Hofmann elimination</u>, making it safe for patients with multi-organ failure.</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> Competitive antagonist at nicotinic ACh receptors at the NMJ.</li><li><b>Metabolism:</b> <b>Hofmann Elimination</b> (organ-independent degradation dependent on pH and temperature).</li><li><b>Advantages:</b> Does not release histamine (unlike [[atracurium]]), no renal/hepatic clearance required.</li><li><b>Clinical Use:</b> Paralysis for mechanical ventilation or surgery, especially in renal/hepatic failure.</li><li><b>Reversal:</b> [[neostigmine]] (AChE inhibitor).</li></ul>",
      "takeAway": "<p><b>Cisatracurium</b> is the preferred paralytic for patients with organ failure because it clears via Hofmann elimination without relying on the liver or kidneys.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_a_type_of",
        "to": "nondepolarizing_neuromuscular_blocking_drugs"
      },
      {
        "type": "undergoes",
        "to": "hofmann_elimination"
      },
      {
        "type": "is_contrasted_with",
        "to": "atracurium"
      }
    ]
  },
  "clasp_knife_spasticity": {
    "title": "Clasp-Knife Spasticity",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Physical Exam",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Neurologic Examination",
      "Tone"
    ],
    "content": {
      "definition": "<p><b>Clasp-Knife Spasticity</b> is a clinical sign of an [[upper_motor_neuron_lesion]] characterized by initial resistance to passive extension of a limb followed by a sudden release of tension, analogous to opening a pocket knife.</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> Hyperactive stretch reflex (spasticity) causes initial resistance; excessive tension eventually activates the <b>[[golgi_tendon_organ]]</b> (autogenic inhibition), causing sudden relaxation.</li><li><b>Localization:</b> Indicates damage to the <b>Corticospinal Tract</b> (UMN).</li><li><b>Associations:</b> Stroke, MS, Spinal cord injury.</li><li><b>USMLE Tip:</b> Velocity-dependent resistance (\"Catch and give\") = Spasticity (UMN). Constant resistance (\"Lead pipe\") = Rigidity (Basal Ganglia/Parkinson's).</li></ul>",
      "takeAway": "<p><b>Clasp-Knife Spasticity</b> is a specific type of hypertonia indicating UMN damage, mediated by the Golgi Tendon Organ reflex overcoming the stretch reflex.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "indicates",
        "to": "upper_motor_neuron_lesion"
      },
      {
        "type": "mediated_by",
        "to": "golgi_tendon_organ"
      },
      {
        "type": "is_distinguished_from",
        "to": "lead_pipe_rigidity"
      }
    ]
  },
  "lidocaine": {
    "title": "Lidocaine",
    "primaryType": "substance",
    "tags": [
      "Pharmacology",
      "Cardiology",
      "Anesthesiology",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Local Anesthetics",
      "Amides"
    ],
    "content": {
      "definition": "<p><b>Lidocaine</b> is an <i>amide local anesthetic</i> and <i>Class IB antiarrhythmic</i> that blocks voltage-gated <u>sodium channels</u>, used for regional anesthesia and treating ventricular arrhythmias.</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> Blocks Na<sup>+</sup> channels from the <i>intracellular</i> side. Preferentially affects rapidly firing or depolarized tissue (state-dependent).</li><li><b>Class:</b> <b>Amide</b> (two 'i's in name). Metabolized by liver cytochrome P450.</li><li><b>Clinical Uses:</b><br> - <i>Anesthesia:</i> Infiltration, nerve block, epidural.<br> - <i>Cardiology:</i> Ventricular Tachycardia (especially post-MI).</li><li><b>Adverse Effects:</b> CNS excitation (seizures), drowsiness, cardiovascular depression.</li><li><b>USMLE Tip:</b> Co-administered with <b>Epinephrine</b> (vasoconstrictor) to decrease systemic absorption and prolong local duration.</li></ul>",
      "takeAway": "<p><b>Lidocaine</b> is the prototype amide anesthetic and Class IB antiarrhythmic, blocking sodium channels to stop nerve conduction and suppress ventricular ectopy.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "blocks_channel",
        "to": "voltage_gated_sodium_channel"
      },
      {
        "type": "is_a_type_of",
        "to": "local_anesthetics"
      },
      {
        "type": "treats",
        "to": "ventricular_tachycardia"
      }
    ]
  },
  "deep_tendon_reflexes": {
    "title": "Deep Tendon Reflexes (Clinical Reflexes)",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Physical Exam",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Neurologic Examination",
      "Reflexes"
    ],
    "content": {
      "definition": "<p><b>Deep Tendon Reflexes (DTRs)</b> are monosynaptic stretch reflexes used to test the integrity of specific spinal nerve roots and the balance between upper and lower motor neuron inputs.</p>",
      "atAGlance": "<ul><li><b>Key Reflexes & Roots:</b><br> - <b>Achilles:</b> S1, S2 (\"Buckle my shoe\").<br> - <b>Patellar:</b> L3, L4 (\"Kick the door\").<br> - <b>Biceps:</b> C5, C6 (\"Pick up sticks\").<br> - <b>Triceps:</b> C7, C8 (\"Lay them straight\").</li><li><b>Grading:</b><br> - <b>0:</b> Absent (LMN lesion, shock).<br> - <b>2+:</b> Normal.<br> - <b>3+/4+:</b> Hyperactive/Clonus (UMN lesion).</li><li><b>USMLE Tip:</b> Count up the spine: S1,2 (Ankle) &rarr; L3,4 (Knee) &rarr; C5,6 (Biceps) &rarr; C7,8 (Triceps).</li></ul>",
      "takeAway": "<p>Testing <b>Deep Tendon Reflexes</b> localizes spinal pathology; hyperreflexia suggests a UMN lesion, while hyporeflexia suggests an LMN lesion or root compression.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "includes",
        "to": "achilles_reflex"
      },
      {
        "type": "includes",
        "to": "patellar_reflex"
      },
      {
        "type": "includes",
        "to": "biceps_reflex"
      },
      {
        "type": "includes",
        "to": "triceps_reflex"
      }
    ]
  },
  "clopidogrel": {
    "title": "Clopidogrel",
    "primaryType": "substance",
    "tags": [
      "Pharmacology",
      "Cardiology",
      "Neurology",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Antiplatelets",
      "ADP Receptor Inhibitors"
    ],
    "content": {
      "definition": "<p><b>Clopidogrel</b> is an antiplatelet agent that <u>irreversibly inhibits the P2Y<sub>12</sub> ADP receptor</u> on platelets, preventing activation and aggregation (expression of GpIIb/IIIa).</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> Irreversible blockade of ADP receptor (P2Y<sub>12</sub>) &rarr; prevents GpIIb/IIIa activation &rarr; no fibrinogen binding.</li><li><b>Clinical Use:</b> Acute Coronary Syndrome (ACS), Coronary Stenting, <b>Ischemic Stroke</b> prevention (alternative to Aspirin).</li><li><b>Pharmacokinetics:</b> Prodrug requiring activation by <b>CYP2C19</b>.</li><li><b>Adverse Effects:</b> Bleeding, TTP (rare).</li><li><b>USMLE Tip:</b> Efficacy is reduced in \"poor metabolizers\" of CYP2C19 (genetic polymorphism).</li></ul>",
      "takeAway": "<p><b>Clopidogrel</b> prevents platelet aggregation by blocking ADP receptors, serving as a critical secondary prevention tool in stroke and cardiac disease.</p>",
      "mermaid": "graph TD; A[Clopidogrel] -->|CYP2C19| B[Active Metabolite]; B --x|Inhibits| C[P2Y12 ADP Receptor]; C --> D[Reduced GpIIb/IIIa Expression]; D --> E[Reduced Platelet Aggregation];"
    },
    "connections": [
      {
        "type": "inhibits",
        "to": "p2y12_receptor"
      },
      {
        "type": "metabolized_by",
        "to": "cytochrome_p450"
      },
      {
        "type": "treats",
        "to": "ischemic_stroke"
      }
    ]
  },
  "cluster_headache": {
    "title": "Cluster Headache",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Pathology",
      "Headache",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Headache Disorders",
      "Trigeminal Autonomic Cephalalgias"
    ],
    "content": {
      "definition": "<p><b>Cluster Headache</b> is a primary headache disorder characterized by severe, unilateral periorbital pain occurring in cyclical patterns (\"clusters\"), associated with ipsilateral <u>autonomic symptoms</u>.</p>",
      "atAGlance": "<ul><li><b>Epidemiology:</b> <b>Males</b> > Females, Smokers.</li><li><b>Presentation:</b> \"Suicide headache.\" Excruciating, sharp pain behind one eye. Attacks last 15 min - 3 hours, occur daily for weeks.</li><li><b>Associated Symptoms:</b> Ipsilateral <b>Lacrimation</b>, Rhinorrhea, Conjunctival injection, [[horner_syndrome]] (ptosis/miosis).</li><li><b>Timing:</b> Circadian rhythmicity (often wakes patient at night).</li><li><b>Treatment:</b><br> - <i>Acute:</i> <b>100% Oxygen</b>, [[sumatriptan]].<br> - <i>Prophylaxis:</i> [[verapamil]].</li><li><b>USMLE Tip:</b> Differentiate from Migraine: Cluster patients are restless/agitated; Migraine patients want to lie still in the dark.</li></ul>",
      "takeAway": "<p><b>Cluster Headaches</b> are severe unilateral headaches in men with autonomic features (tearing, rhinorrhea), uniquely responsive to 100% Oxygen.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "treated_by",
        "to": "oxygen_therapy"
      },
      {
        "type": "treated_by",
        "to": "sumatriptan"
      },
      {
        "type": "manifests_as",
        "to": "horner_syndrome"
      },
      {
        "type": "is_contrasted_with",
        "to": "migraine"
      }
    ]
  },
  "cocaine": {
    "title": "Cocaine",
    "primaryType": "substance",
    "tags": [
      "Pharmacology",
      "Neurology",
      "Toxicology",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Stimulants",
      "Local Anesthetics"
    ],
    "content": {
      "definition": "<p><b>Cocaine</b> is a potent stimulant and ester local anesthetic that inhibits the reuptake of monoamines ([[dopamine]], [[norepinephrine]], [[serotonin]]), leading to sympathetic activation and euphoria.</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> <br> 1. <b>Stimulant:</b> Blocks reuptake of NE, DA, 5-HT &rarr; Sympathetic surge (Tachycardia, HTN, Mydriasis).<br> 2. <b>Anesthetic:</b> Blocks Na<sup>+</sup> channels.</li><li><b>Clinical Effects:</b> Euphoria, agitation, <b>vasoconstriction</b> (can cause ischemia/angina).</li><li><b>Ophthalmic Use:</b> Used to diagnose [[horner_syndrome]] (blocks NE reuptake &rarr; normal eye dilates, Horner's eye does NOT dilate due to lack of NE).</li><li><b>Adverse Effects:</b> Coronary vasospasm (Angina/MI), Seizures, Nasal septum perforation.</li><li><b>USMLE Tip:</b> Never give <b>Beta-blockers</b> alone for Cocaine toxicity (leads to unopposed Alpha-adrenergic stimulation &rarr; hypertensive crisis).</li></ul>",
      "takeAway": "<p><b>Cocaine</b> acts as a monoamine reuptake inhibitor causing sympathomimetic toxicity and vasoconstriction; it serves as a diagnostic tool for Horner syndrome but carries significant cardiovascular risks.</p>",
      "mermaid": "graph TD; A[Cocaine] --x|Blocks Reuptake| B[Synaptic NE/DA]; B --> C[Increased Sympathetic Tone]; C --> D[Vasoconstriction]; C --> E[Tachycardia/Hypertension];"
    },
    "connections": [
      {
        "type": "increases_levels_of",
        "to": "norepinephrine"
      },
      {
        "type": "increases_levels_of",
        "to": "dopamine"
      },
      {
        "type": "diagnoses",
        "to": "horner_syndrome"
      },
      {
        "type": "is_a_type_of",
        "to": "local_anesthetics"
      }
    ]
  },
  "cochlea": {
    "title": "Cochlea",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Anatomy",
      "Hearing",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Auditory System",
      "Inner Ear"
    ],
    "content": {
      "definition": "<p>The <b>Cochlea</b> is the spiral-shaped cavity of the inner ear containing the <u>Organ of Corti</u>, responsible for transducing sound waves into neural signals via mechanosensory hair cells.</p>",
      "atAGlance": "<ul><li><b>Structure:</b> Three fluid-filled chambers (Scala Vestibuli, Media, Tympani). Organ of Corti sits on the Basilar Membrane.</li><li><b>Tonotopy:</b><br> - <b>Base:</b> Narrow and stiff &rarr; Detects <b>High</b> frequencies.<br> - <b>Apex:</b> Wide and floppy &rarr; Detects <b>Low</b> frequencies.</li><li><b>Pathology:</b> [[presbycusis]] involves loss of hair cells at the <b>base</b> (loss of high-frequency hearing). Noise-induced hearing loss damages stereocilia.</li><li><b>Innervation:</b> Cochlear nerve (CN VIII).</li><li><b>USMLE Tip:</b> Remember the base is like a \"Bass\" guitar? No, it's the opposite! Base = High pitch (Stiff). Apex = Low pitch.</li></ul>",
      "takeAway": "<p>The <b>Cochlea</b> performs frequency analysis of sound via the tonotopic properties of the basilar membrane, with the base encoding high frequencies and the apex encoding low frequencies.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "contains",
        "to": "organ_of_corti"
      },
      {
        "type": "is_damaged_in",
        "to": "presbycusis"
      },
      {
        "type": "innervated_by",
        "to": "vestibulocochlear_nerve"
      }
    ]
  },
  "codeine": {
    "title": "Codeine",
    "primaryType": "substance",
    "tags": [
      "Pharmacology",
      "Analgesics",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Analgesics",
      "Opioids"
    ],
    "content": {
      "definition": "<p><b>Codeine</b> is a weak opioid agonist and <u>prodrug</u> that is metabolized by CYP2D6 into morphine, used primarily for mild-to-moderate pain and as a <b>cough suppressant</b> (antitussive).</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> Agonist at Mu-opioid receptors (after conversion).</li><li><b>Metabolism:</b> Converted to Morphine by <b>CYP2D6</b>.</li><li><b>Pharmacogenetics:</b> Efficacy depends on CYP2D6 activity. Ultra-rapid metabolizers risk toxicity; Poor metabolizers get no effect.</li><li><b>Clinical Use:</b> Cough suppression, Pain (often combined with Acetaminophen).</li><li><b>Adverse Effects:</b> Constipation, sedation, respiratory depression (dose-dependent).</li></ul>",
      "takeAway": "<p><b>Codeine</b> relies on CYP2D6 metabolism for its analgesic effect (conversion to morphine) and is widely used as an antitussive.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_a_type_of",
        "to": "opioid_analgesics"
      },
      {
        "type": "metabolized_by",
        "to": "cytochrome_p450"
      },
      {
        "type": "converted_to",
        "to": "morphine"
      }
    ]
  },
  "coma": {
    "title": "Coma",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Pathology",
      "Consciousness",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Coma and Disorders of Consciousness"
    ],
    "content": {
      "definition": "<p><b>Coma</b> is a state of prolonged unresponsiveness where the patient cannot be aroused, resulting from dysfunction of either the <u>Reticular Activating System (RAS)</u> in the brainstem or bilateral <u>cerebral hemispheres</u>.</p>",
      "atAGlance": "<ul><li><b>Pathophysiology:</b> Requires damage to the <b>Brainstem RAS</b> (arousal center) OR diffuse <b>Bi-hemispheric</b> damage. Unilateral cortical lesions do <u>not</u> cause coma (unless mass effect compresses brainstem).</li><li><b>Etiologies:</b> Trauma, metabolic (hypoglycemia, toxins), vascular (basilar artery stroke), herniation (uncal).</li><li><b>Evaluation:</b> Glasgow Coma Scale (GCS). Brainstem reflexes (pupils, oculocephalic).</li><li><b>USMLE Tip:</b> A \"Locked-in\" patient (ventral pontine lesion) is <b>not</b> in a coma; they are awake but paralyzed (spared RAS).</li></ul>",
      "takeAway": "<p><b>Coma</b> signifies failure of the arousal system, necessitating damage to the reticular activating system or widespread cortical dysfunction.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "caused_by_dysfunction_of",
        "to": "reticular_activating_system"
      },
      {
        "type": "is_distinguished_from",
        "to": "locked_in_syndrome"
      },
      {
        "type": "can_be_caused_by",
        "to": "brain_herniation"
      }
    ]
  },
  "communicating_hydrocephalus": {
    "title": "Communicating Hydrocephalus",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Pathology",
      "CSF Disorders",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Hydrocephalus",
      "Communicating"
    ],
    "content": {
      "definition": "<p><b>Communicating Hydrocephalus</b> is a form of hydrocephalus caused by impaired <u>reabsorption</u> of cerebrospinal fluid (CSF) by the [[arachnoid_granulations]], leading to dilation of <b>all</b> ventricular compartments without an internal obstruction.</p>",
      "atAGlance": "<ul><li><b>Pathophysiology:</b> CSF flow is open (\"communicating\") but resorption is blocked.</li><li><b>Etiologies:</b> Scarring of arachnoid granulations post-<b>Meningitis</b> or <b>Subarachnoid Hemorrhage</b>. Rarely, CSF overproduction (Choroid Plexus Papilloma).</li><li><b>Imaging:</b> Dilation of Lateral, 3rd, and 4th ventricles.</li><li><b>Clinical:</b> Headache, papilledema, signs of increased ICP.</li><li><b>USMLE Tip:</b> Differentiate from Non-communicating (Obstructive) where only upstream ventricles dilate. [[normal_pressure_hydrocephalus]] is a subtype of communicating hydrocephalus affecting the elderly.</li></ul>",
      "takeAway": "<p><b>Communicating Hydrocephalus</b> results from failure of CSF resorption at the arachnoid granulations, typically sequelae of meningitis or hemorrhage, causing diffuse ventricular dilation.</p>",
      "mermaid": "graph TD; A[Meningitis/Hemorrhage] --> B[Scarring of Arachnoid Granulations]; B --> C[Decreased CSF Resorption]; C --> D[CSF Accumulation]; D --> E[Dilation of All Ventricles];"
    },
    "connections": [
      {
        "type": "caused_by_dysfunction_of",
        "to": "arachnoid_granulations"
      },
      {
        "type": "can_follow",
        "to": "meningitis"
      },
      {
        "type": "can_follow",
        "to": "subarachnoid_hemorrhage"
      },
      {
        "type": "is_contrasted_with",
        "to": "noncommunicating_hydrocephalus"
      }
    ]
  },
  "conduction_aphasia": {
    "title": "Conduction Aphasia",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Pathology",
      "Language",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Cognitive Disorders",
      "Aphasias"
    ],
    "content": {
      "definition": "<p><b>Conduction Aphasia</b> is a fluent aphasia characterized by a selective deficit in <u>repetition</u> with preserved fluency and comprehension, caused by a lesion of the [[arcuate_fasciculus]] connecting Broca's and Wernicke's areas.</p>",
      "atAGlance": "<ul><li><b>Lesion:</b> <b>Arcuate Fasciculus</b> (White matter tract in parietal/temporal lobe).</li><li><b>Characteristics:</b><br> - <b>Fluency:</b> Intact.<br> - <b>Comprehension:</b> Intact.<br> - <b>Repetition:</b> <b>Impaired</b> (Patient cannot repeat \"No ifs, ands, or buts\").</li><li><b>USMLE Tip:</b> Patient understands you and speaks fluently (though maybe some errors), but cannot repeat a phrase.</li></ul>",
      "takeAway": "<p><b>Conduction Aphasia</b> disconnects speech reception (Wernicke) from production (Broca), isolating the deficit to repetition.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "caused_by_lesion_in",
        "to": "arcuate_fasciculus"
      },
      {
        "type": "connects",
        "to": "broca_area"
      },
      {
        "type": "connects",
        "to": "wernicke_area"
      }
    ]
  },
  "conductive_hearing_loss": {
    "title": "Conductive Hearing Loss",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Otolaryngology",
      "Diagnosis",
      "USMLE"
    ],
    "classificationPath": [
      "Otolaryngology",
      "Hearing Loss",
      "Conductive"
    ],
    "content": {
      "definition": "<p><b>Conductive Hearing Loss</b> is hearing impairment caused by obstruction of sound transmission through the outer or middle ear to the cochlea.</p>",
      "atAGlance": "<ul><li><b>Etiologies:</b> Cerumen impaction, [[otitis_media]], <b>Otosclerosis</b> (bony overgrowth of stapes), Tympanic membrane perforation.</li><li><b>Tuning Fork Tests:</b><br> - <b>Rinne:</b> Abnormal (Bone Conduction > Air Conduction).<br> - <b>Weber:</b> Localizes to the <b>Affected</b> (bad) ear (decreased ambient noise makes bone conduction relatively louder).</li><li><b>USMLE Tip:</b> If Weber goes to the Right and Rinne is BC>AC on the Right, it's Right Conductive Loss.</li></ul>",
      "takeAway": "<p><b>Conductive Hearing Loss</b> involves the mechanical blockade of sound; characterized by Bone Conduction > Air Conduction on the Rinne test.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "caused_by",
        "to": "otitis_media"
      },
      {
        "type": "is_distinguished_from",
        "to": "sensorineural_hearing_loss"
      }
    ]
  },
  "confluence_of_sinuses": {
    "title": "Confluence of Sinuses (Torcular Herophili)",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Anatomy",
      "Vascular",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Cerebrovascular System",
      "Venous Sinuses"
    ],
    "content": {
      "definition": "<p>The <b>Confluence of Sinuses</b> is the junction at the posterior occiput where the [[superior_sagittal_sinus]], straight sinus, and occipital sinus meet to drain into the transverse sinuses.</p>",
      "atAGlance": "<ul><li><b>Inputs:</b> Superior Sagittal Sinus, Straight Sinus, Occipital Sinus.</li><li><b>Outputs:</b> Transverse Sinuses (Left and Right) &rarr; Sigmoid Sinuses &rarr; [[internal_jugular_vein]].</li><li><b>Clinical Relevance:</b> Site of dural venous sinus thrombosis; drains the majority of cerebral blood.</li></ul>",
      "takeAway": "<p>The <b>Confluence of Sinuses</b> is the major posterior drainage hub of the cerebral venous system, connecting midline sinuses to the lateral outflow tracts.</p>",
      "mermaid": "graph TD; A[Superior Sagittal Sinus] --> D[Confluence]; B[Straight Sinus] --> D; C[Occipital Sinus] --> D; D --> E[Transverse Sinuses]; E --> F[Sigmoid Sinuses]; F --> G[Internal Jugular Vein];"
    },
    "connections": [
      {
        "type": "receives_drainage_from",
        "to": "superior_sagittal_sinus"
      },
      {
        "type": "drains_into",
        "to": "internal_jugular_vein"
      }
    ]
  }
}
``````json
{
  "conjugate_horizontal_gaze_palsy": {
    "title": "Conjugate Horizontal Gaze Palsy",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Ophthalmology",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Neuro-Ophthalmology",
      "Gaze Palsies"
    ],
    "content": {
      "definition": "<p><b>Conjugate Horizontal Gaze Palsy</b> is the inability of both eyes to move simultaneously in the same horizontal direction, typically caused by a lesion in the <u>Paramedian Pontine Reticular Formation (PPRF)</u> or the <u>Abducens (CN VI) Nucleus</u>.</p>",
      "atAGlance": "<ul><li><b>Localization:</b> Ipsilateral PPRF or CN VI nucleus (Pons).</li><li><b>Mechanism:</b> The PPRF coordinates horizontal gaze by activating the ipsilateral CN VI nucleus, which stimulates the ipsilateral Lateral Rectus and sends signals via the MLF to the contralateral CN III nucleus (Medial Rectus).</li><li><b>Clinical Finding:</b> Patient cannot look toward the side of the lesion with <i>either</i> eye.</li><li><b>Preserved Function:</b> Convergence is usually preserved (different pathway).</li><li><b>USMLE Tip:</b> If <i>only</i> the adducting eye fails to move (with nystagmus in the abducting eye), it is an [[internuclear_ophthalmoplegia]] (MLF lesion), not a conjugate gaze palsy.</li></ul>",
      "takeAway": "<p><b>Conjugate Horizontal Gaze Palsy</b> results from damage to the \"gaze center\" (PPRF) or CN VI nucleus in the pons, preventing lateral gaze toward the lesion side.</p>",
      "mermaid": "graph TD; A[Cortical Input] --> B[PPRF]; B --> C[CN VI Nucleus]; C --> D[Ipsilateral Lateral Rectus]; C -->|MLF| E[Contralateral CN III Nucleus]; E --> F[Contralateral Medial Rectus];"
    },
    "connections": [
      {
        "type": "caused_by_lesion_in",
        "to": "paramedian_pontine_reticular_formation"
      },
      {
        "type": "caused_by_lesion_in",
        "to": "abducens_nucleus"
      },
      {
        "type": "is_distinguished_from",
        "to": "internuclear_ophthalmoplegia"
      }
    ]
  },
  "conjunctivitis": {
    "title": "Conjunctivitis",
    "primaryType": "disease",
    "tags": [
      "Ophthalmology",
      "Infectious Disease",
      "USMLE"
    ],
    "classificationPath": [
      "Ophthalmology",
      "Conjunctival Disorders"
    ],
    "content": {
      "definition": "<p><b>Conjunctivitis</b> (\"Pink Eye\") is the inflammation of the conjunctiva, characterized by vascular dilation (redness) and discharge, with etiologies including viral, bacterial, and allergic causes.</p>",
      "atAGlance": "<ul><li><b>Viral:</b> Most common (Adenovirus). <b>Watery</b> discharge, follicles, preauricular lymphadenopathy. Highly contagious.</li><li><b>Bacterial:</b> <i>S. aureus, S. pneumoniae, H. influenzae</i>. <b>Purulent</b> (pus-like) discharge, \"glued\" eyes.</li><li><b>Allergic:</b> <b>Bilateral</b>, itchy, watery, chemosis (edema). Type I hypersensitivity.</li><li><b>Neonatal:</b> Chemical (24h), Gonococcal (2-5 days, severe purulent), Chlamydial (5-14 days, watery/mucopurulent).</li><li><b>USMLE Tip:</b> Bilateral + Itchy = Allergic. Preauricular node + Watery = Viral.</li></ul>",
      "takeAway": "<p><b>Conjunctivitis</b> presents as a red eye with discharge; differentiating the discharge type (watery vs. purulent) and associated symptoms (itch vs. lymphadenopathy) guides etiology.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "caused_by",
        "to": "adenovirus"
      },
      {
        "type": "caused_by",
        "to": "staphylococcus_aureus"
      },
      {
        "type": "caused_by",
        "to": "neisseria_gonorrhoeae"
      },
      {
        "type": "caused_by",
        "to": "chlamydia_trachomatis"
      }
    ]
  },
  "consensual_light_reflex": {
    "title": "Consensual Light Reflex",
    "primaryType": "process",
    "tags": [
      "Neurology",
      "Ophthalmology",
      "Physiology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Neuro-Ophthalmology",
      "Pupillary Reflexes"
    ],
    "content": {
      "definition": "<p>The <b>Consensual Light Reflex</b> is the constriction of the pupil in the <u>unilluminated eye</u> when light is shone into the opposite eye, mediated by the bilateral projection of the pretectal nuclei to the Edinger-Westphal nuclei.</p>",
      "atAGlance": "<ul><li><b>Pathway:</b> Retina &rarr; Optic Nerve (CN II) &rarr; Pretectal Nucleus (Midbrain) &rarr; <b>Bilateral</b> [[edinger_westphal_nucleus]] &rarr; Oculomotor Nerve (CN III) &rarr; Ciliary Ganglion &rarr; Sphincter Pupillae.</li><li><b>Mechanism:</b> The pretectal nucleus sends fibers to <b>both</b> ipsilateral and contralateral Edinger-Westphal nuclei via the posterior commissure.</li><li><b>Clinical Significance:</b> Demonstrates integrity of the midbrain crossing fibers. Loss of direct but preserved consensual response implies efferent defect (CN III) in the illuminated eye. Loss of both implies afferent defect (CN II).</li></ul>",
      "takeAway": "<p>The <b>Consensual Light Reflex</b> relies on the bilateral innervation of the Edinger-Westphal nuclei by the pretectal area, ensuring that light in one eye constricts both pupils.</p>",
      "mermaid": "graph TD; A[Light in Left Eye] --> B[Left CN II]; B --> C[Left Pretectal Nucleus]; C --> D[Left Edinger-Westphal]; C -->|Posterior Commissure| E[Right Edinger-Westphal]; D --> F[Left CN III -> Left Miosis (Direct)]; E --> G[Right CN III -> Right Miosis (Consensual)];"
    },
    "connections": [
      {
        "type": "mediated_by",
        "to": "oculomotor_nerve"
      },
      {
        "type": "involves_nucleus",
        "to": "edinger_westphal_nucleus"
      },
      {
        "type": "assesses_integrity_of",
        "to": "midbrain"
      }
    ]
  },
  "convergence_retraction_nystagmus": {
    "title": "Convergence-Retraction Nystagmus",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Ophthalmology",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Neuro-Ophthalmology",
      "Nystagmus"
    ],
    "content": {
      "definition": "<p><b>Convergence-Retraction Nystagmus</b> is a distinctive ocular motor sign characterized by the eyes jerking back into the orbit (retraction) and turning inward (convergence) on attempted upgaze, classically seen in [[parinaud_syndrome]].</p>",
      "atAGlance": "<ul><li><b>Localization:</b> Dorsal Midbrain (Superior Colliculus/Pretectal area).</li><li><b>Mechanism:</b> Co-contraction of extraocular muscles on attempted upgaze due to supranuclear disinhibition.</li><li><b>Etiology:</b> Pinealoma (compressing the dorsal midbrain), Hydrocephalus, Stroke.</li><li><b>Associated Findings (Parinaud's):</b> Vertical gaze palsy (upgaze), Light-near dissociation (pseudo-Argyll Robertson pupils), Lid retraction (Collier's sign).</li><li><b>USMLE Tip:</b> Look for a child with headaches (hydrocephalus) and inability to look up.</li></ul>",
      "takeAway": "<p><b>Convergence-Retraction Nystagmus</b> is a hallmark of dorsal midbrain compression (Parinaud Syndrome), often due to a pineal tumor.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_feature_of",
        "to": "parinaud_syndrome"
      },
      {
        "type": "caused_by_compression_of",
        "to": "midbrain"
      },
      {
        "type": "associated_with",
        "to": "pineal_gland_tumor"
      }
    ]
  },
  "rosenthal_fibers": {
    "title": "Rosenthal Fibers (Corkscrew Fibers)",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Pathology",
      "Histology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Neuro-Oncology",
      "Histopathologic Findings"
    ],
    "content": {
      "definition": "<p><b>Rosenthal Fibers</b> are eosinophilic, corkscrew-shaped, intracytoplasmic inclusions found in astrocytic processes, classically serving as a histologic hallmark of [[pilocytic_astrocytoma]].</p>",
      "atAGlance": "<ul><li><b>Appearance:</b> Thick, elongated, eosinophilic (pink) bundles; \"corkscrew\" shape.</li><li><b>Composition:</b> Aggregates of intermediate filaments (GFAP) and heat shock proteins.</li><li><b>Disease Association:</b> Highly characteristic of <b>Pilocytic Astrocytoma</b> (WHO Grade I, benign, cystic tumor in cerebellum of children).</li><li><b>Other associations:</b> Alexander disease (leukodystrophy), long-standing gliosis.</li><li><b>USMLE Tip:</b> \"Cyst with a mural nodule\" + \"Rosenthal fibers\" = Pilocytic Astrocytoma.</li></ul>",
      "takeAway": "<p><b>Rosenthal Fibers</b> are eosinophilic corkscrew fibers indicative of Pilocytic Astrocytoma, a benign cerebellar tumor in children.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_hallmark_of",
        "to": "pilocytic_astrocytoma"
      },
      {
        "type": "composed_of",
        "to": "glial_fibrillary_acidic_protein"
      },
      {
        "type": "found_in",
        "to": "astrocytes"
      }
    ]
  },
  "cornea": {
    "title": "Cornea",
    "primaryType": "structure",
    "tags": [
      "Ophthalmology",
      "Anatomy",
      "USMLE"
    ],
    "classificationPath": [
      "Ophthalmology",
      "Anatomy",
      "Anterior Segment"
    ],
    "content": {
      "definition": "<p>The <b>Cornea</b> is the transparent, avascular anterior part of the eye responsible for the majority of the eye's refractive power, focusing light onto the retina.</p>",
      "atAGlance": "<ul><li><b>Function:</b> Primary refractive element (2/3 of optical power). Protection.</li><li><b>Structure:</b> 5 layers (Epithelium, Bowman's, Stroma, Descemet's, Endothelium). <b>Stroma</b> contains Type I Collagen arranged in a regular lattice (transparency).</li><li><b>Innervation:</b> V1 branch of [[trigeminal_nerve]] (Nasociliary branch) via the long ciliary nerves.</li><li><b>Pathology:</b><br> - <i>Wilson Disease:</i> Kayser-Fleischer rings (Descemet membrane).<br> - <i>Astigmatism:</i> Irregular curvature.<br> - <i>Keratitis:</i> Inflammation/Infection (e.g., HSV-1).</li><li><b>Reflex:</b> Afferent limb of the [[corneal_reflex]].</li></ul>",
      "takeAway": "<p>The <b>Cornea</b> is the eye's main focusing element; its transparency depends on avascularity and precise collagen arrangement, and it is the site of copper deposition in Wilson Disease.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "innervated_by",
        "to": "ophthalmic_nerve"
      },
      {
        "type": "involved_in",
        "to": "corneal_reflex"
      },
      {
        "type": "site_of_deposition_in",
        "to": "wilson_disease"
      }
    ]
  },
  "corneal_reflex": {
    "title": "Corneal Reflex",
    "primaryType": "process",
    "tags": [
      "Neurology",
      "Physical Exam",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Neurologic Examination",
      "Brainstem Reflexes"
    ],
    "content": {
      "definition": "<p>The <b>Corneal Reflex</b> (Blink Reflex) is an involuntary blinking of both eyelids in response to stimulation of the cornea, testing the integrity of the <u>Trigeminal (V1)</u> afferent and <u>Facial (VII)</u> efferent pathways.</p>",
      "atAGlance": "<ul><li><b>Afferent Limb:</b> Nasociliary branch of <b>CN V1</b> (Ophthalmic) senses touch/pain.</li><li><b>Efferent Limb:</b> Temporal/Zygomatic branches of <b>CN VII</b> (Facial) contract the [[orbicularis_oculi]].</li><li><b>Response:</b> Bilateral blinking (Direct and Consensual).</li><li><b>Localization:</b><br> - <i>CN V1 Lesion:</i> No blink in either eye when affected cornea touched.<br> - <i>CN VII Lesion:</i> No blink in ipsilateral eye, but contralateral eye blinks.</li><li><b>USMLE Tip:</b> Often used to assess brainstem function in coma (Pontine integrity).</li></ul>",
      "takeAway": "<p>The <b>Corneal Reflex</b> assesses the V1-VII reflex arc; loss indicates damage to the sensory trigeminal nerve, the motor facial nerve, or the pons.</p>",
      "mermaid": "graph TD; A[Corneal Stimulus] --> B[CN V1 Afferent]; B --> C[Spinal Trigeminal Nucleus]; C --> D[Bilateral Facial Nuclei]; D --> E[CN VII Efferent]; E --> F[Orbicularis Oculi Contraction];"
    },
    "connections": [
      {
        "type": "mediated_by_afferent",
        "to": "ophthalmic_nerve"
      },
      {
        "type": "mediated_by_efferent",
        "to": "facial_nerve"
      },
      {
        "type": "processed_in",
        "to": "pons"
      }
    ]
  },
  "coronary_vasospasm": {
    "title": "Coronary Vasospasm",
    "primaryType": "disease",
    "tags": [
      "Cardiology",
      "Pharmacology",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Cardiology",
      "Ischemic Heart Disease",
      "Angina"
    ],
    "content": {
      "definition": "<p><b>Coronary Vasospasm</b> is a transient, sudden constriction of a coronary artery leading to ischemia, chest pain (Prinzmetal angina), and ST-segment elevation, often triggered by drugs or autonomic imbalance.</p>",
      "atAGlance": "<ul><li><b>Drug Triggers:</b><br> - <b>[[cocaine]]:</b> Blocks NE reuptake &rarr; Alpha-1 mediated vasoconstriction.<br> - <b>[[sumatriptan]]/Ergotamines:</b> 5-HT agonists.<br> - <b>Amphetamines.</b></li><li><b>Clinical Presentation:</b> Chest pain at rest (often early morning), transient ST elevation.</li><li><b>Treatment:</b> Calcium Channel Blockers, Nitrates. <b>Avoid Beta-blockers</b> in Cocaine toxicity (unopposed alpha vasoconstriction).</li><li><b>USMLE Tip:</b> Young patient with chest pain and ST elevation after drug use = Cocaine Vasospasm.</li></ul>",
      "takeAway": "<p><b>Coronary Vasospasm</b> causes reversible ischemia (Prinzmetal angina); it is a major mechanism of cocaine cardiotoxicity and a contraindication for triptan use.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "caused_by",
        "to": "cocaine"
      },
      {
        "type": "caused_by",
        "to": "sumatriptan"
      },
      {
        "type": "manifests_as",
        "to": "prinzmetal_angina"
      }
    ]
  },
  "cortical_signs": {
    "title": "Cortical Signs",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Physical Exam",
      "Stroke",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Localization",
      "Cerebral Cortex"
    ],
    "content": {
      "definition": "<p><b>Cortical Signs</b> are neurological deficits that localize pathology to the <u>cerebral cortex</u>, distinguishing large vessel strokes (MCA, ACA, PCA) from subcortical (lacunar) strokes.</p>",
      "atAGlance": "<ul><li><b>Specific Signs:</b><br> - <b>Aphasia:</b> Dominant hemisphere (Left Frontal/Temporal).<br> - <b>Neglect:</b> Non-dominant hemisphere (Right Parietal).<br> - <b>Agnosia/Apraxia:</b> Association cortices.<br> - <b>Visual Field Defects:</b> Homonymous hemianopsia (Occipital/Temporal/Parietal).<br> - <b>Gaze Deviation:</b> Toward lesion (Frontal Eye Fields).</li><li><b>Significance:</b> Presence implies a \"Cortical Stroke\" (e.g., MCA), typically embolic.</li><li><b>Absence:</b> Pure motor or pure sensory deficits without cortical signs suggest a <b>Lacunar Stroke</b> (Internal Capsule/Thalamus).</li></ul>",
      "takeAway": "<p><b>Cortical Signs</b> (aphasia, neglect, vision loss) localize lesions to the brain surface, ruling out deep lacunar syndromes which present with pure motor/sensory deficits.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "distinguishes_from",
        "to": "lacunar_stroke"
      },
      {
        "type": "includes",
        "to": "aphasia"
      },
      {
        "type": "includes",
        "to": "hemispatial_neglect"
      },
      {
        "type": "seen_in",
        "to": "middle_cerebral_artery_stroke"
      }
    ]
  },
  "corticospinal_tract": {
    "title": "Corticospinal Tract",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Anatomy",
      "Motor Pathways",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Spinal Cord",
      "Descending Tracts"
    ],
    "content": {
      "definition": "<p>The <b>Corticospinal Tract</b> is the primary descending motor pathway responsible for voluntary movement of the body, originating in the motor cortex and decussating in the medulla.</p>",
      "atAGlance": "<ul><li><b>Origin:</b> Primary Motor Cortex (Precentral Gyrus).</li><li><b>Course:</b> Corona Radiata &rarr; Internal Capsule (Posterior Limb) &rarr; Cerebral Peduncles (Midbrain) &rarr; Basilar Pons &rarr; Medullary Pyramids.</li><li><b>Decussation:</b> <b>Pyramidal Decussation</b> (Lower Medulla). 90% cross to become the <b>Lateral Corticospinal Tract</b>.</li><li><b>Termination:</b> Anterior Horn Cells (Lower Motor Neurons).</li><li><b>Lesions:</b><br> - <i>Above Decussation:</i> Contralateral weakness.<br> - <i>Below Decussation:</i> Ipsilateral weakness (e.g., [[brown_sequard_syndrome]]).<br> - <i>Signs:</i> UMN signs (Spasticity, Hyperreflexia, Babinski).</li><li><b>USMLE Tip:</b> Internal Capsule stroke causes pure motor hemiparesis via this tract.</li></ul>",
      "takeAway": "<p>The <b>Corticospinal Tract</b> drives voluntary movement; lesions result in UMN signs, with the side of deficit determined by the location relative to the medullary decussation.</p>",
      "mermaid": "graph TD; A[Motor Cortex] --> B[Internal Capsule]; B --> C[Medullary Pyramids]; C --> D{Decussation}; D -->|Crossed 90%| E[Lateral Corticospinal Tract]; D -->|Uncrossed 10%| F[Anterior Corticospinal Tract]; E --> G[Anterior Horn Cell];"
    },
    "connections": [
      {
        "type": "originates_in",
        "to": "primary_motor_cortex"
      },
      {
        "type": "passes_through",
        "to": "internal_capsule"
      },
      {
        "type": "decussates_at",
        "to": "medulla_oblongata"
      },
      {
        "type": "lesion_causes",
        "to": "upper_motor_neuron_lesion"
      }
    ]
  },
  "cotton_wool_spots": {
    "title": "Cotton-Wool Spots",
    "primaryType": "finding",
    "tags": [
      "Ophthalmology",
      "Pathology",
      "Vascular",
      "USMLE"
    ],
    "classificationPath": [
      "Ophthalmology",
      "Retinal Signs"
    ],
    "content": {
      "definition": "<p><b>Cotton-Wool Spots</b> are fluffy, white retinal lesions representing areas of microinfarction of the <u>retinal nerve fiber layer</u> due to occlusion of precapillary arterioles.</p>",
      "atAGlance": "<ul><li><b>Pathophysiology:</b> Ischemia blocks axoplasmic flow in ganglion cell axons &rarr; accumulation of organelles &rarr; swelling (white patches).</li><li><b>Etiologies:</b><br> - <b>[[diabetic_retinopathy]]:</b> (Pre-proliferative/Proliferative).<br> - <b>[[hypertension]]:</b> Malignant hypertension.<br> - <b>HIV/AIDS:</b> Microvasculopathy.<br> - <b>[[central_retinal_vein_occlusion]].</b></li><li><b>Appearance:</b> Soft, fuzzy, white patches with indistinct margins (unlike hard exudates which are yellow/lipid).</li><li><b>USMLE Tip:</b> Look for these in a patient with poorly controlled diabetes or BP.</li></ul>",
      "takeAway": "<p><b>Cotton-Wool Spots</b> are signs of retinal ischemia/infarction of the nerve fiber layer, classically seen in diabetes, hypertension, and HIV.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "associated_with",
        "to": "diabetic_retinopathy"
      },
      {
        "type": "associated_with",
        "to": "hypertension"
      },
      {
        "type": "indicates",
        "to": "retinal_ischemia"
      }
    ]
  },
  "cough_reflex": {
    "title": "Cough Reflex",
    "primaryType": "process",
    "tags": [
      "Neurology",
      "Respiratory",
      "Physiology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Brainstem Reflexes"
    ],
    "content": {
      "definition": "<p>The <b>Cough Reflex</b> is a protective brainstem reflex initiated by irritation of the respiratory tract, mediated by the afferent <u>Vagus Nerve (CN X)</u> and efferent Vagus/Phrenic/Spinal nerves.</p>",
      "atAGlance": "<ul><li><b>Afferent Limb:</b> <b>Vagus Nerve (CN X)</b> (sensation from larynx, trachea, bronchi).</li><li><b>Center:</b> Medulla (Nucleus Tractus Solitarius).</li><li><b>Efferent Limb:</b> <b>Vagus (CN X)</b> (laryngeal muscles), Phrenic (diaphragm), Spinal motors (intercostals/abdominal).</li><li><b>Clinical Use:</b> Tests integrity of CN X and medullary function.</li><li><b>Pharmacology:</b> Suppressed by opioids (e.g., Codeine, Dextromethorphan).</li><li><b>USMLE Tip:</b> Foreign body in the piriform recess can damage the internal laryngeal nerve (branch of CN X), impairing the cough reflex.</li></ul>",
      "takeAway": "<p>The <b>Cough Reflex</b> protects the airway via a vagal-vagal arc processed in the medulla; its dysfunction risks aspiration.</p>",
      "mermaid": "graph TD; A[Irritation] --> B[CN X Afferent]; B --> C[Medulla]; C --> D[CN X Efferent / Spinal Nerves]; D --> E[Explosive Expiration];"
    },
    "connections": [
      {
        "type": "mediated_by",
        "to": "vagus_nerve"
      },
      {
        "type": "processed_in",
        "to": "medulla_oblongata"
      },
      {
        "type": "suppressed_by",
        "to": "opioid_analgesics"
      }
    ]
  },
  "cranial_dysraphism": {
    "title": "Cranial Dysraphism",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Embryology",
      "Pediatrics",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Congenital Malformations",
      "Neural Tube Defects"
    ],
    "content": {
      "definition": "<p><b>Cranial Dysraphism</b> refers to the failure of the cranial (rostral) end of the neural tube to close properly, resulting in defects like [[anencephaly]] and [[encephalocele]].</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> Failure of rostral neuropore closure (Week 4).</li><li><b>Types:</b><br> - <b>[[anencephaly]]:</b> Absence of brain/calvarium. Lethal.<br> - <b>[[encephalocele]]:</b> Herniation of brain/meninges through a skull defect (usually occipital).</li><li><b>Markers:</b> Elevated AFP, Polyhydramnios.</li><li><b>Prevention:</b> Folic Acid.</li></ul>",
      "takeAway": "<p><b>Cranial Dysraphism</b> comprises severe neural tube defects of the head caused by failed rostral closure, ranging from herniation (encephalocele) to total agenesis (anencephaly).</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "includes",
        "to": "anencephaly"
      },
      {
        "type": "includes",
        "to": "encephalocele"
      },
      {
        "type": "prevented_by",
        "to": "folic_acid"
      }
    ]
  },
  "cranial_nerve_nuclei": {
    "title": "Cranial Nerve Nuclei",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Anatomy",
      "Brainstem",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Brain Anatomy",
      "Brainstem Nuclei"
    ],
    "content": {
      "definition": "<p><b>Cranial Nerve Nuclei</b> are collections of cell bodies in the brainstem that serve as the origin (motor) or termination (sensory) of the cranial nerves, organized into medial (motor) and lateral (sensory) columns.</p>",
      "atAGlance": "<ul><li><b>Organization:</b> Sulcus Limitans separates Alar (Sensory/Lateral) and Basal (Motor/Medial) plates.</li><li><b>Location (Rule of 4s):</b><br> - <b>Midbrain:</b> III, IV.<br> - <b>Pons:</b> V, VI, VII, VIII.<br> - <b>Medulla:</b> IX, X, XI, XII.</li><li><b>Medial (Motor) Nuclei:</b> Factors of 12 (except 1,2): III, IV, VI, XII. (Close to midline).</li><li><b>Lateral (Sensory) Nuclei:</b> V, VII, VIII, IX, X.</li><li><b>Functional Columns:</b><br> - <i>Somatic Motor:</i> III, IV, VI, XII.<br> - <i>Branchial Motor:</i> V, VII, Nucleus Ambiguus (IX, X, XI).<br> - <i>Parasympathetic:</i> Edinger-Westphal (III), Salivatory (VII, IX), Dorsal Motor X.</li></ul>",
      "takeAway": "<p><b>Cranial Nerve Nuclei</b> follow a strict anatomical logic in the brainstem: Motor nuclei (III, IV, VI, XII) are medial, while sensory and branchial motor nuclei are lateral.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "located_in",
        "to": "brainstem"
      },
      {
        "type": "includes",
        "to": "nucleus_ambiguus"
      },
      {
        "type": "includes",
        "to": "dorsal_motor_nucleus"
      },
      {
        "type": "includes",
        "to": "nucleus_tractus_solitarius"
      }
    ]
  }
}
``````json
{
  "cranial_nerves": {
    "title": "Cranial Nerves",
    "primaryType": "concept",
    "tags": [
      "Index Stub"
    ],
    "classificationPath": [
      "Neurology",
      "Anatomy",
      "Peripheral Nervous System"
    ],
    "content": {
      "definition": "<p><i>(Placeholder)</i> The set of 12 paired nerves that arise directly from the brain and brainstem, relaying information between the brain and parts of the body, primarily to and from regions of the head and neck.</p>",
      "atAGlance": "<ul><li>See [[olfactory_nerve]], [[optic_nerve]], [[oculomotor_nerve]], [[trochlear_nerve]], [[trigeminal_nerve]], [[abducens_nerve]], [[facial_nerve]], [[vestibulocochlear_nerve]], [[glossopharyngeal_nerve]], [[vagus_nerve]], [[accessory_nerve]], [[hypoglossal_nerve]].</li></ul>",
      "takeAway": "",
      "mermaid": ""
    },
    "connections": []
  },
  "cranial_nerve_vascular_relationships": {
    "title": "Cranial Nerve Vascular Relationships",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Anatomy",
      "Vascular",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Neuroanatomy",
      "Neurovascular Anatomy"
    ],
    "content": {
      "definition": "<p><b>Cranial Nerve Vascular Relationships</b> describe the specific anatomical proximities between cranial nerves and cerebral arteries, which are critical for localizing [[aneurysm]]s or vascular compressions that result in specific nerve palsies.</p>",
      "atAGlance": "<ul><li><b>CN III (Oculomotor):</b> Exits between the <b>Posterior Cerebral Artery (PCA)</b> and the <b>Superior Cerebellar Artery (SCA)</b>. Compression (e.g., [[posterior_communicating_artery_aneurysm]]) causes a \"down and out\" eye with pupil dilation.</li><li><b>CN VI (Abducens):</b> Exits near the <b>Anterior Inferior Cerebellar Artery (AICA)</b>.</li><li><b>CN VII/VIII (Facial/Vestibulocochlear):</b> Located near the <b>AICA</b> at the cerebellopontine angle.</li><li><b>CN XII (Hypoglossal):</b> Exits near the <b>Anterior Spinal Artery</b> and Vertebral Artery.</li><li><b>Trigeminal Nerve (CN V):</b> Compression by the <b>Superior Cerebellar Artery</b> can cause [[trigeminal_neuralgia]].</li><li><b>USMLE Tip:</b> CN III is the \"meat\" in the PCA/SCA \"sandwich\".</li></ul>",
      "takeAway": "<p>The close proximity of cranial nerves to specific arteries (e.g., CN III between PCA/SCA) makes them reliable localizing signs for vascular pathology like aneurysms or compression syndromes.</p>",
      "mermaid": "graph TD; A[Basilar Artery] --> B[PCA]; A --> C[SCA]; D[CN III] --- B; D --- C; E[Vertebral Artery] --> F[PICA]; G[CN IX/X/XI] --- F;"
    },
    "connections": [
      {
        "type": "compresses",
        "to": "oculomotor_nerve"
      },
      {
        "type": "associated_with",
        "to": "posterior_cerebral_artery"
      },
      {
        "type": "associated_with",
        "to": "superior_cerebellar_artery"
      },
      {
        "type": "associated_with",
        "to": "anterior_inferior_cerebellar_artery"
      }
    ]
  },
  "craniopharyngioma": {
    "title": "Craniopharyngioma",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Oncology",
      "Pediatrics",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Neuro-Oncology",
      "Suprasellar Tumors"
    ],
    "content": {
      "definition": "<p><b>Craniopharyngioma</b> is a benign, suprasellar neoplasm derived from remnants of <u>Rathke's pouch</u> (surface ectoderm), typically presenting in children with bitemporal hemianopsia and endocrine deficits due to compression of the optic chiasm and pituitary stalk.</p>",
      "atAGlance": "<ul><li><b>Pathology:</b> Derived from <b>Rathke's Pouch</b> (oral ectoderm). Two types: <i>Adamantinomatous</i> (children, calcified) and <i>Papillary</i> (adults).</li><li><b>Histology:</b> Cholesterol crystals found in \"<b>motor oil</b>\"-like fluid within the tumor. Palisading epithelium with wet keratin.</li><li><b>Imaging:</b> Suprasellar mass with <b>calcifications</b> (highly characteristic).</li><li><b>Clinical:</b> <b>Bitemporal Hemianopsia</b> (chiasm compression), Hypopituitarism (Growth failure, DI), Headache/Hydrocephalus.</li><li><b>USMLE Tip:</b> Look for a child with vision problems and a calcified suprasellar mass. Don't confuse with Pituitary Adenoma (adults, usually not calcified).</li></ul>",
      "takeAway": "<p><b>Craniopharyngioma</b> is a calcified, cystic suprasellar tumor of childhood derived from Rathke's pouch, containing \"motor oil\" fluid and causing visual/endocrine dysfunction.</p>",
      "mermaid": "graph TD; A[Rathke's Pouch Remnants] --> B[Neoplastic Growth]; B --> C[Suprasellar Mass]; C --> D[Optic Chiasm Compression]; D --> E[Bitemporal Hemianopsia]; C --> F[Pituitary Stalk Compression]; F --> G[Hypopituitarism/DI];"
    },
    "connections": [
      {
        "type": "derived_from",
        "to": "rathke_pouch"
      },
      {
        "type": "causes",
        "to": "bitemporal_hemianopia"
      },
      {
        "type": "causes",
        "to": "hypopituitarism"
      },
      {
        "type": "is_distinguished_from",
        "to": "pituitary_adenoma"
      }
    ]
  },
  "cremasteric_reflex": {
    "title": "Cremasteric Reflex",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Physical Exam",
      "Urology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Neurologic Examination",
      "Superficial Reflexes"
    ],
    "content": {
      "definition": "<p>The <b>Cremasteric Reflex</b> is a superficial reflex elicited by stroking the medial aspect of the superior thigh, which stimulates sensory fibers of the ilioinguinal nerve and motor fibers of the <u>genitofemoral nerve</u> (L1-L2), causing contraction of the cremaster muscle and elevation of the ipsilateral testis.</p>",
      "atAGlance": "<ul><li><b>Afferent Limb:</b> Femoral branch of Genitofemoral nerve and/or Ilioinguinal nerve (L1).</li><li><b>Efferent Limb:</b> Genital branch of <b>Genitofemoral nerve</b> (L1-L2).</li><li><b>Muscle:</b> Cremaster muscle (extension of Internal Oblique).</li><li><b>Clinical Significance:</b> <br> - <i>Absent:</i> Testicular Torsion (highly sensitive), L1-L2 spinal cord lesion, LMN lesion.<br> - <i>Present:</i> Rules out torsion (mostly), intact L1-L2 reflex arc.</li><li><b>USMLE Tip:</b> \"L1, L2, testicles move.\"</li></ul>",
      "takeAway": "<p>The <b>Cremasteric Reflex</b> tests the integrity of the L1-L2 spinal levels and is a critical physical exam maneuver to evaluate for [[testicular_torsion]].</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "mediated_by",
        "to": "genitofemoral_nerve"
      },
      {
        "type": "tests_nerve_root",
        "to": "l1_nerve_root"
      },
      {
        "type": "tests_nerve_root",
        "to": "l2_nerve_root"
      },
      {
        "type": "is_absent_in",
        "to": "testicular_torsion"
      }
    ]
  },
  "creutzfeldt_jakob_disease": {
    "title": "Creutzfeldt-Jakob Disease (CJD)",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Infectious Disease",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Neurodegenerative Diseases",
      "Prion Diseases"
    ],
    "content": {
      "definition": "<p><b>Creutzfeldt-Jakob Disease (CJD)</b> is a rapidly progressive, fatal neurodegenerative disorder caused by the accumulation of misfolded <u>prion proteins</u> (PrP<sup>Sc</sup>), leading to neuronal death and spongiform changes in the brain.</p>",
      "atAGlance": "<ul><li><b>Pathophysiology:</b> Conversion of normal PrP<sup>c</sup> (alpha-helical) to pathogenic <b>PrP<sup>Sc</sup></b> (beta-pleated sheet) &rarr; Resistant to proteases &rarr; Accumulation &rarr; Spongiform encephalopathy.</li><li><b>Clinical Presentation:</b> <b>Rapidly progressive dementia</b> (weeks to months), <b>Startle Myoclonus</b> (involuntary jerking), Ataxia.</li><li><b>Diagnosis:</b><br> - <i>EEG:</i> Periodic sharp wave complexes.<br> - <i>CSF:</i> Positive <b>14-3-3 protein</b>.<br> - <i>MRI:</i> Cortical ribboning, basal ganglia hyperintensity.<br> - <i>Biopsy:</i> Spongiform changes (vacuolation).</li><li><b>Forms:</b> Sporadic (most common), Familial, Variant (Mad Cow), Iatrogenic (corneal transplant, dural graft).</li><li><b>USMLE Tip:</b> \"Startle myoclonus\" + Rapid Dementia = CJD.</li></ul>",
      "takeAway": "<p><b>CJD</b> is a prion disease characterized by rapid dementia and myoclonus, caused by the infectious propagation of beta-sheet rich prion proteins that induce spongiform cortical degeneration.</p>",
      "mermaid": "graph TD; A[PrPc Alpha-Helix] -->|Conversion| B[PrPSc Beta-Sheet]; B -->|Accumulation| C[Amyloid Plaques]; B -->|Neurotoxicity| D[Spongiform Degeneration]; D --> E[Rapid Dementia / Myoclonus];"
    },
    "connections": [
      {
        "type": "caused_by",
        "to": "prion"
      },
      {
        "type": "manifests_as",
        "to": "rapidly_progressive_dementia"
      },
      {
        "type": "manifests_as",
        "to": "myoclonus"
      },
      {
        "type": "diagnosed_by",
        "to": "14_3_3_protein"
      }
    ]
  },
  "cushing_reflex": {
    "title": "Cushing Reflex",
    "primaryType": "process",
    "tags": [
      "Neurology",
      "Physiology",
      "Critical Care",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Intracranial Pressure Disorders",
      "Autonomic Response"
    ],
    "content": {
      "definition": "<p>The <b>Cushing Reflex</b> (or Cushing Response/Triad) is a physiological nervous system response to <u>increased intracranial pressure (ICP)</u> that results in the triad of <b>hypertension</b>, <b>bradycardia</b>, and <b>irregular respirations</b>.</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> Increased ICP compromises [[cerebral_perfusion_pressure]] (CPP) &rarr; Hypothalamus/Brainstem detect ischemia &rarr; Massive Sympathetic discharge &rarr; Peripheral vasoconstriction &rarr; <b>Hypertension</b> (to maintain CPP).</li><li><b>Reflex Bradycardia:</b> Hypertension stimulates [[carotid_sinus]] baroreceptors &rarr; Vagal stimulation &rarr; <b>Bradycardia</b>.</li><li><b>Respiratory Depression:</b> Brainstem compression affects respiratory centers &rarr; Irregular breathing (Cheyne-Stokes or apnea).</li><li><b>Clinical Significance:</b> Sign of <b>impending brain herniation</b>. Immediate intervention required (Hyperventilation, Mannitol).</li><li><b>USMLE Tip:</b> High BP + Low HR = Cushing Reflex (High ICP). Low BP + High HR = Shock.</li></ul>",
      "takeAway": "<p>The <b>Cushing Reflex</b> is a last-ditch autonomic effort to preserve cerebral perfusion in the face of lethal intracranial hypertension, manifesting as hypertension and reflex bradycardia.</p>",
      "mermaid": "graph TD; A[Increased ICP] --> B[Decreased Cerebral Perfusion]; B --> C[Brainstem Ischemia]; C --> D[Sympathetic Surge]; D --> E[Hypertension]; E --> F[Baroreceptor Activation]; F --> G[Vagal Output]; G --> H[Bradycardia];"
    },
    "connections": [
      {
        "type": "caused_by",
        "to": "increased_intracranial_pressure"
      },
      {
        "type": "attempts_to_maintain",
        "to": "cerebral_perfusion_pressure"
      },
      {
        "type": "results_in",
        "to": "hypertension"
      },
      {
        "type": "results_in",
        "to": "bradycardia"
      }
    ]
  },
  "cyclobenzaprine": {
    "title": "Cyclobenzaprine",
    "primaryType": "substance",
    "tags": [
      "Pharmacology",
      "Neurology",
      "Musculoskeletal",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Muscle Relaxants",
      "Centrally Acting"
    ],
    "content": {
      "definition": "<p><b>Cyclobenzaprine</b> is a centrally acting skeletal muscle relaxant structurally related to <u>Tricyclic Antidepressants (TCAs)</u>, used to treat muscle spasms associated with acute musculoskeletal conditions.</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> Acts at the brainstem level to reduce tonic somatic motor activity (influences gamma and alpha motor systems). Strong <b>anticholinergic</b> effects.</li><li><b>Clinical Use:</b> Acute muscle spasms (e.g., back pain). NOT effective for spasticity (e.g., CP, MS).</li><li><b>Adverse Effects:</b> <b>Sedation</b> (very common), Anticholinergic effects (Dry mouth, urinary retention), Confusion.</li><li><b>Structure:</b> Similar to TCAs &rarr; Similar side effects (QT prolongation, Serotonin syndrome risk if combined with SSRIs).</li><li><b>USMLE Tip:</b> Do not combine with MAO inhibitors (hypertensive crisis/serotonin syndrome).</li></ul>",
      "takeAway": "<p><b>Cyclobenzaprine</b> treats acute muscle spasms via central mechanisms but carries significant sedation and anticholinergic side effects due to its TCA-like structure.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "structurally_related_to",
        "to": "tricyclic_antidepressants"
      },
      {
        "type": "treats",
        "to": "muscle_spasm"
      },
      {
        "type": "causes_side_effect",
        "to": "sedation"
      },
      {
        "type": "causes_side_effect",
        "to": "anticholinergic_toxicity"
      }
    ]
  },
  "cytotoxic_edema": {
    "title": "Cytotoxic Edema",
    "primaryType": "process",
    "tags": [
      "Neurology",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Intracranial Pressure Disorders",
      "Cerebral Edema"
    ],
    "content": {
      "definition": "<p><b>Cytotoxic Edema</b> is a type of cerebral edema characterized by the <u>intracellular</u> accumulation of fluid caused by the failure of ATP-dependent ion pumps (Na<sup>+</sup>/K<sup>+</sup> ATPase) during <u>acute ischemia</u> or hypoxia, while the blood-brain barrier remains intact.</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> Ischemia &rarr; ATP depletion &rarr; Na<sup>+</sup>/K<sup>+</sup> pump failure &rarr; Na<sup>+</sup> accumulates inside cell &rarr; Water follows &rarr; Cell swelling.</li><li><b>Location:</b> Affects both <b>Gray and White Matter</b>.</li><li><b>Radiology:</b> Loss of gray-white matter differentiation on CT.</li><li><b>Timing:</b> Occurs within minutes to hours of stroke/injury (Early phase).</li><li><b>Contrast:</b> [[vasogenic_edema]] involves extracellular fluid due to BBB breakdown (Tumors/Late ischemia) and affects white matter predominantly.</li></ul>",
      "takeAway": "<p><b>Cytotoxic Edema</b> represents cellular swelling due to pump failure in early ischemia, distinguishing it from the vascular leakage of vasogenic edema.</p>",
      "mermaid": "graph TD; A[Ischemia] --> B[ATP Depletion]; B --> C[Na+/K+ Pump Failure]; C --> D[Intracellular Na+ Accumulation]; D --> E[Water Influx]; E --> F[Cellular Swelling];"
    },
    "connections": [
      {
        "type": "caused_by",
        "to": "ischemia"
      },
      {
        "type": "involves_failure_of",
        "to": "na_k_atpase"
      },
      {
        "type": "is_contrasted_with",
        "to": "vasogenic_edema"
      }
    ]
  },
  "dress_syndrome": {
    "title": "DRESS Syndrome",
    "primaryType": "disease",
    "tags": [
      "Dermatology",
      "Pharmacology",
      "Immunology",
      "USMLE"
    ],
    "classificationPath": [
      "Dermatology",
      "Drug Eruptions",
      "Severe Cutaneous Adverse Reactions"
    ],
    "content": {
      "definition": "<p><b>DRESS Syndrome</b> (Drug Reaction with Eosinophilia and Systemic Symptoms) is a severe, delayed Type IV hypersensitivity reaction characterized by fever, rash, lymphadenopathy, <u>eosinophilia</u>, and internal organ involvement (e.g., liver, kidney).</p>",
      "atAGlance": "<ul><li><b>Latency:</b> <b>2-8 weeks</b> after starting the drug (Delayed).</li><li><b>Triggers:</b> Anticonvulsants ([[carbamazepine]], [[phenytoin]], [[lamotrigine]]), [[allopurinol]], Sulfonamides, [[vancomycin]].</li><li><b>Clinical Features:</b> Morbilliform rash, Facial edema, Fever, Lymphadenopathy.</li><li><b>Labs:</b> <b>Eosinophilia</b>, Atypical lymphocytes, Elevated LFTs (Hepatitis), Elevated Creatinine (Nephritis).</li><li><b>Pathophysiology:</b> Drug-induced herpesvirus reactivation (HHV-6, HHV-7, EBV) + T-cell activation.</li><li><b>USMLE Tip:</b> Look for a patient starting a seizure med or allopurinol weeks ago who now has a rash, fever, and high eosinophils.</li></ul>",
      "takeAway": "<p><b>DRESS Syndrome</b> is a life-threatening drug reaction defined by the triad of Rash, Eosinophilia, and Internal Organ involvement, typically occurring weeks after drug initiation.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "triggered_by",
        "to": "carbamazepine"
      },
      {
        "type": "triggered_by",
        "to": "phenytoin"
      },
      {
        "type": "triggered_by",
        "to": "allopurinol"
      },
      {
        "type": "characterized_by",
        "to": "eosinophilia"
      }
    ]
  },
  "danazol": {
    "title": "Danazol",
    "primaryType": "substance",
    "tags": [
      "Pharmacology",
      "Endocrinology",
      "Reproductive",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Endocrine Drugs",
      "Androgens"
    ],
    "content": {
      "definition": "<p><b>Danazol</b> is a synthetic androgen that acts as a <u>partial agonist</u> at androgen receptors and inhibits gonadotropin release (FSH/LH), used to treat endometriosis and hereditary angioedema.</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> Partial androgen agonist; Suppresses pituitary-ovarian axis (decreases LH/FSH) &rarr; endometrial atrophy. Increases C1 esterase inhibitor levels.</li><li><b>Clinical Uses:</b> [[endometriosis]], [[hereditary_angioedema]].</li><li><b>Adverse Effects:</b> <b>Androgenic:</b> Hirsutism, acne, voice deepening. <b>Other:</b> Weight gain, edema, hepatotoxicity, [[pseudotumor_cerebri]].</li><li><b>Contraindications:</b> Pregnancy (virilization of fetus).</li><li><b>USMLE Tip:</b> The drug that treats Hereditary Angioedema by increasing C1 esterase inhibitor production is Danazol.</li></ul>",
      "takeAway": "<p><b>Danazol</b> creates a hypoestrogenic/hyperandrogenic state useful for endometriosis and boosts protein synthesis for hereditary angioedema, but causes significant androgenic side effects.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "treats",
        "to": "endometriosis"
      },
      {
        "type": "treats",
        "to": "hereditary_angioedema"
      },
      {
        "type": "can_cause",
        "to": "idiopathic_intracranial_hypertension"
      },
      {
        "type": "causes_side_effect",
        "to": "hirsutism"
      }
    ]
  },
  "dandy_walker_malformation": {
    "title": "Dandy-Walker Malformation",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Pediatrics",
      "Congenital Malformations",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Congenital Malformations",
      "Posterior Fossa Defects"
    ],
    "content": {
      "definition": "<p><b>Dandy-Walker Malformation</b> is a congenital posterior fossa anomaly characterized by <u>agenesis of the cerebellar vermis</u>, cystic dilation of the <u>fourth ventricle</u>, and an enlarged posterior fossa.</p>",
      "atAGlance": "<ul><li><b>Triad:</b><br> 1. Hypoplasia/Agenesis of the <b>Cerebellar Vermis</b>.<br> 2. Cystic dilation of the <b>4th Ventricle</b> filling the posterior fossa.<br> 3. Enlarged Posterior Fossa (elevation of the tentorium).</li><li><b>Clinical Presentation:</b> [[noncommunicating_hydrocephalus]] (headache, macrocephaly), developmental delay, ataxia.</li><li><b>Associations:</b> Spina bifida, agenesis of corpus callosum.</li><li><b>Imaging:</b> Large cyst replacing the cerebellum.</li><li><b>USMLE Tip:</b> Don't confuse with [[chiari_malformation]]. Dandy-Walker = <b>Missing</b> vermis + <b>Big</b> 4th ventricle. Chiari = <b>Herniated</b> vermis/tonsils.</li></ul>",
      "takeAway": "<p><b>Dandy-Walker Malformation</b> is a developmental failure of the cerebellar vermis leading to a massive cystic fourth ventricle and hydrocephalus.</p>",
      "mermaid": "graph TD; A[Developmental Defect] --> B[Agenesis of Cerebellar Vermis]; B --> C[Cystic Dilation of 4th Ventricle]; C --> D[CSF Obstruction]; D --> E[Noncommunicating Hydrocephalus];"
    },
    "connections": [
      {
        "type": "characterized_by_agenesis_of",
        "to": "cerebellar_vermis"
      },
      {
        "type": "causes",
        "to": "noncommunicating_hydrocephalus"
      },
      {
        "type": "is_distinguished_from",
        "to": "chiari_malformation"
      }
    ]
  },
  "dantrolene": {
    "title": "Dantrolene",
    "primaryType": "substance",
    "tags": [
      "Pharmacology",
      "Anesthesiology",
      "Neurology",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Muscle Relaxants",
      "Direct Acting"
    ],
    "content": {
      "definition": "<p><b>Dantrolene</b> is a direct-acting skeletal muscle relaxant that inhibits the <u>Ryanodine Receptor (RyR1)</u> on the sarcoplasmic reticulum, preventing calcium release and uncoupling excitation-contraction.</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> Antagonizes <b>Ryanodine receptors</b> &rarr; blocks Ca<sup>2+</sup> release from SR &rarr; Reduces muscle contraction/metabolism.</li><li><b>Clinical Uses:</b><br> - <b>[[malignant_hyperthermia]]:</b> Life-saving antidote.<br> - <b>[[neuroleptic_malignant_syndrome]]:</b> (Off-label).<br> - Spasticity (Cerebral Palsy, Spinal Cord Injury).</li><li><b>Adverse Effects:</b> Hepatotoxicity (Black box warning), muscle weakness, sedation.</li><li><b>USMLE Tip:</b> The <u>only</u> treatment for Malignant Hyperthermia. Treats the \"Heat\" by stopping the muscle fire (Ca<sup>2+</sup>).</li></ul>",
      "takeAway": "<p><b>Dantrolene</b> saves lives in Malignant Hyperthermia by blocking calcium release from the sarcoplasmic reticulum, halting the hypermetabolic muscle state.</p>",
      "mermaid": "graph TD; A[Ryanodine Receptor RyR1]; B[Dantrolene] --x|Inhibits| A; A --> C[Calcium Release]; C --> D[Muscle Contraction/Heat]; B --> E[Decreased Calcium]; E --> F[Muscle Relaxation];"
    },
    "connections": [
      {
        "type": "antagonizes",
        "to": "ryanodine_receptor"
      },
      {
        "type": "treats",
        "to": "malignant_hyperthermia"
      },
      {
        "type": "treats",
        "to": "neuroleptic_malignant_syndrome"
      }
    ]
  },
  "daptomycin": {
    "title": "Daptomycin",
    "primaryType": "substance",
    "tags": [
      "Pharmacology",
      "Infectious Disease",
      "Microbiology",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Antibiotics",
      "Lipopeptides"
    ],
    "content": {
      "definition": "<p><b>Daptomycin</b> is a cyclic lipopeptide antibiotic that inserts its lipid tail into the cell membrane of Gram-positive bacteria, causing rapid depolarization and cell death (bactericidal).</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> Inserts into cell membrane &rarr; pore formation &rarr; K<sup>+</sup> efflux &rarr; Depolarization &rarr; DNA/RNA/Protein synthesis arrest.</li><li><b>Spectrum:</b> <b>Gram-Positives Only</b> (too big for Gram-neg porins). Excellent for MRSA, VRE, Endocarditis, Skin infections.</li><li><b>Limitations:</b> <b>Inactivated by Pulmonary Surfactant.</b> DO NOT use for [[pneumonia]].</li><li><b>Adverse Effects:</b> <b>Myopathy</b>/Rhabdomyolysis. Monitor <b>CPK</b> (Creatine Phosphokinase) levels weekly.</li><li><b>USMLE Tip:</b> If a patient has MRSA pneumonia, do <u>not</u> use Daptomycin. Use Vancomycin or Linezolid.</li></ul>",
      "takeAway": "<p><b>Daptomycin</b> is a potent agent for resistant Gram-positives (MRSA/VRE) but causes myopathy (check CPK) and fails in pneumonia due to surfactant inactivation.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "treats",
        "to": "methicillin_resistant_staphylococcus_aureus"
      },
      {
        "type": "treats",
        "to": "vancomycin_resistant_enterococcus"
      },
      {
        "type": "causes_side_effect",
        "to": "myopathy"
      },
      {
        "type": "inactivated_by",
        "to": "pulmonary_surfactant"
      }
    ]
  },
  "decerebrate_posturing": {
    "title": "Decerebrate Posturing",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Trauma",
      "Physical Exam",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Neurologic Examination",
      "Motor Signs"
    ],
    "content": {
      "definition": "<p><b>Decerebrate Posturing</b> (Extensor Posturing) is an abnormal body posture characterized by rigid <u>extension</u> of the arms and legs, pronation of the arms, and plantar flexion of the feet, indicating severe damage to the brainstem <u>below</u> the [[red_nucleus]].</p>",
      "atAGlance": "<ul><li><b>Lesion Localization:</b> Brainstem lesion <b>at or below</b> the level of the [[red_nucleus]] (e.g., Midbrain/Upper Pons).</li><li><b>Appearance:</b> Arms extended by sides, wrists pronated/flexed, legs extended.</li><li><b>Pathophysiology:</b><br> - Lesion cuts off the <b>Rubrospinal Tract</b> (which normally promotes flexion).<br> - Unopposed activity of the <b>Vestibulospinal Tract</b> (promotes extension).</li><li><b>Prognosis:</b> Generally worse than Decorticate posturing.</li><li><b>USMLE Tip:</b> Decerebrate has lots of <b>E</b>'s = <b>E</b>xtensor posturing.</li></ul>",
      "takeAway": "<p><b>Decerebrate Posturing</b> signifies a lesion below the red nucleus, leaving extensor vestibular reflexes unopposed, resulting in rigid extension of all limbs.</p>",
      "mermaid": "graph TD; A[Brainstem Lesion] --> B{Below Red Nucleus?}; B -->|Yes| C[Loss of Rubrospinal Flexion]; C --> D[Unopposed Vestibulospinal Extension]; D --> E[Decerebrate Posturing];"
    },
    "connections": [
      {
        "type": "indicates_lesion_below",
        "to": "red_nucleus"
      },
      {
        "type": "is_caused_by_dominance_of",
        "to": "vestibulospinal_tract"
      },
      {
        "type": "is_contrasted_with",
        "to": "decorticate_posturing"
      }
    ]
  }
}
``````json
{
  "decorticate_posturing": {
    "title": "Decorticate Posturing",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Trauma",
      "Physical Exam",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Neurologic Examination",
      "Motor Signs"
    ],
    "content": {
      "definition": "<p><b>Decorticate Posturing</b> (Flexor Posturing) is an abnormal body posture characterized by <u>flexion</u> of the arms, clenched fists, and extension of the legs, indicating severe damage to the cerebral hemispheres or internal capsule <u>above</u> the [[red_nucleus]].</p>",
      "atAGlance": "<ul><li><b>Lesion Localization:</b> Damage <b>above</b> the [[red_nucleus]] (e.g., Cerebral Hemispheres, Internal Capsule, Thalamus).</li><li><b>Appearance:</b> Arms flexed/bent inward on the chest (hands like 'C's moving toward the 'Cord'), legs extended.</li><li><b>Pathophysiology:</b> Disinhibition of the <b>Rubrospinal Tract</b> (which facilitates upper limb flexion) due to loss of cortical inhibition. The [[vestibulospinal_tract]] maintains extensor tone in the legs.</li><li><b>Prognosis:</b> Generally better than Decerebrate posturing.</li><li><b>USMLE Tip:</b> De<b>cor</b>ticate = Hands near the <b>Cor</b> (Heart). Flexor posturing.</li></ul>",
      "takeAway": "<p><b>Decorticate Posturing</b> signifies a lesion above the red nucleus, resulting in disinhibited flexion of the upper extremities via the rubrospinal tract.</p>",
      "mermaid": "graph TD; A[Supratentorial Lesion] --> B[Loss of Cortical Inhibition]; B --> C[Disinhibited Rubrospinal Tract]; C --> D[Upper Limb Flexion]; B --> E[Disinhibited Vestibulospinal Tract]; E --> F[Lower Limb Extension];"
    },
    "connections": [
      {
        "type": "indicates_lesion_above",
        "to": "red_nucleus"
      },
      {
        "type": "is_caused_by_activity_of",
        "to": "rubrospinal_tract"
      },
      {
        "type": "is_contrasted_with",
        "to": "decerebrate_posturing"
      }
    ]
  },
  "dementia": {
    "title": "Dementia",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Psychiatry",
      "Geriatrics",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Neurodegenerative Diseases",
      "Dementia"
    ],
    "content": {
      "definition": "<p><b>Dementia</b> is a syndrome of chronic, progressive decline in cognitive function (e.g., memory, executive function, language) severe enough to interfere with daily life, occurring with <u>intact consciousness</u>.</p>",
      "atAGlance": "<ul><li><b>Major Types:</b><br> - <b>[[alzheimer_disease]]:</b> Most common. Memory loss, neurofibrillary tangles, amyloid plaques.<br> - <b>[[vascular_dementia]]:</b> Step-wise decline, associated with stroke risk factors.<br> - <b>[[lewy_body_dementia]]:</b> Visual hallucinations, parkinsonism, REM sleep behavior disorder.<br> - <b>[[frontotemporal_dementia]]:</b> Personality/behavioral changes or aphasia.<br> - <b>[[creutzfeldt_jakob_disease]]:</b> Rapidly progressive, myoclonus.</li><li><b>Reversible Causes:</b> Hypothyroidism, [[vitamin_b12_deficiency]], [[normal_pressure_hydrocephalus]], Neurosyphilis, Depression (Pseudodementia).</li><li><b>USMLE Tip:</b> Dementia = Intact consciousness. [[delirium]] = Waxing/waning consciousness.</li></ul>",
      "takeAway": "<p><b>Dementia</b> is chronic cognitive failure without clouded consciousness; distinguishing the subtype relies on specific clinical features like hallucinations (Lewy Body), personality changes (Frontotemporal), or step-wise decline (Vascular).</p>",
      "mermaid": "graph TD; A[Cognitive Decline] --> B{Consciousness?}; B -->|Impaired| C[Delirium]; B -->|Intact| D[Dementia]; D --> E{Features?}; E -->|Memory Loss| F[Alzheimer's]; E -->|Step-wise| G[Vascular]; E -->|Hallucinations| H[Lewy Body]; E -->|Behavioral| I[Frontotemporal];"
    },
    "connections": [
      {
        "type": "includes",
        "to": "alzheimer_disease"
      },
      {
        "type": "includes",
        "to": "vascular_dementia"
      },
      {
        "type": "includes",
        "to": "lewy_body_dementia"
      },
      {
        "type": "includes",
        "to": "frontotemporal_dementia"
      },
      {
        "type": "is_distinguished_from",
        "to": "delirium"
      }
    ]
  },
  "demyelinating_diseases": {
    "title": "Demyelinating Diseases",
    "primaryType": "group",
    "tags": [
      "Neurology",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Demyelinating Diseases"
    ],
    "content": {
      "definition": "<p><b>Demyelinating Diseases</b> are a group of disorders characterized by damage to the myelin sheath of the nervous system, impairing signal conduction and leading to neurological deficits.</p>",
      "atAGlance": "<ul><li><b>Central Nervous System (Oligodendrocytes):</b><br> - <b>[[multiple_sclerosis]]:</b> Autoimmune, disseminated in time/space.<br> - <b>[[progressive_multifocal_leukoencephalopathy]]:</b> JC virus, immunocompromised.<br> - <b>[[acute_disseminated_encephalomyelitis]]:</b> Post-viral/vaccination.<br> - <b>[[central_pontine_myelinolysis]]:</b> Rapid correction of hyponatremia.</li><li><b>Peripheral Nervous System (Schwann Cells):</b><br> - <b>[[guillain_barre_syndrome]]:</b> Acute, ascending paralysis.<br> - <b>[[charcot_marie_tooth_disease]]:</b> Hereditary motor/sensory neuropathy.</li><li><b>Leukodystrophies:</b> Genetic defects (e.g., [[metachromatic_leukodystrophy]], [[krabbe_disease]], [[adrenoleukodystrophy]]).</li></ul>",
      "takeAway": "<p><b>Demyelinating Diseases</b> target myelin in the CNS (Oligodendrocytes) or PNS (Schwann cells), disrupting saltatory conduction and causing deficits ranging from sensory loss to paralysis.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "includes",
        "to": "multiple_sclerosis"
      },
      {
        "type": "includes",
        "to": "guillain_barre_syndrome"
      },
      {
        "type": "includes",
        "to": "progressive_multifocal_leukoencephalopathy"
      },
      {
        "type": "involves_damage_to",
        "to": "myelin"
      }
    ]
  },
  "dentate_nucleus": {
    "title": "Dentate Nucleus",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Anatomy",
      "Cerebellum",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Brain Anatomy",
      "Cerebellum",
      "Deep Nuclei"
    ],
    "content": {
      "definition": "<p>The <b>Dentate Nucleus</b> is the largest and most lateral of the <u>deep cerebellar nuclei</u>, responsible for planning, initiating, and controlling voluntary movements via the dentato-rubro-thalamic tract.</p>",
      "atAGlance": "<ul><li><b>Input:</b> Receives input from the <b>Lateral Hemispheres</b> of the cerebellum (Cerebrocerebellum).</li><li><b>Output:</b> Projects to the Contralateral <b>Thalamus</b> (VL/VA nuclei) and Red Nucleus via the [[superior_cerebellar_peduncle]].</li><li><b>Function:</b> Planning and coordination of fine motor movements.</li><li><b>Mnemonics:</b> Deep nuclei from Lateral to Medial: \"<b>D</b>on't <b>E</b>at <b>G</b>reasy <b>F</b>oods\" (<b>D</b>entate, <b>E</b>mboliform, <b>G</b>lobose, <b>F</b>astigial).</li><li><b>Lesions:</b> Cause [[dysmetria]], intention tremor, and \"decomposition of movement\" in the extremities.</li></ul>",
      "takeAway": "<p>The <b>Dentate Nucleus</b> is the output center for the cerebrocerebellum, crucial for motor planning; lesions result in ipsilateral limb ataxia and intention tremor.</p>",
      "mermaid": "graph TD; A[Cerebellar Hemispheres] --> B[Dentate Nucleus]; B -->|Superior Cerebellar Peduncle| C[Contralateral Thalamus VL]; C --> D[Motor Cortex]; D --> E[Corticospinal Tract];"
    },
    "connections": [
      {
        "type": "is_part_of",
        "to": "cerebellum"
      },
      {
        "type": "projects_via",
        "to": "superior_cerebellar_peduncle"
      },
      {
        "type": "lesion_causes",
        "to": "intention_tremor"
      }
    ]
  },
  "depolarizing_neuromuscular_blockers": {
    "title": "Depolarizing Neuromuscular Blockers",
    "primaryType": "group",
    "tags": [
      "Pharmacology",
      "Anesthesiology",
      "Neurology",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Neuromuscular Blockers",
      "Depolarizing"
    ],
    "content": {
      "definition": "<p><b>Depolarizing Neuromuscular Blockers</b> are agents that act as acetylcholine agonists at the neuromuscular junction, causing initial depolarization (fasciculations) followed by desensitization and flaccid paralysis.</p>",
      "atAGlance": "<ul><li><b>Prototype:</b> [[succinylcholine]].</li><li><b>Phase I Block:</b> Sustained depolarization. Na<sup>+</sup> channels remain inactivated. <b>Potentiated</b> by AChE inhibitors. Fasciculations observed.</li><li><b>Phase II Block:</b> Desensitization. Receptors become insensitive to ACh. Resembles nondepolarizing block. <b>Reversed</b> by AChE inhibitors (e.g., [[neostigmine]]).</li><li><b>Adverse Effects:</b> [[malignant_hyperthermia]], Hyperkalemia (risk in burns/trauma), Myalgia.</li><li><b>Metabolism:</b> Hydrolyzed by plasma pseudocholinesterase.</li></ul>",
      "takeAway": "<p><b>Depolarizing Blockers</b> like Succinylcholine cause paralysis via sustained depolarization; they have two phases of block and carry a risk of hyperkalemia and malignant hyperthermia.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "includes",
        "to": "succinylcholine"
      },
      {
        "type": "can_cause",
        "to": "malignant_hyperthermia"
      },
      {
        "type": "acts_on_receptor",
        "to": "nicotinic_acetylcholine_receptor"
      }
    ]
  },
  "depression_disorder": {
    "title": "Major Depressive Disorder",
    "primaryType": "disease",
    "tags": [
      "Psychiatry",
      "Neurology",
      "USMLE"
    ],
    "classificationPath": [
      "Psychiatry",
      "Mood Disorders",
      "Depression"
    ],
    "content": {
      "definition": "<p><b>Major Depressive Disorder (MDD)</b> is a mood disorder characterized by at least 2 weeks of depressed mood or anhedonia accompanied by neurovegetative symptoms (SIG E CAPS), associated with monoamine deficiency.</p>",
      "atAGlance": "<ul><li><b>Neurobiology:</b> Decreased <b>[[serotonin]]</b>, <b>[[norepinephrine]]</b>, and <b>[[dopamine]]</b>.</li><li><b>Diagnostic Criteria (SIG E CAPS):</b> <b>S</b>leep change, <b>I</b>nterest loss (Anhedonia), <b>G</b>uilt, <b>E</b>nergy low, <b>C</b>oncentration poor, <b>A</b>ppetite change, <b>P</b>sychomotor changes, <b>S</b>uicidal ideation. (Requires 5/9 for 2 weeks).</li><li><b>Treatment:</b> [[ssris]] (First-line), [[snris]], [[tricyclic_antidepressants]], [[monoamine_oxidase_inhibitors]] (Refractory/Atypical), CBT, ECT.</li><li><b>USMLE Tip:</b> MDD with psychotic features requires antidepressant + antipsychotic. Postpartum depression onset is usually within 4 weeks of delivery.</li></ul>",
      "takeAway": "<p><b>Depression</b> is a monoamine-deficiency state treated by increasing synaptic serotonin/NE; diagnosis hinges on the presence of anhedonia/depressed mood plus somatic symptoms.</p>",
      "mermaid": "graph TD; A[Monoamine Deficiency] --> B[Downregulated Neurotransmission]; B --> C[Mood/Vegetative Symptoms]; D[Antidepressants] -->|Increase 5HT/NE| A;"
    },
    "connections": [
      {
        "type": "treated_by",
        "to": "ssris"
      },
      {
        "type": "associated_with_decrease_in",
        "to": "serotonin"
      },
      {
        "type": "associated_with_decrease_in",
        "to": "norepinephrine"
      }
    ]
  },
  "dermatome_landmarks": {
    "title": "Dermatome Landmarks",
    "primaryType": "concept",
    "tags": [
      "Neurology",
      "Anatomy",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Neuroanatomy",
      "Sensory Levels"
    ],
    "content": {
      "definition": "<p><b>Dermatome Landmarks</b> are specific areas of skin supplied by a single spinal nerve root, used clinically to localize spinal cord lesions or radiculopathies.</p>",
      "atAGlance": "<ul><li><b>C2:</b> Posterior half of skull.</li><li><b>C3:</b> High turtleneck.</li><li><b>C4:</b> Low collar/Shoulder ridge.</li><li><b>C6:</b> Thumb (Thumbs up = 6).</li><li><b>C7:</b> Middle finger.</li><li><b>C8:</b> Little finger.</li><li><b>T4:</b> <b>Nipple</b> line (\"T4 at the Teat pore\").</li><li><b>T7:</b> Xiphoid process.</li><li><b>T10:</b> <b>Umbilicus</b> (\"Belly but-ten\").</li><li><b>L1:</b> Inguinal Ligament (1nguinal).</li><li><b>L4:</b> Kneecaps (\"Down on all 4s\").</li><li><b>S2, S3, S4:</b> Perineum/Genitals (\"S2, 3, 4 keep the penis off the floor\").</li></ul>",
      "takeAway": "<p>Key <b>Dermatomes</b> (T4 Nipple, T10 Umbilicus, L4 Knee, C6 Thumb) act as the map for localizing spinal cord sensory levels.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "localizes_lesion_in",
        "to": "spinal_cord"
      },
      {
        "type": "associated_with",
        "to": "spinal_nerves"
      }
    ]
  },
  "desflurane": {
    "title": "Desflurane",
    "primaryType": "substance",
    "tags": [
      "Pharmacology",
      "Anesthesiology",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Anesthetics",
      "Inhaled"
    ],
    "content": {
      "definition": "<p><b>Desflurane</b> is a halogenated <i>inhaled anesthetic</i> characterized by a very low blood-gas partition coefficient, resulting in rapid induction and recovery.</p>",
      "atAGlance": "<ul><li><b>Properties:</b> Low blood solubility (Rapid onset/offset). Pungent odor (can cause airway irritation/coughing).</li><li><b>Mechanism:</b> Potentiates GABA<sub>A</sub> receptors; inhibits NMDA receptors.</li><li><b>Pharmacokinetics:</b> Low blood/gas coefficient = Fast induction.</li><li><b>Adverse Effects:</b> <b>Airway irritation</b> (laryngospasm), [[malignant_hyperthermia]], respiratory depression, increased cerebral blood flow (increased ICP).</li><li><b>USMLE Tip:</b> Fast on/fast off, but smells bad (irritates airway). Don't use for induction in asthmatics.</li></ul>",
      "takeAway": "<p><b>Desflurane</b> allows for rapid anesthetic control due to low solubility but is limited by airway irritation; like all halogenated gases, it can trigger malignant hyperthermia.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_a_type_of",
        "to": "general_anesthetics"
      },
      {
        "type": "can_cause",
        "to": "malignant_hyperthermia"
      },
      {
        "type": "increases",
        "to": "intracranial_pressure"
      }
    ]
  },
  "diabetes_mellitus_neuro": {
    "title": "Diabetes Mellitus (Neurologic Complications)",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Endocrinology",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Peripheral Neuropathy",
      "Metabolic"
    ],
    "content": {
      "definition": "<p><b>Diabetes Mellitus</b> causes significant neurological morbidity via microvascular ischemia and metabolic toxicity (sorbitol accumulation), leading to peripheral neuropathy, cranial nerve palsies, and autonomic dysfunction.</p>",
      "atAGlance": "<ul><li><b>Diabetic Neuropathy:</b> \"Stocking-glove\" sensory loss (distal symmetric polyneuropathy). Small fiber injury = Pain/Temp loss. Large fiber injury = Vibration/Proprioception loss.</li><li><b>Cranial Mononeuropathy:</b> <b>CN III Palsy:</b> Ischemic damage to central motor fibers. <u>Pupil is spared</u> (peripheral parasympathetic fibers fed by pial vessels are preserved). Down-and-out eye.</li><li><b>Autonomic Neuropathy:</b> Gastroparesis, orthostatic hypotension, erectile dysfunction, silent MI.</li><li><b>Pathophysiology:</b> Osmotic damage (Sorbitol accumulation via Aldose Reductase) and microangiopathy (vasa nervorum ischemia).</li></ul>",
      "takeAway": "<p><b>Diabetes</b> damages nerves via sorbitol and ischemia; classic neuro findings include stocking-glove neuropathy and a <b>pupil-sparing</b> CN III palsy.</p>",
      "mermaid": "graph TD; A[Hyperglycemia] --> B[Sorbitol Accumulation]; A --> C[Microvascular Ischemia]; B --> D[Osmotic Damage to Schwann Cells]; C --> E[Vasa Nervorum Occlusion]; D & E --> F[Demyelination/Axonal Loss];"
    },
    "connections": [
      {
        "type": "causes",
        "to": "peripheral_neuropathy"
      },
      {
        "type": "causes",
        "to": "oculomotor_nerve"
      },
      {
        "type": "associated_with",
        "to": "sorbitol"
      }
    ]
  },
  "diabetic_retinopathy": {
    "title": "Diabetic Retinopathy",
    "primaryType": "disease",
    "tags": [
      "Ophthalmology",
      "Endocrinology",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Ophthalmology",
      "Retinal Vascular Disease",
      "Diabetic"
    ],
    "content": {
      "definition": "<p><b>Diabetic Retinopathy</b> is a retinal microangiopathy caused by chronic hyperglycemia, classified into <u>Non-Proliferative</u> (vascular damage) and <u>Proliferative</u> (neovascularization) stages, serving as a leading cause of blindness.</p>",
      "atAGlance": "<ul><li><b>Pathophysiology:</b> Glycation/Sorbitol &rarr; Pericyte loss &rarr; Microaneurysms &rarr; Ischemia &rarr; VEGF release &rarr; Neovascularization.</li><li><b>Non-Proliferative (NPDR):</b> Microaneurysms, Dot-blot hemorrhages, <b>[[cotton_wool_spots]]</b> (nerve fiber infarcts), Hard exudates (lipids), Macular edema.</li><li><b>Proliferative (PDR):</b> Chronic hypoxia leads to <b>Neovascularization</b> (new vessels). Risk of vitreous hemorrhage and tractional [[retinal_detachment]].</li><li><b>Treatment:</b> Glucose control, Anti-VEGF (e.g., Bevacizumab), Laser photocoagulation.</li><li><b>USMLE Tip:</b> \"Cotton-wool spots\" indicate ischemia. \"New vessels\" define Proliferative disease.</li></ul>",
      "takeAway": "<p><b>Diabetic Retinopathy</b> progresses from microvascular damage (NPDR: exudates/hemorrhages) to ischemia-driven neovascularization (PDR), treated by targeting VEGF or laser coagulation.</p>",
      "mermaid": "graph TD; A[Hyperglycemia] --> B[Pericyte Loss]; B --> C[Microaneurysms]; C --> D[Retinal Ischemia]; D --> E[VEGF Upregulation]; E --> F[Neovascularization (Proliferative)];"
    },
    "connections": [
      {
        "type": "caused_by",
        "to": "diabetes_mellitus"
      },
      {
        "type": "characterized_by",
        "to": "cotton_wool_spots"
      },
      {
        "type": "can_lead_to",
        "to": "retinal_detachment"
      }
    ]
  },
  "cholinergic_toxidrome": {
    "title": "Cholinergic Toxidrome",
    "primaryType": "finding",
    "tags": [
      "Pharmacology",
      "Toxicology",
      "Neurology",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Toxicology",
      "Toxidromes"
    ],
    "content": {
      "definition": "<p><b>Cholinergic Toxidrome</b> is a constellation of symptoms caused by excessive stimulation of muscarinic and nicotinic receptors due to acetylcholine accumulation, classically seen with [[organophosphates]] or [[cholinesterase_inhibitors]].</p>",
      "atAGlance": "<ul><li><b>Etiology:</b> Organophosphates (insecticides, nerve gas), Carbamates (Physostigmine, Neostigmine).</li><li><b>Muscarinic Signs (DUMBELS):</b> <b>D</b>iarrhea, <b>U</b>rination, <b>M</b>iosis, <b>B</b>radycardia/Bronchospasm, <b>E</b>mesis, <b>L</b>acrimation, <b>S</b>alivation/Sweating.</li><li><b>Nicotinic Signs:</b> Muscle fasciculations, weakness/paralysis (depolarizing block).</li><li><b>Treatment:</b><br> 1. <b>[[atropine]]:</b> Blocks Muscarinic effects (life-saving for bradycardia/secretions).<br> 2. <b>[[pralidoxime]] (2-PAM):</b> Regenerates AChE (reverses Nicotinic paralysis) if given early (before \"aging\").</li><li><b>USMLE Tip:</b> \"Leaking from every orifice\" = Cholinergic. Atropine fixes the leaks (Muscarinic), 2-PAM fixes the weakness (Nicotinic).</li></ul>",
      "takeAway": "<p><b>Cholinergic Toxicity</b> presents as \"DUMBELS\" (wet/leaky) due to muscarinic excess and paralysis due to nicotinic excess; Atropine treats the former, Pralidoxime the latter.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "caused_by",
        "to": "organophosphates"
      },
      {
        "type": "treated_by",
        "to": "atropine"
      },
      {
        "type": "treated_by",
        "to": "pralidoxime"
      },
      {
        "type": "includes_symptom",
        "to": "miosis"
      }
    ]
  },
  "diazepam": {
    "title": "Diazepam",
    "primaryType": "substance",
    "tags": [
      "Pharmacology",
      "Neurology",
      "Psychiatry",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Psychotropic Drugs",
      "Benzodiazepines"
    ],
    "content": {
      "definition": "<p><b>Diazepam</b> (Valium) is a long-acting <i>benzodiazepine</i> that potentiates GABA<sub>A</sub> receptor activity, used for anxiety, muscle spasms, seizures, and alcohol withdrawal.</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> Increases <b>frequency</b> of Cl<sup>-</sup> channel opening at GABA<sub>A</sub> receptors.</li><li><b>Pharmacokinetics:</b> Long half-life with active metabolites. Hepatic metabolism.</li><li><b>Clinical Uses:</b> [[status_epilepticus]] (acute), [[alcohol_withdrawal]], Muscle spasticity/spasms, Anxiety.</li><li><b>Adverse Effects:</b> Sedation, dependence, respiratory depression.</li><li><b>USMLE Tip:</b> Useful for tapering alcohol withdrawal due to its self-tapering long half-life. Avoid in liver failure (use Lorazepam instead).</li></ul>",
      "takeAway": "<p><b>Diazepam</b> is a long-acting benzo ideal for muscle relaxation and preventing withdrawal seizures, mediating inhibition via the GABA-A receptor.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "modulates",
        "to": "gaba_a_receptor"
      },
      {
        "type": "treats",
        "to": "status_epilepticus"
      },
      {
        "type": "treats",
        "to": "alcohol_withdrawal"
      }
    ]
  },
  "diencephalon": {
    "title": "Diencephalon",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Embryology",
      "Anatomy",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Brain Anatomy",
      "Forebrain"
    ],
    "content": {
      "definition": "<p>The <b>Diencephalon</b> is the posterior division of the embryonic forebrain (prosencephalon) that gives rise to the <u>thalamus</u>, <u>hypothalamus</u>, epithalamus, and retina.</p>",
      "atAGlance": "<ul><li><b>Derivatives:</b><br> - <b>Thalamus:</b> Sensory relay.<br> - <b>Hypothalamus:</b> Homeostasis/Endocrine.<br> - <b>Retina/Optic Nerve:</b> Outgrowth of the diencephalon (CN II is CNS tissue!).<br> - <b>Posterior Pituitary:</b> Neurohypophysis.</li><li><b>Ventricle:</b> Third Ventricle.</li><li><b>USMLE Tip:</b> The <b>Optic Nerve</b> and Retina are part of the CNS (Diencephalon derivatives), which is why the optic nerve is myelinated by oligodendrocytes (susceptible to MS).</li></ul>",
      "takeAway": "<p>The <b>Diencephalon</b> forms the central core of the brain (Thalamus/Hypothalamus) and the visual structures (Retina/Optic Nerve), surrounding the third ventricle.</p>",
      "mermaid": "graph TD; A[Prosencephalon] --> B[Telencephalon]; A --> C[Diencephalon]; C --> D[Thalamus]; C --> E[Hypothalamus]; C --> F[Retina/Optic Nerve]; C --> G[Third Ventricle];"
    },
    "connections": [
      {
        "type": "gives_rise_to",
        "to": "thalamus"
      },
      {
        "type": "gives_rise_to",
        "to": "hypothalamus"
      },
      {
        "type": "gives_rise_to",
        "to": "retina"
      }
    ]
  },
  "diffuse_axonal_injury": {
    "title": "Diffuse Axonal Injury (DAI)",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Trauma",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Traumatic Brain Injury"
    ],
    "content": {
      "definition": "<p><b>Diffuse Axonal Injury (DAI)</b> is a severe form of traumatic brain injury caused by <u>shearing forces</u> from rapid acceleration/deceleration (e.g., car accidents), leading to widespread axonal damage particularly at the gray-white matter junction.</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> Shearing/tearing of axons due to rotational forces.</li><li><b>Clinical Presentation:</b> Immediate coma or persistent vegetative state after trauma, often with disproportionately normal initial CT.</li><li><b>Imaging:</b> MRI is more sensitive. Shows multiple punctate micro-hemorrhages, typically at the <b>Gray-White Junction</b>, Corpus Callosum, and Brainstem.</li><li><b>Pathology:</b> Axonal swelling (spheroids), interruption of transport.</li><li><b>USMLE Tip:</b> Patient in a coma after a high-speed MVA with a \"normal\" CT scan -> Suspect DAI.</li></ul>",
      "takeAway": "<p><b>Diffuse Axonal Injury</b> is a devastating TBI caused by shearing forces, diagnosed by MRI showing punctate hemorrhages at white matter tracts, often resulting in poor neurologic outcomes.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "caused_by",
        "to": "brain_injury"
      },
      {
        "type": "affects_structure",
        "to": "corpus_callosum"
      },
      {
        "type": "results_in",
        "to": "coma"
      }
    ]
  },
  "dihydroergotamine": {
    "title": "Dihydroergotamine",
    "primaryType": "substance",
    "tags": [
      "Pharmacology",
      "Neurology",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Neurology Drugs",
      "Antimigraine Agents"
    ],
    "content": {
      "definition": "<p><b>Dihydroergotamine</b> is an <u>ergot alkaloid</u> used as an abortive therapy for [[migraine]] and [[cluster_headache]], acting as a partial agonist at 5-HT and alpha-adrenergic receptors to cause vasoconstriction.</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> Agonist at 5-HT<sub>1B/1D</sub> receptors (vasoconstriction) and interaction with Dopamine/Adrenergic receptors.</li><li><b>Clinical Use:</b> Acute Migraine, Cluster Headache.</li><li><b>Adverse Effects:</b> Nausea (stimulates CTZ), Vasospasm (ergotism), Coronary vasospasm.</li><li><b>Contraindications:</b> CAD, Prinzmetal angina, Pregnancy, uncontrolled HTN.</li><li><b>USMLE Tip:</b> Similar to Triptans but \"dirtier\" receptor profile (more side effects like nausea).</li></ul>",
      "takeAway": "<p><b>Dihydroergotamine</b> is a vasoconstrictive ergot used for migraines, limited by significant side effects like nausea and vascular spasm.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "treats",
        "to": "migraine"
      },
      {
        "type": "treats",
        "to": "cluster_headache"
      },
      {
        "type": "can_cause",
        "to": "coronary_vasospasm"
      }
    ]
  }
}
``````json
{
  "diphenoxylate": {
    "title": "Diphenoxylate",
    "primaryType": "substance",
    "tags": [
      "Pharmacology",
      "Gastroenterology",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Gastrointestinal Drugs",
      "Antidiarrheals"
    ],
    "content": {
      "definition": "<p><b>Diphenoxylate</b> is an opioid agonist used as an antidiarrheal agent, which slows gut motility by binding to mu-opioid receptors in the GI tract; it is formulated with [[atropine]] to discourage abuse.</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> Agonizes mu-opioid receptors in the myenteric plexus &rarr; inhibits acetylcholine release &rarr; decreases peristalsis/increases transit time.</li><li><b>Formulation:</b> Combined with sub-therapeutic doses of <b>Atropine</b> to produce unpleasant anticholinergic side effects (dry mouth, blurred vision) if taken in high doses, deterring abuse.</li><li><b>Clinical Use:</b> Diarrhea.</li><li><b>Adverse Effects:</b> Constipation, mild sedation. High doses can cause opioid toxicity (respiratory depression).</li><li><b>USMLE Tip:</b> Differentiate from [[loperamide]], which does not cross the BBB significantly and has lower abuse potential.</li></ul>",
      "takeAway": "<p><b>Diphenoxylate</b> treats diarrhea by slowing gut motility via opioid receptors; atropine is added solely to prevent abuse.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "agonizes",
        "to": "mu_opioid_receptor"
      },
      {
        "type": "combined_with",
        "to": "atropine"
      },
      {
        "type": "treats",
        "to": "diarrhea"
      },
      {
        "type": "is_contrasted_with",
        "to": "loperamide"
      }
    ]
  },
  "direct_pathway_basal_ganglia": {
    "title": "Direct Pathway (Basal Ganglia)",
    "primaryType": "process",
    "tags": [
      "Neurology",
      "Physiology",
      "Motor Control",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Basal Ganglia Pathways"
    ],
    "content": {
      "definition": "<p>The <b>Direct Pathway</b> of the basal ganglia facilitates voluntary movement by disinhibiting the thalamus, initiated by [[dopamine]] binding to D1 receptors in the striatum.</p>",
      "atAGlance": "<ul><li><b>Circuitry:</b> Cortex &rarr; Striatum (GABA/Substance P) &rarr; Inhibits <b>GPi/SNr</b> &rarr; Decreased inhibition of Thalamus &rarr; Thalamus stimulates Motor Cortex.</li><li><b>Dopamine Effect:</b> Nigrostriatal dopamine binds <b>D1 Receptors</b> (stimulatory) in the striatum &rarr; Activates Direct Pathway &rarr; Increases movement.</li><li><b>Pathology:</b> Underactive in [[parkinson_disease]] (bradykinesia).</li><li><b>Mnemonic:</b> <b>D</b>irect pathway = <b>D</b>1 Receptor = <b>D</b>isinhibits Thalamus = <b>D</b>o it (Move!).</li></ul>",
      "takeAway": "<p>The <b>Direct Pathway</b> promotes movement by inhibiting the inhibitors (GPi/SNr), thereby releasing the thalamus to excite the motor cortex.</p>",
      "mermaid": "graph TD; A[Cortex] --(+)--> B[Striatum]; B --(-)|GABA| C[GPi/SNr]; C --(-)|GABA| D[Thalamus]; D --(+)|Glutamate| E[Motor Cortex]; F[SNc Dopamine] --(+)|D1| B;"
    },
    "connections": [
      {
        "type": "involves_neurotransmitter",
        "to": "dopamine"
      },
      {
        "type": "utilizes_receptor",
        "to": "d1_receptor"
      },
      {
        "type": "is_impaired_in",
        "to": "parkinson_disease"
      },
      {
        "type": "opposes",
        "to": "indirect_pathway_basal_ganglia"
      }
    ]
  },
  "direct_light_reflex": {
    "title": "Direct Light Reflex",
    "primaryType": "process",
    "tags": [
      "Neurology",
      "Ophthalmology",
      "Physiology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Neuro-Ophthalmology",
      "Pupillary Reflexes"
    ],
    "content": {
      "definition": "<p>The <b>Direct Light Reflex</b> is the constriction of the pupil in the <u>same eye</u> that is illuminated, mediated by the afferent optic nerve and efferent oculomotor nerve.</p>",
      "atAGlance": "<ul><li><b>Afferent Limb:</b> Retina &rarr; [[optic_nerve]] (CN II) &rarr; Pretectal Nucleus (Midbrain).</li><li><b>Integration:</b> Pretectal Nucleus projects bilaterally to the [[edinger_westphal_nucleus]].</li><li><b>Efferent Limb:</b> Edinger-Westphal &rarr; [[oculomotor_nerve]] (CN III) parasympathetics &rarr; Ciliary Ganglion &rarr; Sphincter Pupillae.</li><li><b>Clinical Significance:</b> Loss of direct reflex with preserved consensual response (in the other eye) indicates an <b>efferent</b> (CN III) defect in the illuminated eye. Loss of both suggests an <b>afferent</b> (CN II) defect.</li></ul>",
      "takeAway": "<p>The <b>Direct Light Reflex</b> tests the ipsilateral sensory (CN II) and motor (CN III) arc; intactness confirms the pathway from retina to midbrain and back to the iris.</p>",
      "mermaid": "graph TD; A[Light Source] --> B[Ipsilateral Retina]; B --> C[CN II]; C --> D[Pretectal Nucleus]; D --> E[Ipsilateral Edinger-Westphal]; E --> F[Ipsilateral CN III]; F --> G[Pupillary Constriction];"
    },
    "connections": [
      {
        "type": "mediated_by_afferent",
        "to": "optic_nerve"
      },
      {
        "type": "mediated_by_efferent",
        "to": "oculomotor_nerve"
      },
      {
        "type": "involves_nucleus",
        "to": "edinger_westphal_nucleus"
      }
    ]
  },
  "diuretics": {
    "title": "Diuretics",
    "primaryType": "group",
    "tags": [
      "Pharmacology",
      "Nephrology",
      "Cardiology",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Renal Drugs",
      "Diuretics"
    ],
    "content": {
      "definition": "<p><b>Diuretics</b> are a class of drugs that increase urine output and sodium excretion by targeting specific transporters along the nephron, used to manage hypertension, heart failure, and edema.</p>",
      "atAGlance": "<ul><li><b>Proximal Tubule:</b> [[acetazolamide]] (Carbonic anhydrase inhibitor), [[mannitol]] (Osmotic).</li><li><b>Thick Ascending Limb:</b> [[loop_diuretics]] (Inhibit NKCC2). Strongest effect.</li><li><b>Distal Convoluted Tubule:</b> [[thiazide_diuretics]] (Inhibit NCC).</li><li><b>Collecting Duct:</b> [[potassium_sparing_diuretics]] (Aldosterone antagonists, ENaC blockers).</li><li><b>Electrolyte Effects:</b> Most cause hypokalemia (except K<sup>+</sup>-sparing). Thiazides increase Ca<sup>2+</sup>; Loops decrease Ca<sup>2+</sup>.</li><li><b>USMLE Tip:</b> \"Loops Lose Calcium\" (Hypocalcemia). Thiazides retain calcium (Hypercalcemia).</li></ul>",
      "takeAway": "<p><b>Diuretics</b> alter renal handling of sodium and water at distinct nephron segments; knowing the site of action predicts electrolyte disturbances (e.g., Loops vs. Thiazides on calcium).</p>",
      "mermaid": "graph LR; A[Proximal Tubule] --> B[Loop of Henle]; B --> C[Distal Tubule]; C --> D[Collecting Duct]; E[Acetazolamide] -.-> A; F[Loop Diuretics] -.-> B; G[Thiazides] -.-> C; H[K+ Sparing] -.-> D;"
    },
    "connections": [
      {
        "type": "includes",
        "to": "loop_diuretics"
      },
      {
        "type": "includes",
        "to": "thiazide_diuretics"
      },
      {
        "type": "includes",
        "to": "potassium_sparing_diuretics"
      },
      {
        "type": "includes",
        "to": "acetazolamide"
      }
    ]
  },
  "donepezil": {
    "title": "Donepezil",
    "primaryType": "substance",
    "tags": [
      "Pharmacology",
      "Neurology",
      "Geriatrics",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Neurology Drugs",
      "Cholinesterase Inhibitors"
    ],
    "content": {
      "definition": "<p><b>Donepezil</b> is a centrally acting, reversible <i>acetylcholinesterase inhibitor</i> used to treat the cognitive symptoms of mild to moderate [[alzheimer_disease]] by increasing synaptic acetylcholine levels.</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> Inhibits central AChE &rarr; Increases Acetylcholine availability &rarr; Compensates for loss of cholinergic neurons in the [[basal_nucleus_of_meynert]].</li><li><b>Clinical Use:</b> First-line symptomatic treatment for [[alzheimer_disease]].</li><li><b>Adverse Effects:</b> Cholinergic excess (Nausea, dizziness, insomnia, bradycardia). <b>\"Done\"</b> with the puzzle (memory aid).</li><li><b>Comparison:</b> Similar to [[rivastigmine]] and [[galantamine]].</li></ul>",
      "takeAway": "<p><b>Donepezil</b> boosts cholinergic transmission to improve cognition in Alzheimer's disease but does not alter the underlying disease progression.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "treats",
        "to": "alzheimer_disease"
      },
      {
        "type": "inhibits",
        "to": "acetylcholinesterase"
      },
      {
        "type": "increases_levels_of",
        "to": "acetylcholine"
      }
    ]
  },
  "dopamine": {
    "title": "Dopamine",
    "primaryType": "substance",
    "tags": [
      "Neuroscience",
      "Pharmacology",
      "Endocrinology",
      "USMLE"
    ],
    "classificationPath": [
      "Neuroscience",
      "Neurotransmitters",
      "Catecholamines"
    ],
    "content": {
      "definition": "<p><b>Dopamine</b> is a catecholamine neurotransmitter synthesized from L-DOPA that regulates motor control, reward/motivation, and endocrine function, acting on D1-like (stimulatory) and D2-like (inhibitory) receptors.</p>",
      "atAGlance": "<ul><li><b>Synthesis:</b> Tyrosine &rarr; L-DOPA &rarr; Dopamine (via Dopa Decarboxylase). Precursor to [[norepinephrine]].</li><li><b>Pathways:</b><br> - <i>Nigrostriatal:</i> Motor control (Parkinson's).<br> - <i>Mesolimbic:</i> Reward, Addiction, Positive symptoms of Schizophrenia.<br> - <i>Mesocortical:</i> Negative symptoms of Schizophrenia.<br> - <i>Tuberoinfundibular:</i> Inhibits [[prolactin]].</li><li><b>Receptors:</b><br> - <b>D1:</b> G<sub>s</sub> coupled (Direct pathway).<br> - <b>D2:</b> G<sub>i</sub> coupled (Indirect pathway, Antipsychotic target).</li><li><b>Peripheral Effects:</b> Low dose (Renal vasodilation), Medium dose (Beta-1/Cardiac), High dose (Alpha-1/Vasoconstriction).</li></ul>",
      "takeAway": "<p><b>Dopamine</b> is the central regulator of movement and reward; its depletion causes Parkinson's, its excess contributes to psychosis, and it tonically inhibits prolactin.</p>",
      "mermaid": "graph TD; A[Tyrosine] --> B[L-DOPA]; B --> C[Dopamine]; C --> D[Norepinephrine]; C --> E[Receptors D1-D5];"
    },
    "connections": [
      {
        "type": "is_precursor_to",
        "to": "norepinephrine"
      },
      {
        "type": "inhibits_secretion_of",
        "to": "prolactin"
      },
      {
        "type": "deficient_in",
        "to": "parkinson_disease"
      },
      {
        "type": "blocked_by",
        "to": "antipsychotics"
      }
    ]
  },
  "dopamine_agonists": {
    "title": "Dopamine Agonists",
    "primaryType": "group",
    "tags": [
      "Pharmacology",
      "Neurology",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Neurology Drugs",
      "Antiparkinsonian Agents"
    ],
    "content": {
      "definition": "<p><b>Dopamine Agonists</b> are drugs that directly stimulate dopamine receptors, used in the treatment of [[parkinson_disease]], restless legs syndrome, and hyperprolactinemia.</p>",
      "atAGlance": "<ul><li><b>Ergot Derivatives:</b> [[bromocriptine]]. (Rarely used for PD due to fibrosis risk).</li><li><b>Non-Ergot Derivatives:</b> [[pramipexole]], [[ropinirole]], Rotigotine. (Preferred for PD).</li><li><b>Mechanism:</b> Direct stimulation of D2 (and D3) receptors, bypassing degenerating nigrostriatal neurons.</li><li><b>Clinical Use:</b> First-line for younger Parkinson's patients (to delay Levodopa), Restless Legs Syndrome.</li><li><b>Adverse Effects:</b> Nausea, orthostatic hypotension, <b>impulse control disorders</b> (gambling, hypersexuality), hallucinations.</li></ul>",
      "takeAway": "<p><b>Dopamine Agonists</b> like Pramipexole and Ropinirole are non-ergot agents used in early Parkinson's to spare Levodopa, but carry a unique risk of impulse control disorders.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "includes",
        "to": "pramipexole"
      },
      {
        "type": "includes",
        "to": "ropinirole"
      },
      {
        "type": "includes",
        "to": "bromocriptine"
      },
      {
        "type": "treats",
        "to": "parkinson_disease"
      }
    ]
  },
  "dopamine_receptor_d2": {
    "title": "Dopamine D2 Receptor",
    "primaryType": "structure",
    "tags": [
      "Neuroscience",
      "Pharmacology",
      "USMLE"
    ],
    "classificationPath": [
      "Neuroscience",
      "Receptors",
      "G-Protein Coupled"
    ],
    "content": {
      "definition": "<p>The <b>Dopamine D2 Receptor</b> is a G-protein coupled receptor (G<sub>i</sub>) that inhibits adenylate cyclase, playing a central role in the indirect pathway of the basal ganglia, psychosis, and prolactin regulation.</p>",
      "atAGlance": "<ul><li><b>Signaling:</b> <b>G<sub>i</sub></b> coupled &rarr; Inhibits Adenylate Cyclase &rarr; Decreases cAMP.</li><li><b>Functions:</b><br> - <i>Basal Ganglia:</i> Inhibits the <b>Indirect Pathway</b> (normally inhibitory) &rarr; Promotes movement.<br> - <i>Pituitary:</i> Tonic inhibition of [[prolactin]] secretion.<br> - <i>Limbic:</i> Mediates positive symptoms of schizophrenia.</li><li><b>Pharmacology:</b> Target of [[antipsychotics]] (Antagonists) and Parkinson's drugs (Agonists).</li><li><b>USMLE Tip:</b> Blockade of D2 causes Extrapyramidal Symptoms (EPS) and Hyperprolactinemia.</li></ul>",
      "takeAway": "<p>The <b>D2 Receptor</b> is the primary inhibitory dopamine receptor; its blockade treats psychosis but causes movement disorders and prolactin elevation.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "inhibits",
        "to": "indirect_pathway_basal_ganglia"
      },
      {
        "type": "inhibits_secretion_of",
        "to": "prolactin"
      },
      {
        "type": "blocked_by",
        "to": "antipsychotics"
      }
    ]
  },
  "dopaminergic_pathways": {
    "title": "Dopaminergic Pathways",
    "primaryType": "process",
    "tags": [
      "Neuroscience",
      "Psychiatry",
      "USMLE"
    ],
    "classificationPath": [
      "Neuroscience",
      "Functional Systems",
      "Neurotransmitter Systems"
    ],
    "content": {
      "definition": "<p>The four major <b>Dopaminergic Pathways</b> in the brain are the Nigrostriatal, Mesolimbic, Mesocortical, and Tuberoinfundibular tracts, each mediating distinct physiological functions and pathologies.</p>",
      "atAGlance": "<ul><li><b>1. Nigrostriatal:</b> Substantia Nigra &rarr; Striatum. <i>Function:</i> Motor control. <i>Pathology:</i> Parkinson's (low DA), EPS (D2 blockade).</li><li><b>2. Mesolimbic:</b> VTA &rarr; Nucleus Accumbens. <i>Function:</i> Reward, emotion. <i>Pathology:</i> Schizophrenia (Positive symptoms, high DA).</li><li><b>3. Mesocortical:</b> VTA &rarr; Prefrontal Cortex. <i>Function:</i> Cognition, motivation. <i>Pathology:</i> Schizophrenia (Negative symptoms, low DA).</li><li><b>4. Tuberoinfundibular:</b> Hypothalamus &rarr; Pituitary. <i>Function:</i> Inhibits Prolactin. <i>Pathology:</i> Hyperprolactinemia (D2 blockade).</li></ul>",
      "takeAway": "<p>Understanding the four <b>Dopaminergic Pathways</b> explains the therapeutic effects (Mesolimbic blockade) and side effects (Nigrostriatal EPS, Tuberoinfundibular hyperprolactinemia) of antipsychotics.</p>",
      "mermaid": "graph TD; A[Dopamine Neurons] -->|Nigrostriatal| B[Motor Control]; A -->|Mesolimbic| C[Reward/Psychosis]; A -->|Mesocortical| D[Cognition/Negative Sx]; A -->|Tuberoinfundibular| E[Prolactin Inhibition];"
    },
    "connections": [
      {
        "type": "includes",
        "to": "nigrostriatal_pathway"
      },
      {
        "type": "includes",
        "to": "mesolimbic_pathway"
      },
      {
        "type": "includes",
        "to": "tuberoinfundibular_pathway"
      }
    ]
  },
  "dorsal_column_medial_lemniscus": {
    "title": "Dorsal Column-Medial Lemniscus Pathway (DCML)",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Anatomy",
      "Sensory Pathways",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Spinal Cord",
      "Ascending Tracts"
    ],
    "content": {
      "definition": "<p>The <b>Dorsal Column-Medial Lemniscus (DCML)</b> pathway is the ascending sensory tract responsible for transmitting <u>fine touch</u>, <u>vibration</u>, and <u>proprioception</u> from the body to the brain.</p>",
      "atAGlance": "<ul><li><b>Modalities:</b> Vibration, Proprioception, Fine Touch, Two-point discrimination.</li><li><b>Pathway:</b><br> 1. <b>1st Order:</b> DRG &rarr; Ascend ipsilaterally in Dorsal Columns (Gracilis=Legs/Medial, Cuneatus=Arms/Lateral).<br> 2. <b>Synapse:</b> Nucleus Gracilis/Cuneatus (Medulla).<br> 3. <b>2nd Order:</b> Decussate (Internal Arcuate Fibers) &rarr; Ascend as <b>Medial Lemniscus</b>.<br> 4. <b>Synapse:</b> VPL of Thalamus.<br> 5. <b>3rd Order:</b> Somatosensory Cortex.</li><li><b>Lesions:</b><br> - <i>Spinal Cord:</i> Ipsilateral loss below lesion (e.g., [[brown_sequard_syndrome]], [[subacute_combined_degeneration]], [[tabes_dorsalis]] - syphilis).<br> - <i>Brainstem/Cortex:</i> Contralateral loss.</li></ul>",
      "takeAway": "<p>The <b>DCML</b> carries vibration/proprioception ipsilaterally in the spinal cord, decussating in the medulla; damage in the cord results in ipsilateral deficits (Tabes Dorsalis, B12 deficiency).</p>",
      "mermaid": "graph TD; A[Sensory Receptors] --> B[Dorsal Columns (Ipsilateral)]; B --> C[Medulla Nuclei]; C -->|Decussation| D[Medial Lemniscus (Contralateral)]; D --> E[VPL Thalamus]; E --> F[Cortex];"
    },
    "connections": [
      {
        "type": "transmits_sensation_of",
        "to": "proprioception"
      },
      {
        "type": "transmits_sensation_of",
        "to": "vibration_sensation"
      },
      {
        "type": "is_damaged_in",
        "to": "tabes_dorsalis"
      },
      {
        "type": "is_damaged_in",
        "to": "subacute_combined_degeneration"
      }
    ]
  },
  "parinaud_syndrome": {
    "title": "Dorsal Midbrain Syndrome (Parinaud Syndrome)",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Ophthalmology",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Brainstem Syndromes",
      "Midbrain"
    ],
    "content": {
      "definition": "<p><b>Dorsal Midbrain Syndrome (Parinaud Syndrome)</b> is a constellation of oculomotor abnormalities caused by compression of the dorsal midbrain (tectum/pretectum), classically by a [[pineal_gland_tumor]] (e.g., germinoma).</p>",
      "atAGlance": "<ul><li><b>Triad:</b><br> 1. <b>Vertical Gaze Palsy:</b> Limitation of <u>upgaze</u> (compression of vertical gaze center in superior colliculus).<br> 2. <b>Light-Near Dissociation:</b> Pupils accommodate but do not react to light (Pseudo-Argyll Robertson).<br> 3. <b>Convergence-Retraction Nystagmus:</b> Eyes jerk inward and backward on attempted upgaze.</li><li><b>Other Signs:</b> Eyelid retraction (Collier's sign), Hydrocephalus (Aqueductal stenosis).</li><li><b>Etiology:</b> Pinealoma, Hydrocephalus, Stroke.</li><li><b>USMLE Tip:</b> \"Setting sun sign\" (eyes forced down) in hydrocephalus is related. Look for a child with headaches (ICP) and inability to look up.</li></ul>",
      "takeAway": "<p><b>Parinaud Syndrome</b> manifests as upgaze paralysis and light-near dissociation due to compression of the dorsal midbrain, typically by a pineal tumor.</p>",
      "mermaid": "graph TD; A[Pineal Mass] --> B[Compresses Superior Colliculus]; B --> C[Vertical Gaze Palsy]; A --> D[Compresses Pretectum]; D --> E[Light-Near Dissociation]; A --> F[Compresses Cerebral Aqueduct]; F --> G[Hydrocephalus];"
    },
    "connections": [
      {
        "type": "caused_by",
        "to": "pineal_gland_tumor"
      },
      {
        "type": "manifests_as",
        "to": "convergence_retraction_nystagmus"
      },
      {
        "type": "manifests_as",
        "to": "light_near_dissociation"
      },
      {
        "type": "associated_with",
        "to": "noncommunicating_hydrocephalus"
      }
    ]
  },
  "dorsal_motor_nucleus": {
    "title": "Dorsal Motor Nucleus (Vagus)",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Anatomy",
      "Autonomic Nervous System",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Brain Anatomy",
      "Cranial Nerve Nuclei"
    ],
    "content": {
      "definition": "<p>The <b>Dorsal Motor Nucleus of the Vagus</b> is a cranial nerve nucleus located in the medulla that provides <u>parasympathetic</u> visceral motor innervation to the heart, lungs, and upper gastrointestinal tract.</p>",
      "atAGlance": "<ul><li><b>Location:</b> Dorsal Medulla (floor of 4th ventricle), lateral to Hypoglossal nucleus.</li><li><b>Function:</b> General Visceral Efferent (GVE). Controls secretomotor functions of GI tract, heart rate, and bronchi.</li><li><b>Nerve:</b> [[vagus_nerve]] (CN X).</li><li><b>Comparison:</b> Distinct from <b>Nucleus Ambiguus</b> (Branchial motor to pharynx/larynx/heart) and <b>Nucleus Solitarius</b> (Sensory).</li><li><b>USMLE Tip:</b> Remember CN X has multiple nuclei. Dorsal Motor = Visceral \"Rest and Digest\" output.</li></ul>",
      "takeAway": "<p>The <b>Dorsal Motor Nucleus</b> is the source of preganglionic parasympathetic fibers for the Vagus nerve, regulating thoracoabdominal viscera.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "component_of",
        "to": "vagus_nerve"
      },
      {
        "type": "located_in",
        "to": "medulla_oblongata"
      },
      {
        "type": "provides_innervation_to",
        "to": "parasympathetic_nervous_system"
      }
    ]
  },
  "dorsal_optic_radiation": {
    "title": "Dorsal Optic Radiation (Baum's Loop)",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Anatomy",
      "Visual Pathway",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Brain Anatomy",
      "Visual Pathway"
    ],
    "content": {
      "definition": "<p>The <b>Dorsal Optic Radiation (Baum's Loop)</b> is the superior bundle of the geniculocalcarine tract passing through the <u>parietal lobe</u>, carrying visual information from the <u>superior retina</u> (inferior visual field) to the visual cortex.</p>",
      "atAGlance": "<ul><li><b>Pathway:</b> Lateral Geniculate Nucleus (LGN) &rarr; Parietal Lobe (Internal Capsule) &rarr; Visual Cortex (Cuneus gyrus, upper bank of calcarine fissure).</li><li><b>Visual Field:</b> Carries info from Superior Retina &rarr; sees <b>Inferior Visual Field</b>.</li><li><b>Lesion:</b> Damage to the Parietal Lobe (e.g., MCA stroke) causes <b>Contralateral Inferior Quadrantanopia</b> (\"Pie on the Floor\").</li><li><b>Mnemonic:</b> \"<b>P</b>arietal pathway = <b>P</b>ie on the Floor\". (Contrast with Temporal/Meyer's Loop = Pie in the Sky).</li></ul>",
      "takeAway": "<p>The <b>Dorsal Optic Radiation</b> traverses the parietal lobe; lesions here result in a contralateral \"Pie on the Floor\" visual field defect.</p>",
      "mermaid": "graph LR; A[LGN] --> B[Dorsal Radiation]; B --> C[Parietal Lobe]; C --> D[Visual Cortex Cuneus]; D --> E[Inferior Visual Field Defect];"
    },
    "connections": [
      {
        "type": "located_in",
        "to": "parietal_lobe"
      },
      {
        "type": "lesion_causes",
        "to": "quadrantanopia"
      },
      {
        "type": "is_contrasted_with",
        "to": "meyer_loop"
      }
    ]
  }
}
``````json
{
  "xyy_syndrome": {
    "title": "47,XYY Syndrome",
    "primaryType": "disease",
    "tags": [
      "Genetics",
      "Pediatrics",
      "USMLE"
    ],
    "classificationPath": [
      "Genetics",
      "Chromosomal Abnormalities",
      "Sex Chromosome Aneuploidy"
    ],
    "content": {
      "definition": "<p><b>47,XYY Syndrome</b> is a sex chromosome aneuploidy characterized by the presence of an extra Y chromosome in males, resulting from nondisjunction during paternal meiosis II.</p>",
      "atAGlance": "<ul><li><b>Karyotype:</b> 47,XYY.</li><li><b>Clinical Features:</b> Phenotypically <b>normal male</b>. May be <b>very tall</b>, have severe acne, and mild learning disabilities or behavioral problems (impulsivity).</li><li><b>Fertility:</b> Normal fertility (unlike [[klinefelter_syndrome]]).</li><li><b>Pathogenesis:</b> Paternal nondisjunction at Meiosis II (YY sperm).</li><li><b>USMLE Tip:</b> Often diagnosed incidentally. Differentiate from Klinefelter (47,XXY) which presents with hypogonadism/infertility.</li></ul>",
      "takeAway": "<p><b>47,XYY Syndrome</b> affects tall males with normal fertility and variable behavioral issues, caused by paternal meiosis II nondisjunction.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "caused_by",
        "to": "nondisjunction"
      },
      {
        "type": "is_distinguished_from",
        "to": "klinefelter_syndrome"
      }
    ]
  },
  "dream_enactment_behavior": {
    "title": "Dream Enactment Behavior",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Sleep Medicine",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Sleep Disorders",
      "Parasomnias"
    ],
    "content": {
      "definition": "<p><b>Dream Enactment Behavior</b> is the hallmark clinical finding of [[rem_sleep_behavior_disorder]], characterized by the loss of normal REM muscle atonia, allowing patients to physically act out vivid, often violent dreams.</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> Dysfunction of brainstem nuclei (sublaterodorsal nucleus) that normally mediate REM atonia.</li><li><b>Clinical Presentation:</b> Punching, kicking, yelling, or leaping from bed during REM sleep.</li><li><b>Associations:</b> Highly predictive of alpha-synucleinopathies: [[parkinson_disease]], [[lewy_body_dementia]], and [[multiple_system_atrophy]].</li><li><b>USMLE Tip:</b> If an elderly patient \"fights in his sleep,\" suspect a developing synucleinopathy.</li></ul>",
      "takeAway": "<p><b>Dream Enactment</b> signifies a breakdown in REM atonia and is a strong prodromal sign for neurodegenerative diseases like Parkinson's.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_hallmark_of",
        "to": "rem_sleep_behavior_disorder"
      },
      {
        "type": "predicts",
        "to": "parkinson_disease"
      },
      {
        "type": "predicts",
        "to": "lewy_body_dementia"
      }
    ]
  },
  "sialorrhea": {
    "title": "Sialorrhea (Drooling)",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Pharmacology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Cranial Nerve Disorders",
      "Bulbar Symptoms"
    ],
    "content": {
      "definition": "<p><b>Sialorrhea</b> is the excessive flow of saliva, often due to neuromuscular dysfunction impairing swallowing (rather than hypersecretion), commonly seen in conditions like [[parkinson_disease]], [[cerebral_palsy]], and [[bulbar_palsy]].</p>",
      "atAGlance": "<ul><li><b>Etiology:</b> Impaired swallowing reflex (CN IX, X), poor lip closure (CN VII), or cholinergic excess (e.g., [[organophosphates]], [[clozapine]]).</li><li><b>Treatment:</b> <b>Antimuscarinics</b> (e.g., [[glycopyrrolate]], Scopolamine patches) to decrease salivary production. Botulinum toxin injections into salivary glands.</li><li><b>Adverse Effects of Treatment:</b> Anticholinergic toxicity (dry mouth, constipation, urinary retention).</li><li><b>USMLE Tip:</b> Glycopyrrolate is often preferred because it does not cross the [[blood_brain_barrier]], minimizing central side effects.</li></ul>",
      "takeAway": "<p><b>Sialorrhea</b> in neurologic disease usually reflects dysphagia; treatment targets salivary production using antimuscarinics like [[glycopyrrolate]].</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "treated_by",
        "to": "glycopyrrolate"
      },
      {
        "type": "associated_with",
        "to": "parkinson_disease"
      },
      {
        "type": "associated_with",
        "to": "bulbar_palsy"
      },
      {
        "type": "caused_by_toxicity_of",
        "to": "organophosphates"
      }
    ]
  },
  "drug_safety": {
    "title": "Drug Safety",
    "primaryType": "concept",
    "tags": [
      "Index Stub"
    ],
    "classificationPath": [
      "Pharmacology",
      "Toxicology"
    ],
    "content": {
      "definition": "<p><i>(Placeholder)</i> A broad concept covering pharmacovigilance, adverse drug reactions, therapeutic index, and medication error prevention.</p>",
      "atAGlance": "<ul><li>See [[therapeutic_index]], [[cytochrome_p450]], [[drug_induced_liver_injury]], [[teratogenicity]].</li></ul>",
      "takeAway": "",
      "mermaid": ""
    },
    "connections": []
  },
  "drusen": {
    "title": "Drusen",
    "primaryType": "finding",
    "tags": [
      "Ophthalmology",
      "Pathology",
      "Aging",
      "USMLE"
    ],
    "classificationPath": [
      "Ophthalmology",
      "Retinal Signs"
    ],
    "content": {
      "definition": "<p><b>Drusen</b> are small, yellow, extracellular deposits of lipid and protein that accumulate between the <u>retinal pigment epithelium (RPE)</u> and <u>Bruch's membrane</u>, serving as the hallmark finding of <b>Dry</b> [[age_related_macular_degeneration]].</p>",
      "atAGlance": "<ul><li><b>Appearance:</b> Yellowish-white spots on the retina during fundoscopy.</li><li><b>Composition:</b> Lipids, proteins (complement factors), cellular debris.</li><li><b>Types:</b><br> - <i>Hard Drusen:</i> Small, distinct margins (lower risk).<br> - <i>Soft Drusen:</i> Large, indistinct margins (higher risk for progression to Wet AMD).</li><li><b>Pathophysiology:</b> Impaired clearance of metabolic waste from photoreceptors/RPE &rarr; inflammation &rarr; RPE atrophy.</li><li><b>USMLE Tip:</b> Drusen = Dry AMD. Neovascularization = Wet AMD.</li></ul>",
      "takeAway": "<p><b>Drusen</b> are the characteristic subretinal deposits of Dry AMD, indicating metabolic stress and aging of the retinal pigment epithelium.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_hallmark_of",
        "to": "age_related_macular_degeneration"
      },
      {
        "type": "accumulates_in",
        "to": "retina"
      },
      {
        "type": "precedes",
        "to": "choroidal_neovascularization"
      }
    ]
  },
  "dura_mater": {
    "title": "Dura Mater",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Anatomy",
      "Meninges",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Brain Anatomy",
      "Meninges"
    ],
    "content": {
      "definition": "<p>The <b>Dura Mater</b> is the tough, outermost layer of the [[meninges]], composed of dense fibrous connective tissue, which forms the dural venous sinuses and partitions the cranial cavity (e.g., [[falx_cerebri]], [[tentorium_cerebelli]]).</p>",
      "atAGlance": "<ul><li><b>Layers:</b> Periosteal (attached to skull) and Meningeal (inner). Separation creates <b>Venous Sinuses</b>.</li><li><b>Innervation:</b> Branches of [[trigeminal_nerve]] (CN V) &rarr; source of headache pain (brain tissue itself has no pain receptors).</li><li><b>Spaces:</b><br> - <i>Epidural Space:</i> Potential space above dura (site of [[epidural_hematoma]] - MMA rupture).<br> - <i>Subdural Space:</i> Potential space below dura (site of [[subdural_hematoma]] - Bridging vein rupture).</li><li><b>Folds:</b> Falx Cerebri, Tentorium Cerebelli (sites of herniation).</li></ul>",
      "takeAway": "<p>The <b>Dura Mater</b> provides structural support, houses venous sinuses, and defines the epidural and subdural spaces, critical sites for intracranial hemorrhage.</p>",
      "mermaid": "graph TD; A[Skull] --> B[Epidural Space]; B --> C[Dura Mater]; C --> D[Subdural Space]; D --> E[Arachnoid Mater]; E --> F[Subarachnoid Space];"
    },
    "connections": [
      {
        "type": "forms_boundary_of",
        "to": "epidural_hematoma"
      },
      {
        "type": "forms_boundary_of",
        "to": "subdural_hematoma"
      },
      {
        "type": "contains",
        "to": "dural_venous_sinuses"
      },
      {
        "type": "innervated_by",
        "to": "trigeminal_nerve"
      }
    ]
  },
  "dural_venous_sinuses": {
    "title": "Dural Venous Sinuses",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Anatomy",
      "Vascular",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Cerebrovascular System",
      "Venous Sinuses"
    ],
    "content": {
      "definition": "<p>The <b>Dural Venous Sinuses</b> are endothelium-lined channels located between the periosteal and meningeal layers of the [[dura_mater]] that drain venous blood from the brain and [[cerebrospinal_fluid]] (via arachnoid granulations) into the internal jugular vein.</p>",
      "atAGlance": "<ul><li><b>Key Sinuses:</b> [[superior_sagittal_sinus]], Inferior Sagittal Sinus, Straight Sinus, Transverse Sinus, Sigmoid Sinus, [[cavernous_sinus]].</li><li><b>Flow:</b> SSS/Straight Sinus &rarr; [[confluence_of_sinuses]] &rarr; Transverse &rarr; Sigmoid &rarr; Jugular Foramen &rarr; Internal Jugular Vein.</li><li><b>Pathology:</b> <b>Venous Sinus Thrombosis</b> (Hypercoagulable state, infection). Presents with headache, seizures, papilledema, focal deficits.</li><li><b>USMLE Tip:</b> Thrombosis of the Superior Sagittal Sinus blocks CSF resorption &rarr; Increased ICP.</li></ul>",
      "takeAway": "<p>The <b>Dural Venous Sinuses</b> drain CNS blood and CSF; occlusion leads to venous congestion and elevated intracranial pressure.</p>",
      "mermaid": "graph TD; A[Cerebral Veins] --> B[Dural Sinuses]; C[CSF via Arachnoid Granulations] --> B; B --> D[Internal Jugular Vein];"
    },
    "connections": [
      {
        "type": "drains",
        "to": "cerebrospinal_fluid"
      },
      {
        "type": "formed_by",
        "to": "dura_mater"
      },
      {
        "type": "includes",
        "to": "cavernous_sinus"
      },
      {
        "type": "includes",
        "to": "superior_sagittal_sinus"
      }
    ]
  },
  "duret_hemorrhage": {
    "title": "Duret Hemorrhage",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Pathology",
      "Trauma",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Intracranial Pressure Disorders",
      "Brain Herniation"
    ],
    "content": {
      "definition": "<p><b>Duret Hemorrhages</b> are secondary brainstem hemorrhages, typically in the <u>pons and midbrain</u>, caused by the stretching and rupture of <u>paramedian perforating arteries</u> during downward [[central_herniation]] or severe uncal herniation.</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> Increased ICP &rarr; Brainstem displaced caudally &rarr; Basilar artery anchored &rarr; Perforating arteries stretched/torn &rarr; Linear hemorrhages.</li><li><b>Clinical Context:</b> Terminal sign of severe brain herniation. Usually fatal.</li><li><b>Location:</b> Midline Pons and Midbrain.</li><li><b>USMLE Tip:</b> If a vignette describes a patient with a blown pupil who then develops \"linear hemorrhages in the midbrain/pons\" and dies, it's a Duret hemorrhage sequela of herniation.</li></ul>",
      "takeAway": "<p><b>Duret Hemorrhages</b> are fatal brainstem bleeds caused by vascular shearing during caudal herniation, marking an irreversible stage of intracranial hypertension.</p>",
      "mermaid": "graph TD; A[Uncal/Central Herniation] --> B[Brainstem Shifted Downward]; B --> C[Basilar Artery stays fixed]; C --> D[Paramedian Arteries Stretched]; D --> E[Arterial Rupture]; E --> F[Duret Hemorrhage];"
    },
    "connections": [
      {
        "type": "caused_by",
        "to": "central_herniation"
      },
      {
        "type": "caused_by",
        "to": "uncal_herniation"
      },
      {
        "type": "involves_rupture_of",
        "to": "pontine_arteries"
      }
    ]
  },
  "dysarthria": {
    "title": "Dysarthria",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Signs & Symptoms",
      "Speech",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Motor Disorders",
      "Speech Disorders"
    ],
    "content": {
      "definition": "<p><b>Dysarthria</b> is a motor speech disorder characterized by <u>poor articulation</u>, respiration, or phonation due to weakness or incoordination of the speech muscles, distinct from aphasia (language processing disorder).</p>",
      "atAGlance": "<ul><li><b>Etiologies:</b><br> - <b>LMN (Bulbar):</b> Flaccid, nasal speech. (e.g., [[bulbar_palsy]], MG).<br> - <b>UMN (Pseudobulbar):</b> Spastic, strained speech. (e.g., [[pseudobulbar_palsy]], ALS).<br> - <b>Cerebellar:</b> Scanning speech (irregular volume/timing). (e.g., MS, Alcohol).<br> - <b>Basal Ganglia:</b> Hypokinetic (Parkinson's - quiet/monotone) or Hyperkinetic (Huntington's).</li><li><b>USMLE Tip:</b> Dysarthria = \"Mechanical\" problem (muscles/nerves). Aphasia = \"software\" problem (Language centers).</li></ul>",
      "takeAway": "<p><b>Dysarthria</b> is a defect in the mechanics of speech production (articulation), localizing to the motor pathways (UMN, LMN, Cerebellum, Basal Ganglia), not the language cortex.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_distinguished_from",
        "to": "aphasia"
      },
      {
        "type": "manifests_in",
        "to": "bulbar_palsy"
      },
      {
        "type": "manifests_in",
        "to": "cerebellar_ataxia"
      }
    ]
  },
  "dyskinesia": {
    "title": "Dyskinesia",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Movement Disorders",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Movement Disorders",
      "Hyperkinetic"
    ],
    "content": {
      "definition": "<p><b>Dyskinesia</b> refers to any involuntary, abnormal movement, encompassing a broad range of hyperkinetic disorders including chorea, athetosis, ballismus, and dystonia, often associated with [[basal_ganglia]] pathology or medication side effects.</p>",
      "atAGlance": "<ul><li><b>Types:</b><br> - <b>[[chorea]]:</b> Rapid, dance-like.<br> - <b>[[athetosis]]:</b> Slow, writhing.<br> - <b>Ballismus:</b> Violent flinging.<br> - <b>[[dystonia]]:</b> Sustained twisting postures.<br> - <b>[[tardive_dyskinesia]]:</b> Orofacial movements from chronic antipsychotic use (D2 supersensitivity).<br> - <b>Levodopa-induced Dyskinesia:</b> Peak-dose movements in Parkinson's.</li><li><b>Localization:</b> Basal Ganglia circuitry.</li></ul>",
      "takeAway": "<p><b>Dyskinesia</b> is an umbrella term for involuntary movements, with specific types (Tardive, L-Dopa induced) pointing to specific drug etiologies or basal ganglia lesions.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "includes",
        "to": "chorea"
      },
      {
        "type": "includes",
        "to": "athetosis"
      },
      {
        "type": "includes",
        "to": "tardive_dyskinesia"
      },
      {
        "type": "associated_with",
        "to": "basal_ganglia"
      }
    ]
  },
  "dysmetria": {
    "title": "Dysmetria",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Physical Exam",
      "Cerebellum",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Neurologic Examination",
      "Cerebellar Signs"
    ],
    "content": {
      "definition": "<p><b>Dysmetria</b> is a sign of <u>cerebellar</u> ataxia characterized by the inability to judge the distance or range of a movement, typically manifested as overshooting (hypermetria) or undershooting (hypometria) a target.</p>",
      "atAGlance": "<ul><li><b>Test:</b> Finger-to-Nose test or Heel-to-Shin test.</li><li><b>Localization:</b> Ipsilateral <b>Cerebellar Hemisphere</b> (Intermediate/Lateral zone).</li><li><b>Associations:</b> [[intention_tremor]] (oscillation near the target).</li><li><b>Etiology:</b> Stroke (AICA/PICA/SCA), MS, Tumor.</li><li><b>USMLE Tip:</b> If a patient trying to touch the examiner's finger passes it or stops short, it is Dysmetria, pointing to the Cerebellum.</li></ul>",
      "takeAway": "<p><b>Dysmetria</b> is a cardinal sign of cerebellar hemisphere dysfunction, representing a failure in the precise endpoint control of voluntary movement.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "localizes_to",
        "to": "cerebellum"
      },
      {
        "type": "is_often_accompanied_by",
        "to": "intention_tremor"
      },
      {
        "type": "is_a_type_of",
        "to": "ataxia"
      }
    ]
  },
  "dysphagia": {
    "title": "Dysphagia",
    "primaryType": "finding",
    "tags": [
      "Gastroenterology",
      "Neurology",
      "Symptoms",
      "USMLE"
    ],
    "classificationPath": [
      "Gastroenterology",
      "Esophageal Disorders"
    ],
    "content": {
      "definition": "<p><b>Dysphagia</b> is the sensation of difficulty or obstruction during swallowing, classified into <u>Oropharyngeal</u> (transfer problem) and <u>Esophageal</u> (transport problem) types.</p>",
      "atAGlance": "<ul><li><b>Oropharyngeal (Transfer):</b> Difficulty initiating swallow, coughing/choking, nasal regurgitation. <i>Causes:</i> Stroke, [[amyotrophic_lateral_sclerosis]], [[myasthenia_gravis]], [[zenker_diverticulum]].</li><li><b>Esophageal (Transport):</b> Sensation of food sticking in chest.<br> - <i>Solids only:</i> Mechanical obstruction (e.g., Stricture, Web, Cancer).<br> - <i>Solids & Liquids:</i> Motility disorder (e.g., [[achalasia]], [[diffuse_esophageal_spasm]], Scleroderma).</li><li><b>USMLE Tip:</b> \"Food sticks immediately\" = Oropharyngeal. \"Sticks later\" = Esophageal. Progressive solids-only = Cancer.</li></ul>",
      "takeAway": "<p><b>Dysphagia</b> classification guides workup: Oropharyngeal suggests neuromuscular/structural oral pathology, while Esophageal suggests motility disorders (solids+liquids) or obstruction (solids only).</p>",
      "mermaid": "graph TD; A[Dysphagia] --> B{Type?}; B -->|Oropharyngeal| C[Neuro/Muscular Workup]; B -->|Esophageal| D{Solids or Liquids?}; D -->|Solids Only| E[Mechanical Obstruction]; D -->|Solids + Liquids| F[Motility Disorder];"
    },
    "connections": [
      {
        "type": "can_be_caused_by",
        "to": "achalasia"
      },
      {
        "type": "can_be_caused_by",
        "to": "esophageal_cancer"
      },
      {
        "type": "can_be_caused_by",
        "to": "bulbar_palsy"
      }
    ]
  },
  "dystonia": {
    "title": "Dystonia",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Movement Disorders",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Movement Disorders",
      "Hyperkinetic"
    ],
    "content": {
      "definition": "<p><b>Dystonia</b> is a movement disorder characterized by sustained or repetitive muscle contractions leading to abnormal, twisting postures or repetitive movements.</p>",
      "atAGlance": "<ul><li><b>Features:</b> Involuntary, patterned, sustained. Often worsened by voluntary movement.</li><li><b>Examples:</b><br> - <i>Focal:</i> Torticollis (Cervical), Blepharospasm (Eyelids), Writer's Cramp.<br> - <i>Acute Dystonic Reaction:</i> Oculogyric crisis/Torticollis post-antipsychotics (Treat with [[benztropine]]).<br> - <i>Generalized:</i> DYT1 mutation.</li><li><b>Localization:</b> Basal Ganglia dysfunction.</li><li><b>Treatment:</b> Anticholinergics ([[benztropine]]), [[botulinum_toxin]] (focal), Muscle relaxants ([[baclofen]]).</li><li><b>USMLE Tip:</b> \"Torticollis\" or \"Writer's Cramp\" = Focal Dystonia. Acute onset after Haloperidol = Acute Dystonia (Treat with Diphenhydramine/Benztropine).</li></ul>",
      "takeAway": "<p><b>Dystonia</b> involves sustained twisting muscle contractions; acute drug-induced forms respond rapidly to anticholinergics, while chronic focal forms are treated with botulinum toxin.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "treated_by",
        "to": "benztropine"
      },
      {
        "type": "treated_by",
        "to": "botulinum_toxin"
      },
      {
        "type": "can_be_caused_by",
        "to": "antipsychotics"
      },
      {
        "type": "associated_with",
        "to": "basal_ganglia"
      }
    ]
  },
  "echothiophate": {
    "title": "Echothiophate",
    "primaryType": "substance",
    "tags": [
      "Pharmacology",
      "Ophthalmology",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Autonomic Drugs",
      "Indirect Cholinomimetics"
    ],
    "content": {
      "definition": "<p><b>Echothiophate</b> is a long-acting, <u>irreversible</u> acetylcholinesterase inhibitor (Organophosphate) used topically for the treatment of [[glaucoma]].</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> Irreversibly inhibits AChE &rarr; Increased ACh &rarr; Miosis + Ciliary Muscle Contraction &rarr; Increased aqueous outflow.</li><li><b>Clinical Use:</b> Open-angle [[glaucoma]] (rarely used now due to side effects).</li><li><b>Adverse Effects:</b> Cataracts, Retinal Detachment, Systemic cholinergic effects (DUMBELS). Prolongs effects of [[succinylcholine]] (by inhibiting pseudocholinesterase).</li><li><b>USMLE Tip:</b> It's an Organophosphate used therapeutically. Toxicity treated with [[atropine]] + [[pralidoxime]].</li></ul>",
      "takeAway": "<p><b>Echothiophate</b> is an irreversible AChE inhibitor for glaucoma, notable for its organophosphate nature and potential to prolong succinylcholine paralysis.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "treats",
        "to": "glaucoma"
      },
      {
        "type": "irreversibly_inhibits",
        "to": "acetylcholinesterase"
      },
      {
        "type": "interacts_with",
        "to": "succinylcholine"
      }
    ]
  },
  "ectopia_lentis": {
    "title": "Ectopia Lentis",
    "primaryType": "disease",
    "tags": [
      "Ophthalmology",
      "Genetics",
      "Connective Tissue",
      "USMLE"
    ],
    "classificationPath": [
      "Ophthalmology",
      "Lens Disorders",
      "Dislocation"
    ],
    "content": {
      "definition": "<p><b>Ectopia Lentis</b> is the displacement or dislocation of the crystalline lens from its normal position, often due to weakness or rupture of the zonular fibers, and is a hallmark of specific connective tissue disorders.</p>",
      "atAGlance": "<ul><li><b>Etiologies:</b><br> - <b>[[marfan_syndrome]]:</b> <u>Upward</u> and Outward (Superotemporal) dislocation. (Fibrillin-1 defect).<br> - <b>[[homocystinuria]]:</b> <u>Downward</u> and Inward (Inferonasal) dislocation. (Cystathionine beta-synthase defect).<br> - <b>Trauma.</b></li><li><b>Pathophysiology:</b> Defective fibrillin or collagen in the suspensory ligaments (zonules).</li><li><b>USMLE Tip:</b> Marfan = Up (Look up at a tall person). Homocystinuria = Down.</li></ul>",
      "takeAway": "<p><b>Ectopia Lentis</b> differentiates Marfan syndrome (Upward) from Homocystinuria (Downward) based on the direction of lens dislocation.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "associated_with",
        "to": "marfan_syndrome"
      },
      {
        "type": "associated_with",
        "to": "homocystinuria"
      },
      {
        "type": "involves_structure",
        "to": "lens"
      }
    ]
  }
}
```{
  "edinger_westphal_nucleus": {
    "title": "Edinger-Westphal Nucleus",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Anatomy",
      "Autonomic Nervous System",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Brain Anatomy",
      "Cranial Nerve Nuclei"
    ],
    "content": {
      "definition": "<p>The <b>Edinger-Westphal Nucleus</b> is the visceral accessory nucleus of the [[oculomotor_nerve]] located in the midbrain, serving as the source of preganglionic <u>parasympathetic</u> fibers that control pupillary constriction and lens accommodation.</p>",
      "atAGlance": "<ul><li><b>Location:</b> Dorsal Midbrain, rostral to the Oculomotor Nucleus.</li><li><b>Input:</b> Pretectal nuclei (Light Reflex), Visual Cortex (Accommodation).</li><li><b>Output:</b> Preganglionic parasympathetic fibers travel with CN III &rarr; [[ciliary_ganglion]].</li><li><b>Function:</b> Innervates Sphincter Pupillae (Miosis) and Ciliary Muscle (Accommodation).</li><li><b>Clinical Relevance:</b> Damage results in a dilated, fixed pupil (loss of parasympathetic tone).</li><li><b>USMLE Tip:</b> In [[argyll_robertson_pupil]] (Neurosyphilis), the pretectal input is damaged (no light reflex), but cortical input remains (accommodation intact).</li></ul>",
      "takeAway": "<p>The <b>Edinger-Westphal Nucleus</b> provides the parasympathetic drive for the eye; its fibers run superficially on CN III, making them vulnerable to compression (e.g., PCom aneurysm).</p>",
      "mermaid": "graph TD; A[Light Stimulus] --> B[Pretectal Nucleus]; B -->|Bilateral Projection| C[Edinger-Westphal Nucleus]; C -->|CN III| D[Ciliary Ganglion]; D -->|Short Ciliary Nerves| E[Sphincter Pupillae];"
    },
    "connections": [
      {
        "type": "component_of",
        "to": "oculomotor_nerve"
      },
      {
        "type": "projects_to",
        "to": "ciliary_ganglion"
      },
      {
        "type": "controls",
        "to": "pupillary_light_reflex"
      }
    ]
  },
  "ehlers_danlos_syndrome": {
    "title": "Ehlers-Danlos Syndrome",
    "primaryType": "disease",
    "tags": [
      "Pathology",
      "Genetics",
      "Connective Tissue",
      "USMLE"
    ],
    "classificationPath": [
      "Pathology",
      "Genetic Disorders",
      "Connective Tissue"
    ],
    "content": {
      "definition": "<p><b>Ehlers-Danlos Syndrome (EDS)</b> is a heterogeneous group of connective tissue disorders caused by defects in <u>collagen synthesis</u> or processing, characterized by tissue fragility, skin hyperextensibility, and joint hypermobility.</p>",
      "atAGlance": "<ul><li><b>Pathophysiology:</b> Mutations in Collagen (Type III or V) or processing enzymes (e.g., procollagen peptidase).</li><li><b>Clinical Features:</b> Stretchy skin, easy bruising, joint dislocations, poor wound healing (\"cigarette paper\" scars).</li><li><b>Vascular Type (Type IV):</b> Mutation in <b>Type III Collagen</b> (<i>COL3A1</i>). Risk of <b>[[saccular_aneurysm]]</b>, organ rupture (uterus, bowel), and [[aortic_dissection]].</li><li><b>Classic Type:</b> Mutation in <b>Type V Collagen</b> (<i>COL5A1/2</i>). Skin/Joint symptoms predominant.</li><li><b>USMLE Tip:</b> Differentiate from [[marfan_syndrome]]: Marfan has tall stature/lens dislocation (Fibrillin); EDS has stretchy skin/easy bruising (Collagen).</li></ul>",
      "takeAway": "<p><b>Ehlers-Danlos Syndrome</b> involves defective collagen, leading to structural weakness; the Vascular type is particularly dangerous due to the risk of spontaneous [[saccular_aneurysm]] rupture.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "associated_with",
        "to": "saccular_aneurysm"
      },
      {
        "type": "caused_by_defect_in",
        "to": "collagen"
      },
      {
        "type": "can_cause",
        "to": "carotid_cavernous_fistula"
      }
    ]
  },
  "embolic_stroke": {
    "title": "Embolic Stroke",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Vascular",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Cerebrovascular Disease",
      "Ischemic Stroke"
    ],
    "content": {
      "definition": "<p><b>Embolic Stroke</b> is a type of ischemic stroke caused by a blood clot or debris traveling from a distant site (usually the heart or carotids) and lodging in a cerebral artery, typically characterized by <u>sudden onset</u> of maximal deficits.</p>",
      "atAGlance": "<ul><li><b>Etiologies:</b><br> - <i>Cardiac:</i> [[atrial_fibrillation]], mural thrombus (post-MI), infective endocarditis (septic emboli), [[patent_foramen_ovale]] (paradoxical embolus).<br> - <i>Arterial:</i> Carotid plaque rupture.</li><li><b>Territory:</b> Often affects <b>multiple vascular territories</b> or the [[middle_cerebral_artery]] (largest target).</li><li><b>Imaging:</b> CT may show wedge-shaped infarcts at the gray-white junction (cortical).</li><li><b>Clinical:</b> Abrupt onset symptoms (unlike thrombotic, which may stutter).</li><li><b>USMLE Tip:</b> A patient with \"sudden onset\" aphasia and a history of \"palpitations\" (A-fib) likely has an embolic stroke.</li></ul>",
      "takeAway": "<p><b>Embolic Strokes</b> are acute ischemic events originating largely from cardiac sources (like A-fib), producing sudden, often cortical, neurologic deficits.</p>",
      "mermaid": "graph TD; A[Atrial Fibrillation] --> B[Left Atrial Thrombus]; B --> C[Embolization to Brain]; C --> D[Occlusion of MCA]; D --> E[Cortical Ischemia/Stroke];"
    },
    "connections": [
      {
        "type": "caused_by",
        "to": "atrial_fibrillation"
      },
      {
        "type": "can_affect",
        "to": "middle_cerebral_artery"
      },
      {
        "type": "is_a_type_of",
        "to": "ischemic_stroke"
      }
    ]
  },
  "emboliform_nucleus": {
    "title": "Emboliform Nucleus",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Anatomy",
      "Cerebellum",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Brain Anatomy",
      "Cerebellum",
      "Deep Nuclei"
    ],
    "content": {
      "definition": "<p>The <b>Emboliform Nucleus</b> is one of the deep cerebellar nuclei (part of the <u>Interposed Nuclei</u> along with the Globose) involved in the coordination of limb movements via the spinocerebellar pathway.</p>",
      "atAGlance": "<ul><li><b>Location:</b> Deep white matter of the cerebellum.</li><li><b>Functional Group:</b> <b>Interposed Nuclei</b> (Emboliform + Globose).</li><li><b>Input:</b> Paravermis (Spinocerebellum).</li><li><b>Output:</b> Contralateral <b>Red Nucleus</b> (via Superior Cerebellar Peduncle) to influence the Rubrospinal tract.</li><li><b>Function:</b> Adjusts limb movements and muscle tone.</li><li><b>Mnemonic:</b> \"<b>D</b>on't <b>E</b>at <b>G</b>reasy <b>F</b>oods\" (Lateral to Medial: <b>D</b>entate, <b>E</b>mboliform, <b>G</b>lobose, <b>F</b>astigial).</li></ul>",
      "takeAway": "<p>The <b>Emboliform Nucleus</b> works with the Globose nucleus to regulate limb motor execution, projecting primarily to the red nucleus.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_part_of",
        "to": "cerebellum"
      },
      {
        "type": "projects_to",
        "to": "red_nucleus"
      }
    ]
  },
  "encephalotrigeminal_angiomatosis": {
    "title": "Encephalotrigeminal Angiomatosis (Sturge-Weber Syndrome)",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Dermatology",
      "Genetics",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Neurocutaneous Disorders"
    ],
    "content": {
      "definition": "<p><b>Encephalotrigeminal Angiomatosis</b>, commonly known as <b>[[sturge_weber_syndrome]]</b>, is a congenital neurocutaneous disorder caused by a somatic mosaic mutation in <u>GNAQ</u>, characterized by a facial port-wine stain, leptomeningeal angiomas, and glaucoma.</p>",
      "atAGlance": "<ul><li><b>Pathophysiology:</b> Somatic mosaicism of activating mutation in <b>GNAQ</b> gene (Neural crest derivative defect). <i>Not hereditary</i>.</li><li><b>Clinical Triad:</b><br> 1. <b>Port-Wine Stain (Nevus Flammeus):</b> V1/V2 trigeminal distribution (face).<br> 2. <b>Leptomeningeal Angioma:</b> Ipsilateral vascular malformation &rarr; Seizures, Intellectual Disability.<br> 3. <b>Glaucoma:</b> Episcleral hemangioma increases IOP.</li><li><b>Imaging:</b> \"Tram-track\" calcifications (calcified gyri) on skull X-ray/CT.</li><li><b>USMLE Tip:</b> Look for a child with a large facial birthmark and new-onset seizures.</li></ul>",
      "takeAway": "<p><b>Encephalotrigeminal Angiomatosis</b> (Sturge-Weber) links a facial vascular nevus with ipsilateral brain angiomas (causing seizures/calcifications) due to a somatic GNAQ mutation.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_synonymous_with",
        "to": "sturge_weber_syndrome"
      },
      {
        "type": "caused_by_mutation_in",
        "to": "gnaq_gene"
      },
      {
        "type": "manifests_as",
        "to": "port_wine_stain"
      },
      {
        "type": "manifests_as",
        "to": "glaucoma"
      }
    ]
  },
  "endolymphatic_hydrops": {
    "title": "Endolymphatic Hydrops",
    "primaryType": "disease",
    "tags": [
      "Otolaryngology",
      "Neurology",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Otolaryngology",
      "Inner Ear Pathology",
      "Vestibular Disorders"
    ],
    "content": {
      "definition": "<p><b>Endolymphatic Hydrops</b> is the distension of the endolymphatic compartment of the inner ear due to excess fluid accumulation, serving as the underlying pathologic mechanism of <b>[[meniere_disease]]</b>.</p>",
      "atAGlance": "<ul><li><b>Pathophysiology:</b> Impaired resorption of endolymph (via endolymphatic sac) &rarr; Increased pressure &rarr; Distortion/Rupture of membranous labyrinth.</li><li><b>Clinical Presentation (Meniere's):</b> Episodic <b>Vertigo</b>, fluctuating <b>Hearing Loss</b> (sensorineural), <b>Tinnitus</b>, and aural fullness.</li><li><b>Treatment:</b> Low salt diet, Diuretics (e.g., [[acetazolamide]], HCTZ) to reduce fluid pressure.</li><li><b>USMLE Tip:</b> \"Hydrops\" = Water/Fluid. Meniere's is \"glaucoma of the ear.\"</li></ul>",
      "takeAway": "<p><b>Endolymphatic Hydrops</b> causes the classic triad of Ménière disease (vertigo, tinnitus, hearing loss) via pressure-induced dysfunction of the cochlear and vestibular hair cells.</p>",
      "mermaid": "graph TD; A[Decreased Resorption] --> B[Accumulation of Endolymph]; B --> C[Distension of Labyrinth]; C --> D[Hair Cell Dysfunction]; D --> E[Vertigo / Hearing Loss];"
    },
    "connections": [
      {
        "type": "is_mechanism_of",
        "to": "meniere_disease"
      },
      {
        "type": "causes",
        "to": "peripheral_vertigo"
      },
      {
        "type": "causes",
        "to": "sensorineural_hearing_loss"
      }
    ]
  },
  "endoneurium": {
    "title": "Endoneurium",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Histology",
      "Anatomy",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Peripheral Nervous System",
      "Nerve Sheaths"
    ],
    "content": {
      "definition": "<p>The <b>Endoneurium</b> is the delicate layer of loose connective tissue that surrounds <u>individual</u> nerve fibers (axons and their myelin sheaths) within a peripheral nerve.</p>",
      "atAGlance": "<ul><li><b>Location:</b> Innermost layer, wrapping single axons. (Endo = Inside).</li><li><b>Structure:</b> Collagen fibers and endoneurial fluid.</li><li><b>Pathology:</b> Site of inflammatory infiltration in <b>[[guillain_barre_syndrome]]</b> (Acute Inflammatory Demyelinating Polyneuropathy).</li><li><b>Hierarchy:</b> <b>Endo</b>neurium (fiber) &lt; <b>Peri</b>neurium (fascicle, blood-nerve barrier) &lt; <b>Epi</b>neurium (entire nerve).</li><li><b>USMLE Tip:</b> Guillain-Barré inflammation is <i>endoneurial</i>.</li></ul>",
      "takeAway": "<p>The <b>Endoneurium</b> is the deepest nerve sheath, surrounding individual axons, and is the specific site of autoimmune attack in Guillain-Barré syndrome.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_site_of_inflammation_in",
        "to": "guillain_barre_syndrome"
      },
      {
        "type": "surrounds",
        "to": "axon"
      },
      {
        "type": "is_surrounded_by",
        "to": "perineurium"
      }
    ]
  },
  "entacapone": {
    "title": "Entacapone",
    "primaryType": "substance",
    "tags": [
      "Pharmacology",
      "Neurology",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Neurology Drugs",
      "COMT Inhibitors"
    ],
    "content": {
      "definition": "<p><b>Entacapone</b> is a <u>peripheral</u> <i>COMT inhibitor</i> (Catechol-O-methyltransferase) used as an adjunct to [[carbidopa_levodopa]] in Parkinson's disease to prolong the half-life of Levodopa.</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> Inhibits peripheral COMT &rarr; Prevents degradation of L-DOPA to 3-O-methyldopa (3-OMD) &rarr; Increases L-DOPA availability to cross the BBB.</li><li><b>Permeability:</b> Does <b>NOT</b> cross the BBB (unlike [[tolcapone]]).</li><li><b>Clinical Use:</b> [[parkinson_disease]] (specifically to reduce \"wearing-off\" effects of Levodopa).</li><li><b>Adverse Effects:</b> Enhances L-DOPA toxicity (dyskinesia, nausea), orange discoloration of urine. No hepatotoxicity (unlike Tolcapone).</li><li><b>USMLE Tip:</b> <b>Ent</b>acapone enters only the <b>Ent</b>eric system (Peripheral). <b>Tol</b>capone takes a <b>Tol</b>l on the liver (Central + Peripheral).</li></ul>",
      "takeAway": "<p><b>Entacapone</b> extends the duration of Levodopa action by inhibiting its peripheral breakdown, useful for motor fluctuations in Parkinson's without the liver toxicity of Tolcapone.</p>",
      "mermaid": "graph TD; A[Levodopa] -->|COMT| B[3-OMD (Inactive)]; A -->|BBB| C[CNS Levodopa]; D[Entacapone] --x|Inhibits| A; A -->|Increased| C;"
    },
    "connections": [
      {
        "type": "inhibits",
        "to": "catechol_o_methyltransferase"
      },
      {
        "type": "adjunct_to",
        "to": "carbidopa_levodopa"
      },
      {
        "type": "treats",
        "to": "parkinson_disease"
      },
      {
        "type": "is_contrasted_with",
        "to": "tolcapone"
      }
    ]
  },
  "entorhinal_cortex": {
    "title": "Entorhinal Cortex",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Anatomy",
      "Limbic System",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Brain Anatomy",
      "Temporal Lobe"
    ],
    "content": {
      "definition": "<p>The <b>Entorhinal Cortex</b> is a region of the medial temporal lobe that functions as the main interface between the hippocampus and the neocortex, playing a critical role in <u>memory</u> and spatial navigation.</p>",
      "atAGlance": "<ul><li><b>Location:</b> Medial Temporal Lobe (part of the Parahippocampal gyrus).</li><li><b>Function:</b> Gateway for information entering and leaving the [[hippocampus]].</li><li><b>Pathology:</b> One of the <b>first</b> sites affected in [[alzheimer_disease]] (neurofibrillary tangles appear here early).</li><li><b>USMLE Tip:</b> Damage here disconnects the hippocampus from the cortex, causing profound anterograde [[amnesia]].</li></ul>",
      "takeAway": "<p>The <b>Entorhinal Cortex</b> is the bridge to the hippocampus for memory formation and is the site of earliest pathology in Alzheimer's Disease.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "projects_to",
        "to": "hippocampus"
      },
      {
        "type": "degenerates_in",
        "to": "alzheimer_disease"
      },
      {
        "type": "is_part_of",
        "to": "limbic_system"
      }
    ]
  },
  "ependymal_cells": {
    "title": "Ependymal Cells",
    "primaryType": "cell",
    "tags": [
      "Neurology",
      "Histology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Neurohistology",
      "Glial Cells"
    ],
    "content": {
      "definition": "<p><b>Ependymal Cells</b> are ciliated glial cells that line the [[ventricular_system]] of the brain and the central canal of the spinal cord, involved in the production and circulation of [[cerebrospinal_fluid]].</p>",
      "atAGlance": "<ul><li><b>Structure:</b> Simple columnar/cuboidal epithelium with cilia (move CSF) and microvilli (absorb CSF).</li><li><b>Specialization:</b> Modified ependymal cells + capillaries form the <b>[[choroid_plexus]]</b>, which produces CSF.</li><li><b>Barrier:</b> Form a barrier between CSF and interstitial fluid (though leaky compared to BBB).</li><li><b>Pathology:</b> Source of [[ependymoma]]. Viral inclusions (e.g., CMV) can be found here.</li></ul>",
      "takeAway": "<p><b>Ependymal Cells</b> line the CNS fluid spaces, facilitating CSF flow via cilia and forming the secretory choroid plexus.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "forms_lining_of",
        "to": "ventricular_system"
      },
      {
        "type": "component_of",
        "to": "choroid_plexus"
      },
      {
        "type": "gives_rise_to",
        "to": "ependymoma"
      }
    ]
  },
  "ependymoma": {
    "title": "Ependymoma",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Oncology",
      "Pathology",
      "Pediatrics",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Neuro-Oncology",
      "Glial Tumors"
    ],
    "content": {
      "definition": "<p><b>Ependymoma</b> is a malignant glial tumor derived from [[ependymal_cells]], most commonly occurring in the <u>4th ventricle</u> in children, where it causes obstructive hydrocephalus.</p>",
      "atAGlance": "<ul><li><b>Location:</b><br> - <i>Children:</i> Intracranial, <b>4th Ventricle</b> (Posterior Fossa).<br> - <i>Adults:</i> Spinal cord (Cauda equina).</li><li><b>Pathology:</b> <b>Perivascular Pseudorosettes</b> (tumor cells arranged around a blood vessel) and Ependymal Rosettes. Rod-shaped blepharoplasts (basal ciliary bodies).</li><li><b>Clinical:</b> [[noncommunicating_hydrocephalus]] (headache, papilledema) due to 4th ventricle compression.</li><li><b>Prognosis:</b> Poor (difficult to resect completely from ventricle floor).</li><li><b>USMLE Tip:</b> Differentiate from [[medulloblastoma]] (also 4th ventricle in kids). Ependymoma has \"Rosettes\" and originates from the <i>lining</i> of the ventricle.</li></ul>",
      "takeAway": "<p><b>Ependymomas</b> are pediatric posterior fossa tumors arising from the ventricular lining, characterized histologically by perivascular pseudorosettes and clinically by hydrocephalus.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "originates_from",
        "to": "ependymal_cells"
      },
      {
        "type": "causes",
        "to": "noncommunicating_hydrocephalus"
      },
      {
        "type": "located_in",
        "to": "fourth_ventricle"
      }
    ]
  },
  "epidural_hematoma": {
    "title": "Epidural Hematoma",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Trauma",
      "Radiology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Traumatic Brain Injury",
      "Intracranial Hemorrhage"
    ],
    "content": {
      "definition": "<p><b>Epidural Hematoma</b> is a collection of arterial blood between the skull and the [[dura_mater]], typically caused by traumatic rupture of the <u>middle meningeal artery</u> (MMA) at the pterion.</p>",
      "atAGlance": "<ul><li><b>Pathophysiology:</b> Fracture of the temporal bone (pterion) lacerates the high-pressure <b>Middle Meningeal Artery</b>. Blood strips the dura from the skull.</li><li><b>Clinical Presentation:</b> Trauma &rarr; Loss of consciousness &rarr; <b>Lucid Interval</b> (feels fine) &rarr; Rapid deterioration (coma) due to expanding mass.</li><li><b>Complications:</b> [[uncal_herniation]] (CN III palsy: down/out pupil).</li><li><b>Imaging:</b> CT shows a <b>Biconvex (Lentiform)</b> hyperdensity that does <u>not</u> cross suture lines (dura is tethered at sutures).</li><li><b>USMLE Tip:</b> \"Talk and Die\" syndrome. Lens-shaped bleed bounded by sutures.</li></ul>",
      "takeAway": "<p><b>Epidural Hematoma</b> is a life-threatening arterial bleed (MMA) defined by a biconvex shape on CT and a classic lucid interval, requiring emergent decompression.</p>",
      "mermaid": "graph TD; A[Temporal Bone Fracture] --> B[MMA Rupture]; B --> C[Arterial Bleed]; C --> D[Epidural Space Expansion]; D --> E[Mass Effect/Herniation];"
    },
    "connections": [
      {
        "type": "caused_by_rupture_of",
        "to": "middle_meningeal_artery"
      },
      {
        "type": "causes",
        "to": "uncal_herniation"
      },
      {
        "type": "is_contrasted_with",
        "to": "subdural_hematoma"
      }
    ]
  }
}
``````json
{
  "epidural_space": {
    "title": "Epidural Space",
    "primaryType": "structure",
    "tags": [
      "Anatomy",
      "Neurology",
      "Anesthesiology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Spine Anatomy",
      "Meningeal Spaces"
    ],
    "content": {
      "definition": "<p>The <b>Epidural Space</b> is the anatomical compartment located between the <u>dura mater</u> and the vertebral wall (in the spine) or the skull (in the cranium), containing fat and the internal vertebral venous plexus.</p>",
      "atAGlance": "<ul><li><b>Spinal Epidural Space:</b> A <i>real</i> space containing fat and veins. Target for <b>Epidural Anesthesia</b> (needle passes through Ligamentum Flavum to reach it).</li><li><b>Cranial Epidural Space:</b> A <i>potential</i> space between the skull and the periosteal layer of the dura. Site of [[epidural_hematoma]] (Middle Meningeal Artery rupture).</li><li><b>Clinical Relevance:</b> <br> - <b>Anesthesia:</b> Injection of local anesthetics/opioids.<br> - <b>Hemorrhage:</b> Arterial bleed creates a biconvex mass.<br> - <b>Abscess:</b> Spinal epidural abscess.</li><li><b>USMLE Tip:</b> During a lumbar puncture, the needle passes through the Ligamentum Flavum <i>before</i> entering the Epidural Space (often stopping there for epidural, or continuing through Dura for spinal tap).</li></ul>",
      "takeAway": "<p>The <b>Epidural Space</b> is a real fat-filled space in the spine used for anesthesia, but a potential space in the cranium where arterial hematomas form.</p>",
      "mermaid": "graph TD; A[Skin] --> B[Supraspinous Ligament]; B --> C[Interspinous Ligament]; C --> D[Ligamentum Flavum]; D --> E[Epidural Space]; E --> F[Dura Mater]; F --> G[Subarachnoid Space];"
    },
    "connections": [
      {
        "type": "located_outside",
        "to": "dura_mater"
      },
      {
        "type": "site_of",
        "to": "epidural_hematoma"
      },
      {
        "type": "bounded_by",
        "to": "ligamentum_flavum"
      }
    ]
  },
  "epilepsy": {
    "title": "Epilepsy",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Pathology",
      "Seizures",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Epilepsy"
    ],
    "content": {
      "definition": "<p><b>Epilepsy</b> is a chronic neurological disorder characterized by a predisposition to generate <u>recurrent, unprovoked seizures</u> due to abnormal, excessive, or synchronous neuronal activity in the brain.</p>",
      "atAGlance": "<ul><li><b>Diagnosis:</b> At least two unprovoked seizures occurring >24 hours apart, or one unprovoked seizure with a high probability of recurrence (e.g., abnormal EEG).</li><li><b>Classification:</b><br> - <b>Focal:</b> Originates in one hemisphere (Aware vs. Impaired Awareness).<br> - <b>Generalized:</b> Involves both hemispheres (e.g., [[tonic_clonic_seizure]], [[absence_seizure]], [[myoclonic_seizure]]).</li><li><b>Etiologies:</b> Genetic (e.g., [[juvenile_myoclonic_epilepsy]]), Structural (Tumor, Stroke, Mesial Temporal Sclerosis), Metabolic, Infectious.</li><li><b>Status Epilepticus:</b> Seizure >5 min or recurrent without recovery. Treat with [[benzodiazepines]].</li><li><b>USMLE Tip:</b> Differentiate from \"provoked\" seizures (e.g., alcohol withdrawal, hyponatremia, febrile seizures), which do <i>not</i> constitute epilepsy.</li></ul>",
      "takeAway": "<p><b>Epilepsy</b> is the disease of recurrent spontaneous seizures, requiring long-term management with [[anticonvulsants]] tailored to the seizure type (Focal vs. Generalized).</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "manifests_as",
        "to": "seizure"
      },
      {
        "type": "treated_by",
        "to": "broad_spectrum_anticonvulsants"
      },
      {
        "type": "includes",
        "to": "juvenile_myoclonic_epilepsy"
      }
    ]
  },
  "epinephrine": {
    "title": "Epinephrine",
    "primaryType": "substance",
    "tags": [
      "Pharmacology",
      "Autonomic Nervous System",
      "Ophthalmology",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Adrenergic Agonists"
    ],
    "content": {
      "definition": "<p><b>Epinephrine</b> is a direct-acting sympathomimetic catecholamine that stimulates &alpha;<sub>1</sub>, &alpha;<sub>2</sub>, &beta;<sub>1</sub>, and &beta;<sub>2</sub> adrenergic receptors, used for anaphylaxis, cardiac arrest, and glaucoma.</p>",
      "atAGlance": "<ul><li><b>Mechanism (Ophthalmology):</b> Stimulates &alpha;<sub>1</sub> (vasoconstriction) and &alpha;<sub>2</sub> receptors in the ciliary body &rarr; Decreases aqueous humor synthesis. Also increases uveoscleral outflow.</li><li><b>Clinical Use:</b> [[open_angle_glaucoma]] (rarely used now), Anaphylaxis (DOC), Cardiac Arrest, Croup (Racemic).</li><li><b>Adverse Effects:</b> Mydriasis (Contraindicated in <b>Closed-Angle Glaucoma</b>), Hypertension, Arrhythmias, Anxiety.</li><li><b>USMLE Tip:</b> DO NOT use in closed-angle glaucoma because mydriasis (via &alpha;<sub>1</sub> on radial muscle) crowds the angle and worsens obstruction.</li></ul>",
      "takeAway": "<p><b>Epinephrine</b> is a potent non-selective adrenergic agonist that lowers intraocular pressure by reducing aqueous production, but its mydriatic effect makes it dangerous in closed-angle glaucoma.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "activates",
        "to": "alpha_1_adrenergic_receptor"
      },
      {
        "type": "activates",
        "to": "beta_2_adrenergic_receptor"
      },
      {
        "type": "contraindicated_in",
        "to": "angle_closure_glaucoma"
      },
      {
        "type": "decreases_synthesis_of",
        "to": "aqueous_humor"
      }
    ]
  },
  "epineurium": {
    "title": "Epineurium",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Histology",
      "Anatomy",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Peripheral Nervous System",
      "Nerve Sheaths"
    ],
    "content": {
      "definition": "<p>The <b>Epineurium</b> is the dense, irregular connective tissue layer that surrounds the <u>entire peripheral nerve</u> trunk, binding multiple nerve fascicles together and containing the nutrient blood vessels (vasa nervorum).</p>",
      "atAGlance": "<ul><li><b>Location:</b> Outermost layer of a peripheral nerve.</li><li><b>Function:</b> Structural support, protection, and housing for blood supply.</li><li><b>Hierarchy:</b> <br> 1. <b>Epineurium:</b> Surrounds entire nerve.<br> 2. [[perineurium]]: Surrounds fascicles (Blood-Nerve Barrier).<br> 3. [[endoneurium]]: Surrounds individual axons.</li><li><b>Clinical Relevance:</b> Often sutured during surgical nerve repair (neurorrhaphy).</li></ul>",
      "takeAway": "<p>The <b>Epineurium</b> is the tough outer sheath of a peripheral nerve, encasing fascicles wrapped in perineurium and axons wrapped in endoneurium.</p>",
      "mermaid": "graph TD; A[Peripheral Nerve] --> B[Epineurium]; B --> C[Fascicles]; C --> D[Perineurium]; D --> E[Axons]; E --> F[Endoneurium];"
    },
    "connections": [
      {
        "type": "surrounds",
        "to": "peripheral_nerve"
      },
      {
        "type": "contains",
        "to": "perineurium"
      },
      {
        "type": "contains",
        "to": "endoneurium"
      }
    ]
  },
  "esotropia": {
    "title": "Esotropia",
    "primaryType": "finding",
    "tags": [
      "Ophthalmology",
      "Neurology",
      "Pediatrics",
      "USMLE"
    ],
    "classificationPath": [
      "Ophthalmology",
      "Strabismus"
    ],
    "content": {
      "definition": "<p><b>Esotropia</b> is a form of [[strabismus]] characterized by the inward deviation (convergence) of one or both eyes (\"crossed eyes\"), potentially leading to amblyopia if untreated.</p>",
      "atAGlance": "<ul><li><b>Presentation:</b> Eye turns <b>inward</b> toward the nose.</li><li><b>Etiologies:</b><br> - <b>Congenital:</b> Infantile esotropia.<br> - <b>Accommodative:</b> Due to uncorrected [[hyperopia]] (farsightedness) causing excessive convergence.<br> - <b>Paralytic:</b> [[abducens_nerve]] (CN VI) palsy (Lateral Rectus weakness).</li><li><b>Complications:</b> [[amblyopia]] (brain suppresses image from deviating eye), loss of binocular vision/stereopsis.</li><li><b>Treatment:</b> Glasses (for accommodative), Patching (for amblyopia), Surgery.</li></ul>",
      "takeAway": "<p><b>Esotropia</b> is inward eye deviation; in children, it requires prompt correction to prevent permanent cortical visual loss ([[amblyopia]]), while in adults, it often signals CN VI palsy.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_a_type_of",
        "to": "strabismus"
      },
      {
        "type": "can_cause",
        "to": "amblyopia"
      },
      {
        "type": "caused_by_palsy_of",
        "to": "abducens_nerve"
      }
    ]
  },
  "essential_tremor": {
    "title": "Essential Tremor",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Movement Disorders",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Movement Disorders",
      "Tremor"
    ],
    "content": {
      "definition": "<p><b>Essential Tremor</b> is the most common movement disorder, characterized by a high-frequency <u>action</u> and <u>postural</u> tremor of the upper extremities (and often head/voice) that worsens with movement and anxiety.</p>",
      "atAGlance": "<ul><li><b>Features:</b> <b>Action tremor</b> (worsens when holding a posture or reaching for a target). Bilateral. Improves with <b>Alcohol</b>.</li><li><b>Genetics:</b> Often familial (Autosomal Dominant).</li><li><b>Differentiation:</b> Contrast with [[parkinson_disease]] (Resting tremor, pill-rolling, gets <i>better</i> with movement).</li><li><b>Treatment:</b><br> - First-line: <b>[[propranolol]]</b> (Beta-blocker) or <b>[[primidone]]</b> (Barbiturate).</li><li><b>USMLE Tip:</b> \"Patient drinks a glass of wine and the shaking stops.\"</li></ul>",
      "takeAway": "<p><b>Essential Tremor</b> is a familial action tremor relieved by alcohol and beta-blockers, distinguishing it from the resting tremor of Parkinson's.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "treated_by",
        "to": "propranolol"
      },
      {
        "type": "treated_by",
        "to": "primidone"
      },
      {
        "type": "is_contrasted_with",
        "to": "resting_tremor"
      },
      {
        "type": "ameliorated_by",
        "to": "alcohol_use_disorder"
      }
    ]
  },
  "eszopiclone": {
    "title": "Eszopiclone",
    "primaryType": "substance",
    "tags": [
      "Pharmacology",
      "Neurology",
      "Psychiatry",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Sedative-Hypnotics",
      "Nonbenzodiazepines"
    ],
    "content": {
      "definition": "<p><b>Eszopiclone</b> is a non-benzodiazepine sedative-hypnotic (\"Z-drug\") that acts as an agonist at the BZ1 subtype of the [[gaba_a_receptor]], used for the treatment of insomnia.</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> Binds GABA<sub>A</sub> receptor at a distinct site from benzos; selective for BZ1 subtype (sedation > anxiolysis).</li><li><b>Pharmacokinetics:</b> Rapid onset, relatively short duration. Reversible by [[flumazenil]].</li><li><b>Clinical Use:</b> Insomnia (difficulty falling or staying asleep).</li><li><b>Adverse Effects:</b> Ataxia, headaches, confusion, metallic taste. Less tolerance/dependence risk than benzodiazepines.</li><li><b>USMLE Tip:</b> \"All the <b>Z</b>zzs put you to sleep\" (Zolpidem, Zaleplon, esZopiclone).</li></ul>",
      "takeAway": "<p><b>Eszopiclone</b> is a Z-drug that induces sleep via GABA<sub>A</sub> modulation with a lower side-effect profile than benzodiazepines, reversible by flumazenil.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "modulates",
        "to": "gaba_a_receptor"
      },
      {
        "type": "reversed_by",
        "to": "flumazenil"
      },
      {
        "type": "is_grouped_with",
        "to": "zolpidem"
      }
    ]
  },
  "ethosuximide_repeat": {
    "title": "Ethosuximide",
    "primaryType": "substance",
    "tags": [
      "Pharmacology",
      "Neurology",
      "Anticonvulsants",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Neurology Drugs",
      "Anticonvulsants"
    ],
    "content": {
      "definition": "<p><b>Ethosuximide</b> is a narrow-spectrum anticonvulsant that specifically blocks <u>T-type calcium channels</u> in thalamic neurons, making it the first-line treatment for [[absence_seizure]].</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> Blocks T-type Ca<sup>2+</sup> channels in the [[thalamus]], disrupting the 3 Hz spike-and-wave rhythmicity.</li><li><b>Clinical Use:</b> <b>Absence Seizures</b> (Petit mal) only. Ineffective for tonic-clonic or focal seizures.</li><li><b>Adverse Effects:</b> <b>EFGH:</b> <b>E</b>thosuximide causes <b>F</b>atigue, <b>G</b>I distress, <b>H</b>eadache. Rare: [[stevens_johnson_syndrome]].</li><li><b>USMLE Tip:</b> If a patient has <i>both</i> absence and tonic-clonic seizures, use [[valproate]] instead (Ethosuximide won't cover the tonic-clonic).</li></ul>",
      "takeAway": "<p><b>Ethosuximide</b> targets thalamic T-type calcium channels to treat absence seizures exclusively.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "treats",
        "to": "absence_seizure"
      },
      {
        "type": "blocks_channel",
        "to": "t_type_calcium_channel"
      },
      {
        "type": "acts_on_structure",
        "to": "thalamus"
      }
    ]
  },
  "etomidate": {
    "title": "Etomidate",
    "primaryType": "substance",
    "tags": [
      "Pharmacology",
      "Anesthesiology",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Anesthetics",
      "Intravenous"
    ],
    "content": {
      "definition": "<p><b>Etomidate</b> is a short-acting intravenous anesthetic agent that potentiates [[gaba_a_receptor]] activity, favored for induction in hemodynamically unstable patients due to its minimal cardiovascular depression.</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> Potentiates GABA<sub>A</sub> receptors.</li><li><b>Clinical Use:</b> Rapid Sequence Intubation (RSI), anesthesia induction.</li><li><b>Advantages:</b> <b>Hemodynamic stability</b> (minimal effect on BP/HR/CO). ideal for trauma/shock patients.</li><li><b>Adverse Effects:</b> <b>Adrenal Suppression</b> (inhibits 11&beta;-hydroxylase), Postoperative nausea/vomiting, Myoclonus.</li><li><b>USMLE Tip:</b> Use in the hypotensive trauma patient, but watch out for adrenal insufficiency.</li></ul>",
      "takeAway": "<p><b>Etomidate</b> is the induction agent of choice for hemodynamically unstable patients but carries a risk of transient adrenal suppression.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "modulates",
        "to": "gaba_a_receptor"
      },
      {
        "type": "causes_side_effect",
        "to": "adrenal_insufficiency"
      },
      {
        "type": "is_a_type_of",
        "to": "general_anesthetics"
      }
    ]
  },
  "ex_vacuo_ventriculomegaly": {
    "title": "Ex Vacuo Ventriculomegaly",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Radiology",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Brain Imaging",
      "Hydrocephalus Mimics"
    ],
    "content": {
      "definition": "<p><b>Ex Vacuo Ventriculomegaly</b> is the compensatory enlargement of the cerebral ventricles and subarachnoid spaces secondary to the loss of brain tissue (atrophy), rather than increased cerebrospinal fluid pressure.</p>",
      "atAGlance": "<ul><li><b>Pathophysiology:</b> Brain atrophy (neuronal loss) &rarr; Brain shrinks &rarr; CSF fills the empty space.</li><li><b>Intracranial Pressure (ICP):</b> <b>Normal</b>.</li><li><b>Etiologies:</b> [[alzheimer_disease]], [[huntington_disease]], [[frontotemporal_dementia]], HIV-associated dementia, Normal aging.</li><li><b>Imaging:</b> Enlarged ventricles with prominent/widened sulci (cortical atrophy).</li><li><b>Differentiation:</b> Contrast with [[normal_pressure_hydrocephalus]] (Ventricles disproportionately large compared to sulci/atrophy; triad of wet/wobbly/wacky).</li></ul>",
      "takeAway": "<p><b>Ex Vacuo Ventriculomegaly</b> is an appearance of hydrocephalus caused by brain atrophy, distinguished by normal ICP and proportionate sulcal widening.</p>",
      "mermaid": "graph TD; A[Neurodegeneration] --> B[Cortical Atrophy]; B --> C[Loss of Brain Volume]; C --> D[Passive Expansion of Ventricles]; D --> E[Hydrocephalus Ex Vacuo];"
    },
    "connections": [
      {
        "type": "caused_by",
        "to": "alzheimer_disease"
      },
      {
        "type": "caused_by",
        "to": "huntington_disease"
      },
      {
        "type": "is_distinguished_from",
        "to": "normal_pressure_hydrocephalus"
      },
      {
        "type": "is_distinguished_from",
        "to": "hydrocephalus"
      }
    ]
  },
  "broca_aphasia_ref": {
    "title": "Broca Aphasia",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Language",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Cognitive Disorders",
      "Aphasias"
    ],
    "content": {
      "definition": "<p><b>Broca Aphasia</b> (Expressive Aphasia) is a non-fluent aphasia caused by a lesion in the posterior inferior frontal gyrus ([[broca_area]]), characterized by sparse, halting speech, impaired repetition, but relatively preserved comprehension.</p>",
      "atAGlance": "<ul><li><b>Lesion:</b> Left Inferior Frontal Gyrus.</li><li><b>Vessel:</b> Superior division of the [[middle_cerebral_artery]].</li><li><b>Clinical:</b> \"Broken\" speech (agrammatic), frustration (insight intact). Often associated with right hemiparesis (face/arm).</li></ul>",
      "takeAway": "<p><b>Broca Aphasia</b> destroys speech production (\"Expressive\") while sparing comprehension, localizing to the frontal lobe.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "caused_by_lesion_in",
        "to": "broca_area"
      },
      {
        "type": "is_contrasted_with",
        "to": "wernicke_aphasia"
      }
    ]
  },
  "neonatal_extracranial_injuries": {
    "title": "Neonatal Extracranial Injuries",
    "primaryType": "group",
    "tags": [
      "Pediatrics",
      "Neonatology",
      "Trauma",
      "USMLE"
    ],
    "classificationPath": [
      "Pediatrics",
      "Birth Injuries",
      "Head Trauma"
    ],
    "content": {
      "definition": "<p><b>Neonatal Extracranial Injuries</b> are traumatic scalp swellings occurring during birth, distinguished by their anatomical location relative to the skull sutures and periosteum.</p>",
      "atAGlance": "<ul><li><b>[[caput_succedaneum]]:</b> Edema above periosteum. Soft/boggy. <b>Crosses suture lines</b>. Resolves quickly.</li><li><b>[[cephalohematoma]]:</b> Subperiosteal blood. Firm. <b>Bounded by suture lines</b>. Resolves slowly; risk of jaundice.</li><li><b>[[subgaleal_hemorrhage]]:</b> Blood under galea aponeurosis. Diffuse, fluctuant, crosses sutures. <b>Life-threatening</b> (can hold large volume of blood).</li><li><b>USMLE Tip:</b> Caput <b>C</b>rosses. Cephalohematoma is <b>C</b>onfined. Subgaleal is <b>S</b>cary.</li></ul>",
      "takeAway": "<p>Differentiating neonatal scalp swelling relies on suture line boundaries: Caput (crosses, benign), Cephalohematoma (bounded, jaundice risk), Subgaleal (diffuse, hemorrhage risk).</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "includes",
        "to": "caput_succedaneum"
      },
      {
        "type": "includes",
        "to": "cephalohematoma"
      },
      {
        "type": "includes",
        "to": "subgaleal_hemorrhage"
      }
    ]
  },
  "eye_movements": {
    "title": "Eye Movements",
    "primaryType": "process",
    "tags": [
      "Neurology",
      "Ophthalmology",
      "Physiology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Neuro-Ophthalmology",
      "Ocular Motility"
    ],
    "content": {
      "definition": "<p><b>Eye Movements</b> are coordinated by the six extraocular muscles, innervated by Cranial Nerves III, IV, and VI, and controlled by brainstem gaze centers.</p>",
      "atAGlance": "<ul><li><b>Innervation Formula:</b> <b>LR6 SO4 R3</b> (Lateral Rectus = CN VI; Superior Oblique = CN IV; Rest = CN III).</li><li><b>Actions:</b><br> - <i>Lateral Rectus:</i> Abduction.<br> - <i>Medial Rectus:</i> Adduction.<br> - <i>Superior Oblique:</i> Intorsion, Depression.<br> - <i>Inferior Oblique:</i> Extorsion, Elevation.<br> - <i>Superior Rectus:</i> Elevation.<br> - <i>Inferior Rectus:</i> Depression.</li><li><b>Gaze Centers:</b><br> - <i>Horizontal:</i> [[paramedian_pontine_reticular_formation]] (PPRF).<br> - <i>Vertical:</i> Rostral interstitial nucleus of MLF (Midbrain).</li><li><b>Pathology:</b> Palsies (CN III down/out; CN IV vertical diplopia/head tilt; CN VI medial deviation).</li></ul>",
      "takeAway": "<p><b>Eye Movements</b> depend on the precise coordination of CN III, IV, and VI; dysfunction leads to specific patterns of diplopia and strabismus.</p>",
      "mermaid": "graph TD; A[CN VI] --> B[Lateral Rectus (Abduct)]; C[CN IV] --> D[Superior Oblique (Intort/Depress)]; E[CN III] --> F[Medial/Sup/Inf Recti + Inf Oblique];"
    },
    "connections": [
      {
        "type": "controlled_by",
        "to": "oculomotor_nerve"
      },
      {
        "type": "controlled_by",
        "to": "trochlear_nerve"
      },
      {
        "type": "controlled_by",
        "to": "abducens_nerve"
      },
      {
        "type": "coordinated_by",
        "to": "medial_longitudinal_fasciculus"
      }
    ]
  },
  "eyelid_disorders": {
    "title": "Eyelid Disorders",
    "primaryType": "group",
    "tags": [
      "Ophthalmology",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Ophthalmology",
      "Eyelid Pathology"
    ],
    "content": {
      "definition": "<p><b>Eyelid Disorders</b> encompass inflammatory, infectious, and structural pathologies of the eyelid, including blepharitis, hordeolum, chalazion, and cellulitis.</p>",
      "atAGlance": "<ul><li><b>[[blepharitis]]:</b> Chronic inflammation of lid margins (crusting).</li><li><b>[[hordeolum]] (Stye):</b> Acute, <b>painful</b> infection of eyelash follicle or Zeis gland (usually S. aureus).</li><li><b>[[chalazion]]:</b> Chronic, <b>painless</b> lipogranuloma of Meibomian gland.</li><li><b>Preseptal Cellulitis:</b> Infection anterior to orbital septum (mild).</li><li><b>Orbital Cellulitis:</b> Infection posterior to septum (pain with movement, proptosis, vision loss). Emergency.</li><li><b>Ptosis:</b> Drooping (CN III palsy, Horner's, MG).</li></ul>",
      "takeAway": "<p>Differentiating eyelid lumps relies on pain: Hordeolum hurts, Chalazion is chill (painless). Orbital cellulitis is a vision-threatening emergency.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "includes",
        "to": "blepharitis"
      },
      {
        "type": "includes",
        "to": "hordeolum"
      },
      {
        "type": "includes",
        "to": "chalazion"
      },
      {
        "type": "includes",
        "to": "orbital_cellulitis"
      }
    ]
  },
  "eye_anatomy": {
    "title": "Eye (Anatomy)",
    "primaryType": "structure",
    "tags": [
      "Ophthalmology",
      "Anatomy",
      "USMLE"
    ],
    "classificationPath": [
      "Ophthalmology",
      "Anatomy"
    ],
    "content": {
      "definition": "<p>The <b>Eye</b> is the sensory organ of vision, comprised of three layers (Fibrous, Vascular/Uvea, Neural) and refractive media (Cornea, Aqueous, Lens, Vitreous).</p>",
      "atAGlance": "<ul><li><b>Layers:</b><br> 1. <i>Fibrous:</i> [[sclera]], [[cornea]].<br> 2. <i>Uvea:</i> [[choroid_layer]], [[ciliary_body]], [[iris]].<br> 3. <i>Neural:</i> [[retina]].</li><li><b>Chambers:</b><br> - <i>Anterior:</i> Cornea to Iris (Aqueous).<br> - <i>Posterior:</i> Iris to Lens (Aqueous).<br> - <i>Vitreous:</i> Behind Lens (Vitreous humor).</li><li><b>Refraction:</b> Cornea (2/3), Lens (1/3, adjustable).</li><li><b>Pathology:</b> Glaucoma (Anterior chamber angle), Cataract (Lens), Macular Degeneration (Retina).</li></ul>",
      "takeAway": "<p>The <b>Eye</b> is a complex optical system where the cornea and lens focus light onto the retina, maintained by the uveal tract and aqueous dynamics.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "contains",
        "to": "retina"
      },
      {
        "type": "contains",
        "to": "lens"
      },
      {
        "type": "contains",
        "to": "cornea"
      },
      {
        "type": "contains",
        "to": "uvea"
      }
    ]
  }
}
``````json
{
  "facial_nerve": {
    "title": "Facial Nerve (CN VII)",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Anatomy",
      "Cranial Nerves",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Cranial Nerves",
      "CN VII"
    ],
    "content": {
      "definition": "<p>The <b>Facial Nerve (CN VII)</b> is a mixed cranial nerve responsible for <u>muscles of facial expression</u> (branchial motor), taste to the anterior 2/3 of the tongue (special sensory), and parasympathetic innervation to the lacrimal and salivary glands.</p>",
      "atAGlance": "<ul><li><b>Motor:</b> Muscles of facial expression, Stapedius (dampens sound), Stylohyoid, Posterior digastric.</li><li><b>Sensory:</b> Taste anterior 2/3 tongue (Chorda Tympani). Somatic sensation from ear canal.</li><li><b>Parasympathetic:</b> Lacrimal glands (tearing), Submandibular/Sublingual glands (salivation).</li><li><b>Reflexes:</b> Efferent limb of <b>Corneal Reflex</b> (Blink).</li><li><b>Lesions:</b><br> - <b>UMN (Stroke):</b> Contralateral lower face weakness (forehead spared due to bilateral innervation).<br> - <b>LMN (Bell's Palsy):</b> Ipsilateral hemifacial weakness (forehead involved), [[hyperacusis]], loss of taste.</li></ul>",
      "takeAway": "<p><b>CN VII</b> controls facial expression and taste; UMN lesions spare the forehead, while LMN lesions (Bell's Palsy) affect the entire hemiface.</p>",
      "mermaid": "graph TD; A[Facial Nucleus] -->|Motor| B[Facial Muscles/Stapedius]; C[Superior Salivatory Nucleus] -->|Parasympathetic| D[Lacrimal/Salivary Glands]; E[Solitary Nucleus] -->|Sensory| F[Taste Ant 2/3 Tongue];"
    },
    "connections": [
      {
        "type": "innervates",
        "to": "stapedius_muscle"
      },
      {
        "type": "mediates",
        "to": "corneal_reflex"
      },
      {
        "type": "lesion_causes",
        "to": "bells_palsy"
      },
      {
        "type": "lesion_causes",
        "to": "hyperacusis"
      }
    ]
  },
  "factor_v_leiden": {
    "title": "Factor V Leiden",
    "primaryType": "disease",
    "tags": [
      "Hematology",
      "Genetics",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Hematology",
      "Coagulation Disorders",
      "Thrombophilia"
    ],
    "content": {
      "definition": "<p><b>Factor V Leiden</b> is the most common inherited thrombophilia, caused by a point mutation (Arg506Gln) in <u>Factor V</u> that renders it resistant to cleavage and inactivation by [[protein_c]].</p>",
      "atAGlance": "<ul><li><b>Pathophysiology:</b> Mutation makes Factor V resistant to degradation by <b>Activated Protein C (APC)</b>. Factor V remains active &rarr; increased thrombin &rarr; hypercoagulability.</li><li><b>Genetics:</b> Autosomal Dominant (incomplete penetrance).</li><li><b>Clinical Presentation:</b> Recurrent <b>Deep Venous Thrombosis (DVT)</b>, Pulmonary Embolism (PE), cerebral vein thrombosis, recurrent pregnancy loss.</li><li><b>Diagnosis:</b> APC Resistance Assay, Genetic testing.</li><li><b>USMLE Tip:</b> Most common cause of inherited hypercoagulability in Caucasians. Complications increase with OCP use.</li></ul>",
      "takeAway": "<p><b>Factor V Leiden</b> causes hypercoagulability via resistance to Activated Protein C, leading to increased risk of venous thromboembolism.</p>",
      "mermaid": "graph TD; A[Factor V Leiden Mutation] --> B[Factor V Resistant to APC]; B --> C[Prolonged Factor V Activity]; C --> D[Increased Thrombin]; D --> E[Venous Thrombosis];"
    },
    "connections": [
      {
        "type": "causes",
        "to": "hypercoagulability"
      },
      {
        "type": "resists_inactivation_by",
        "to": "protein_c"
      },
      {
        "type": "increases_risk_of",
        "to": "deep_venous_thrombosis"
      }
    ]
  },
  "hyperopia": {
    "title": "Hyperopia (Farsightedness)",
    "primaryType": "disease",
    "tags": [
      "Ophthalmology",
      "Physics",
      "USMLE"
    ],
    "classificationPath": [
      "Ophthalmology",
      "Refractive Errors"
    ],
    "content": {
      "definition": "<p><b>Hyperopia</b> (Farsightedness) is a refractive error where the eye is too short or the cornea is too flat, causing light to focus <u>behind the retina</u>, resulting in difficulty seeing near objects.</p>",
      "atAGlance": "<ul><li><b>Pathophysiology:</b> Axial length of eye is too short OR refractive power is too weak. Focal point is retro-retinal.</li><li><b>Clinical Presentation:</b> Blurry near vision, eye strain (from constant accommodation). Risk factor for [[angle_closure_glaucoma]] (small eye).</li><li><b>Correction:</b> <b>Convex (Converging) Lens</b> (\"Plus\" lens).</li><li><b>USMLE Tip:</b> Hyperopia = \"Hyper\" (too much excitement to get to the retina, goes past it). Correct with Convex.</li></ul>",
      "takeAway": "<p><b>Hyperopia</b> occurs when light focuses behind the retina; it is corrected with a <b>convex</b> lens to converge light earlier.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "corrected_by",
        "to": "convex_lens"
      },
      {
        "type": "is_risk_factor_for",
        "to": "angle_closure_glaucoma"
      },
      {
        "type": "is_contrasted_with",
        "to": "myopia"
      }
    ]
  },
  "fasciculations": {
    "title": "Fasciculations",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Physical Exam",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Neurologic Examination",
      "Motor Signs"
    ],
    "content": {
      "definition": "<p><b>Fasciculations</b> are spontaneous, involuntary muscle twitches visible under the skin, representing the contraction of a single motor unit due to the spontaneous firing of a degenerating <u>lower motor neuron</u>.</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> Hyperexcitability of sick lower motor neurons (LMN) or denervation hypersensitivity.</li><li><b>Clinical Significance:</b> Hallmark sign of <b>LMN injury</b>.</li><li><b>Associations:</b><br> - <b>[[amyotrophic_lateral_sclerosis]] (ALS):</b> Fasciculations + Weakness + UMN signs.<br> - <b>Spinal Muscular Atrophy.</b><br> - <b>[[organophosphates]] Toxicity:</b> Acetylcholine excess.<br> - <b>Benign Fasciculation Syndrome:</b> No weakness.</li><li><b>USMLE Tip:</b> Tongue fasciculations are a classic sign of ALS or Bulbar Palsy.</li></ul>",
      "takeAway": "<p><b>Fasciculations</b> indicate lower motor neuron irritability or degeneration, classically seen in [[amyotrophic_lateral_sclerosis]] alongside atrophy and weakness.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_sign_of",
        "to": "lower_motor_neuron_lesion"
      },
      {
        "type": "seen_in",
        "to": "amyotrophic_lateral_sclerosis"
      },
      {
        "type": "caused_by",
        "to": "organophosphates"
      }
    ]
  },
  "fastigial_nucleus": {
    "title": "Fastigial Nucleus",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Anatomy",
      "Cerebellum",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Brain Anatomy",
      "Cerebellum"
    ],
    "content": {
      "definition": "<p>The <b>Fastigial Nucleus</b> is the most medial of the deep cerebellar nuclei, receiving input from the <u>vermis</u> and projecting to the vestibular nuclei and reticular formation to control <u>balance</u>, posture, and eye movements.</p>",
      "atAGlance": "<ul><li><b>Location:</b> Medial-most deep cerebellar nucleus.</li><li><b>Input:</b> <b>Vermis</b> (Spinocerebellum) and Flocculonodular lobe.</li><li><b>Output:</b> Vestibular Nuclei and Reticular Formation via Inferior Cerebellar Peduncle.</li><li><b>Function:</b> Axial/Truncal balance and stance.</li><li><b>Mnemonic:</b> \"<b>D</b>on't <b>E</b>at <b>G</b>reasy <b>F</b>oods\" (Lateral to Medial: Dentate, Emboliform, Globose, <b>F</b>astigial). Fastigial is closest to the Fast-food (Midline/Mouth).</li></ul>",
      "takeAway": "<p>The <b>Fastigial Nucleus</b> regulates medial motor systems (trunk/balance) via input from the vermis.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_part_of",
        "to": "cerebellum"
      },
      {
        "type": "receives_input_from",
        "to": "cerebellar_vermis"
      },
      {
        "type": "projects_to",
        "to": "vestibular_nuclei"
      }
    ]
  },
  "febrile_seizure": {
    "title": "Febrile Seizure",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Pediatrics",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Epilepsy",
      "Pediatric Seizures"
    ],
    "content": {
      "definition": "<p>A <b>Febrile Seizure</b> is a convulsion occurring in a child (typically 6 months to 5 years) triggered by a rapid rise in body temperature (fever) in the absence of CNS infection or metabolic imbalance.</p>",
      "atAGlance": "<ul><li><b>Epidemiology:</b> 6 months to 5 years. Common (2-5% of children).</li><li><b>Types:</b><br> - <i>Simple:</i> Generalized tonic-clonic, <15 mins, no recurrence in 24h. Benign.<br> - <i>Complex:</i> Focal, >15 mins, or recurrence in 24h. Slightly higher epilepsy risk.</li><li><b>Management:</b> Reassurance and antipyretics (for comfort, doesn't prevent seizure). Workup (LP/CT) only if signs of meningitis.</li><li><b>Prognosis:</b> Excellent. Risk of epilepsy is slightly higher than general population (~1-2% vs 1%).</li><li><b>USMLE Tip:</b> HHV-6 (Roseola) is a classic cause of high fever and febrile seizures.</li></ul>",
      "takeAway": "<p><b>Febrile Seizures</b> are benign, fever-associated events in young children; simple cases require no workup or medication beyond reassurance.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "triggered_by",
        "to": "fever"
      },
      {
        "type": "associated_with",
        "to": "human_herpesvirus_6"
      },
      {
        "type": "is_distinguished_from",
        "to": "epilepsy"
      }
    ]
  },
  "fenestrated_capillaries": {
    "title": "Fenestrated Capillaries",
    "primaryType": "structure",
    "tags": [
      "Histology",
      "Physiology",
      "USMLE"
    ],
    "classificationPath": [
      "Histology",
      "Cardiovascular System",
      "Microvasculature"
    ],
    "content": {
      "definition": "<p><b>Fenestrated Capillaries</b> are blood vessels with endothelial cells containing pores (fenestrae) that allow for rapid exchange of water and larger solutes, found in organs with high filtration or absorption needs.</p>",
      "atAGlance": "<ul><li><b>Structure:</b> Endothelial pores (fenestrae) covered by a thin diaphragm (except in kidney glomerulus).</li><li><b>Locations:</b><br> - <b>Kidney:</b> Glomerulus (filtration).<br> - <b>Endocrine Glands:</b> Pancreas, Thyroid, Pituitary (hormone secretion).<br> - <b>Intestine:</b> Villi (absorption).<br> - <b>Choroid Plexus:</b> CSF production.</li><li><b>USMLE Tip:</b> Contrast with <b>Continuous</b> capillaries (BBB, muscle, skin) and <b>Sinusoidal</b> capillaries (Liver, Spleen, Bone Marrow - large gaps).</li></ul>",
      "takeAway": "<p><b>Fenestrated Capillaries</b> are porous vessels designed for high rates of exchange, crucial for renal filtration and endocrine secretion.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "found_in",
        "to": "glomerulus"
      },
      {
        "type": "found_in",
        "to": "choroid_plexus"
      },
      {
        "type": "is_contrasted_with",
        "to": "blood_brain_barrier"
      }
    ]
  },
  "fentanyl": {
    "title": "Fentanyl",
    "primaryType": "substance",
    "tags": [
      "Pharmacology",
      "Anesthesiology",
      "Pain Management",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Analgesics",
      "Opioids"
    ],
    "content": {
      "definition": "<p><b>Fentanyl</b> is a potent synthetic <u>mu-opioid receptor agonist</u> (approx. 100x stronger than morphine) used for analgesia and anesthesia due to its rapid onset and short duration of action.</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> Agonist at Mu-opioid receptors &rarr; closes presynaptic Ca<sup>2+</sup> channels / opens postsynaptic K<sup>+</sup> channels &rarr; inhibits neurotransmission.</li><li><b>Properties:</b> Highly lipid-soluble (rapid CNS entry). No histamine release (cardiovascular stability).</li><li><b>Clinical Use:</b> Anesthesia adjunct, severe pain, chronic pain (transdermal patch).</li><li><b>Adverse Effects:</b> <b>Chest Wall Rigidity</b> (Wooden Chest syndrome) with rapid IV bolus, Respiratory depression, Constipation.</li><li><b>USMLE Tip:</b> The opioid of choice for hemodynamically unstable patients (no histamine/minimal hypotensive effect).</li></ul>",
      "takeAway": "<p><b>Fentanyl</b> is a highly potent, lipid-soluble opioid ideal for anesthesia and severe pain, notable for causing chest wall rigidity if pushed too fast.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "agonizes",
        "to": "mu_opioid_receptor"
      },
      {
        "type": "is_a_type_of",
        "to": "opioid_analgesics"
      },
      {
        "type": "causes_side_effect",
        "to": "chest_wall_rigidity"
      }
    ]
  },
  "fever": {
    "title": "Fever (Pyrexia)",
    "primaryType": "process",
    "tags": [
      "Pathology",
      "Immunology",
      "Physiology",
      "USMLE"
    ],
    "classificationPath": [
      "Pathology",
      "Inflammation",
      "Systemic Effects"
    ],
    "content": {
      "definition": "<p><b>Fever</b> is a cytokine-mediated elevation of the body's temperature set-point in the <u>hypothalamus</u>, typically in response to infection or inflammation.</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> Pyrogens (e.g., LPS) &rarr; Macrophages release <b>IL-1, IL-6, TNF-&alpha;</b> &rarr; Hypothalamic synthesis of <b>PGE<sub>2</sub></b> (via COX-2) &rarr; Increases set-point in Anterior Hypothalamus.</li><li><b>Physiologic Response:</b> Shivering (to generate heat), Vasoconstriction (to conserve heat).</li><li><b>Treatment:</b> NSAIDs/Acetaminophen (inhibit COX &rarr; decrease PGE<sub>2</sub>).</li><li><b>Hyperthermia vs. Fever:</b> Fever respects the set-point (hypothalamus intact); Hyperthermia (e.g., Heat Stroke, Malignant Hyperthermia) overrides regulatory mechanisms.</li></ul>",
      "takeAway": "<p><b>Fever</b> is a hypothalamic response to cytokines (IL-1, IL-6) driven by PGE<sub>2</sub>, distinct from uncontrolled hyperthermia.</p>",
      "mermaid": "graph TD; A[Infection/Inflammation] --> B[IL-1, IL-6, TNF-alpha]; B --> C[Hypothalamus]; C --> D[COX-2 Activation]; D --> E[PGE2 Synthesis]; E --> F[Increased Temperature Set Point];"
    },
    "connections": [
      {
        "type": "mediated_by",
        "to": "prostaglandin_e2"
      },
      {
        "type": "involves_structure",
        "to": "hypothalamus"
      },
      {
        "type": "treated_by",
        "to": "acetaminophen"
      }
    ]
  },
  "gerstmann_syndrome": {
    "title": "Gerstmann Syndrome",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Cognition",
      "Stroke",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Cognitive Disorders",
      "Parietal Lobe Syndromes"
    ],
    "content": {
      "definition": "<p><b>Gerstmann Syndrome</b> is a cognitive disorder caused by a lesion in the <u>dominant parietal lobe</u> (specifically the Angular Gyrus), characterized by a tetrad of specific deficits.</p>",
      "atAGlance": "<ul><li><b>Lesion:</b> Dominant (usually Left) Inferior Parietal Lobule (Angular Gyrus).</li><li><b>Tetrad of Symptoms:</b><br> 1. <b>Agraphia</b> (Inability to write).<br> 2. <b>Acalculia</b> (Inability to calculate).<br> 3. <b>Finger Agnosia</b> (Inability to distinguish fingers).<br> 4. <b>Left-Right Disorientation</b>.</li><li><b>Etiology:</b> [[middle_cerebral_artery]] stroke, tumor.</li><li><b>USMLE Tip:</b> Look for a patient who can't do math, write, or tell their left hand from their right.</li></ul>",
      "takeAway": "<p><b>Gerstmann Syndrome</b> localizes to the dominant angular gyrus, presenting with agraphia, acalculia, finger agnosia, and left-right confusion.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "includes",
        "to": "agraphia"
      },
      {
        "type": "includes",
        "to": "acalculia"
      },
      {
        "type": "includes",
        "to": "finger_agnosia"
      },
      {
        "type": "localizes_to",
        "to": "parietal_lobe"
      }
    ]
  },
  "finger_agnosia": {
    "title": "Finger Agnosia",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Signs & Symptoms",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Cognitive Disorders",
      "Agnosias"
    ],
    "content": {
      "definition": "<p><b>Finger Agnosia</b> is the inability to distinguish, name, or recognize one's own fingers or the fingers of others, typically associated with lesions of the <u>dominant parietal lobe</u>.</p>",
      "atAGlance": "<ul><li><b>Localization:</b> Dominant Angular Gyrus (Parietal Lobe).</li><li><b>Significance:</b> One of the four components of [[gerstmann_syndrome]].</li><li><b>Testing:</b> Ask patient to \"Show me your index finger\" or identify which finger the examiner is touching.</li></ul>",
      "takeAway": "<p><b>Finger Agnosia</b> is a specific body schema disorder pointing to dominant parietal lobe dysfunction, often seen in Gerstmann Syndrome.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_part_of",
        "to": "gerstmann_syndrome"
      },
      {
        "type": "localizes_to",
        "to": "parietal_lobe"
      }
    ]
  },
  "flaccid_paralysis": {
    "title": "Flaccid Paralysis",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Physical Exam",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Motor Disorders",
      "Muscle Tone"
    ],
    "content": {
      "definition": "<p><b>Flaccid Paralysis</b> is a form of paralysis characterized by <u>loss of muscle tone</u> (hypotonia) and absent deep tendon reflexes (areflexia), indicative of a [[lower_motor_neuron_lesion]] or acute spinal shock.</p>",
      "atAGlance": "<ul><li><b>Pathophysiology:</b> Interruption of the final common pathway (Anterior Horn Cell &rarr; Nerve &rarr; NMJ &rarr; Muscle).</li><li><b>Signs:</b> Atrophy, Fasciculations, Hypotonia, Hyporeflexia.</li><li><b>Etiologies:</b> [[polio]], [[guillain_barre_syndrome]], [[botulinum_toxin]], Spinal Muscular Atrophy, Cauda Equina Syndrome.</li><li><b>Contrast:</b> Spastic Paralysis (UMN lesion).</li></ul>",
      "takeAway": "<p><b>Flaccid Paralysis</b> localizes pathology to the Lower Motor Neuron unit, presenting with limp muscles and absent reflexes.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_sign_of",
        "to": "lower_motor_neuron_lesion"
      },
      {
        "type": "caused_by",
        "to": "botulinum_toxin"
      },
      {
        "type": "caused_by",
        "to": "polio"
      }
    ]
  },
  "focal_aware_seizure": {
    "title": "Focal Aware Seizure",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Epilepsy",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Epilepsy",
      "Focal Seizures"
    ],
    "content": {
      "definition": "<p>A <b>Focal Aware Seizure</b> (formerly Simple Partial) is a seizure arising from a specific area of one cerebral hemisphere where <u>consciousness is preserved</u>.</p>",
      "atAGlance": "<ul><li><b>Clinical Features:</b> Depends on location (e.g., Motor twitching, Sensory paresthesias, Autonomic changes, Psychic symptoms like déjà vu).</li><li><b>Key Feature:</b> Patient remains awake and aware of the event.</li><li><b>Terminology:</b> \"Aura\" is often a focal aware seizure.</li><li><b>Progression:</b> Can evolve into Focal Impaired Awareness or Generalized Tonic-Clonic seizure.</li></ul>",
      "takeAway": "<p><b>Focal Aware Seizures</b> localize to a specific brain region and do not impair consciousness, often serving as a warning (aura) for larger seizures.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_a_type_of",
        "to": "focal_seizures"
      },
      {
        "type": "can_progress_to",
        "to": "generalized_tonic_clonic_seizure"
      }
    ]
  },
  "focal_impaired_awareness_seizure": {
    "title": "Focal Impaired Awareness Seizure",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Epilepsy",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Epilepsy",
      "Focal Seizures"
    ],
    "content": {
      "definition": "<p>A <b>Focal Impaired Awareness Seizure</b> (formerly Complex Partial) is a seizure arising from one hemisphere that results in an <u>alteration of consciousness</u> or awareness, often associated with automatisms.</p>",
      "atAGlance": "<ul><li><b>Localization:</b> Most commonly <b>Temporal Lobe</b> (Mesial Temporal Sclerosis).</li><li><b>Clinical Features:</b> Staring, unresponsiveness, <b>Automatisms</b> (lip smacking, picking at clothes, fumbling).</li><li><b>Post-ictal State:</b> Confusion and lethargy (differentiates from Absence seizures).</li><li><b>USMLE Tip:</b> Differentiate from Absence: Focal has <b>post-ictal confusion</b> and lasts longer (>30s). Absence has immediate recovery.</li></ul>",
      "takeAway": "<p><b>Focal Impaired Awareness Seizures</b> involve altered consciousness and automatisms, classically originating in the temporal lobe, and are followed by a post-ictal state.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_a_type_of",
        "to": "focal_seizures"
      },
      {
        "type": "often_originates_in",
        "to": "temporal_lobe"
      },
      {
        "type": "is_distinguished_from",
        "to": "absence_seizure"
      }
    ]
  },
  "focal_seizures": {
    "title": "Focal Seizures",
    "primaryType": "group",
    "tags": [
      "Neurology",
      "Epilepsy",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Epilepsy",
      "Seizure Classification"
    ],
    "content": {
      "definition": "<p><b>Focal Seizures</b> (Partial Seizures) originate within networks limited to <u>one hemisphere</u> of the brain, classified by awareness (Aware vs. Impaired Awareness) and motor onset.</p>",
      "atAGlance": "<ul><li><b>Types:</b><br> - <b>Focal Aware:</b> No loss of consciousness.<br> - <b>Focal Impaired Awareness:</b> Loss of consciousness/contact.<br> - <b>Focal to Bilateral Tonic-Clonic:</b> Secondary generalization.</li><li><b>Etiologies:</b> Structural lesions (Tumor, Stroke, scar tissue/gliosis), Infection, Vascular malformation.</li><li><b>Treatment:</b> Narrow spectrum anticonvulsants (e.g., [[carbamazepine]], [[phenytoin]], [[gabapentin]]) or Broad spectrum (e.g., [[levetiracetam]], [[lamotrigine]]).</li></ul>",
      "takeAway": "<p><b>Focal Seizures</b> start locally and are often driven by structural pathology; treatment targets sodium channels or SV2A, unlike the T-type calcium channels targeted in absence epilepsy.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "includes",
        "to": "focal_aware_seizure"
      },
      {
        "type": "includes",
        "to": "focal_impaired_awareness_seizure"
      },
      {
        "type": "treated_by",
        "to": "carbamazepine"
      },
      {
        "type": "treated_by",
        "to": "phenytoin"
      }
    ]
  },
  "foramen_of_magendie": {
    "title": "Foramen of Magendie",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Anatomy",
      "CSF",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Brain Anatomy",
      "Ventricular System"
    ],
    "content": {
      "definition": "<p>The <b>Foramen of Magendie</b> is the single <u>median aperture</u> of the fourth ventricle that allows cerebrospinal fluid (CSF) to exit the ventricular system into the cisterna magna of the subarachnoid space.</p>",
      "atAGlance": "<ul><li><b>Location:</b> Midline of the roof of the 4th Ventricle.</li><li><b>Function:</b> Outflow of CSF to Subarachnoid Space.</li><li><b>Relationship:</b> Complemented by the two lateral <b>Foramina of Luschka</b>.</li><li><b>Mnemonic:</b> <b>M</b>agendie is <b>M</b>edial. <b>L</b>uschka is <b>L</b>ateral.</li><li><b>Pathology:</b> Obstruction leads to [[noncommunicating_hydrocephalus]].</li></ul>",
      "takeAway": "<p>The <b>Foramen of Magendie</b> acts as the central drain for the fourth ventricle; its patency is essential for CSF circulation into the spinal and cranial subarachnoid spaces.</p>",
      "mermaid": "graph TD; A[4th Ventricle] -->|Foramen of Magendie| B[Cisterna Magna]; A -->|Foramina of Luschka| C[Pontine Cistern]; B & C --> D[Subarachnoid Space];"
    },
    "connections": [
      {
        "type": "drains",
        "to": "fourth_ventricle"
      },
      {
        "type": "connects_to",
        "to": "subarachnoid_space"
      },
      {
        "type": "blockage_causes",
        "to": "noncommunicating_hydrocephalus"
      }
    ]
  }
}
``````json
{
  "foramen_of_monro": {
    "title": "Foramen of Monro (Interventricular Foramen)",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Anatomy",
      "CSF",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Brain Anatomy",
      "Ventricular System"
    ],
    "content": {
      "definition": "<p>The <b>Foramen of Monro</b> is the paired communication channel connecting the <u>lateral ventricles</u> to the <u>third ventricle</u> of the brain, allowing for the circulation of cerebrospinal fluid.</p>",
      "atAGlance": "<ul><li><b>Function:</b> Drains CSF from the Lateral Ventricles into the Third Ventricle.</li><li><b>Pathology:</b><br> - <i>Obstruction:</i> Leads to dilation of the lateral ventricles (unilateral or bilateral) while the 3rd and 4th ventricles remain normal size. Common cause: <b>Colloid Cyst</b> of the third ventricle.<br> - <i>Result:</i> [[noncommunicating_hydrocephalus]].</li><li><b>USMLE Tip:</b> A \"ball-valve\" obstruction (e.g., Colloid Cyst) here can cause intermittent positional headaches and sudden death.</li></ul>",
      "takeAway": "<p>The <b>Foramen of Monro</b> is the bottleneck between the lateral and third ventricles; blockage here causes specific enlargement of the lateral ventricles.</p>",
      "mermaid": "graph TD; A[Lateral Ventricles] -->|Foramen of Monro| B[Third Ventricle]; B -->|Cerebral Aqueduct| C[Fourth Ventricle];"
    },
    "connections": [
      {
        "type": "connects",
        "to": "lateral_ventricles"
      },
      {
        "type": "connects",
        "to": "third_ventricle"
      },
      {
        "type": "obstruction_causes",
        "to": "noncommunicating_hydrocephalus"
      }
    ]
  },
  "foramina_of_luschka": {
    "title": "Foramina of Luschka",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Anatomy",
      "CSF",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Brain Anatomy",
      "Ventricular System"
    ],
    "content": {
      "definition": "<p>The <b>Foramina of Luschka</b> are the two <u>lateral apertures</u> of the fourth ventricle that allow cerebrospinal fluid to exit the ventricular system and enter the subarachnoid space (specifically the cerebellopontine angle cistern).</p>",
      "atAGlance": "<ul><li><b>Location:</b> Lateral recesses of the 4th Ventricle.</li><li><b>Function:</b> Outflow of CSF to Subarachnoid Space.</li><li><b>Mnemonic:</b> <b>L</b>uschka = <b>L</b>ateral (There are 2). <b>M</b>agendie = <b>M</b>edial (There is 1).</li><li><b>Pathology:</b> Obstruction contributes to [[noncommunicating_hydrocephalus]] (along with Magendie obstruction).</li></ul>",
      "takeAway": "<p>The <b>Foramina of Luschka</b> are the paired lateral drains of the fourth ventricle, complementing the medial Foramen of Magendie.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "drains",
        "to": "fourth_ventricle"
      },
      {
        "type": "is_contrasted_with",
        "to": "foramen_of_magendie"
      },
      {
        "type": "connects_to",
        "to": "subarachnoid_space"
      }
    ]
  },
  "frataxin": {
    "title": "Frataxin",
    "primaryType": "substance",
    "tags": [
      "Biochemistry",
      "Genetics",
      "Neurology",
      "USMLE"
    ],
    "classificationPath": [
      "Biochemistry",
      "Proteins",
      "Mitochondrial Proteins"
    ],
    "content": {
      "definition": "<p><b>Frataxin</b> is a mitochondrial protein involved in iron-sulfur cluster assembly and iron homeostasis; decreased expression due to a trinucleotide repeat expansion causes <b>[[friedreich_ataxia]]</b>.</p>",
      "atAGlance": "<ul><li><b>Function:</b> Regulates mitochondrial iron transport and respiration.</li><li><b>Pathology:</b> Deficiency leads to mitochondrial iron accumulation &rarr; Oxidative stress (free radical damage) &rarr; Degeneration of nerve tissue (spinal cord/cerebellum) and heart.</li><li><b>Genetics:</b> <i>FXN</i> gene on Chromosome 9. <b>GAA</b> repeat expansion in an <u>intron</u> (transcriptional silencing via heterochromatin).</li><li><b>USMLE Tip:</b> <b>Fra</b>taxin implies <b>Fra</b>gile mitochondria due to Iron overload (Friedreich Ataxia).</li></ul>",
      "takeAway": "<p><b>Frataxin</b> deficiency leads to mitochondrial iron overload and oxidative damage, the central mechanism of [[friedreich_ataxia]].</p>",
      "mermaid": "graph TD; A[GAA Repeat Expansion] --> B[Silencing of FXN Gene]; B --> C[Decreased Frataxin]; C --> D[Mitochondrial Iron Accumulation]; D --> E[Oxidative Stress / Free Radicals]; E --> F[Neuronal and Cardiac Death];"
    },
    "connections": [
      {
        "type": "deficiency_causes",
        "to": "friedreich_ataxia"
      },
      {
        "type": "regulates",
        "to": "iron"
      },
      {
        "type": "associated_with_gene",
        "to": "fxn_gene"
      }
    ]
  },
  "free_nerve_endings": {
    "title": "Free Nerve Endings",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Histology",
      "Sensory Systems",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Sensory Receptors",
      "Nociceptors"
    ],
    "content": {
      "definition": "<p><b>Free Nerve Endings</b> are unencapsulated sensory receptors found in the skin and viscera that function as nociceptors and thermoreceptors, detecting <u>pain</u> and <u>temperature</u>.</p>",
      "atAGlance": "<ul><li><b>Fiber Types:</b><br> - <b>A&delta; fibers:</b> Fast, myelinated. Sharp/localized pain (and cold).<br> - <b>C fibers:</b> Slow, unmyelinated. Dull/aching/burning pain (and warmth).</li><li><b>Location:</b> Epidermis, dermis, cornea (purely free nerve endings), pulp of teeth, viscera.</li><li><b>Pathway:</b> Synapse in dorsal horn &rarr; [[spinothalamic_tract]].</li><li><b>USMLE Tip:</b> C fibers are blocked <u>later</u> than A fibers by pressure/hypoxia but blocked <u>earlier</u> by local anesthetics.</li></ul>",
      "takeAway": "<p><b>Free Nerve Endings</b> transduce pain and temperature via A-delta (fast) and C (slow) fibers, feeding into the [[spinothalamic_tract]].</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "transmits_sensation_of",
        "to": "pain"
      },
      {
        "type": "transmits_sensation_of",
        "to": "temperature_sensation"
      },
      {
        "type": "projects_to",
        "to": "spinothalamic_tract"
      }
    ]
  },
  "fresh_frozen_plasma": {
    "title": "Fresh Frozen Plasma (FFP)",
    "primaryType": "substance",
    "tags": [
      "Hematology",
      "Pharmacology",
      "Transfusion Medicine",
      "USMLE"
    ],
    "classificationPath": [
      "Hematology",
      "Blood Products"
    ],
    "content": {
      "definition": "<p><b>Fresh Frozen Plasma (FFP)</b> is a blood product containing <u>all clotting factors</u> and plasma proteins, used to reverse coagulopathy (e.g., [[warfarin]] overdose, DIC, liver failure).</p>",
      "atAGlance": "<ul><li><b>Contents:</b> All coagulation factors (II, VII, IX, X, V, VIII, Fibrinogen, etc.), Antithrombin, Albumin.</li><li><b>Indications:</b> Immediate reversal of <b>Warfarin</b> (if PCC not available), massive transfusion protocols, DIC, liver cirrhosis coagulopathy.</li><li><b>Comparison:</b> <b>Prothrombin Complex Concentrate (PCC)</b> is preferred for Warfarin reversal (contains Factors II, VII, IX, X; lower volume, faster onset). FFP requires large volume (risk of TACO/TRALI).</li><li><b>USMLE Tip:</b> For immediate Warfarin reversal: PCC > FFP. Vitamin K takes too long (hours/days).</li></ul>",
      "takeAway": "<p><b>FFP</b> replenishes all clotting factors and is used for acute reversal of coagulopathy, though PCC is preferred for Warfarin reversal due to volume considerations.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "reverses_effect_of",
        "to": "warfarin"
      },
      {
        "type": "contains",
        "to": "clotting_factors"
      },
      {
        "type": "is_contrasted_with",
        "to": "prothrombin_complex_concentrate"
      }
    ]
  },
  "friedreich_ataxia": {
    "title": "Friedreich Ataxia",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Genetics",
      "Cardiology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Hereditary Neuropathies",
      "Spinocerebellar Degeneration"
    ],
    "content": {
      "definition": "<p><b>Friedreich Ataxia</b> is an autosomal recessive neurodegenerative disorder caused by a trinucleotide repeat expansion (GAA) in the <i>FXN</i> gene, leading to [[frataxin]] deficiency, mitochondrial dysfunction, and degeneration of multiple spinal tracts.</p>",
      "atAGlance": "<ul><li><b>Genetics:</b> <b>AR</b>, Chromosome 9. <b>GAA</b> repeat expansion (\"<b>G</b>aith <b>A</b>taxic <b>A</b>lways\"). Frataxin deficiency &rarr; Iron overload in mitochondria.</li><li><b>Tracts Affected:</b><br> 1. <b>Spinocerebellar:</b> Ataxia, gait instability.<br> 2. <b>Dorsal Columns:</b> Loss of vibration/proprioception.<br> 3. <b>Corticospinal:</b> Weakness, UMN signs (Babinski).<br> - <i>Also:</i> Dorsal root ganglia (loss of DTRs).</li><li><b>Clinical Features:</b> Staggering gait (childhood), nystagmus, dysarthria, <b>Pes Cavus</b> (high arches), Hammer toes, <b>Kyphoscoliosis</b>.</li><li><b>Complications:</b> <b>Hypertrophic Cardiomyopathy</b> (most common cause of death), Diabetes Mellitus.</li><li><b>USMLE Tip:</b> Ataxia + Hammer Toes + Heart problems in a child = Friedreich Ataxia.</li></ul>",
      "takeAway": "<p><b>Friedreich Ataxia</b> involves the degeneration of the dorsal columns, corticospinal, and spinocerebellar tracts due to mitochondrial iron toxicity (GAA repeat/Frataxin), presenting with ataxia, skeletal deformities, and hypertrophic cardiomyopathy.</p>",
      "mermaid": "graph TD; A[GAA Expansion] --> B[Low Frataxin]; B --> C[Mitochondrial Iron Accumulation]; C --> D[ROS Damage]; D --> E[Degeneration of Neural Tracts]; D --> F[Hypertrophic Cardiomyopathy]; E --> G[Ataxia / Weakness / Sensory Loss];"
    },
    "connections": [
      {
        "type": "caused_by_deficiency_of",
        "to": "frataxin"
      },
      {
        "type": "damages_structure",
        "to": "dorsal_column_medial_lemniscus"
      },
      {
        "type": "damages_structure",
        "to": "spinocerebellar_tract"
      },
      {
        "type": "damages_structure",
        "to": "corticospinal_tract"
      },
      {
        "type": "associated_with",
        "to": "hypertrophic_cardiomyopathy"
      },
      {
        "type": "manifests_as",
        "to": "pes_cavus"
      }
    ]
  },
  "frontal_eye_fields": {
    "title": "Frontal Eye Fields (FEF)",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Anatomy",
      "Ophthalmology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Brain Anatomy",
      "Cerebral Cortex",
      "Frontal Lobe"
    ],
    "content": {
      "definition": "<p>The <b>Frontal Eye Fields (FEF)</b> are cortical areas located in the posterior middle frontal gyrus (Brodmann area 8) responsible for initiating <u>voluntary rapid eye movements (saccades)</u> to the <b>contralateral</b> side.</p>",
      "atAGlance": "<ul><li><b>Function:</b> Generates horizontal saccades to the <b>opposite</b> side. (Left FEF pushes eyes Right).</li><li><b>Pathway:</b> FEF &rarr; Contralateral [[paramedian_pontine_reticular_formation]] (PPRF) &rarr; CN VI Nucleus.</li><li><b>Lesions (Destructive):</b> Eyes deviate <b>toward</b> the lesion. (Example: Left MCA stroke &rarr; Left FEF damage &rarr; Right gaze palsy &rarr; Eyes look Left).</li><li><b>Seizures (Irritative):</b> Eyes deviate <b>away</b> from the lesion (seizure focus). (Example: Left FEF seizure &rarr; Eyes look Right).</li><li><b>USMLE Tip:</b> \"Right-Way Eyes\" in stroke (looks at the lesion). \"Wrong-Way Eyes\" in seizure.</li></ul>",
      "takeAway": "<p>The <b>Frontal Eye Fields</b> control voluntary contralateral gaze; destructive lesions cause gaze deviation <i>toward</i> the lesion, while irritation causes deviation <i>away</i>.</p>",
      "mermaid": "graph TD; A[Frontal Eye Field] -->|Stimulates| B[Contralateral PPRF]; B -->|Stimulates| C[CN VI Nucleus]; C --> D[Ipsilateral Lateral Rectus]; C -->|MLF| E[Contralateral CN III]; E --> F[Contralateral Medial Rectus];"
    },
    "connections": [
      {
        "type": "located_in",
        "to": "frontal_lobe"
      },
      {
        "type": "projects_to",
        "to": "paramedian_pontine_reticular_formation"
      },
      {
        "type": "lesion_causes_deviation_toward",
        "to": "lesion_side"
      }
    ]
  },
  "frontal_lobe": {
    "title": "Frontal Lobe",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Anatomy",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Brain Anatomy",
      "Cerebral Cortex"
    ],
    "content": {
      "definition": "<p>The <b>Frontal Lobe</b> is the largest lobe of the brain, located anterior to the central sulcus, responsible for <u>motor function</u>, <u>executive function</u>, personality, and language production ([[broca_area]]).</p>",
      "atAGlance": "<ul><li><b>Key Areas:</b><br> - <b>Primary Motor Cortex:</b> Voluntary movement (Precentral gyrus).<br> - <b>Premotor/Supplementary Motor:</b> Planning movement.<br> - <b>[[frontal_eye_fields]]:</b> Voluntary gaze.<br> - <b>[[broca_area]]:</b> Speech production (Dominant hemisphere).<br> - <b>Prefrontal Cortex:</b> Personality, judgment, social inhibition, concentration.</li><li><b>Pathology:</b> [[frontal_lobe_syndrome]] (Disinhibition/Apathy), [[broca_aphasia]], Gaze deviation.</li><li><b>USMLE Tip:</b> A change in personality or social behavior (e.g., Phineas Gage) localizes to the Prefrontal Cortex.</li></ul>",
      "takeAway": "<p>The <b>Frontal Lobe</b> integrates motor output with executive control and personality; damage leads to weakness, aphasia, or profound behavioral changes.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "contains",
        "to": "primary_motor_cortex"
      },
      {
        "type": "contains",
        "to": "broca_area"
      },
      {
        "type": "contains",
        "to": "frontal_eye_fields"
      },
      {
        "type": "dysfunction_causes",
        "to": "frontal_lobe_syndrome"
      }
    ]
  },
  "frontal_lobe_syndrome": {
    "title": "Frontal Lobe Syndrome",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Psychiatry",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Cognitive Disorders",
      "Behavioral Neurology"
    ],
    "content": {
      "definition": "<p><b>Frontal Lobe Syndrome</b> refers to a constellation of behavioral and cognitive deficits resulting from damage to the prefrontal cortex, characterized by <u>disinhibition</u>, apathy, and impaired executive function.</p>",
      "atAGlance": "<ul><li><b>Types:</b><br> - <b>Disinhibited (Orbitofrontal):</b> Impulsivity, social inappropriateness, poor judgment, emotional lability (e.g., Phineas Gage).<br> - <b>Apathetic (Dorsolateral):</b> Lack of motivation (abulia), lethargy, poor planning/working memory.</li><li><b>Primitive Reflexes:</b> Re-emergence of Suck, Grasp, Rooting, Glabellar reflexes (\"Frontal Release Signs\").</li><li><b>Etiologies:</b> Trauma, [[frontotemporal_dementia]], Tumor (e.g., Butterfly glioma), Stroke (ACA).</li><li><b>USMLE Tip:</b> \"Witzelsucht\" (inappropriate joking) is a sign of orbitofrontal damage.</li></ul>",
      "takeAway": "<p><b>Frontal Lobe Syndrome</b> manifests as a radical change in personality and behavior, ranging from chaotic disinhibition to profound apathy, often accompanied by primitive reflexes.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "caused_by_lesion_in",
        "to": "frontal_lobe"
      },
      {
        "type": "manifests_as",
        "to": "disinhibition"
      },
      {
        "type": "associated_with",
        "to": "primitive_reflexes"
      }
    ]
  },
  "frontotemporal_dementia": {
    "title": "Frontotemporal Dementia (Pick Disease)",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Pathology",
      "Neurodegenerative",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Neurodegenerative Diseases",
      "Dementia"
    ],
    "content": {
      "definition": "<p><b>Frontotemporal Dementia (FTD)</b> is a neurodegenerative disorder characterized by early, prominent changes in <u>personality, behavior, and language</u> (aphasia) due to selective atrophy of the frontal and temporal lobes, often sparing memory initially.</p>",
      "atAGlance": "<ul><li><b>Clinical Variants:</b><br> - <b>Behavioral:</b> Disinhibition, apathy, hyperorality, compulsive behaviors.<br> - <b>Primary Progressive Aphasia:</b> Gradual loss of language function.</li><li><b>Pathology:</b> Frontal/Temporal atrophy (\"Knife-edge\" gyri).</li><li><b>Histology:</b><br> - <b>Pick Bodies:</b> Round, silver-staining inclusions of hyperphosphorylated <b>Tau</b>.<br> - <b>TDP-43:</b> Ubiquitinated inclusions (associated with ALS).</li><li><b>Onset:</b> Younger than Alzheimer's (40s-60s).</li><li><b>USMLE Tip:</b> Dementia with <i>personality changes</i> coming <u>before</u> memory loss = FTD.</li></ul>",
      "takeAway": "<p><b>Frontotemporal Dementia</b> presents with early behavioral or language deficits due to lobar atrophy, histologically marked by Tau (Pick bodies) or TDP-43 inclusions.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "characterized_by",
        "to": "pick_bodies"
      },
      {
        "type": "accumulates",
        "to": "tau_protein"
      },
      {
        "type": "causes",
        "to": "aphasia"
      },
      {
        "type": "is_distinguished_from",
        "to": "alzheimer_disease"
      }
    ]
  },
  "funduscopic_examination": {
    "title": "Funduscopic Examination",
    "primaryType": "procedure",
    "tags": [
      "Ophthalmology",
      "Neurology",
      "Diagnosis",
      "USMLE"
    ],
    "classificationPath": [
      "Ophthalmology",
      "Diagnostic Procedures"
    ],
    "content": {
      "definition": "<p><b>Funduscopic Examination</b> is the visualization of the retina, optic disc, macula, and retinal vessels using an ophthalmoscope, crucial for diagnosing systemic and ocular pathology.</p>",
      "atAGlance": "<ul><li><b>Key Findings:</b><br> - <b>[[papilledema]]:</b> Blurring of optic disc margins (Increased ICP).<br> - <b>Cupping:</b> Increased cup-to-disc ratio (Glaucoma).<br> - <b>[[cherry_red_spot]]:</b> Central Retinal Artery Occlusion, Tay-Sachs.<br> - <b>AV Nicking/Cotton Wool Spots:</b> Hypertension/Diabetes.<br> - <b>Drusen:</b> Macular Degeneration.<br> - <b>Roth Spots:</b> Endocarditis (white-centered hemorrhages).</li><li><b>USMLE Tip:</b> It acts as a window to the brain (ICP) and microvasculature (HTN/Diabetes).</li></ul>",
      "takeAway": "<p><b>Fundoscopy</b> provides direct visualization of neurovascular health, identifying critical signs like papilledema (intracranial pressure) and vascular retinopathy.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "detects",
        "to": "papilledema"
      },
      {
        "type": "detects",
        "to": "diabetic_retinopathy"
      },
      {
        "type": "visualizes",
        "to": "retina"
      }
    ]
  }
}
``````json
{
  "gaba": {
    "title": "GABA (Gamma-Aminobutyric Acid)",
    "primaryType": "substance",
    "tags": [
      "Neuroscience",
      "Physiology",
      "Pharmacology",
      "USMLE"
    ],
    "classificationPath": [
      "Neuroscience",
      "Neurotransmitters",
      "Inhibitory Amino Acids"
    ],
    "content": {
      "definition": "<p><b>GABA (Gamma-Aminobutyric Acid)</b> is the primary <u>inhibitory neurotransmitter</u> of the central nervous system, synthesized from glutamate by glutamate decarboxylase (GAD) using Vitamin B6 as a cofactor.</p>",
      "atAGlance": "<ul><li><b>Synthesis:</b> Glutamate &rarr; GABA (via GAD + <b>Vitamin B6</b>).</li><li><b>Metabolism:</b> Broken down by GABA transaminase (requires B6).</li><li><b>Receptors:</b><br> - <b>GABA<sub>A</sub>:</b> Ionotropic (Cl<sup>-</sup> channel) &rarr; Hyperpolarization. Target of [[benzodiazepines]], [[barbiturates]], Alcohol.<br> - <b>GABA<sub>B</sub>:</b> Metabotropic (G<sub>i</sub>) &rarr; K<sup>+</sup> efflux. Target of [[baclofen]].</li><li><b>Pathology:</b><br> - <i>Decreased:</i> [[anxiety_disorders]], [[huntington_disease]] (Loss of striatal GABA neurons).<br> - <i>Vitamin B6 Deficiency:</i> Decreased GABA synthesis &rarr; Seizures.</li><li><b>Production Site:</b> Nucleus Accumbens (Subcortex).</li></ul>",
      "takeAway": "<p><b>GABA</b> acts as the brain's main \"brake,\" inducing inhibition via chloride influx or potassium efflux; its deficiency leads to anxiety and seizures, while its potentiation causes sedation.</p>",
      "mermaid": "graph TD; A[Glutamate] -->|GAD + B6| B[GABA]; B --> C[GABA-A Receptor]; B --> D[GABA-B Receptor]; C --> E[Cl- Influx]; D --> F[K+ Efflux]; E & F --> G[Hyperpolarization / Inhibition];"
    },
    "connections": [
      {
        "type": "binds_to",
        "to": "gaba_a_receptor"
      },
      {
        "type": "binds_to",
        "to": "gaba_b_receptor"
      },
      {
        "type": "requires_cofactor",
        "to": "vitamin_b6"
      },
      {
        "type": "deficient_in",
        "to": "huntington_disease"
      }
    ]
  },
  "gaba_a_receptor": {
    "title": "GABA-A Receptor",
    "primaryType": "structure",
    "tags": [
      "Neuroscience",
      "Pharmacology",
      "USMLE"
    ],
    "classificationPath": [
      "Neuroscience",
      "Receptors",
      "Ion Channels"
    ],
    "content": {
      "definition": "<p>The <b>GABA<sub>A</sub> Receptor</b> is a ligand-gated ion channel (ionotropic) that, upon binding GABA, opens a central pore allowing <u>chloride (Cl<sup>-</sup>) influx</u>, resulting in neuronal hyperpolarization and inhibition.</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> Ligand-gated Cl<sup>-</sup> channel. Activation &rarr; Cl<sup>-</sup> influx &rarr; Hyperpolarization &rarr; Decreased neuronal firing.</li><li><b>Pharmacology:</b><br> - <b>[[benzodiazepines]]:</b> Increase <i>Frequency</i> of opening.<br> - <b>[[barbiturates]]:</b> Increase <i>Duration</i> of opening.<br> - <b>Alcohol/Zolpidem:</b> Bind specific sites to enhance activity.</li><li><b>Clinical Relevance:</b> Target for sedatives, anxiolytics, and anticonvulsants. Withdrawal precipitates seizures due to receptor downregulation.</li><li><b>USMLE Tip:</b> \"Frenzodiazepines\" (Frequency) vs \"Barbidurates\" (Duration).</li></ul>",
      "takeAway": "<p>The <b>GABA<sub>A</sub> Receptor</b> mediates fast synaptic inhibition via chloride influx and is the site of action for major sedative-hypnotic drug classes.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "activated_by",
        "to": "gaba"
      },
      {
        "type": "modulated_by",
        "to": "benzodiazepines"
      },
      {
        "type": "modulated_by",
        "to": "barbiturates"
      },
      {
        "type": "transports",
        "to": "chloride_ion"
      }
    ]
  },
  "gnaq_gene": {
    "title": "GNAQ Gene",
    "primaryType": "concept",
    "tags": [
      "Genetics",
      "Neurology",
      "Dermatology",
      "USMLE"
    ],
    "classificationPath": [
      "Genetics",
      "Somatic Mutations"
    ],
    "content": {
      "definition": "<p>The <b>GNAQ Gene</b> encodes a G-protein alpha subunit; a somatic mosaic activating mutation in this gene is the underlying cause of <b>[[sturge_weber_syndrome]]</b> (Encephalotrigeminal Angiomatosis).</p>",
      "atAGlance": "<ul><li><b>Mutation Type:</b> Somatic mosaicism (post-zygotic mutation). <u>Not</u> inherited (sporadic).</li><li><b>Pathophysiology:</b> Constitutive activation of G-protein signaling affects neural crest derivatives (vasculature).</li><li><b>Clinical Phenotype:</b><br> - <b>Port-Wine Stain:</b> V1/V2 capillary malformation.<br> - <b>Leptomeningeal Angioma:</b> Ipsilateral brain vascular malformation &rarr; Seizures, Calcification.<br> - <b>Glaucoma:</b> Episcleral hemangioma.</li><li><b>USMLE Tip:</b> Sturge-Weber is a <b>GNAQ</b> mutation. Think \"<b>G</b>narly <b>N</b>euro-<b>A</b>ngioma <b>Q</b>ueue\" (or just GNAQ = Sturge-Weber).</li></ul>",
      "takeAway": "<p>A somatic mosaic mutation in the <b>GNAQ</b> gene drives the vascular malformations characteristic of Sturge-Weber syndrome.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "mutation_causes",
        "to": "sturge_weber_syndrome"
      },
      {
        "type": "results_in",
        "to": "port_wine_stain"
      },
      {
        "type": "results_in",
        "to": "leptomeningeal_angioma"
      }
    ]
  },
  "gabapentin": {
    "title": "Gabapentin",
    "primaryType": "substance",
    "tags": [
      "Pharmacology",
      "Neurology",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Neurology Drugs",
      "Anticonvulsants"
    ],
    "content": {
      "definition": "<p><b>Gabapentin</b> is an anticonvulsant and analgesic structurally related to GABA (but does <u>not</u> bind GABA receptors) that inhibits voltage-gated <u>calcium channels</u> (alpha-2-delta subunit), reducing excitatory neurotransmitter release.</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> Blocks voltage-gated <b>Ca<sup>2+</sup> channels</b> (specifically the &alpha;<sub>2</sub>&delta; subunit) &rarr; decreased glutamate release.</li><li><b>Clinical Uses:</b><br> - <b>Neuropathic Pain:</b> [[postherpetic_neuralgia]], Diabetic neuropathy.<br> - <b>Epilepsy:</b> Focal seizures (adjunct).</li><li><b>Adverse Effects:</b> Sedation, ataxia, dizziness, peripheral edema.</li><li><b>USMLE Tip:</b> Despite the name, it does <b>not</b> work on GABA receptors. Primarily used for <b>Neuropathic Pain</b>.</li></ul>",
      "takeAway": "<p><b>Gabapentin</b> blocks calcium channels to treat neuropathic pain and focal seizures, causing sedation and ataxia as primary side effects.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "blocks_channel",
        "to": "voltage_gated_calcium_channel"
      },
      {
        "type": "treats",
        "to": "neuropathic_pain"
      },
      {
        "type": "treats",
        "to": "postherpetic_neuralgia"
      },
      {
        "type": "is_included_in",
        "to": "gabapentinoids"
      }
    ]
  },
  "gabapentinoids": {
    "title": "Gabapentinoids",
    "primaryType": "group",
    "tags": [
      "Pharmacology",
      "Neurology",
      "Pain Management",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Neurology Drugs",
      "Calcium Channel Blockers"
    ],
    "content": {
      "definition": "<p><b>Gabapentinoids</b> are a class of drugs including [[gabapentin]] and [[pregabalin]] that function by blocking the alpha-2-delta subunit of voltage-gated <u>calcium channels</u>, thereby inhibiting the release of excitatory neurotransmitters.</p>",
      "atAGlance": "<ul><li><b>Agents:</b> Gabapentin, Pregabalin.</li><li><b>Mechanism:</b> Inhibit presynaptic voltage-gated Ca<sup>2+</sup> channels &rarr; decrease glutamate/substance P release.</li><li><b>Clinical Uses:</b> Neuropathic pain (Diabetic, Postherpetic), Fibromyalgia, Focal seizures, Restless Legs Syndrome.</li><li><b>Adverse Effects:</b> Dizziness, Sedation, Ataxia, Weight gain, Edema.</li><li><b>USMLE Tip:</b> First-line agents for neuropathic pain.</li></ul>",
      "takeAway": "<p><b>Gabapentinoids</b> target calcium channels to dampen neuronal excitability, making them effective for neuropathic pain and seizures.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "includes",
        "to": "gabapentin"
      },
      {
        "type": "includes",
        "to": "pregabalin"
      },
      {
        "type": "treats",
        "to": "neuropathic_pain"
      }
    ]
  },
  "gag_reflex": {
    "title": "Gag Reflex",
    "primaryType": "process",
    "tags": [
      "Neurology",
      "Physical Exam",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Neurologic Examination",
      "Brainstem Reflexes"
    ],
    "content": {
      "definition": "<p>The <b>Gag Reflex</b> (Pharyngeal Reflex) is a protective reflex contraction of the back of the throat elicited by touching the soft palate/pharynx, mediated by the afferent <u>Glossopharyngeal (CN IX)</u> and efferent <u>Vagus (CN X)</u> nerves.</p>",
      "atAGlance": "<ul><li><b>Afferent Limb:</b> <b>[[glossopharyngeal_nerve]] (CN IX)</b> (senses touch on posterior tongue/pharynx).</li><li><b>Efferent Limb:</b> <b>[[vagus_nerve]] (CN X)</b> (elevates palate/pharynx).</li><li><b>Center:</b> Medulla Oblongata.</li><li><b>Clinical Significance:</b><br> - <i>Absent:</i> Lesion of CN IX, CN X, or Medulla (e.g., [[lateral_medullary_syndrome]], [[bulbar_palsy]]).<br> - <i>Hyperactive:</i> UMN lesion (e.g., [[pseudobulbar_palsy]]).</li><li><b>USMLE Tip:</b> \"In on 9, Out on 10\". Absent gag reflex puts patients at high risk for aspiration.</li></ul>",
      "takeAway": "<p>The <b>Gag Reflex</b> tests the integrity of the IX-X reflex arc and the medulla; its absence indicates bulbar dysfunction, while hyperactivity suggests pseudobulbar palsy.</p>",
      "mermaid": "graph TD; A[Touch Pharynx] --> B[CN IX Afferent]; B --> C[Medulla]; C --> D[CN X Efferent]; D --> E[Pharyngeal Constriction/Elevation];"
    },
    "connections": [
      {
        "type": "mediated_by_afferent",
        "to": "glossopharyngeal_nerve"
      },
      {
        "type": "mediated_by_efferent",
        "to": "vagus_nerve"
      },
      {
        "type": "absent_in",
        "to": "bulbar_palsy"
      },
      {
        "type": "hyperactive_in",
        "to": "pseudobulbar_palsy"
      }
    ]
  },
  "galant_reflex": {
    "title": "Galant Reflex",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Pediatrics",
      "Reflexes",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Neurologic Examination",
      "Primitive Reflexes"
    ],
    "content": {
      "definition": "<p>The <b>Galant Reflex</b> (Truncal Incurvation Reflex) is a primitive reflex present in newborns where stroking along one side of the spine creates <u>lateral flexion</u> of the lower body toward the stimulated side.</p>",
      "atAGlance": "<ul><li><b>Elicitation:</b> Hold infant in ventral suspension (face down); stroke paravertebral skin.</li><li><b>Response:</b> Spine curves toward stimulus (buttocks swing toward touch).</li><li><b>Timeline:</b> Present at birth, disappears by ~6-9 months.</li><li><b>Clinical Significance:</b> Absence suggests spinal cord lesion; persistence suggests delayed development or cerebral palsy (frontal lobe inhibition failure).</li><li><b>USMLE Tip:</b> Primitive reflexes disappear as the frontal lobe matures.</li></ul>",
      "takeAway": "<p>The <b>Galant Reflex</b> helps assess spinal cord integrity in newborns and should disappear in the first year of life.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_a_type_of",
        "to": "primitive_reflexes"
      },
      {
        "type": "disappears_with_maturation_of",
        "to": "frontal_lobe"
      }
    ]
  },
  "galantamine": {
    "title": "Galantamine",
    "primaryType": "substance",
    "tags": [
      "Pharmacology",
      "Neurology",
      "Geriatrics",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Neurology Drugs",
      "Cholinesterase Inhibitors"
    ],
    "content": {
      "definition": "<p><b>Galantamine</b> is a centrally acting, reversible <i>acetylcholinesterase inhibitor</i> used to treat the cognitive symptoms of mild to moderate [[alzheimer_disease]] by increasing synaptic acetylcholine.</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> Competitive inhibition of AChE &rarr; Increases ACh levels in the CNS. Also acts as an allosteric modulator of nicotinic receptors.</li><li><b>Clinical Use:</b> [[alzheimer_disease]].</li><li><b>Adverse Effects:</b> Cholinergic toxicity (Nausea, vomiting, diarrhea, bradycardia).</li><li><b>USMLE Tip:</b> Part of the \"Donepezil, Rivastigmine, Galantamine\" trio for Alzheimer's symptomatic management.</li></ul>",
      "takeAway": "<p><b>Galantamine</b> boosts cholinergic transmission to treat Alzheimer's dementia, targeting the ACh deficit caused by basal forebrain degeneration.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "treats",
        "to": "alzheimer_disease"
      },
      {
        "type": "inhibits",
        "to": "acetylcholinesterase"
      },
      {
        "type": "is_grouped_with",
        "to": "donepezil"
      }
    ]
  },
  "vertical_gaze_palsy": {
    "title": "Vertical Gaze Palsy",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Ophthalmology",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Neuro-Ophthalmology",
      "Gaze Palsies"
    ],
    "content": {
      "definition": "<p><b>Vertical Gaze Palsy</b> is the inability to move the eyes vertically (usually <u>upgaze</u>), typically caused by a lesion in the dorsal midbrain involving the vertical gaze center (rostral interstitial nucleus of MLF/superior colliculus).</p>",
      "atAGlance": "<ul><li><b>Localization:</b> Dorsal Midbrain (Tectum/Pretectum).</li><li><b>Etiologies:</b><br> - <b>[[pineal_gland_tumor]] (Pinealoma):</b> Compresses the superior colliculus.<br> - <b>Hydrocephalus:</b> Dilation of cerebral aqueduct.<br> - <b>Stroke:</b> Midbrain infarction.</li><li><b>Clinical Syndrome:</b> Hallmark of <b>[[parinaud_syndrome]]</b> (Dorsal Midbrain Syndrome).</li><li><b>Associated Findings:</b> Light-near dissociation, Convergence-retraction nystagmus, Eyelid retraction.</li><li><b>USMLE Tip:</b> Patient cannot look up + Headache + Child = Pinealoma (Parinaud Syndrome).</li></ul>",
      "takeAway": "<p><b>Vertical Gaze Palsy</b> localizes to the dorsal midbrain and is the cardinal sign of Parinaud Syndrome, most often caused by a pineal tumor compressing the tectal plate.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_hallmark_of",
        "to": "parinaud_syndrome"
      },
      {
        "type": "caused_by_compression_of",
        "to": "midbrain"
      },
      {
        "type": "caused_by",
        "to": "pineal_gland_tumor"
      }
    ]
  },
  "generalized_seizures": {
    "title": "Generalized Seizures",
    "primaryType": "group",
    "tags": [
      "Neurology",
      "Epilepsy",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Epilepsy",
      "Seizure Classification"
    ],
    "content": {
      "definition": "<p><b>Generalized Seizures</b> involve epileptiform activity occurring in <u>both cerebral hemispheres</u> simultaneously from onset, characterized by loss of consciousness (except myoclonic) and bilateral motor manifestations.</p>",
      "atAGlance": "<ul><li><b>Types:</b><br> - <b>[[absence_seizure]]:</b> Staring, 3Hz spike-wave (Ethosuximide).<br> - <b>[[tonic_clonic_seizure]]:</b> Stiffening + Jerking.<br> - <b>[[myoclonic_seizure]]:</b> Quick jerks (no LOC).<br> - <b>[[atonic_seizure]]:</b> Drop attacks.<br> - <b>Tonic:</b> Stiffening only.</li><li><b>Treatment:</b> <b>[[broad_spectrum_anticonvulsants]]</b> (Valproate, Levetiracetam, Lamotrigine, Topiramate).</li><li><b>USMLE Tip:</b> Avoid narrow spectrum drugs (Carbamazepine, Phenytoin) for generalized seizures as they may worsen Absence/Myoclonic seizures.</li></ul>",
      "takeAway": "<p><b>Generalized Seizures</b> engage the entire brain at onset, necessitating broad-spectrum anticonvulsants like Valproate or Levetiracetam for management.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "includes",
        "to": "absence_seizure"
      },
      {
        "type": "includes",
        "to": "tonic_clonic_seizure"
      },
      {
        "type": "includes",
        "to": "myoclonic_seizure"
      },
      {
        "type": "includes",
        "to": "atonic_seizure"
      },
      {
        "type": "treated_by",
        "to": "broad_spectrum_anticonvulsants"
      }
    ]
  },
  "geriatric_neurology": {
    "title": "Geriatric Neurology",
    "primaryType": "concept",
    "tags": [
      "Neurology",
      "Geriatrics",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Aging"
    ],
    "content": {
      "definition": "<p><b>Geriatric Neurology</b> encompasses the age-related changes and pathologies affecting the nervous system in the elderly, characterized by brain atrophy, increased susceptibility to vascular insults, and neurodegenerative processes.</p>",
      "atAGlance": "<ul><li><b>Physiologic Changes:</b> Brain atrophy (widened sulci, ventriculomegaly ex vacuo), decreased neurotransmitters, lipofuscin accumulation.</li><li><b>Pathology Risk:</b><br> - <b>[[subdural_hematoma]]:</b> Atrophy stretches bridging veins &rarr; rupture with minor trauma.<br> - <b>[[normal_pressure_hydrocephalus]]:</b> Gait apraxia, incontinence, dementia.<br> - <b>Dementia:</b> [[alzheimer_disease]], [[vascular_dementia]].<br> - <b>Stroke/TIA:</b> Increased risk.</li><li><b>Pharmacology:</b> Increased sensitivity to anticholinergics (delirium) and benzodiazepines (falls).</li><li><b>USMLE Tip:</b> Bridging veins tear easily in the elderly due to brain atrophy (Subdural).</li></ul>",
      "takeAway": "<p><b>Geriatric Neurology</b> is defined by the consequences of brain atrophy (subdural risk) and neurodegeneration, requiring careful differentiation between normal aging and pathologic dementia.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "risk_factor_for",
        "to": "subdural_hematoma"
      },
      {
        "type": "risk_factor_for",
        "to": "normal_pressure_hydrocephalus"
      },
      {
        "type": "risk_factor_for",
        "to": "alzheimer_disease"
      }
    ]
  },
  "gerstmann_syndrome_ref": {
    "title": "Gerstmann Syndrome",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Cognition",
      "Stroke",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Cognitive Disorders",
      "Parietal Lobe Syndromes"
    ],
    "content": {
      "definition": "<p><b>Gerstmann Syndrome</b> is a cognitive disorder caused by a lesion in the <u>dominant parietal lobe</u> (Angular Gyrus), characterized by the tetrad of agraphia, acalculia, finger agnosia, and left-right disorientation.</p>",
      "atAGlance": "<ul><li><b>Localization:</b> Dominant (Left) Inferior Parietal Lobule (Angular Gyrus).</li><li><b>Tetrad:</b><br> 1. <b>[[agraphia]]:</b> Can't write.<br> 2. <b>[[acalculia]]:</b> Can't calculate.<br> 3. <b>[[finger_agnosia]]:</b> Can't identify fingers.<br> 4. <b>Left-Right Disorientation.</b></li><li><b>Etiology:</b> [[middle_cerebral_artery]] stroke (parietal branch).</li></ul>",
      "takeAway": "<p><b>Gerstmann Syndrome</b> localizes to the dominant angular gyrus, presenting with the specific tetrad of acalculia, agraphia, finger agnosia, and left-right confusion.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "localizes_to",
        "to": "parietal_lobe"
      },
      {
        "type": "includes",
        "to": "agraphia"
      },
      {
        "type": "includes",
        "to": "acalculia"
      }
    ]
  },
  "ghrelin": {
    "title": "Ghrelin",
    "primaryType": "substance",
    "tags": [
      "Endocrinology",
      "Physiology",
      "Gastroenterology",
      "USMLE"
    ],
    "classificationPath": [
      "Endocrinology",
      "Appetite Regulation"
    ],
    "content": {
      "definition": "<p><b>Ghrelin</b> is an orexigenic (appetite-stimulating) peptide hormone secreted primarily by the <u>stomach</u> that acts on the [[hypothalamus]] to increase hunger and stimulate growth hormone release.</p>",
      "atAGlance": "<ul><li><b>Source:</b> Gastric cells (Stomach).</li><li><b>Action:</b> Stimulates lateral [[hypothalamus]] &rarr; Increases appetite/hunger. Stimulates GH secretion.</li><li><b>Regulation:</b> Increased in fasting/sleep deprivation; Decreased after meals.</li><li><b>Pathology:</b><br> - <b>[[prader_willi_syndrome]]:</b> Elevated Ghrelin contributes to hyperphagia.<br> - <b>Gastric Bypass:</b> Removes Ghrelin-secreting cells &rarr; reduced appetite.</li><li><b>USMLE Tip:</b> \"<b>Ghr</b>elin makes your stomach <b>grr</b>owl.\" It opposes [[leptin]].</li></ul>",
      "takeAway": "<p><b>Ghrelin</b> is the \"hunger hormone\" from the stomach, driving appetite via the lateral hypothalamus and notably elevated in Prader-Willi syndrome.</p>",
      "mermaid": "graph TD; A[Fasting] --> B[Stomach Secretes Ghrelin]; B --> C[Lateral Hypothalamus]; C --> D[Increased Appetite]; B --> E[Anterior Pituitary]; E --> F[Increased Growth Hormone];"
    },
    "connections": [
      {
        "type": "secreted_by",
        "to": "stomach"
      },
      {
        "type": "acts_on",
        "to": "hypothalamus"
      },
      {
        "type": "elevated_in",
        "to": "prader_willi_syndrome"
      },
      {
        "type": "opposes",
        "to": "leptin"
      }
    ]
  },
  "glatiramer": {
    "title": "Glatiramer Acetate",
    "primaryType": "substance",
    "tags": [
      "Pharmacology",
      "Neurology",
      "Immunology",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Neurology Drugs",
      "Immunomodulators"
    ],
    "content": {
      "definition": "<p><b>Glatiramer Acetate</b> is an immunomodulatory drug used to treat [[multiple_sclerosis]], consisting of a random polymer of four amino acids found in myelin basic protein, acting as a <u>decoy</u> to divert autoimmune attack.</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> Resembles Myelin Basic Protein. Acts as a <b>Decoy</b> for T-cells &rarr; shifts immune response from Th1 (pro-inflammatory) to Th2 (anti-inflammatory).</li><li><b>Clinical Use:</b> Relapsing-Remitting [[multiple_sclerosis]] (Disease Modifying Therapy).</li><li><b>Adverse Effects:</b> Injection site reactions, flushing, chest tightness.</li><li><b>USMLE Tip:</b> The \"Glat\" stands for Glutamic acid, Lysine, Alanine, Tyrosine (the 4 amino acids). Mechanism = Decoy.</li></ul>",
      "takeAway": "<p><b>Glatiramer</b> acts as a myelin decoy to modulate the immune system in multiple sclerosis, reducing relapse rates.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "treats",
        "to": "multiple_sclerosis"
      },
      {
        "type": "mimics",
        "to": "myelin_basic_protein"
      }
    ]
  }
}
``````json
{
  "glaucoma": {
    "title": "Glaucoma",
    "primaryType": "disease",
    "tags": [
      "Ophthalmology",
      "Neurology",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Ophthalmology",
      "Optic Nerve Disorders",
      "Glaucoma"
    ],
    "content": {
      "definition": "<p><b>Glaucoma</b> is a group of optic neuropathies characterized by progressive structural damage to the optic nerve (optic disc cupping) and visual field loss (peripheral to central), usually associated with elevated [[intraocular_pressure]] (IOP) due to impaired aqueous humor drainage.</p>",
      "atAGlance": "<ul><li><b>Types:</b><br> - <b>[[open_angle_glaucoma]]:</b> Chronic, painless. Increased resistance to outflow through trabecular meshwork.<br> - <b>[[angle_closure_glaucoma]]:</b> Acute, painful emergency. Physical obstruction of the angle by the iris.</li><li><b>Fundoscopy:</b> Increased cup-to-disc ratio (\"cupping\") due to loss of nerve fibers.</li><li><b>Visual Field:</b> Peripheral vision loss followed by central loss.</li><li><b>Treatment:</b><br> - <i>Decrease Production:</i> [[beta_blockers]] (Timolol), Alpha-2 agonists ([[brimonidine]]), [[acetazolamide]].<br> - <i>Increase Outflow:</i> [[prostaglandin_analogs]] (Latanoprost), Muscarinic agonists ([[pilocarpine]]).</li><li><b>USMLE Tip:</b> Disc cupping > 0.5 is suggestive. Treat Open-angle with Prostaglandins (1st line); Treat Closed-angle with Iridotomy (definitive).</li></ul>",
      "takeAway": "<p><b>Glaucoma</b> is an optic neuropathy driven by intraocular pressure, leading to \"cupping\" of the optic disc and peripheral vision loss; management targets aqueous humor dynamics.</p>",
      "mermaid": "graph TD; A[Increased IOP] --> B[Optic Nerve Compression]; B --> C[Retinal Ganglion Cell Death]; C --> D[Optic Disc Cupping]; D --> E[Peripheral Vision Loss];"
    },
    "connections": [
      {
        "type": "characterized_by",
        "to": "increased_intraocular_pressure"
      },
      {
        "type": "includes",
        "to": "open_angle_glaucoma"
      },
      {
        "type": "includes",
        "to": "angle_closure_glaucoma"
      },
      {
        "type": "treated_by",
        "to": "timolol"
      },
      {
        "type": "treated_by",
        "to": "latanoprost"
      }
    ]
  },
  "glial_cells": {
    "title": "Glial Cells",
    "primaryType": "group",
    "tags": [
      "Neurology",
      "Histology",
      "Cell Biology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Neurohistology",
      "Glial Cells"
    ],
    "content": {
      "definition": "<p><b>Glial Cells</b> (Neuroglia) are the non-neuronal support cells of the nervous system, providing physical support, insulation (myelin), and metabolic maintenance for neurons.</p>",
      "atAGlance": "<ul><li><b>CNS Glia (Neuroectoderm):</b><br> - <b>[[astrocytes]]:</b> BBB support, K+ metabolism, repair (gliosis). GFAP+.<br> - <b>[[oligodendrocytes]]:</b> Myelinate multiple CNS axons. \"Fried egg\" appearance.<br> - <b>[[ependymal_cells]]:</b> Line ventricles, produce CSF.<br> - <b>[[microglia]] (Mesoderm):</b> Phagocytes (CNS macrophages).</li><li><b>PNS Glia (Neural Crest):</b><br> - <b>[[schwann_cells]]:</b> Myelinate single PNS axon. S-100+.<br> - <b>Satellite Cells:</b> Support ganglia.</li><li><b>USMLE Tip:</b> Microglia are the <u>only</u> glia derived from Mesoderm; all others are Neuroectoderm/Neural Crest.</li></ul>",
      "takeAway": "<p><b>Glial Cells</b> maintain the neural environment; Astrocytes support, Oligodendrocytes/Schwann cells myelinate, and Microglia defend.</p>",
      "mermaid": "graph TD; A[Neural Stem Cell] --> B[Glioblast]; B --> C[Astrocyte]; B --> D[Oligodendrocyte]; E[Mesoderm] --> F[Microglia]; G[Neural Crest] --> H[Schwann Cell];"
    },
    "connections": [
      {
        "type": "includes",
        "to": "astrocytes"
      },
      {
        "type": "includes",
        "to": "oligodendrocytes"
      },
      {
        "type": "includes",
        "to": "microglia"
      },
      {
        "type": "includes",
        "to": "schwann_cells"
      }
    ]
  },
  "glioblastoma": {
    "title": "Glioblastoma",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Oncology",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Neuro-Oncology",
      "Astrocytomas"
    ],
    "content": {
      "definition": "<p><b>Glioblastoma</b> (GBM, WHO Grade IV Astrocytoma) is the most common and most malignant primary brain tumor in adults, characterized by rapid infiltrative growth and necrosis.</p>",
      "atAGlance": "<ul><li><b>Pathology:</b> <b>\"Pseudopalisading\"</b> tumor cells surrounding central necrosis. Vascular proliferation. <b>GFAP</b> positive.</li><li><b>Gross Anatomy:</b> Hemorrhagic, necrotic mass often crossing the corpus callosum (<b>\"Butterfly Glioma\"</b>).</li><li><b>Genetics:</b> <i>EGFR</i> amplification, <i>PTEN</i> loss.</li><li><b>Clinical:</b> Seizures, headache, focal deficits. Rapid progression (< 1 year survival).</li><li><b>USMLE Tip:</b> \"Pseudopalisading necrosis\" and \"Butterfly lesion\" are the buzzwords.</li></ul>",
      "takeAway": "<p><b>Glioblastoma</b> is a high-grade astrocyte tumor with a dismal prognosis, identified by its butterfly appearance on imaging and pseudopalisading necrosis on histology.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "originates_from",
        "to": "astrocytes"
      },
      {
        "type": "crosses",
        "to": "corpus_callosum"
      },
      {
        "type": "markers_include",
        "to": "glial_fibrillary_acidic_protein"
      }
    ]
  },
  "global_aphasia": {
    "title": "Global Aphasia",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Pathology",
      "Language",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Cognitive Disorders",
      "Aphasias"
    ],
    "content": {
      "definition": "<p><b>Global Aphasia</b> is the most severe form of aphasia, characterized by the impairment of <u>all language modalities</u> (fluency, comprehension, and repetition), resulting from extensive damage to the dominant hemisphere.</p>",
      "atAGlance": "<ul><li><b>Lesion:</b> Extensive damage to the Left Perisylvian region, affecting both <b>[[broca_area]]</b> and <b>[[wernicke_area]]</b> (and the [[arcuate_fasciculus]]).</li><li><b>Etiology:</b> Large <b>[[middle_cerebral_artery]]</b> (MCA) infarct (Main stem occlusion).</li><li><b>Clinical:</b> Non-fluent/mute speech, poor comprehension, poor repetition. Often accompanied by dense right hemiparesis and hemianopsia.</li><li><b>USMLE Tip:</b> The patient can neither speak nor understand. Look for a massive Left MCA stroke.</li></ul>",
      "takeAway": "<p><b>Global Aphasia</b> represents a \"wipe-out\" of the language centers, causing non-fluent speech and loss of comprehension, typically due to a proximal MCA occlusion.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "involves_damage_to",
        "to": "broca_area"
      },
      {
        "type": "involves_damage_to",
        "to": "wernicke_area"
      },
      {
        "type": "caused_by_infarct_of",
        "to": "middle_cerebral_artery"
      }
    ]
  },
  "globose_nucleus": {
    "title": "Globose Nucleus",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Anatomy",
      "Cerebellum",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Brain Anatomy",
      "Cerebellum",
      "Deep Nuclei"
    ],
    "content": {
      "definition": "<p>The <b>Globose Nucleus</b> is one of the deep cerebellar nuclei (part of the <u>Interposed Nuclei</u>) that regulates muscle tone and limb movement via projections to the Red Nucleus.</p>",
      "atAGlance": "<ul><li><b>Location:</b> Medial to the Emboliform, lateral to the Fastigial nucleus.</li><li><b>Function:</b> Works with the Emboliform nucleus to control proximal limb muscles.</li><li><b>Input:</b> Paravermis (Spinocerebellum).</li><li><b>Output:</b> Contralateral <b>Red Nucleus</b> (Rubrospinal tract).</li><li><b>Mnemonic:</b> \"<b>G</b>lobose\" is in the middle of \"Don't Eat <b>G</b>reasy Foods\".</li></ul>",
      "takeAway": "<p>The <b>Globose Nucleus</b> is a deep cerebellar nucleus involved in adjusting limb movements, functioning as part of the Interposed Nuclei.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_part_of",
        "to": "cerebellum"
      },
      {
        "type": "projects_to",
        "to": "red_nucleus"
      }
    ]
  },
  "globus_pallidus_externus": {
    "title": "Globus Pallidus Externus (GPe)",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Anatomy",
      "Basal Ganglia",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Brain Anatomy",
      "Basal Ganglia"
    ],
    "content": {
      "definition": "<p>The <b>Globus Pallidus Externus (GPe)</b> is a nucleus of the [[basal_ganglia]] that serves as a central relay in the <u>Indirect Pathway</u>, tonically inhibiting the Subthalamic Nucleus to regulate movement.</p>",
      "atAGlance": "<ul><li><b>Function:</b> Inhibits the [[subthalamic_nucleus]] (STN) via GABA.</li><li><b>Indirect Pathway:</b> Striatum (D2) inhibits GPe &rarr; GPe releases STN &rarr; STN excites GPi &rarr; GPi inhibits Thalamus &rarr; <b>Decreased Movement</b>.</li><li><b>Neurotransmitter:</b> GABA (Inhibitory).</li><li><b>USMLE Tip:</b> In the Indirect Pathway, the GPe acts as the \"inhibitor of the inhibitor.\" Inhibition of GPe releases the STN brake.</li></ul>",
      "takeAway": "<p>The <b>Globus Pallidus Externus</b> is the GABAergic relay of the Indirect Pathway; its inhibition by the striatum leads to suppression of movement via the subthalamic nucleus.</p>",
      "mermaid": "graph TD; A[Striatum D2] --Inhibits--> B[Globus Pallidus Externus]; B --Inhibits--> C[Subthalamic Nucleus]; C --Excites--> D[Globus Pallidus Internus]; D --Inhibits--> E[Thalamus];"
    },
    "connections": [
      {
        "type": "is_part_of",
        "to": "basal_ganglia"
      },
      {
        "type": "is_part_of",
        "to": "indirect_pathway_basal_ganglia"
      },
      {
        "type": "inhibits",
        "to": "subthalamic_nucleus"
      }
    ]
  },
  "glossopharyngeal_nerve": {
    "title": "Glossopharyngeal Nerve (CN IX)",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Anatomy",
      "Cranial Nerves",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Cranial Nerves",
      "CN IX"
    ],
    "content": {
      "definition": "<p>The <b>Glossopharyngeal Nerve (CN IX)</b> is a mixed cranial nerve serving sensory, motor, and autonomic functions for the posterior tongue, pharynx, and parotid gland.</p>",
      "atAGlance": "<ul><li><b>Sensory:</b> Taste and Somatic sensation to <b>Posterior 1/3 of Tongue</b>; Tonsils; Pharynx; Middle Ear.</li><li><b>Visceral Sensory:</b> Carotid Body (Chemoreceptors) and Carotid Sinus (Baroreceptors).</li><li><b>Motor:</b> <b>Stylopharyngeus</b> muscle (elevates pharynx/larynx).</li><li><b>Parasympathetic:</b> <b>Parotid Gland</b> (via Otic Ganglion).</li><li><b>Reflex:</b> Afferent limb of the <b>[[gag_reflex]]</b>.</li><li><b>Lesions:</b> Loss of gag reflex, loss of taste/sensation post. 1/3 tongue, dysphagia.</li></ul>",
      "takeAway": "<p><b>CN IX</b> is the nerve of the posterior tongue and pharynx, governing taste, sensation, swallowing (afferent gag), and parotid secretion.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "innervates",
        "to": "stylopharyngeus_muscle"
      },
      {
        "type": "provides_sensory_to",
        "to": "posterior_tongue"
      },
      {
        "type": "mediates_afferent_limb_of",
        "to": "gag_reflex"
      },
      {
        "type": "stimulates",
        "to": "parotid_gland"
      }
    ]
  },
  "gonadotropin_releasing_hormone": {
    "title": "Gonadotropin-Releasing Hormone (GnRH)",
    "primaryType": "substance",
    "tags": [
      "Endocrinology",
      "Neurology",
      "Physiology",
      "USMLE"
    ],
    "classificationPath": [
      "Endocrinology",
      "Hypothalamic Hormones"
    ],
    "content": {
      "definition": "<p><b>Gonadotropin-Releasing Hormone (GnRH)</b> is a decapeptide produced by the <u>preoptic nucleus</u> of the hypothalamus that stimulates the anterior pituitary to secrete FSH and LH in a pulsatile manner.</p>",
      "atAGlance": "<ul><li><b>Source:</b> Preoptic nucleus of the [[hypothalamus]].</li><li><b>Target:</b> Gonadotrophs in the [[adenohypophysis]].</li><li><b>Action:</b> Stimulates release of <b>FSH</b> and <b>LH</b>.</li><li><b>Regulation:</b> <b>Pulsatile</b> release is required for stimulation. Continuous administration (e.g., [[leuprolide]]) leads to downregulation/suppression (chemical castration).</li><li><b>Pathology:</b> Kallmann Syndrome (failure of GnRH neuron migration) &rarr; Hypogonadotropic hypogonadism + Anosmia.</li><li><b>USMLE Tip:</b> Prolactin inhibits GnRH release (mechanism of lactational amenorrhea).</li></ul>",
      "takeAway": "<p><b>GnRH</b> drives the reproductive axis via pulsatile stimulation of the pituitary; its continuous analogs are used to suppress the axis in conditions like prostate cancer or endometriosis.</p>",
      "mermaid": "graph TD; A[Hypothalamus] -->|Pulsatile GnRH| B[Anterior Pituitary]; B --> C[FSH/LH Release]; C --> D[Gonads]; E[Continuous GnRH] --x|Downregulation| B;"
    },
    "connections": [
      {
        "type": "synthesized_in",
        "to": "hypothalamus"
      },
      {
        "type": "stimulates",
        "to": "adenohypophysis"
      },
      {
        "type": "analog_is",
        "to": "leuprolide"
      },
      {
        "type": "deficient_in",
        "to": "kallmann_syndrome"
      }
    ]
  },
  "generalized_tonic_clonic_seizure": {
    "title": "Generalized Tonic-Clonic Seizure",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Epilepsy",
      "Emergency Medicine",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Epilepsy",
      "Generalized Seizures"
    ],
    "content": {
      "definition": "<p>A <b>Generalized Tonic-Clonic Seizure</b> (Grand Mal) is a type of seizure involving the entire brain, characterized by an initial <u>tonic</u> phase (stiffening, loss of consciousness) followed by a <u>clonic</u> phase (rhythmic jerking), and a postictal state.</p>",
      "atAGlance": "<ul><li><b>Phases:</b><br> 1. <b>Tonic:</b> Sudden loss of consciousness, diffuse muscle contraction (stiffening), \"ictal cry\" (expiration against closed glottis).<br> 2. <b>Clonic:</b> Rhythmic jerking of limbs.<br> 3. <b>Postictal:</b> Confusion, lethargy, gradual return to baseline.</li><li><b>Physiology:</b> Diffuse, synchronous electrical discharges across both hemispheres.</li><li><b>Management:</b> ABCs. Abort with [[benzodiazepines]] if prolonged. Maintenance with [[valproate]], [[levetiracetam]], or [[lamotrigine]].</li><li><b>USMLE Tip:</b> Differentiate from syncope (quick recovery, no postictal confusion). Lateral tongue biting implies seizure.</li></ul>",
      "takeAway": "<p><b>Tonic-Clonic Seizures</b> are the most dramatic generalized seizures, involving stiffening and jerking followed by profound postictal confusion; they require broad-spectrum anticonvulsants.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_a_type_of",
        "to": "generalized_seizures"
      },
      {
        "type": "treated_by",
        "to": "broad_spectrum_anticonvulsants"
      },
      {
        "type": "acutely_managed_with",
        "to": "benzodiazepines"
      }
    ]
  },
  "guillain_barre_syndrome": {
    "title": "Guillain-Barré Syndrome (GBS)",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Immunology",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Peripheral Neuropathy",
      "Autoimmune"
    ],
    "content": {
      "definition": "<p><b>Guillain-Barré Syndrome</b> is an acute, autoimmune, demyelinating polyradiculopathy of the peripheral nervous system, characterized by <u>ascending muscle weakness</u>, areflexia, and albuminocytologic dissociation.</p>",
      "atAGlance": "<ul><li><b>Pathophysiology:</b> Autoimmune attack on <b>Schwann cells</b>/myelin (or axons) via molecular mimicry following infection (e.g., <i>[[campylobacter_jejuni]]</i>, CMV, Zika).</li><li><b>Clinical Presentation:</b> Symmetric <b>Ascending Paralysis</b> (Legs &rarr; Arms &rarr; Face/Respiratory). Absent DTRs. Autonomic dysregulation (arrhythmias, BP lability).</li><li><b>Diagnosis:</b> CSF shows <b>[[albuminocytologic_dissociation]]</b> (High protein, normal cells). Nerve conduction studies show slowing.</li><li><b>Treatment:</b> <b>IVIG</b> or <b>Plasmapheresis</b>. Supportive care (ventilator). Steroids are ineffective.</li><li><b>USMLE Tip:</b> The most common cause of acute flaccid paralysis. Monitor <b>Vital Capacity</b> for respiratory failure.</li></ul>",
      "takeAway": "<p><b>GBS</b> is an acute post-infectious demyelinating neuropathy causing ascending paralysis; diagnosis relies on CSF findings (high protein), and management focuses on respiratory support and immunotherapy.</p>",
      "mermaid": "graph TD; A[Campylobacter Infection] --> B[Antibody Production]; B --> C[Cross-reaction with Peripheral Nerve Gangliosides]; C --> D[Schwann Cell Damage]; D --> E[Demyelination]; E --> F[Ascending Weakness/Areflexia];"
    },
    "connections": [
      {
        "type": "triggered_by",
        "to": "campylobacter_jejuni"
      },
      {
        "type": "manifests_as",
        "to": "albuminocytologic_dissociation"
      },
      {
        "type": "destroys_cell_type",
        "to": "schwann_cells"
      },
      {
        "type": "treated_by",
        "to": "plasmapheresis"
      }
    ]
  },
  "gustatory_pathway": {
    "title": "Gustatory Pathway",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Anatomy",
      "Sensory Pathways",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Sensory Systems",
      "Taste"
    ],
    "content": {
      "definition": "<p>The <b>Gustatory Pathway</b> carries taste sensation from the tongue via cranial nerves VII, IX, and X to the <u>Nucleus Tractus Solitarius</u>, then to the VPM of the thalamus, and finally to the gustatory cortex.</p>",
      "atAGlance": "<ul><li><b>Afferent Nerves:</b><br> - <i>Ant 2/3 Tongue:</i> [[facial_nerve]] (Chorda Tympani).<br> - <i>Post 1/3 Tongue:</i> [[glossopharyngeal_nerve]].<br> - <i>Epiglottis/Pharynx:</i> [[vagus_nerve]].</li><li><b>First Relay:</b> <b>[[nucleus_tractus_solitarius]]</b> (Medulla).</li><li><b>Second Relay:</b> <b>[[ventral_posteromedial_nucleus]] (VPM)</b> of the Thalamus.</li><li><b>Cortex:</b> Gustatory Cortex (Insula/Frontal Operculum).</li><li><b>USMLE Tip:</b> VPM = Mouth/Face (Taste + Trigeminal sensation).</li></ul>",
      "takeAway": "<p>Taste travels via CN VII, IX, and X to the solitary nucleus, then relays through the thalamic VPM to reach the cortex.</p>",
      "mermaid": "graph TD; A[Tongue Taste Buds] --> B[CN VII/IX/X]; B --> C[Nucleus Tractus Solitarius]; C --> D[VPM of Thalamus]; D --> E[Gustatory Cortex];"
    },
    "connections": [
      {
        "type": "synapses_in",
        "to": "nucleus_tractus_solitarius"
      },
      {
        "type": "relays_through",
        "to": "ventral_posteromedial_nucleus"
      },
      {
        "type": "carried_by",
        "to": "facial_nerve"
      }
    ]
  },
  "hiv_associated_dementia": {
    "title": "HIV-Associated Dementia",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Infectious Disease",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Neurodegenerative Diseases",
      "Infectious"
    ],
    "content": {
      "definition": "<p><b>HIV-Associated Dementia</b> is a subcortical dementia occurring in advanced HIV infection, caused by direct viral neurotoxicity and macrophage activation, leading to microglial nodules and multinucleated giant cells.</p>",
      "atAGlance": "<ul><li><b>Pathophysiology:</b> HIV infects microglia/macrophages (via CCR5/CXCR4) &rarr; Cytokine release/Neurotoxicity. Neurons are <u>not</u> directly infected.</li><li><b>Histology:</b> <b>Microglial Nodules</b> with <b>Multinucleated Giant Cells</b>. Diffuse white matter pallor.</li><li><b>Clinical Presentation:</b> Subcortical dementia: Psychomotor slowing, impaired attention, memory deficits, gait disturbance, depressive symptoms.</li><li><b>Imaging:</b> Cerebral atrophy, diffuse white matter hyperintensities.</li><li><b>USMLE Tip:</b> \"Multinucleated giant cells\" in the brain of an AIDS patient = HIV Encephalitis.</li></ul>",
      "takeAway": "<p><b>HIV Dementia</b> is a direct consequence of HIV infection of CNS microglia, forming characteristic nodules and giant cells, causing a subcortical cognitive decline.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "caused_by",
        "to": "human_immunodeficiency_virus"
      },
      {
        "type": "characterized_by",
        "to": "microglial_nodules"
      },
      {
        "type": "affects_cell_type",
        "to": "microglia"
      }
    ]
  },
  "haemophilus_influenzae": {
    "title": "Haemophilus influenzae",
    "primaryType": "organism",
    "tags": [
      "Microbiology",
      "Infectious Disease",
      "USMLE"
    ],
    "classificationPath": [
      "Microbiology",
      "Bacteria",
      "Gram-Negative Coccobacilli"
    ],
    "content": {
      "definition": "<p><b>Haemophilus influenzae</b> is a Gram-negative coccobacillus that requires Factors V (NAD+) and X (Hematin) for growth, causing respiratory infections and, in unvaccinated children (Type b), serious invasive diseases like [[meningitis]] and [[epiglottitis]].</p>",
      "atAGlance": "<ul><li><b>Characteristics:</b> Gram(-) coccobacillus. Growth on <b>Chocolate Agar</b> (provides Factors V and X).</li><li><b>Serotypes:</b><br> - <i>Type b (Capsular):</i> Polyribosylribitol phosphate (PRP) capsule. Causes Meningitis, Epiglottitis, Septic Arthritis.<br> - <i>Non-typeable (Unencapsulated):</i> Mucosal infections ([[otitis_media]], Sinusitis, Pneumonia, COPD exacerbations).</li><li><b>Virulence:</b> IgA Protease, Capsule (Type b).</li><li><b>Prevention:</b> Hib Vaccine (Capsule conjugated to diphtheria toxoid) &rarr; drastic reduction in meningitis/epiglottitis.</li><li><b>USMLE Tip:</b> Can grow on Blood Agar <i>only</i> if surrounding <i>S. aureus</i> (\"Satellite Phenomenon\" - Staph provides Factor V).</li></ul>",
      "takeAway": "<p><b>Haemophilus influenzae</b> requires chocolate agar; Type b causes invasive meningitis/epiglottitis (prevented by vaccine), while non-typeable strains cause common mucosal infections like otitis media.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "causes",
        "to": "meningitis"
      },
      {
        "type": "causes",
        "to": "otitis_media"
      },
      {
        "type": "causes",
        "to": "epiglottitis"
      },
      {
        "type": "grown_on",
        "to": "chocolate_agar"
      }
    ]
  },
  "hamartin": {
    "title": "Hamartin",
    "primaryType": "substance",
    "tags": [
      "Genetics",
      "Neurology",
      "Oncology",
      "USMLE"
    ],
    "classificationPath": [
      "Biochemistry",
      "Proteins",
      "Tumor Suppressors"
    ],
    "content": {
      "definition": "<p><b>Hamartin</b> is the protein product of the <i>TSC1</i> gene (Chromosome 9), which forms a complex with [[tuberin]] (TSC2) to inhibit the mTOR pathway, acting as a tumor suppressor; its mutation causes <b>[[tuberous_sclerosis]]</b>.</p>",
      "atAGlance": "<ul><li><b>Gene:</b> <i>TSC1</i> on Chromosome 9.</li><li><b>Function:</b> Forms a complex with Tuberin (TSC2). This complex acts as a GTPase-activating protein (GAP) for Rheb, thereby <b>inhibiting mTOR</b> (mechanistic target of rapamycin).</li><li><b>Pathology:</b> Loss of function &rarr; uncontrolled mTOR activation &rarr; cell growth/proliferation &rarr; Hamartomas.</li><li><b>Clinical Syndrome:</b> [[tuberous_sclerosis]] (Hamartomas in brain/skin/heart/kidney, Seizures, Intellectual disability).</li><li><b>USMLE Tip:</b> TSC<b>1</b> = Hamartin. TSC<b>2</b> = <b>Tu</b>berin.</li></ul>",
      "takeAway": "<p><b>Hamartin</b> (TSC1) works with Tuberin to suppress mTOR; defects lead to the multi-system hamartomas of Tuberous Sclerosis.</p>",
      "mermaid": "graph TD; A[TSC1 (Hamartin)] --- B[TSC2 (Tuberin)]; A & B -->|Inhibit| C[mTOR Pathway]; D[Mutation in TSC1] --> E[Unchecked mTOR]; E --> F[Cell Growth/Hamartomas];"
    },
    "connections": [
      {
        "type": "associated_with_gene",
        "to": "tsc1_gene"
      },
      {
        "type": "deficiency_causes",
        "to": "tuberous_sclerosis"
      },
      {
        "type": "interacts_with",
        "to": "tuberin"
      },
      {
        "type": "inhibits",
        "to": "mtor_pathway"
      }
    ]
  }
}
``````json
{
  "headache_disorders": {
    "title": "Headache Disorders",
    "primaryType": "group",
    "tags": [
      "Neurology",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Headache"
    ],
    "content": {
      "definition": "<p><b>Headache Disorders</b> are classified into primary (no underlying structural cause) and secondary (symptom of underlying pathology) types, with distinct clinical features and management strategies.</p>",
      "atAGlance": "<ul><li><b>Primary Headaches:</b><br> - <b>[[tension_headache]]:</b> Bilateral, band-like, no photophobia/aura.<br> - <b>[[migraine]]:</b> Unilateral, pulsating, photophobia/phonophobia, aura (scintillating scotoma). POUND mnemonic.<br> - <b>[[cluster_headache]]:</b> Unilateral periorbital, excruciating, autonomic symptoms (lacrimation, rhinorrhea), circadian rhythm.</li><li><b>Secondary Headaches:</b> [[subarachnoid_hemorrhage]] (\"Thunderclap\"), [[idiopathic_intracranial_hypertension]], [[giant_cell_arteritis]], Meningitis, Tumor.</li><li><b>USMLE Tip:</b> \"Worst headache of my life\" = SAH. \"Band-like\" = Tension. \"Periorbital + Tearing\" = Cluster.</li></ul>",
      "takeAway": "<p><b>Headache Disorders</b> are distinguished by duration, location, and associated symptoms; Migraines are vascular/neuronal, Tension is musculoskeletal/stress, and Cluster is autonomic/hypothalamic.</p>",
      "mermaid": "graph TD; A[Headache] --> B{Primary or Secondary?}; B -->|Primary| C{Features?}; C -->|Bilateral/Band-like| D[Tension]; C -->|Unilateral/Pulsating| E[Migraine]; C -->|Periorbital/Autonomic| F[Cluster]; B -->|Secondary| G[Red Flags]; G -->|Thunderclap| H[Subarachnoid Hemorrhage]; G -->|Fever/Nuchal Rigidity| I[Meningitis];"
    },
    "connections": [
      {
        "type": "includes",
        "to": "migraine"
      },
      {
        "type": "includes",
        "to": "tension_headache"
      },
      {
        "type": "includes",
        "to": "cluster_headache"
      },
      {
        "type": "includes",
        "to": "idiopathic_intracranial_hypertension"
      }
    ]
  },
  "hearing_loss": {
    "title": "Hearing Loss",
    "primaryType": "disease",
    "tags": [
      "Otolaryngology",
      "Neurology",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Otolaryngology",
      "Hearing Disorders"
    ],
    "content": {
      "definition": "<p><b>Hearing Loss</b> is the partial or total inability to hear, classified anatomically into <u>Conductive</u> (outer/middle ear) and <u>Sensorineural</u> (inner ear/cochlear nerve) types, distinguished by the Rinne and Weber tuning fork tests.</p>",
      "atAGlance": "<ul><li><b>[[conductive_hearing_loss]]:</b> Obstruction (wax), Otitis media, Otosclerosis, Cholesteatoma. <i>Rinne:</i> Bone > Air. <i>Weber:</i> Localizes to <b>affected</b> ear.</li><li><b>[[sensorineural_hearing_loss]]:</b> [[presbycusis]] (aging), [[noise_induced_hearing_loss]], Drugs (Aminoglycosides, Cisplatin), Meniere's, Acoustic Neuroma. <i>Rinne:</i> Air > Bone (Normal). <i>Weber:</i> Localizes to <b>unaffected</b> ear.</li><li><b>Presbycusis:</b> Bilateral high-frequency loss due to hair cell destruction at the cochlear base.</li><li><b>USMLE Tip:</b> Weber goes to the <b>W</b>eaker ear in Conductive, <b>S</b>tronger ear in Sensorineural.</li></ul>",
      "takeAway": "<p><b>Hearing Loss</b> is categorized by the site of pathology; Conductive involves sound transmission failure (Bone > Air), while Sensorineural involves nerve/cochlear failure (Air > Bone, lateralizes to good ear).</p>",
      "mermaid": "graph TD; A[Hearing Loss] --> B{Weber Test}; B -->|Lateralizes to Bad Ear| C[Conductive Loss]; B -->|Lateralizes to Good Ear| D[Sensorineural Loss]; C --> E[Rinne: BC > AC]; D --> F[Rinne: AC > BC];"
    },
    "connections": [
      {
        "type": "includes",
        "to": "conductive_hearing_loss"
      },
      {
        "type": "includes",
        "to": "sensorineural_hearing_loss"
      },
      {
        "type": "caused_by",
        "to": "presbycusis"
      },
      {
        "type": "caused_by",
        "to": "noise_induced_hearing_loss"
      }
    ]
  },
  "heat_stroke": {
    "title": "Heat Stroke",
    "primaryType": "disease",
    "tags": [
      "Emergency Medicine",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Medicine",
      "Environmental Injuries",
      "Hyperthermia"
    ],
    "content": {
      "definition": "<p><b>Heat Stroke</b> is a life-threatening condition defined by a core body temperature >40°C (104°F) accompanied by <u>CNS dysfunction</u> (confusion, coma, seizures) due to failure of thermoregulation.</p>",
      "atAGlance": "<ul><li><b>Pathophysiology:</b> Failure of evaporative cooling (sweating) &rarr; Rapid rise in core temp &rarr; Denaturation of proteins/enzymes &rarr; Multiorgan failure.</li><li><b>Clinical Presentation:</b> Hyperthermia (>40°C), Altered Mental Status, Anhidrosis (hot, dry skin - classic) or Profuse sweating (exertional).</li><li><b>Complications:</b> Rhabdomyolysis, Acute Kidney Injury, DIC, ARDS.</li><li><b>Treatment:</b> Rapid external cooling (ice water immersion), rehydration.</li><li><b>Differentiation:</b> Contrast with <b>Fever</b> (cytokine-mediated set-point change, managed with antipyretics). Heat stroke is not cytokine-mediated; antipyretics do not work.</li></ul>",
      "takeAway": "<p><b>Heat Stroke</b> is a medical emergency of thermoregulatory failure causing hyperthermia and CNS dysfunction, requiring rapid physical cooling rather than antipyretics.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_distinguished_from",
        "to": "fever"
      },
      {
        "type": "causes",
        "to": "rhabdomyolysis"
      },
      {
        "type": "manifests_as",
        "to": "altered_mental_status"
      }
    ]
  },
  "hemangioblastoma": {
    "title": "Hemangioblastoma",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Oncology",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Neuro-Oncology",
      "Vascular Tumors"
    ],
    "content": {
      "definition": "<p><b>Hemangioblastoma</b> is a slow-growing, highly vascular benign tumor of the central nervous system, most commonly found in the <u>cerebellum</u>, often associated with <b>[[von_hippel_lindau_disease]]</b>.</p>",
      "atAGlance": "<ul><li><b>Histology:</b> Closely packed, thin-walled capillaries with intervening stromal cells containing lipid vacuoles.</li><li><b>Location:</b> Cerebellum (most common), Brainstem, Spinal Cord, Retina.</li><li><b>Paraneoplastic Syndrome:</b> Can produce <b>Erythropoietin (EPO)</b> &rarr; [[polycythemia]] (Secondary).</li><li><b>Genetics:</b> Associated with <i>VHL</i> gene deletion on Chromosome 3p (Von Hippel-Lindau).</li><li><b>Imaging:</b> Cystic lesion with a vascular mural nodule.</li><li><b>USMLE Tip:</b> Cerebellar tumor + Polycythemia = Hemangioblastoma.</li></ul>",
      "takeAway": "<p><b>Hemangioblastomas</b> are vascular cerebellar tumors that may secrete EPO causing polycythemia and are a hallmark of Von Hippel-Lindau disease.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "associated_with",
        "to": "von_hippel_lindau_disease"
      },
      {
        "type": "secretes",
        "to": "erythropoietin"
      },
      {
        "type": "causes",
        "to": "polycythemia"
      }
    ]
  },
  "hemianopia": {
    "title": "Hemianopia",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Ophthalmology",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Neuro-Ophthalmology",
      "Visual Field Defects"
    ],
    "content": {
      "definition": "<p><b>Hemianopia</b> is a visual field defect characterized by the loss of vision in <u>half</u> of the visual field of one or both eyes, localizing lesions to the optic chiasm, optic tract, or visual cortex.</p>",
      "atAGlance": "<ul><li><b>[[bitemporal_hemianopia]]:</b> Loss of both temporal fields (\"Tunnel vision\"). Lesion: Optic Chiasm (e.g., Pituitary Adenoma).</li><li><b>Homonymous Hemianopia:</b> Loss of the <i>same</i> side in both eyes (e.g., Left visual field of both eyes). Lesion: Retro-chiasmal (Optic Tract, LGN, Optic Radiations, Visual Cortex).</li><li><b>Macular Sparing:</b> Seen in <b>Occipital Lobe</b> lesions (PCA infarct) because the macula has dual blood supply (MCA + PCA).</li><li><b>USMLE Tip:</b> Right PCA stroke &rarr; Left Homonymous Hemianopia with Macular Sparing.</li></ul>",
      "takeAway": "<p><b>Hemianopia</b> patterns localize lesions along the visual pathway: Chiasmal lesions cause bitemporal defects, while retro-chiasmal lesions cause contralateral homonymous defects.</p>",
      "mermaid": "graph TD; A[Optic Chiasm Lesion] --> B[Bitemporal Hemianopia]; C[Optic Tract/Radiation Lesion] --> D[Contralateral Homonymous Hemianopia]; E[PCA Stroke] --> F[Homonymous Hemianopia w/ Macular Sparing];"
    },
    "connections": [
      {
        "type": "includes",
        "to": "bitemporal_hemianopia"
      },
      {
        "type": "includes",
        "to": "homonymous_hemianopsia"
      },
      {
        "type": "caused_by_lesion_in",
        "to": "optic_chiasm"
      },
      {
        "type": "caused_by_lesion_in",
        "to": "visual_cortex"
      }
    ]
  },
  "hemiballismus": {
    "title": "Hemiballismus",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Movement Disorders",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Movement Disorders",
      "Hyperkinetic"
    ],
    "content": {
      "definition": "<p><b>Hemiballismus</b> is a hyperkinetic movement disorder characterized by involuntary, violent, large-amplitude flinging movements of the <u>contralateral</u> limbs, caused by a lesion in the <b>[[subthalamic_nucleus]]</b>.</p>",
      "atAGlance": "<ul><li><b>Localization:</b> Contralateral <b>Subthalamic Nucleus (STN)</b>.</li><li><b>Mechanism:</b> STN lesion &rarr; Loss of excitation to GPi &rarr; Reduced inhibition of Thalamus &rarr; Excessive movement. (Indirect pathway failure).</li><li><b>Etiology:</b> Classic cause is a <b>Lacunar Stroke</b> (posterior limb of internal capsule or STN). Can also be hyperglycemic non-ketotic state.</li><li><b>USMLE Tip:</b> \"Flinging\" or \"Ballistic\" movements of one side = Contralateral Subthalamic Nucleus lesion.</li></ul>",
      "takeAway": "<p><b>Hemiballismus</b> involves violent contralateral limb flinging due to disinhibition of the thalamus following damage to the subthalamic nucleus.</p>",
      "mermaid": "graph TD; A[STN Lesion] --> B[Decreased Excitation of GPi]; B --> C[Decreased Inhibition of Thalamus]; C --> D[Increased Thalamocortical Drive]; D --> E[Hemiballismus];"
    },
    "connections": [
      {
        "type": "caused_by_lesion_in",
        "to": "subthalamic_nucleus"
      },
      {
        "type": "manifests_as",
        "to": "hyperkinetic_movement"
      },
      {
        "type": "is_contrasted_with",
        "to": "chorea"
      }
    ]
  },
  "hemispatial_neglect": {
    "title": "Hemispatial Neglect",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Cognition",
      "Stroke",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Cognitive Disorders",
      "Agnosias"
    ],
    "content": {
      "definition": "<p><b>Hemispatial Neglect</b> is a deficit in attention to and awareness of one side of space (usually the left), occurring despite intact sensory and motor function, caused by a lesion in the <u>non-dominant parietal lobe</u> (usually Right).</p>",
      "atAGlance": "<ul><li><b>Lesion:</b> Right (Non-dominant) Posterior Parietal Lobe (Brodmann 5, 7).</li><li><b>Clinical Presentation:</b> Patient ignores the <b>Left</b> side of the world. Shaves only right face, draws clock with numbers only on right, eats from right side of plate.</li><li><b>Mechanism:</b> The Right hemisphere attends to <i>both</i> sides of space; the Left hemisphere attends only to the Right. Right lesion = Loss of Left attention. Left lesion = Right hemisphere compensates (so minimal/no neglect).</li><li><b>USMLE Tip:</b> \"Clock drawing test\" is abnormal (numbers crowded on right).</li></ul>",
      "takeAway": "<p><b>Hemispatial Neglect</b> is a profound attention deficit to the left hemispace caused by damage to the right parietal cortex.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "caused_by_lesion_in",
        "to": "parietal_lobe"
      },
      {
        "type": "manifests_as",
        "to": "agnosia"
      },
      {
        "type": "associated_with",
        "to": "middle_cerebral_artery_stroke"
      }
    ]
  },
  "brain_herniation": {
    "title": "Brain Herniation Syndromes",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Pathology",
      "Emergency Medicine",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Intracranial Pressure Disorders",
      "Herniation"
    ],
    "content": {
      "definition": "<p><b>Brain Herniation</b> is the displacement of brain tissue across rigid dural folds (falx, tentorium) or through skull openings due to elevated [[intracranial_pressure]], leading to compression of vital structures.</p>",
      "atAGlance": "<ul><li><b>Types:</b><br> 1. <b>[[cingulate_herniation]] (Subfalcine):</b> Cingulate gyrus under falx cerebri. Compresses ACA (Contralateral leg weakness).<br> 2. <b>[[uncal_herniation]] (Transtentorial):</b> Uncus (temporal lobe) over tentorium. Compresses CN III (Blown pupil), PCA (Blindness), Cerebral Peduncle (Hemiparesis).<br> 3. <b>[[cerebellar_tonsillar_herniation]]:</b> Tonsils through foramen magnum. Compresses Medulla (Respiratory arrest).<br> 4. <b>Central (Downward):</b> Diencephalon downward. Duret hemorrhages.</li><li><b>USMLE Tip:</b> Blown pupil = Uncal. Resp arrest = Tonsillar. Leg weakness = Subfalcine.</li></ul>",
      "takeAway": "<p><b>Brain Herniation</b> is the lethal consequence of untreated ICP; specific syndromes (Uncal, Tonsillar, Subfalcine) are defined by the structure displaced and the adjacent anatomy compressed.</p>",
      "mermaid": "graph TD; A[Increased ICP] --> B{Location?}; B -->|Supratentorial Lateral| C[Uncal Herniation]; B -->|Supratentorial Midline| D[Central Herniation]; B -->|Posterior Fossa| E[Tonsillar Herniation]; C --> F[CN III / Midbrain Compression]; E --> G[Medullary Compression];"
    },
    "connections": [
      {
        "type": "includes",
        "to": "cingulate_herniation"
      },
      {
        "type": "includes",
        "to": "uncal_herniation"
      },
      {
        "type": "includes",
        "to": "cerebellar_tonsillar_herniation"
      },
      {
        "type": "caused_by",
        "to": "increased_intracranial_pressure"
      }
    ]
  },
  "intracranial_hemorrhage": {
    "title": "Intracranial Hemorrhage",
    "primaryType": "group",
    "tags": [
      "Neurology",
      "Trauma",
      "Vascular",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Cerebrovascular Disease",
      "Hemorrhagic Stroke"
    ],
    "content": {
      "definition": "<p><b>Intracranial Hemorrhage</b> refers to bleeding within the skull, classified by location relative to the meninges and brain parenchyma, including epidural, subdural, subarachnoid, and intraparenchymal types.</p>",
      "atAGlance": "<ul><li><b>[[epidural_hematoma]]:</b> Arterial (MMA), Lens-shaped (Biconvex), Lucid interval.</li><li><b>[[subdural_hematoma]]:</b> Venous (Bridging veins), Crescent-shaped, Elderly/Alcoholics.</li><li><b>[[subarachnoid_hemorrhage]]:</b> Arterial (Aneurysm), \"Worst headache,\" Bloody CSF.</li><li><b>[[intraparenchymal_hemorrhage]]:</b> Systemic HTN (Basal Ganglia), Amyloid Angiopathy (Lobar).</li><li><b>Neonatal:</b> [[intraventricular_hemorrhage]] (Germinal matrix fragility in preemies).</li></ul>",
      "takeAway": "<p><b>Intracranial Hemorrhages</b> are distinguished by vessel origin (arterial vs. venous) and CT appearance (Lens vs. Crescent vs. Diffuse), guiding urgent management.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "includes",
        "to": "epidural_hematoma"
      },
      {
        "type": "includes",
        "to": "subdural_hematoma"
      },
      {
        "type": "includes",
        "to": "subarachnoid_hemorrhage"
      },
      {
        "type": "includes",
        "to": "intraparenchymal_hemorrhage"
      }
    ]
  },
  "drug_induced_liver_injury": {
    "title": "Drug-Induced Liver Injury (Hepatotoxicity)",
    "primaryType": "disease",
    "tags": [
      "Pharmacology",
      "Gastroenterology",
      "Toxicology",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Toxicology",
      "Adverse Drug Reactions"
    ],
    "content": {
      "definition": "<p><b>Drug-Induced Liver Injury (Hepatotoxicity)</b> implies hepatic damage caused by medications, ranging from mild enzyme elevation to fulminant liver failure, mediated by direct toxicity or idiosyncratic reactions.</p>",
      "atAGlance": "<ul><li><b>Key Culprits:</b><br> - <b>[[acetaminophen]]:</b> Direct toxicity (NAPQI).<br> - <b>[[isoniazid]] (INH):</b> Hepatocellular necrosis.<br> - <b>[[valproate]]:</b> Microvesicular fatty change.<br> - <b>[[halothane]]:</b> Immune-mediated massive necrosis.<br> - <b>Statins, Methotrexate, Amiodarone.</b></li><li><b>Patterns:</b><br> - <i>Hepatocellular:</i> ALT/AST elevation (INH, Acetaminophen).<br> - <i>Cholestatic:</i> ALP/Bilirubin elevation (Erythromycin, Oral Contraceptives).</li><li><b>USMLE Tip:</b> Always check LFTs before starting Statins, INH, or Valproate.</li></ul>",
      "takeAway": "<p><b>Hepatotoxicity</b> is a major adverse effect of drugs like Acetaminophen, Isoniazid, and Valproate, necessitating monitoring of liver function.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "caused_by",
        "to": "acetaminophen"
      },
      {
        "type": "caused_by",
        "to": "isoniazid"
      },
      {
        "type": "caused_by",
        "to": "valproate"
      },
      {
        "type": "manifests_as",
        "to": "hepatic_necrosis"
      }
    ]
  },
  "spinal_cord_hemisection": {
    "title": "Spinal Cord Hemisection",
    "primaryType": "concept",
    "tags": [
      "Neurology",
      "Pathology",
      "Trauma",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Spinal Cord Disorders",
      "Lesion Types"
    ],
    "content": {
      "definition": "<p><b>Spinal Cord Hemisection</b> is the pathological transection or damage of one lateral half of the spinal cord, resulting in the clinical syndrome known as [[brown_sequard_syndrome]].</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> Unilateral damage to ascending and descending tracts.</li><li><b>Tracts Affected:</b><br> - <i>Dorsal Column:</i> Ipsilateral loss of proprioception/vibration.<br> - <i>Corticospinal Tract:</i> Ipsilateral motor weakness (UMN).<br> - <i>Spinothalamic Tract:</i> Contralateral loss of pain/temperature (1-2 levels below).</li><li><b>Etiology:</b> Penetrating trauma (knife, bullet), lateral tumor compression, demyelination (MS).</li></ul>",
      "takeAway": "<p><b>Spinal Cord Hemisection</b> is the structural lesion that produces the dissociated sensory and motor deficits of Brown-Séquard Syndrome.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "causes",
        "to": "brown_sequard_syndrome"
      },
      {
        "type": "damages",
        "to": "corticospinal_tract"
      },
      {
        "type": "damages",
        "to": "spinothalamic_tract"
      },
      {
        "type": "damages",
        "to": "dorsal_column_medial_lemniscus"
      }
    ]
  },
  "hereditary_motor_sensory_neuropathy": {
    "title": "Hereditary Motor and Sensory Neuropathy (HMSN)",
    "primaryType": "concept",
    "tags": [
      "Neurology",
      "Genetics",
      "Index Stub"
    ],
    "classificationPath": [
      "Neurology",
      "Hereditary Neuropathies"
    ],
    "content": {
      "definition": "<p><i>(Placeholder)</i> A group of inherited disorders affecting peripheral nerves, most commonly referring to [[charcot_marie_tooth_disease]].</p>",
      "atAGlance": "<ul><li>See [[charcot_marie_tooth_disease]].</li></ul>",
      "takeAway": "",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "see",
        "to": "charcot_marie_tooth_disease"
      }
    ]
  }
}
``````json
{
  "herpes_simplex_virus": {
    "title": "Herpes Simplex Virus (HSV)",
    "primaryType": "organism",
    "tags": [
      "Microbiology",
      "Virology",
      "Neurology",
      "USMLE"
    ],
    "classificationPath": [
      "Microbiology",
      "Viruses",
      "Herpesviruses"
    ],
    "content": {
      "definition": "<p><b>Herpes Simplex Virus (HSV)</b> comprises two enveloped dsDNA viruses (HSV-1 and HSV-2) that establish <u>latency</u> in sensory ganglia, causing mucocutaneous lesions and severe CNS complications like encephalitis and meningitis.</p>",
      "atAGlance": "<ul><li><b>HSV-1:</b> Oral lesions (Cold sores). Latent in <b>Trigeminal</b> Ganglia. Causes <b>Temporal Lobe Encephalitis</b> (most common sporadic encephalitis) and Keratoconjunctivitis.</li><li><b>HSV-2:</b> Genital lesions. Latent in <b>Sacral</b> Ganglia. Causes <b>Meningitis</b> (Mollaret's) and Neonatal Herpes.</li><li><b>Diagnosis:</b> PCR (CSF), Tzanck smear (multinucleated giant cells - older test).</li><li><b>Treatment:</b> [[acyclovir]], Valacyclovir, Famciclovir. Foscarnet for resistant cases.</li><li><b>USMLE Tip:</b> Temporal lobe hemorrhage/edema + fever + altered mental status = HSV-1 Encephalitis.</li></ul>",
      "takeAway": "<p><b>HSV</b> causes recurrent mucocutaneous infections via latency in sensory ganglia; HSV-1 is the primary cause of sporadic encephalitis (temporal lobe), while HSV-2 causes genital herpes and meningitis.</p>",
      "mermaid": "graph TD; A[HSV Infection] --> B[Mucocutaneous Infection]; B --> C[Retrograde Transport]; C --> D[Latency in Sensory Ganglia]; D --> E[Reactivation]; E --> F[Recurrent Lesions]; D -->|HSV-1| G[Encephalitis]; D -->|HSV-2| H[Meningitis];"
    },
    "connections": [
      {
        "type": "causes",
        "to": "herpes_simplex_encephalitis"
      },
      {
        "type": "causes",
        "to": "viral_meningitis"
      },
      {
        "type": "treated_by",
        "to": "acyclovir"
      },
      {
        "type": "establishes_latency_in",
        "to": "trigeminal_ganglion"
      }
    ]
  },
  "hippocampus": {
    "title": "Hippocampus",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Anatomy",
      "Limbic System",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Brain Anatomy",
      "Limbic System"
    ],
    "content": {
      "definition": "<p>The <b>Hippocampus</b> is a critical structure within the medial temporal lobe [[limbic_system]], essential for the consolidation of short-term memory into <u>long-term memory</u> and spatial navigation.</p>",
      "atAGlance": "<ul><li><b>Function:</b> Memory consolidation (Papez circuit).</li><li><b>Vulnerability:</b> Highly sensitive to <b>Hypoxia</b> (Sommer's sector/CA1). First area damaged in global cerebral ischemia.</li><li><b>Pathology:</b><br> - <b>[[alzheimer_disease]]:</b> Early atrophy causing anterograde amnesia.<br> - <b>[[wernicke_korsakoff_syndrome]]:</b> Functional disruption (via mammillary bodies).<br> - <b>Trauma/Stroke:</b> Bilateral damage &rarr; Permanent <b>Anterograde Amnesia</b> (Patient H.M.).</li><li><b>USMLE Tip:</b> \"Hippocampus acts like a Hippo-compass\" (Spatial memory). Bilateral lesions prevent forming <i>new</i> memories.</li></ul>",
      "takeAway": "<p>The <b>Hippocampus</b> is key for memory formation; it is exquisitely sensitive to hypoxia and is the site of early atrophy in Alzheimer's disease.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_part_of",
        "to": "limbic_system"
      },
      {
        "type": "dysfunction_causes",
        "to": "anterograde_amnesia"
      },
      {
        "type": "degenerates_in",
        "to": "alzheimer_disease"
      },
      {
        "type": "sensitive_to",
        "to": "hypoxia"
      }
    ]
  },
  "histamine_h1_receptor": {
    "title": "Histamine H1 Receptor",
    "primaryType": "structure",
    "tags": [
      "Physiology",
      "Pharmacology",
      "Neurology",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Receptors",
      "GPCR"
    ],
    "content": {
      "definition": "<p>The <b>Histamine H1 Receptor</b> is a G<sub>q</sub>-coupled receptor involved in allergic inflammation (periphery) and arousal/vestibular function (CNS), playing a specific role in stimulating the <u>vomiting center</u> via vestibular input.</p>",
      "atAGlance": "<ul><li><b>Location:</b> Vestibular system, Nucleus Tractus Solitarius (Vomiting Center), Cortex (Arousal).</li><li><b>Function (CNS):</b> Mediates <b>Motion Sickness</b> and wakefulness.</li><li><b>Pharmacology:</b><br> - <b>1st Gen Antagonists:</b> [[diphenhydramine]], Meclizine, Promethazine. Cross BBB. Used for <b>Motion Sickness</b> and vestibular nausea. Cause Sedation.<br> - <b>2nd Gen Antagonists:</b> Loratadine, Cetirizine. Peripherally selective (Allergies).</li><li><b>USMLE Tip:</b> For motion sickness, target H1 (and M1) receptors. For Chemo nausea, target 5-HT3/NK1.</li></ul>",
      "takeAway": "<p><b>H1 Receptors</b> in the vestibular system drive motion sickness; 1st generation antihistamines (e.g., Diphenhydramine) block these to treat nausea at the cost of sedation.</p>",
      "mermaid": "graph TD; A[Motion/Vestibular Input] --> B[H1 Receptors in Brainstem]; C[M1 Receptors in Brainstem] --> D[Vomiting Center]; D --> E[Nausea/Emesis]; F[Diphenhydramine] --x|Blocks| B;"
    },
    "connections": [
      {
        "type": "mediates",
        "to": "motion_sickness"
      },
      {
        "type": "blocked_by",
        "to": "diphenhydramine"
      },
      {
        "type": "inputs_to",
        "to": "vomiting_center"
      }
    ]
  },
  "holoprosencephaly": {
    "title": "Holoprosencephaly",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Embryology",
      "Congenital Malformations",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Congenital Malformations",
      "Forebrain Defects"
    ],
    "content": {
      "definition": "<p><b>Holoprosencephaly</b> is a congenital malformation characterized by the failure of the embryonic forebrain (prosencephalon) to cleave into two distinct cerebral hemispheres, resulting in a single ventricle and midline facial defects.</p>",
      "atAGlance": "<ul><li><b>Timing:</b> Weeks 3-5 of gestation.</li><li><b>Etiology:</b> Mutations in <b>[[sonic_hedgehog]]</b> pathway, [[patau_syndrome]] (Trisomy 13), Fetal Alcohol Syndrome.</li><li><b>Spectrum:</b><br> - <i>Severe:</i> Cyclopia (one eye), Proboscis, Alobar brain (monoventricle).<br> - <i>Mild:</i> Cleft lip/palate, hypotelorism (close eyes), single central incisor.</li><li><b>USMLE Tip:</b> \"Fused\" brain structures (basal ganglia, thalami, ventricle) + Midline facial defects = Holoprosencephaly.</li></ul>",
      "takeAway": "<p><b>Holoprosencephaly</b> is a failure of forebrain separation associated with Trisomy 13 and Sonic Hedgehog mutations, presenting with a monoventricle and midline facial anomalies.</p>",
      "mermaid": "graph TD; A[Defective SHH Signaling] --> B[Failure of Prosencephalon Cleavage]; B --> C[Fused Cerebral Hemispheres]; C --> D[Monoventricle]; B --> E[Midline Facial Defects];"
    },
    "connections": [
      {
        "type": "associated_with",
        "to": "patau_syndrome"
      },
      {
        "type": "caused_by_mutation_in",
        "to": "sonic_hedgehog"
      },
      {
        "type": "manifests_as",
        "to": "cleft_lip_palate"
      }
    ]
  },
  "homer_wright_rosettes": {
    "title": "Homer-Wright Rosettes",
    "primaryType": "finding",
    "tags": [
      "Pathology",
      "Oncology",
      "Neurology",
      "USMLE"
    ],
    "classificationPath": [
      "Pathology",
      "Histology",
      "Tumor Features"
    ],
    "content": {
      "definition": "<p><b>Homer-Wright Rosettes</b> are histologic structures found in certain small blue cell tumors, characterized by tumor cells arranged in a circle around a central meshwork of <u>neuropil</u> (neurites), <u>without</u> a central lumen.</p>",
      "atAGlance": "<ul><li><b>Appearance:</b> Halo of cells surrounding a pink, fibrillary center (neuropil). No true lumen (unlike Flexner-Wintersteiner rosettes).</li><li><b>Associations:</b><br> - <b>[[medulloblastoma]]:</b> Cerebellar tumor in children.<br> - <b>[[neuroblastoma]]:</b> Adrenal tumor in children.</li><li><b>USMLE Tip:</b> Differentiate from <i>Perivascular Pseudorosettes</i> ([[ependymoma]] - cells around a blood vessel) and <i>Flexner-Wintersteiner Rosettes</i> ([[retinoblastoma]] - cells around a true lumen).</li></ul>",
      "takeAway": "<p><b>Homer-Wright Rosettes</b> indicate neuroblastic differentiation (neuropil core), classically seen in Medulloblastoma and Neuroblastoma.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_characteristic_of",
        "to": "medulloblastoma"
      },
      {
        "type": "is_characteristic_of",
        "to": "neuroblastoma"
      },
      {
        "type": "is_distinguished_from",
        "to": "perivascular_pseudorosettes"
      }
    ]
  },
  "cortical_homunculus": {
    "title": "Cortical Homunculus",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Anatomy",
      "Physiology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Brain Anatomy",
      "Cerebral Cortex"
    ],
    "content": {
      "definition": "<p>The <b>Cortical Homunculus</b> is a distorted topographic representation of the human body across the primary <u>motor</u> (precentral gyrus) and <u>sensory</u> (postcentral gyrus) cortices, where the amount of cortex devoted to a body part corresponds to its motor/sensory density.</p>",
      "atAGlance": "<ul><li><b>Organization:</b><br> - <b>Medial Surface:</b> Leg, Foot, Genitals. (Supplied by [[anterior_cerebral_artery]]).<br> - <b>Lateral Surface:</b> Face, Hand, Arm, Tongue. (Supplied by [[middle_cerebral_artery]]).</li><li><b>Distortion:</b> Large areas for Face (Lips/Tongue) and Hands; Small areas for Trunk/Legs.</li><li><b>Clinical Relevance:</b><br> - <b>ACA Stroke:</b> Contralateral <i>Leg</i> weakness/sensory loss.<br> - <b>MCA Stroke:</b> Contralateral <i>Face/Arm</i> weakness/sensory loss.</li></ul>",
      "takeAway": "<p>The <b>Homunculus</b> maps body function to cortical anatomy; medial lesions (ACA) affect the legs, while lateral lesions (MCA) affect the face and upper extremities.</p>",
      "mermaid": "graph LR; A[Medial Cortex] --ACA Supply--> B[Leg/Foot]; C[Lateral Cortex] --MCA Supply--> D[Face/Hand/Arm];"
    },
    "connections": [
      {
        "type": "located_in",
        "to": "primary_motor_cortex"
      },
      {
        "type": "located_in",
        "to": "somatosensory_cortex"
      },
      {
        "type": "supplied_by",
        "to": "anterior_cerebral_artery"
      },
      {
        "type": "supplied_by",
        "to": "middle_cerebral_artery"
      }
    ]
  },
  "hordeolum": {
    "title": "Hordeolum (Stye)",
    "primaryType": "disease",
    "tags": [
      "Ophthalmology",
      "Infectious Disease",
      "USMLE"
    ],
    "classificationPath": [
      "Ophthalmology",
      "Eyelid Disorders"
    ],
    "content": {
      "definition": "<p>A <b>Hordeolum</b> (Stye) is an acute, localized, <u>painful</u> infection of an eyelash follicle or sebaceous gland of the eyelid, most commonly caused by <i>[[staphylococcus_aureus]]</i>.</p>",
      "atAGlance": "<ul><li><b>Types:</b><br> - <i>External:</i> Infection of Zeis/Moll glands (eyelash follicle).<br> - <i>Internal:</i> Infection of Meibomian glands.</li><li><b>Clinical Presentation:</b> Erythematous, tender, painful nodule at the lid margin.</li><li><b>Treatment:</b> Warm compresses (spontaneous drainage). Antibiotics if cellulitis.</li><li><b>Differential:</b> [[chalazion]] (Chronic, <b>Painless</b>, sterile granuloma).</li><li><b>USMLE Tip:</b> Hordeolum Hurts. Chalazion is Chill (painless).</li></ul>",
      "takeAway": "<p><b>Hordeolum</b> is an acute painful bacterial infection of the eyelid glands, treated conservatively, distinguishing it from the painless chronic chalazion.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "caused_by",
        "to": "staphylococcus_aureus"
      },
      {
        "type": "is_contrasted_with",
        "to": "chalazion"
      },
      {
        "type": "affects_structure",
        "to": "meibomian_gland"
      }
    ]
  },
  "horner_syndrome_ref": {
    "title": "Horner Syndrome",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Ophthalmology",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Neuro-Ophthalmology",
      "Autonomic Disorders"
    ],
    "content": {
      "definition": "<p><b>Horner Syndrome</b> is a clinical triad of <b>ptosis</b>, <b>miosis</b>, and <b>anhidrosis</b> caused by the interruption of the <u>oculosympathetic pathway</u> anywhere along its three-neuron chain.</p>",
      "atAGlance": "<ul><li><b>Triad:</b><br> 1. <b>Ptosis:</b> Mild drooping (Superior Tarsal muscle paralysis).<br> 2. <b>Miosis:</b> Constricted pupil (Loss of dilator pupillae tone).<br> 3. <b>Anhidrosis:</b> Loss of sweating on ipsilateral face.</li><li><b>Pathway & Lesions:</b><br> - <i>1st Neuron (Central):</i> Hypothalamus to T1. ([[lateral_medullary_syndrome]], [[syringomyelia]]).<br> - <i>2nd Neuron (Preganglionic):</i> T1 to Superior Cervical Ganglion. ([[pancoast_tumor]]).<br> - <i>3rd Neuron (Postganglionic):</i> SCG to Eye. ([[carotid_artery_dissection]]). *Anhidrosis absent if lesion is distal to carotid bifurcation.*</li><li><b>Diagnosis:</b> Cocaine test (No dilation). [[apraclonidine]] test (Dilation - hypersensitivity).</li><li><b>USMLE Tip:</b> Pancoast Tumor (Apex of lung) + Horner's = Compression of Stellate Ganglion/Sympathetic chain.</li></ul>",
      "takeAway": "<p><b>Horner Syndrome</b> localizes to the sympathetic chain; identifying the level (Central vs. Preganglionic vs. Postganglionic) helps identify the etiology (Stroke vs. Tumor vs. Dissection).</p>",
      "mermaid": "graph TD; A[Hypothalamus] -->|1st Neuron| B[Spinal Cord T1]; B -->|2nd Neuron| C[Superior Cervical Ganglion]; C -->|3rd Neuron| D[Pupil Dilation/Lid Elevation];"
    },
    "connections": [
      {
        "type": "caused_by",
        "to": "pancoast_tumor"
      },
      {
        "type": "caused_by",
        "to": "lateral_medullary_syndrome"
      },
      {
        "type": "caused_by",
        "to": "carotid_artery_dissection"
      },
      {
        "type": "diagnosed_by",
        "to": "apraclonidine"
      }
    ]
  },
  "hypothalamic_appetite_regulation": {
    "title": "Hypothalamic Appetite Regulation",
    "primaryType": "process",
    "tags": [
      "Endocrinology",
      "Neurology",
      "Physiology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Hypothalamus",
      "Homeostasis"
    ],
    "content": {
      "definition": "<p><b>Hypothalamic Appetite Regulation</b> involves the interplay between the <u>Lateral Hypothalamus</u> (Hunger center) and the <u>Ventromedial Hypothalamus</u> (Satiety center), regulated by hormones like Ghrelin and Leptin.</p>",
      "atAGlance": "<ul><li><b>Lateral Hypothalamus (LH):</b><br> - Function: Stimulates <b>Hunger</b>.<br> - Regulation: Stimulated by [[ghrelin]]; Inhibited by [[leptin]].<br> - Lesion: Anorexia, failure to thrive. <i>\"Lateral injury makes you Lean.\"</i></li><li><b>Ventromedial Hypothalamus (VMH):</b><br> - Function: Stimulates <b>Satiety</b>.<br> - Regulation: Stimulated by [[leptin]].<br> - Lesion: Hyperphagia, Obesity. <i>\"Ventromedial injury makes you Very Massive.\"</i><br> - Etiology: [[craniopharyngioma]], [[prader_willi_syndrome]].</li></ul>",
      "takeAway": "<p>The <b>Hypothalamus</b> balances hunger (Lateral) and satiety (Ventromedial); lesions disrupt this balance leading to starvation or obesity, respectively.</p>",
      "mermaid": "graph LR; A[Ghrelin] --(+)--> B[Lateral Hypothalamus]; B --> C[Hunger]; D[Leptin] --(-)--> B; D --(+)--> E[Ventromedial Hypothalamus]; E --> F[Satiety];"
    },
    "connections": [
      {
        "type": "controlled_by",
        "to": "hypothalamus"
      },
      {
        "type": "regulated_by",
        "to": "ghrelin"
      },
      {
        "type": "regulated_by",
        "to": "leptin"
      },
      {
        "type": "dysfunction_seen_in",
        "to": "prader_willi_syndrome"
      }
    ]
  },
  "huntington_disease": {
    "title": "Huntington Disease",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Genetics",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Neurodegenerative Diseases",
      "Movement Disorders"
    ],
    "content": {
      "definition": "<p><b>Huntington Disease</b> is an autosomal dominant neurodegenerative disorder caused by a CAG trinucleotide repeat expansion in the <i>HTT</i> gene, leading to the atrophy of the <u>caudate nucleus</u> and putamen.</p>",
      "atAGlance": "<ul><li><b>Genetics:</b> <b>CAG</b> repeats on Chromosome 4. <b>Autosomal Dominant</b>. Demonstrates <b>Anticipation</b> (worsens in subsequent generations).</li><li><b>Pathophysiology:</b> Mutant huntingtin protein causes excitotoxicity (NMDA) and loss of <b>GABAergic</b> neurons in the [[striatum]] ([[caudate_nucleus]] > putamen).</li><li><b>Neurotransmitters:</b> Decreased <b>GABA</b>, Decreased <b>ACh</b>, Increased <b>Dopamine</b>.</li><li><b>Clinical Features:</b><br> - <i>Motor:</i> [[chorea]] (dance-like movements), Athetosis.<br> - <i>Psychiatric:</i> Depression, Aggression, Psychosis.<br> - <i>Cognitive:</i> Dementia.</li><li><b>Imaging:</b> Caudate atrophy causes enlargement of frontal horns of lateral ventricles (<b>\"Boxcar Ventricles\"</b>).</li><li><b>USMLE Tip:</b> \"<b>C</b>audate loss, <b>A</b>Ch/GABA loss, <b>G</b>enetic repeats (CAG) on Chr <b>4</b>.\"</li></ul>",
      "takeAway": "<p><b>Huntington Disease</b> is a genetic striatal degeneration characterized by chorea and dementia, driven by the toxic gain of function of CAG repeats leading to GABAergic neuron loss.</p>",
      "mermaid": "graph TD; A[CAG Expansion] --> B[Mutant Huntingtin]; B --> C[Neuronal Death in Caudate]; C --> D[Loss of GABA/ACh]; C --> E[Relative Dopamine Excess]; E --> F[Chorea];"
    },
    "connections": [
      {
        "type": "caused_by_mutation_in",
        "to": "huntingtin_gene"
      },
      {
        "type": "causes_atrophy_of",
        "to": "caudate_nucleus"
      },
      {
        "type": "characterized_by",
        "to": "chorea"
      },
      {
        "type": "associated_with_decrease_in",
        "to": "gaba"
      }
    ]
  },
  "hydrocephalus": {
    "title": "Hydrocephalus",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Pathology",
      "CSF Disorders",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Hydrocephalus"
    ],
    "content": {
      "definition": "<p><b>Hydrocephalus</b> is a pathological accumulation of cerebrospinal fluid (CSF) within the ventricular system, leading to ventricular dilation and elevated [[intracranial_pressure]].</p>",
      "atAGlance": "<ul><li><b>Types:</b><br> 1. <b>[[communicating_hydrocephalus]]:</b> Impaired resorption (Arachnoid granulations). All ventricles dilated.<br> 2. <b>[[noncommunicating_hydrocephalus]] (Obstructive):</b> Structural block (e.g., Aqueduct). Upstream ventricles dilated.<br> 3. <b>[[normal_pressure_hydrocephalus]]:</b> Periodic pressure spikes. Wet/Wobbly/Wacky triad.<br> 4. <b>[[ex_vacuo_ventriculomegaly]]:</b> Brain atrophy (Alzheimer's). Normal pressure.</li><li><b>Clinical:</b> Headache, Papilledema, Macrocephaly (infants), Herniation risk.</li><li><b>Treatment:</b> Ventriculoperitoneal (VP) shunt, Endoscopic Third Ventriculostomy.</li></ul>",
      "takeAway": "<p><b>Hydrocephalus</b> results from an imbalance in CSF production, flow, or resorption; distinguishing communicating vs. non-communicating types guides etiology and management.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "includes",
        "to": "communicating_hydrocephalus"
      },
      {
        "type": "includes",
        "to": "noncommunicating_hydrocephalus"
      },
      {
        "type": "includes",
        "to": "normal_pressure_hydrocephalus"
      },
      {
        "type": "manifests_as",
        "to": "increased_intracranial_pressure"
      }
    ]
  }
}
``````json
{
  "hypercalcemia": {
    "title": "Hypercalcemia",
    "primaryType": "disease",
    "tags": [
      "Index Stub"
    ],
    "classificationPath": [
      "Endocrinology",
      "Calcium Disorders"
    ],
    "content": {
      "definition": "<p><i>(Placeholder)</i> A metabolic disorder characterized by elevated serum calcium levels, often due to hyperparathyroidism or malignancy, referenced in the graph awaiting detailed population.</p>",
      "atAGlance": "<ul><li>See [[succinylcholine]] (causes hyperkalemia, not hypercalcemia, though often confused), [[sarcoidosis]], [[multiple_myeloma]].</li></ul>",
      "takeAway": "",
      "mermaid": ""
    },
    "connections": []
  },
  "hypercoagulability": {
    "title": "Hypercoagulability",
    "primaryType": "disease",
    "tags": [
      "Index Stub"
    ],
    "classificationPath": [
      "Hematology",
      "Coagulation Disorders"
    ],
    "content": {
      "definition": "<p><i>(Placeholder)</i> A state of increased tendency for blood thrombosis, referenced in the context of venous sinus thrombosis and specific syndromes.</p>",
      "atAGlance": "<ul><li>See [[factor_v_leiden]], [[antiphospholipid_syndrome]], [[dural_venous_sinuses]].</li></ul>",
      "takeAway": "",
      "mermaid": ""
    },
    "connections": []
  },
  "hyperemesis_gravidarum": {
    "title": "Hyperemesis Gravidarum",
    "primaryType": "disease",
    "tags": [
      "Index Stub"
    ],
    "classificationPath": [
      "Obstetrics",
      "Pregnancy Complications"
    ],
    "content": {
      "definition": "<p><i>(Placeholder)</i> Severe nausea and vomiting during pregnancy resulting in weight loss and electrolyte imbalance.</p>",
      "atAGlance": "<ul><li>Referenced in context of antiemetic use.</li></ul>",
      "takeAway": "",
      "mermaid": ""
    },
    "connections": []
  },
  "hyperopia": {
    "title": "Hyperopia (Farsightedness)",
    "primaryType": "disease",
    "tags": [
      "Ophthalmology",
      "Physics",
      "USMLE"
    ],
    "classificationPath": [
      "Ophthalmology",
      "Refractive Errors"
    ],
    "content": {
      "definition": "<p><b>Hyperopia</b> (Farsightedness) is a refractive error where the eye is <u>too short</u> for the refractive power of the cornea and lens, causing light from near objects to focus <u>behind the retina</u>.</p>",
      "atAGlance": "<ul><li><b>Pathophysiology:</b> Focal point is retro-retinal. The eye is axially too short.</li><li><b>Clinical Presentation:</b> Difficulty seeing near objects; eye strain (from constant accommodation).</li><li><b>Correction:</b> <b>Convex</b> (converging) lens.</li><li><b>USMLE Tip:</b> Compare with [[myopia]] (eye too long, focus in front, concave lens).</li></ul>",
      "takeAway": "<p><b>Hyperopia</b> results from a short globe causing light to focus behind the retina, corrected by a <b>convex</b> lens to increase convergence.</p>",
      "mermaid": "graph TD; A[Light Rays] --> B[Cornea/Lens]; B --> C[Focal Point Behind Retina]; D[Convex Lens] --> B; B --> E[Focal Point On Retina];"
    },
    "connections": [
      {
        "type": "corrected_by",
        "to": "convex_lens"
      },
      {
        "type": "is_contrasted_with",
        "to": "myopia"
      },
      {
        "type": "involves_structure",
        "to": "retina"
      }
    ]
  },
  "hyperprolactinemia": {
    "title": "Hyperprolactinemia",
    "primaryType": "disease",
    "tags": [
      "Endocrinology",
      "Neurology",
      "USMLE"
    ],
    "classificationPath": [
      "Endocrinology",
      "Pituitary Disorders"
    ],
    "content": {
      "definition": "<p><b>Hyperprolactinemia</b> is a state of elevated serum [[prolactin]], often caused by a pituitary adenoma or dopamine antagonists (antipsychotics), leading to galactorrhea and hypogonadism via GnRH suppression.</p>",
      "atAGlance": "<ul><li><b>Pathophysiology:</b> Prolactin inhibits [[gonadotropin_releasing_hormone]] (GnRH) &rarr; Decreased FSH/LH &rarr; Hypogonadism.</li><li><b>Etiologies:</b> [[pituitary_adenoma]] (Prolactinoma), [[antipsychotics]] (Dopamine blockade), Hypothyroidism (TRH stimulates Prolactin), Pregnancy.</li><li><b>Clinical Features:</b> Galactorrhea, Amenorrhea, Infertility, Libido loss.</li><li><b>Treatment:</b> Dopamine Agonists ([[cabergoline]], [[bromocriptine]]).</li><li><b>USMLE Tip:</b> <b>Tuberoinfundibular pathway</b> blockade by antipsychotics causes this side effect.</li></ul>",
      "takeAway": "<p><b>Hyperprolactinemia</b> suppresses the reproductive axis (GnRH) and is commonly caused by prolactinomas or dopamine-blocking drugs; treat with dopamine agonists.</p>",
      "mermaid": "graph TD; A[Dopamine Antagonist] --x|Blocks Inhibition| B[Lactotrophs]; B --> C[Increased Prolactin]; C --x|Inhibits| D[GnRH]; D --> E[Decreased FSH/LH]; E --> F[Hypogonadism];"
    },
    "connections": [
      {
        "type": "caused_by",
        "to": "pituitary_adenoma"
      },
      {
        "type": "caused_by",
        "to": "antipsychotics"
      },
      {
        "type": "suppresses",
        "to": "gonadotropin_releasing_hormone"
      },
      {
        "type": "treated_by",
        "to": "cabergoline"
      }
    ]
  },
  "hypertension": {
    "title": "Hypertension",
    "primaryType": "disease",
    "tags": [
      "Cardiology",
      "Index Stub"
    ],
    "classificationPath": [
      "Cardiology",
      "Vascular Disease"
    ],
    "content": {
      "definition": "<p><i>(Placeholder)</i> Chronic elevation of systemic arterial blood pressure, serving as a major risk factor for stroke, retinopathy, and aneurysm formation.</p>",
      "atAGlance": "<ul><li>See [[hypertensive_retinopathy]], [[charcot_bouchard_microaneurysm]], [[intraparenchymal_hemorrhage]], [[lacunar_stroke]].</li></ul>",
      "takeAway": "",
      "mermaid": ""
    },
    "connections": []
  },
  "hypertensive_retinopathy": {
    "title": "Hypertensive Retinopathy",
    "primaryType": "disease",
    "tags": [
      "Ophthalmology",
      "Vascular",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Ophthalmology",
      "Retinal Vascular Disease"
    ],
    "content": {
      "definition": "<p><b>Hypertensive Retinopathy</b> is retinal vascular damage caused by chronic and/or malignant [[hypertension]], characterized by arteriolar sclerosis, flame hemorrhages, and optic disc edema.</p>",
      "atAGlance": "<ul><li><b>Chronic Changes:</b> Arteriolar narrowing, <b>AV Nicking</b> (arteriole compresses vein), <b>Copper/Silver wiring</b> (sclerosis).</li><li><b>Acute/Malignant Changes:</b> <b>[[cotton_wool_spots]]</b> (ischemia), Flame hemorrhages, Hard Exudates (lipid leak).</li><li><b>Macular Star:</b> Exudates radiating from the macula.</li><li><b>Papilledema:</b> Swelling of the optic disc; indicates <b>Hypertensive Emergency</b>.</li><li><b>USMLE Tip:</b> \"AV Nicking\" implies chronic hypertension. \"Papilledema\" implies malignant/emergency hypertension.</li></ul>",
      "takeAway": "<p><b>Hypertensive Retinopathy</b> manifests as vascular sclerosis (wiring, nicking) in chronic stages and ischemia/leakage (cotton-wool spots, papilledema) in acute malignant stages.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "caused_by",
        "to": "hypertension"
      },
      {
        "type": "characterized_by",
        "to": "cotton_wool_spots"
      },
      {
        "type": "can_progress_to",
        "to": "papilledema"
      }
    ]
  },
  "hypertrophic_cardiomyopathy": {
    "title": "Hypertrophic Cardiomyopathy",
    "primaryType": "disease",
    "tags": [
      "Cardiology",
      "Index Stub"
    ],
    "classificationPath": [
      "Cardiology",
      "Cardiomyopathy"
    ],
    "content": {
      "definition": "<p><i>(Placeholder)</i> A genetic disorder of the heart muscle characterized by thickening of the ventricular wall; noted here for its association with Friedreich Ataxia.</p>",
      "atAGlance": "<ul><li>See [[friedreich_ataxia]].</li></ul>",
      "takeAway": "",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "associated_with",
        "to": "friedreich_ataxia"
      }
    ]
  },
  "hyperventilation": {
    "title": "Hyperventilation (Therapeutic)",
    "primaryType": "process",
    "tags": [
      "Neurology",
      "Critical Care",
      "Physiology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Intracranial Pressure Management"
    ],
    "content": {
      "definition": "<p><b>Therapeutic Hyperventilation</b> is a maneuver used to acutely lower [[intracranial_pressure]] by reducing arterial PCO<sub>2</sub>, which induces cerebral vasoconstriction and decreases cerebral blood volume.</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> &darr; PCO<sub>2</sub> (Hypocapnia) &rarr; Cerebral Vasoconstriction &rarr; &darr; Cerebral Blood Flow/Volume &rarr; &darr; ICP.</li><li><b>Indication:</b> Acute herniation syndromes (bridge to definitive therapy).</li><li><b>Trigger for Seizures:</b> Hyperventilation is a potent trigger for <b>[[absence_seizure]]</b> (3 Hz spike-and-wave).</li><li><b>Physiology:</b> Cerebral perfusion is linearly responsive to PCO<sub>2</sub> between 20-80 mmHg.</li><li><b>USMLE Tip:</b> Effect is temporary (CSF pH equilibrates). Prolonged use risks ischemia.</li></ul>",
      "takeAway": "<p><b>Hyperventilation</b> reduces intracranial pressure via CO<sub>2</sub>-mediated vasoconstriction and is also a diagnostic trigger for absence seizures.</p>",
      "mermaid": "graph TD; A[Hyperventilation] --> B[Decreased pCO2]; B --> C[Cerebral Vasoconstriction]; C --> D[Decreased Cerebral Blood Volume]; D --> E[Decreased Intracranial Pressure];"
    },
    "connections": [
      {
        "type": "decreases",
        "to": "intracranial_pressure"
      },
      {
        "type": "affects",
        "to": "cerebral_perfusion"
      },
      {
        "type": "triggers",
        "to": "absence_seizure"
      }
    ]
  },
  "hypoglossal_nerve": {
    "title": "Hypoglossal Nerve (CN XII)",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Anatomy",
      "Cranial Nerves",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Cranial Nerves",
      "CN XII"
    ],
    "content": {
      "definition": "<p>The <b>Hypoglossal Nerve (CN XII)</b> is a purely motor cranial nerve originating in the medulla that innervates all intrinsic and extrinsic muscles of the <u>tongue</u> (except the palatoglossus).</p>",
      "atAGlance": "<ul><li><b>Origin:</b> Hypoglossal nucleus in the midline Medulla.</li><li><b>Exit:</b> Hypoglossal canal.</li><li><b>Vascular Relation:</b> Exits near the [[anterior_spinal_artery]] and Vertebral artery (Medial Medullary Syndrome).</li><li><b>Function:</b> Tongue movement (Genioglossus protrudes tongue).</li><li><b>Lesion (LMN):</b> Tongue deviates <b>toward</b> the side of the lesion (\"Lick your wounds\"). Atrophy and fasciculations present.</li><li><b>USMLE Tip:</b> Medial Medullary Syndrome involves CN XII (Tongue deviation) + Corticospinal (Hemiparesis) + Medial Lemniscus (Proprioception).</li></ul>",
      "takeAway": "<p><b>CN XII</b> drives tongue movement; damage causes deviation toward the lesion side, and its medial location in the medulla makes it a key localizing sign in Medial Medullary Syndrome.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "innervates",
        "to": "tongue"
      },
      {
        "type": "originates_in",
        "to": "medulla_oblongata"
      },
      {
        "type": "involved_in",
        "to": "medial_medullary_syndrome"
      }
    ]
  },
  "hypopyon": {
    "title": "Hypopyon",
    "primaryType": "finding",
    "tags": [
      "Ophthalmology",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Ophthalmology",
      "Anterior Segment"
    ],
    "content": {
      "definition": "<p><b>Hypopyon</b> is the accumulation of <u>pus</u> (leukocytes) in the anterior chamber of the eye, typically settling at the bottom due to gravity, indicating severe anterior [[uveitis]] or endophthalmitis.</p>",
      "atAGlance": "<ul><li><b>Appearance:</b> White/yellowish fluid level in the inferior anterior chamber.</li><li><b>Etiologies:</b><br> - Infectious: Bacterial keratitis, Endophthalmitis.<br> - Inflammatory: <b>HLA-B27</b> associated [[uveitis]] (Ankylosing spondylitis, Reiter's), Behçet syndrome.</li><li><b>USMLE Tip:</b> Often associated with a red, painful eye and photophobia. Marker of severe inflammation.</li></ul>",
      "takeAway": "<p><b>Hypopyon</b> is a layering of white blood cells in the anterior chamber, a sign of intense intraocular inflammation (uveitis) or infection.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_sign_of",
        "to": "uveitis"
      },
      {
        "type": "located_in",
        "to": "anterior_chamber"
      },
      {
        "type": "associated_with",
        "to": "hla_b27"
      }
    ]
  },
  "hypothalamus": {
    "title": "Hypothalamus",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Endocrinology",
      "Physiology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Brain Anatomy",
      "Diencephalon"
    ],
    "content": {
      "definition": "<p>The <b>Hypothalamus</b> is the central regulator of homeostasis, autonomic function, and the endocrine system, located in the diencephalon below the thalamus and connected to the pituitary gland.</p>",
      "atAGlance": "<ul><li><b>Functions (TAN HATS):</b> <b>T</b>hirst/Water, <b>A</b>denohypophysis control, <b>N</b>eurohypophysis release, <b>H</b>unger, <b>A</b>utonomic reg, <b>T</b>emperature, <b>S</b>exual urges.</li><li><b>Key Nuclei:</b><br> - <b>Lateral:</b> Hunger (inhibited by [[leptin]]). Lesion &rarr; Anorexia.<br> - <b>Ventromedial:</b> Satiety (stimulated by Leptin). Lesion &rarr; Hyperphagia/Obesity.<br> - <b>Anterior:</b> Cooling (Parasympathetic). Lesion &rarr; Hyperthermia.<br> - <b>Posterior:</b> Heating (Sympathetic). Lesion &rarr; Poikilothermia.<br> - <b>Suprachiasmatic:</b> Circadian rhythm.<br> - <b>Supraoptic/Paraventricular:</b> ADH/Oxytocin.</li><li><b>USMLE Tip:</b> \"<b>L</b>ateral injury makes you <b>L</b>ean. <b>V</b>entromedial injury makes you <b>V</b>ery Massive.\"</li></ul>",
      "takeAway": "<p>The <b>Hypothalamus</b> maintains body homeostasis through specific nuclei controlling hunger, temperature, circadian rhythms, and pituitary hormone secretion.</p>",
      "mermaid": "graph TD; A[Hypothalamus] --> B[Lateral Nucleus (Hunger)]; A --> C[Ventromedial Nucleus (Satiety)]; A --> D[Anterior Nucleus (Cooling)]; A --> E[Posterior Nucleus (Heating)]; A --> F[SCN (Rhythm)];"
    },
    "connections": [
      {
        "type": "controls",
        "to": "pituitary_gland"
      },
      {
        "type": "is_part_of",
        "to": "limbic_system"
      },
      {
        "type": "regulates",
        "to": "circadian_rhythm"
      },
      {
        "type": "regulates",
        "to": "body_temperature"
      }
    ]
  }
}
``````json
{
  "hypoxic_stroke": {
    "title": "Hypoxic Stroke",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Vascular",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Cerebrovascular Disease",
      "Ischemic Stroke"
    ],
    "content": {
      "definition": "<p><b>Hypoxic Stroke</b> is a type of ischemic stroke caused by systemic <u>hypoperfusion</u> or hypoxemia (rather than local thrombosis/embolism), leading to diffuse injury that preferentially affects the highly vulnerable <b>watershed areas</b> between major arterial territories.</p>",
      "atAGlance": "<ul><li><b>Etiology:</b> Cardiac arrest, severe hypotension (shock), or severe hypoxemia.</li><li><b>Vulnerable Areas:</b> <b>[[watershed_zones]]</b> (border zones between ACA/MCA and MCA/PCA territories).</li><li><b>Clinical Presentation:</b><br> - <i>ACA-MCA Watershed:</i> Proximal upper/lower extremity weakness (\"Man-in-a-barrel\" syndrome).<br> - <i>PCA-MCA Watershed:</i> Higher-order visual dysfunction.</li><li><b>Pathology:</b> Laminar necrosis of the cortex; hippocampus and Purkinje cells are most sensitive.</li><li><b>USMLE Tip:</b> Look for a patient with a history of cardiac arrest who wakes up with proximal weakness (shoulders/thighs) sparing the face/hands.</li></ul>",
      "takeAway": "<p><b>Hypoxic Stroke</b> results from systemic hypoperfusion, damaging the \"watershed\" border zones between major cerebral arteries, causing specific deficits like \"man-in-a-barrel\" syndrome.</p>",
      "mermaid": "graph TD; A[Systemic Hypotension] --> B[Decreased Perfusion Pressure]; B --> C[Ischemia in Distal Arterial Beds]; C --> D[Watershed Infarction]; D --> E[Proximal Limb Weakness];"
    },
    "connections": [
      {
        "type": "affects_region",
        "to": "watershed_zones"
      },
      {
        "type": "is_a_type_of",
        "to": "ischemic_stroke"
      },
      {
        "type": "causes",
        "to": "man_in_a_barrel_syndrome"
      }
    ]
  },
  "idiopathic_intracranial_hypertension": {
    "title": "Idiopathic Intracranial Hypertension (Pseudotumor Cerebri)",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Ophthalmology",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Intracranial Pressure Disorders"
    ],
    "content": {
      "definition": "<p><b>Idiopathic Intracranial Hypertension</b> (Pseudotumor Cerebri) is a condition of elevated <u>intracranial pressure</u> in the absence of a tumor or hydrocephalus, classically affecting obese women of childbearing age and presenting with headaches and papilledema.</p>",
      "atAGlance": "<ul><li><b>Risk Factors:</b> <b>Female, Fat, Forty (Fertile)</b>. Medications: <b>Tetracyclines</b>, Vitamin A (Isotretinoin), Danazol.</li><li><b>Clinical Features:</b> Pulsatile headache, Tinnitus (\"whooshing\"), Diplopia (<b>CN VI palsy</b>), Papilledema.</li><li><b>Diagnosis:</b><br> - <i>MRI:</i> Normal brain, empty sella.<br> - <i>Lumbar Puncture:</i> <b>High opening pressure</b> (>25 cm H2O) with normal CSF composition. Note: LP is also therapeutic (relieves headache).</li><li><b>Treatment:</b> Weight loss (First line), [[acetazolamide]] (decreases CSF production), Topiramate. Shunt or Optic Nerve Sheath Fenestration for vision threat.</li><li><b>USMLE Tip:</b> \"Female TOAD\" (<b>T</b>etracyclines, <b>O</b>besity, vitamin <b>A</b>, <b>D</b>anazol).</li></ul>",
      "takeAway": "<p><b>Idiopathic Intracranial Hypertension</b> is a diagnosis of exclusion in obese women with headache and papilledema, managed with weight loss and acetazolamide to prevent vision loss.</p>",
      "mermaid": "graph TD; A[Risk Factors e.g. Obesity] --> B[Increased Intracranial Pressure]; B --> C[Papilledema]; B --> D[Headache/Tinnitus]; B --> E[CN VI Palsy]; F[Lumbar Puncture] -->|Relieves| B;"
    },
    "connections": [
      {
        "type": "treated_by",
        "to": "acetazolamide"
      },
      {
        "type": "manifests_as",
        "to": "papilledema"
      },
      {
        "type": "associated_with_drug",
        "to": "tetracyclines"
      },
      {
        "type": "associated_with_drug",
        "to": "isotretinoin"
      },
      {
        "type": "can_cause",
        "to": "abducens_nerve_palsy"
      }
    ]
  },
  "increased_intracranial_pressure": {
    "title": "Increased Intracranial Pressure (ICP)",
    "primaryType": "pathology",
    "tags": [
      "Neurology",
      "Pathology",
      "Critical Care",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Intracranial Pressure Disorders"
    ],
    "content": {
      "definition": "<p><b>Increased Intracranial Pressure (ICP)</b> is a dangerous elevation of pressure within the cranium due to mass effect (tumor, blood) or fluid accumulation (edema, hydrocephalus), which compromises cerebral perfusion and risks brain herniation.</p>",
      "atAGlance": "<ul><li><b>Etiologies:</b> Tumors, [[cerebral_edema]], [[hydrocephalus]], Intracranial Hemorrhage, [[idiopathic_intracranial_hypertension]], Venous sinus thrombosis.</li><li><b>Clinical Findings:</b> Headache (worse in morning/lying down), Vomiting, [[papilledema]], [[cushing_reflex]] (HTN, Bradycardia, Irregular respiration).</li><li><b>Complications:</b> [[brain_herniation]] (Uncal, Tonsillar, Subfalcine), Brain death (CPP = 0).</li><li><b>Management:</b> Elevate head, Hyperventilation (vasoconstriction), Mannitol, Surgical decompression.</li><li><b>USMLE Tip:</b> <b>Cushing Triad</b> = Hypertension + Bradycardia + Irregular breathing = Impending Herniation.</li></ul>",
      "takeAway": "<p><b>Increased ICP</b> is a medical emergency characterized by headache, papilledema, and the Cushing reflex, requiring immediate intervention to maintain cerebral perfusion and prevent herniation.</p>",
      "mermaid": "graph TD; A[Mass/Fluid] --> B[Increased ICP]; B --> C[Decreased Cerebral Perfusion]; C --> D[Cushing Reflex]; B --> E[Brain Herniation];"
    },
    "connections": [
      {
        "type": "causes",
        "to": "cushing_reflex"
      },
      {
        "type": "causes",
        "to": "brain_herniation"
      },
      {
        "type": "manifests_as",
        "to": "papilledema"
      },
      {
        "type": "treated_by",
        "to": "hyperventilation"
      }
    ]
  },
  "incus": {
    "title": "Incus",
    "primaryType": "structure",
    "tags": [
      "Otolaryngology",
      "Anatomy",
      "Hearing",
      "USMLE"
    ],
    "classificationPath": [
      "Otolaryngology",
      "Middle Ear Anatomy",
      "Ossicles"
    ],
    "content": {
      "definition": "<p>The <b>Incus</b> (\"Anvil\") is the middle bone of the three auditory <u>ossicles</u> in the middle ear, transmitting vibrations from the [[malleus]] to the [[stapes]].</p>",
      "atAGlance": "<ul><li><b>Location:</b> Middle Ear.</li><li><b>Articulation:</b> Synovial joints with the Malleus (lateral) and Stapes (medial).</li><li><b>Embryology:</b> Derived from the <b>1st Pharyngeal Arch</b> (Neural Crest).</li><li><b>Function:</b> Impedance matching (amplifies sound energy from air to fluid).</li><li><b>Pathology:</b> Disruption (trauma) or fixation (otosclerosis) leads to [[conductive_hearing_loss]].</li></ul>",
      "takeAway": "<p>The <b>Incus</b> is the bridge of the ossicular chain, derived from the 1st pharyngeal arch, essential for conducting sound to the inner ear.</p>",
      "mermaid": "graph LR; A[Tympanic Membrane] --> B[Malleus]; B --> C[Incus]; C --> D[Stapes]; D --> E[Oval Window];"
    },
    "connections": [
      {
        "type": "articulates_with",
        "to": "malleus"
      },
      {
        "type": "articulates_with",
        "to": "stapes"
      },
      {
        "type": "derived_from",
        "to": "first_pharyngeal_arch"
      }
    ]
  },
  "indirect_pathway_basal_ganglia": {
    "title": "Indirect Pathway (Basal Ganglia)",
    "primaryType": "process",
    "tags": [
      "Neurology",
      "Physiology",
      "Motor Control",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Basal Ganglia Pathways"
    ],
    "content": {
      "definition": "<p>The <b>Indirect Pathway</b> of the basal ganglia suppresses unwanted movement by increasing the inhibitory output of the GPi/SNr to the thalamus, modulated by [[dopamine]] binding to D2 receptors.</p>",
      "atAGlance": "<ul><li><b>Circuitry:</b> Cortex &rarr; Striatum (GABA) &rarr; Inhibits <b>GPe</b> &rarr; Disinhibits <b>[[subthalamic_nucleus]]</b> &rarr; Excites <b>GPi/SNr</b> &rarr; Inhibits Thalamus &rarr; <b>Decreased Motion</b>.</li><li><b>Dopamine Effect:</b> Nigrostriatal dopamine binds <b>D2 Receptors</b> (Gi - inhibitory) in the striatum &rarr; <u>Inhibits</u> the Indirect Pathway &rarr; Allows movement.</li><li><b>Pathology:</b> <br> - <i>Loss of D2 stimulation (Parkinson's):</i> Indirect pathway runs wild &rarr; rigidity/bradykinesia.<br> - <i>Loss of Indirect Pathway (Huntington's):</i> Early loss of striatal GABA/Enk neurons &rarr; Hyperkinesia (Chorea).</li><li><b>Mnemonic:</b> <b>In</b>direct = <b>In</b>hibits movement. D<b>2</b> = Inhibition.</li></ul>",
      "takeAway": "<p>The <b>Indirect Pathway</b> acts as a brake on movement; dopamine lifts this brake via D2 receptors. Loss of this pathway leads to chorea (Huntington's), while overactivity leads to parkinsonism.</p>",
      "mermaid": "graph TD; A[Cortex] --(+)--> B[Striatum]; B --(-)|GABA| C[GPe]; C --(-)|GABA| D[Subthalamic Nucleus]; D --(+)|Glutamate| E[GPi/SNr]; E --(-)|GABA| F[Thalamus]; F --(+)|Glutamate| G[Motor Cortex]; H[SNc Dopamine] --(-)|D2| B;"
    },
    "connections": [
      {
        "type": "involves",
        "to": "globus_pallidus_externus"
      },
      {
        "type": "involves",
        "to": "subthalamic_nucleus"
      },
      {
        "type": "is_inhibited_by",
        "to": "dopamine"
      },
      {
        "type": "dysfunction_causes",
        "to": "huntington_disease"
      }
    ]
  },
  "infective_dementia": {
    "title": "Infective Dementia",
    "primaryType": "group",
    "tags": [
      "Neurology",
      "Infectious Disease",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Neurodegenerative Diseases",
      "Infectious"
    ],
    "content": {
      "definition": "<p><b>Infective Dementia</b> refers to cognitive decline caused by transmissible agents affecting the CNS, including viruses (HIV), spirochetes (Syphilis), and prions (CJD).</p>",
      "atAGlance": "<ul><li><b>[[hiv_associated_dementia]]:</b> Subcortical dementia, microglial nodules, multinucleated giant cells.</li><li><b>[[creutzfeldt_jakob_disease]]:</b> Prion disease. Rapidly progressive, myoclonus, spongiform changes.</li><li><b>Neurosyphilis:</b> [[tabes_dorsalis]], General Paresis (\"Paretic Neurosyphilis\" - dementia, personality changes). Argyll Robertson pupil.</li><li><b>PML:</b> JC virus in immunocompromised. White matter lesions.</li></ul>",
      "takeAway": "<p><b>Infective Dementia</b> includes treatable (Syphilis, HIV) and untreatable (Prion) causes; rapid progression suggests CJD, while HIV presents as a subcortical pattern.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "includes",
        "to": "hiv_associated_dementia"
      },
      {
        "type": "includes",
        "to": "creutzfeldt_jakob_disease"
      },
      {
        "type": "includes",
        "to": "neurosyphilis"
      },
      {
        "type": "includes",
        "to": "progressive_multifocal_leukoencephalopathy"
      }
    ]
  },
  "inferior_oblique_muscle": {
    "title": "Inferior Oblique Muscle",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Anatomy",
      "Ophthalmology",
      "USMLE"
    ],
    "classificationPath": [
      "Ophthalmology",
      "Extraocular Muscles"
    ],
    "content": {
      "definition": "<p>The <b>Inferior Oblique Muscle</b> is an extraocular muscle innervated by the [[oculomotor_nerve]] (CN III) that primarily <u>extorts</u> and <u>elevates</u> the eye (especially when adducted).</p>",
      "atAGlance": "<ul><li><b>Innervation:</b> <b>CN III</b> (Oculomotor).</li><li><b>Primary Action:</b> Extorsion (rotates top of eye outward).</li><li><b>Secondary Actions:</b> <b>Elevation</b> (looking up), Abduction.</li><li><b>Testing:</b> Have the patient look <b>In</b> (Adduct) and <b>Up</b>. (\"I <b>O</b> U\" = Inferior Oblique Up).</li><li><b>USMLE Tip:</b> Unlike the Recti muscles, the Obliques act contrary to their names regarding vertical movement (Inferior &rarr; Elevates, Superior &rarr; Depresses).</li></ul>",
      "takeAway": "<p>The <b>Inferior Oblique</b> elevates the eye when it is adducted and is tested by looking \"In and Up\"; it is innervated by CN III.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "innervated_by",
        "to": "oculomotor_nerve"
      },
      {
        "type": "performs_action",
        "to": "elevation"
      },
      {
        "type": "performs_action",
        "to": "extorsion"
      }
    ]
  },
  "inferior_rectus_muscle": {
    "title": "Inferior Rectus Muscle",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Anatomy",
      "Ophthalmology",
      "USMLE"
    ],
    "classificationPath": [
      "Ophthalmology",
      "Extraocular Muscles"
    ],
    "content": {
      "definition": "<p>The <b>Inferior Rectus Muscle</b> is an extraocular muscle innervated by the [[oculomotor_nerve]] (CN III) that primarily <u>depresses</u> the eye (especially when abducted).</p>",
      "atAGlance": "<ul><li><b>Innervation:</b> <b>CN III</b> (Oculomotor).</li><li><b>Primary Action:</b> Depression (looking down).</li><li><b>Secondary Actions:</b> Extorsion, Adduction.</li><li><b>Testing:</b> Have the patient look <b>Out</b> (Abduct) and <b>Down</b>.</li><li><b>Pathology:</b> Entrapment in <b>[[blowout_fracture]]</b> of the orbital floor leads to restriction of upward gaze (tethering) and vertical diplopia.</li></ul>",
      "takeAway": "<p>The <b>Inferior Rectus</b> depresses the eye and is clinically significant for its frequent entrapment in orbital floor fractures, limiting upgaze.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "innervated_by",
        "to": "oculomotor_nerve"
      },
      {
        "type": "entrapped_in",
        "to": "blowout_fracture"
      },
      {
        "type": "performs_action",
        "to": "depression"
      }
    ]
  },
  "inhaled_anesthetics": {
    "title": "Inhaled Anesthetics",
    "primaryType": "group",
    "tags": [
      "Pharmacology",
      "Anesthesiology",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Anesthetics",
      "Inhaled"
    ],
    "content": {
      "definition": "<p><b>Inhaled Anesthetics</b> are volatile liquids or gases used to maintain general anesthesia, characterized by their solubility properties (Blood/Gas and Oil/Gas coefficients) and potency (MAC).</p>",
      "atAGlance": "<ul><li><b>Agents:</b> [[desflurane]], [[isoflurane]], [[sevoflurane]], [[halothane]], Nitrous Oxide (N<sub>2</sub>O).</li><li><b>Properties:</b><br> - <b>Blood/Gas Partition Coefficient:</b> Determines <i>speed</i> of induction/recovery. Low solubility (Desflurane) = Fast. High (Halothane) = Slow.<br> - <b>Oil/Gas Partition Coefficient:</b> Determines <i>potency</i>. High lipid solubility = High potency = Low MAC.</li><li><b>Adverse Effects:</b> <b>[[malignant_hyperthermia]]</b> (except N<sub>2</sub>O), Hepatotoxicity (Halothane), Nephrotoxicity (Methoxyflurane), Respiratory depression, Increased cerebral blood flow (Increased ICP).</li><li><b>USMLE Tip:</b> MAC is inversely proportional to Potency.</li></ul>",
      "takeAway": "<p><b>Inhaled Anesthetics</b> are defined by MAC (potency) and solubility (speed); they carry a class risk of Malignant Hyperthermia and increasing intracranial pressure.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "includes",
        "to": "sevoflurane"
      },
      {
        "type": "includes",
        "to": "desflurane"
      },
      {
        "type": "can_cause",
        "to": "malignant_hyperthermia"
      },
      {
        "type": "can_increase",
        "to": "intracranial_pressure"
      }
    ]
  },
  "inner_ear": {
    "title": "Inner Ear",
    "primaryType": "structure",
    "tags": [
      "Otolaryngology",
      "Anatomy",
      "USMLE"
    ],
    "classificationPath": [
      "Otolaryngology",
      "Anatomy"
    ],
    "content": {
      "definition": "<p>The <b>Inner Ear</b> (Labyrinth) is located within the petrous temporal bone and contains the organs of hearing ([[cochlea]]) and balance (Vestibular system: Semicircular canals, Utricle, Saccule).</p>",
      "atAGlance": "<ul><li><b>Bony Labyrinth:</b> Filled with <b>Perilymph</b> (High Na<sup>+</sup>, Low K<sup>+</sup> - like ECF).</li><li><b>Membranous Labyrinth:</b> Filled with <b>Endolymph</b> (High K<sup>+</sup>, Low Na<sup>+</sup> - like ICF).</li><li><b>Structures:</b><br> - <b>[[cochlea]]:</b> Hearing (Organ of Corti).<br> - <b>Vestibule (Utricle/Saccule):</b> Linear acceleration/Gravity.<br> - <b>Semicircular Canals:</b> Rotational acceleration.</li><li><b>Pathology:</b> [[meniere_disease]] (Endolymphatic hydrops), Labyrinthitis, BPPV (Otoliths).</li></ul>",
      "takeAway": "<p>The <b>Inner Ear</b> houses the sensory apparatus for hearing and balance within fluid-filled compartments (Endolymph/Perilymph), innervated by CN VIII.</p>",
      "mermaid": "graph TD; A[Inner Ear] --> B[Cochlea]; A --> C[Vestibular System]; B --> D[Hearing]; C --> E[Semicircular Canals]; C --> F[Otolith Organs]; E --> G[Rotation]; F --> H[Linear Motion/Gravity];"
    },
    "connections": [
      {
        "type": "contains",
        "to": "cochlea"
      },
      {
        "type": "contains",
        "to": "vestibular_system"
      },
      {
        "type": "affected_in",
        "to": "meniere_disease"
      }
    ]
  },
  "insomnia_therapy": {
    "title": "Insomnia Therapy",
    "primaryType": "group",
    "tags": [
      "Pharmacology",
      "Psychiatry",
      "Sleep Medicine",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Sedative-Hypnotics"
    ],
    "content": {
      "definition": "<p><b>Insomnia Therapy</b> involves a range of pharmacologic agents targeting GABA, Melatonin, or Orexin receptors to induce or maintain sleep.</p>",
      "atAGlance": "<ul><li><b>GABA<sub>A</sub> Modulators (Z-drugs):</b> [[zolpidem]], [[eszopiclone]], Zaleplon. Selective for BZ1 subtype. Less tolerance than benzos. Reversible by Flumazenil.</li><li><b>Orexin Antagonists:</b> [[suvorexant]]. Blocks wakefulness (contraindicated in Narcolepsy).</li><li><b>Melatonin Agonists:</b> [[ramelteon]]. Binds MT1/MT2 in Suprachiasmatic nucleus. Safe in elderly (no dependence).</li><li><b>Others:</b> Trazodone, Antihistamines (Diphenhydramine).</li><li><b>USMLE Tip:</b> For elderly patients, <b>Ramelteon</b> is safest. Avoid Diphenhydramine (anticholinergic delirium) and Benzos (falls).</li></ul>",
      "takeAway": "<p>Pharmacotherapy for insomnia targets sleep-wake pathways via GABA (Z-drugs), Melatonin (Ramelteon), or Orexin (Suvorexant), with selection based on side effect profile and duration.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "includes",
        "to": "zolpidem"
      },
      {
        "type": "includes",
        "to": "eszopiclone"
      },
      {
        "type": "includes",
        "to": "suvorexant"
      },
      {
        "type": "includes",
        "to": "ramelteon"
      }
    ]
  },
  "intention_tremor": {
    "title": "Intention Tremor",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Physical Exam",
      "Cerebellum",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Movement Disorders",
      "Tremor"
    ],
    "content": {
      "definition": "<p><b>Intention Tremor</b> is a slow, zigzagging tremor of the extremities that <u>worsens as the limb approaches a target</u>, serving as a classic sign of <b>cerebellar dysfunction</b>.</p>",
      "atAGlance": "<ul><li><b>Localization:</b> Ipsilateral <b>Cerebellar Hemisphere</b> (specifically the Dentate Nucleus or Superior Cerebellar Peduncle).</li><li><b>Characteristics:</b> Absent at rest. Amplitude increases during guided movement (kinetic tremor) and peaks at the target.</li><li><b>Test:</b> Finger-to-Nose test (patient overshoots/undershoots and shakes near the nose).</li><li><b>Etiologies:</b> [[multiple_sclerosis]] (Charcot Triad), Stroke, Alcohol use disorder (chronic).</li><li><b>Differentiation:</b> Contrast with <b>Resting Tremor</b> (Parkinson's - improves with movement) and <b>Essential Tremor</b> (Action tremor - present throughout movement).</li></ul>",
      "takeAway": "<p><b>Intention Tremor</b> indicates cerebellar pathology (hemisphere/dentate), characterized by worsening oscillation as the target is approached.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "localizes_to",
        "to": "cerebellum"
      },
      {
        "type": "associated_with",
        "to": "multiple_sclerosis"
      },
      {
        "type": "is_contrasted_with",
        "to": "resting_tremor"
      }
    ]
  },
  "internal_carotid_artery": {
    "title": "Internal Carotid Artery (ICA)",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Anatomy",
      "Vascular",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Cerebrovascular System",
      "Arterial Supply"
    ],
    "content": {
      "definition": "<p>The <b>Internal Carotid Artery (ICA)</b> is a major artery supplying the anterior brain circulation, known for its tortuous course through the <u>Cavernous Sinus</u> where it is intimately associated with cranial nerve VI.</p>",
      "atAGlance": "<ul><li><b>Course:</b> Neck &rarr; Carotid Canal &rarr; <b>Cavernous Sinus</b> (Cavernous Segment) &rarr; Cerebral Circle of Willis.</li><li><b>Relations:</b> Inside the Cavernous Sinus, it runs adjacent to <b>[[abducens_nerve]] (CN VI)</b>. Postganglionic sympathetic fibers run along its surface.</li><li><b>Branches:</b> Ophthalmic Artery, PCom, Anterior Choroidal, Bifurcates into ACA and MCA.</li><li><b>Pathology:</b><br> - <b>Aneurysm (Cavernous):</b> Can compress CN VI (isolated lateral rectus palsy).<br> - <b>Dissection:</b> Painful Horner Syndrome (disrupts sympathetics).<br> - <b>Fistula:</b> [[carotid_cavernous_fistula]].</li></ul>",
      "takeAway": "<p>The <b>Internal Carotid Artery</b> supplies the anterior circulation and passes through the cavernous sinus, where pathology can cause specific deficits like CN VI palsy or Horner syndrome.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "passes_through",
        "to": "cavernous_sinus"
      },
      {
        "type": "associated_with",
        "to": "abducens_nerve"
      },
      {
        "type": "carries",
        "to": "sympathetic_fibers"
      },
      {
        "type": "involved_in",
        "to": "carotid_cavernous_fistula"
      }
    ]
  },
  "internal_jugular_vein": {
    "title": "Internal Jugular Vein (IJV)",
    "primaryType": "structure",
    "tags": [
      "Neurology",
      "Anatomy",
      "Vascular",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Cerebrovascular System",
      "Venous Drainage"
    ],
    "content": {
      "definition": "<p>The <b>Internal Jugular Vein</b> is the primary venous outflow tract for the brain, receiving blood from the [[dural_venous_sinuses]] (specifically the sigmoid sinus) at the jugular foramen.</p>",
      "atAGlance": "<ul><li><b>Origin:</b> Continuation of the Sigmoid Sinus at the <b>Jugular Foramen</b>.</li><li><b>Course:</b> Descends in the Carotid Sheath (with ICA/Common Carotid and Vagus Nerve).</li><li><b>Drainage:</b> Brain, Face, Neck.</li><li><b>Clinical:</b> Site for central venous catheterization. Distension reflects Right Atrial Pressure (JVP).</li></ul>",
      "takeAway": "<p>The <b>Internal Jugular Vein</b> drains the dural venous sinuses, exiting the skull via the jugular foramen to return CNS blood to the systemic circulation.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "drains",
        "to": "dural_venous_sinuses"
      },
      {
        "type": "exits_via",
        "to": "jugular_foramen"
      },
      {
        "type": "receives_from",
        "to": "sigmoid_sinus"
      }
    ]
  }
}
``````json
{
  "internuclear_ophthalmoplegia": {
    "title": "Internuclear Ophthalmoplegia (INO)",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Ophthalmology",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Neuro-Ophthalmology",
      "Gaze Palsies"
    ],
    "content": {
      "definition": "<p><b>Internuclear Ophthalmoplegia (INO)</b> is a conjugate gaze palsy caused by a lesion in the <u>Medial Longitudinal Fasciculus (MLF)</u>, characterized by impaired <b>adduction</b> of the ipsilateral eye and dissociated <b>nystagmus</b> of the contralateral abducting eye during horizontal gaze.</p>",
      "atAGlance": "<ul><li><b>Lesion Localization:</b> <b>Medial Longitudinal Fasciculus (MLF)</b> in the dorsomedial Pons/Midbrain.</li><li><b>Mechanism:</b> Disruption of the signal from the contralateral Abducens (CN VI) nucleus to the ipsilateral Oculomotor (CN III) medial rectus subnucleus.</li><li><b>Clinical Presentation:</b><br> - <i>Adducting Eye:</i> Paresis (cannot look medially).<br> - <i>Abducting Eye:</i> Horizontal nystagmus (correctional saccades).<br> - <i>Convergence:</i> Usually <b>preserved</b> (cortical input to CN III bypasses MLF).</li><li><b>Etiologies:</b><br> - <i>Bilateral:</i> Highly suggestive of <b>[[multiple_sclerosis]]</b> (young patient).<br> - <i>Unilateral:</i> Often lacunar stroke (elderly patient).</li><li><b>USMLE Tip:</b> \"Right INO\" means the Right eye cannot adduct (Right MLF lesion).</li></ul>",
      "takeAway": "<p><b>INO</b> is a disconnection syndrome of the MLF resulting in adduction failure and contralateral nystagmus; bilateral presentation strongly suggests Multiple Sclerosis.</p>",
      "mermaid": "graph TD; A[Lateral Gaze Command] --> B[Contralateral PPRF]; B --> C[Contralateral CN VI Nucleus]; C --> D[Contralateral Lateral Rectus (Abducts)]; C --x|Lesion in MLF| E[Ipsilateral CN III Nucleus]; E --> F[Ipsilateral Medial Rectus (Fails to Adduct)];"
    },
    "connections": [
      {
        "type": "caused_by_lesion_in",
        "to": "medial_longitudinal_fasciculus"
      },
      {
        "type": "associated_with",
        "to": "multiple_sclerosis"
      },
      {
        "type": "is_distinguished_from",
        "to": "conjugate_horizontal_gaze_palsy"
      }
    ]
  },
  "intraparenchymal_hemorrhage": {
    "title": "Intraparenchymal Hemorrhage",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Vascular",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Cerebrovascular Disease",
      "Hemorrhagic Stroke"
    ],
    "content": {
      "definition": "<p><b>Intraparenchymal Hemorrhage</b> is a subtype of hemorrhagic stroke involving bleeding directly into the brain tissue, most commonly caused by the rupture of small penetrating arteries due to chronic <u>hypertension</u> or <u>amyloid angiopathy</u>.</p>",
      "atAGlance": "<ul><li><b>Etiologies:</b><br> - <b>Hypertensive:</b> Rupture of <b>[[charcot_bouchard_microaneurysm]]</b>. Affects deep structures: Basal Ganglia (Putamen), Thalamus, Pons, Cerebellum.<br> - <b>[[cerebral_amyloid_angiopathy]]:</b> Beta-amyloid deposition in vessels. Affects <b>Lobar</b> (cortical) regions (e.g., Occipital, Parietal). Common in elderly.<br> - <b>Other:</b> AVM, Tumor, Coagulopathy, Vasculitis.</li><li><b>Clinical Features:</b> Sudden onset focal deficit + Headache, Vomiting, Decreased consciousness (mass effect).</li><li><b>Imaging:</b> CT shows hyperdense (white) collection within brain parenchyma.</li><li><b>USMLE Tip:</b> Putaminal hemorrhage causes contralateral hemiparesis (Internal Capsule compression). Pontine hemorrhage causes \"pinpoint pupils\" and coma.</li></ul>",
      "takeAway": "<p><b>Intraparenchymal Hemorrhage</b> is usually hypertensive (deep/basal ganglia) or amyloid-related (lobar); it causes rapid mass effect and focal deficits based on location.</p>",
      "mermaid": "graph TD; A[Chronic Hypertension] --> B[Lipohyalinosis of Lenticulostriate Arteries]; B --> C[Charcot-Bouchard Microaneurysms]; C --> D[Rupture]; D --> E[Basal Ganglia Hemorrhage];"
    },
    "connections": [
      {
        "type": "caused_by",
        "to": "hypertension"
      },
      {
        "type": "caused_by",
        "to": "cerebral_amyloid_angiopathy"
      },
      {
        "type": "involves_rupture_of",
        "to": "charcot_bouchard_microaneurysm"
      },
      {
        "type": "is_a_type_of",
        "to": "intracranial_hemorrhage"
      }
    ]
  },
  "intravenous_anesthetics": {
    "title": "Intravenous Anesthetics",
    "primaryType": "group",
    "tags": [
      "Pharmacology",
      "Anesthesiology",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Anesthetics",
      "Intravenous"
    ],
    "content": {
      "definition": "<p><b>Intravenous Anesthetics</b> are drugs used for the rapid induction of anesthesia (and maintenance in TIVA), acting primarily by potentiating GABAergic inhibition or blocking NMDA excitation.</p>",
      "atAGlance": "<ul><li><b>[[propofol]]:</b> Potentiates GABA<sub>A</sub>. Rapid on/off. Anti-emetic. <i>SE:</i> Hypotension, respiratory depression, pain on injection.</li><li><b>[[etomidate]]:</b> Potentiates GABA<sub>A</sub>. Hemodynamically stable. <i>SE:</i> <b>Adrenal suppression</b>.</li><li><b>[[ketamine]]:</b> NMDA antagonist. Dissociative anesthesia. Sympathomimetic (increases BP/HR). <i>SE:</i> Hallucinations, emergence delirium.</li><li><b>[[barbiturates]] (Thiopental):</b> Potentiates GABA<sub>A</sub>. Decreases cerebral blood flow/ICP. Highly lipid soluble (redistributes to tissue).</li><li><b>[[benzodiazepines]] (Midazolam):</b> Potentiates GABA<sub>A</sub>. Amnesia/Sedation. Reversal: Flumazenil.</li><li><b>Opioids:</b> Adjuncts for analgesia.</li></ul>",
      "takeAway": "<p><b>IV Anesthetics</b> allow for rapid induction; Propofol is standard, Etomidate is for hemodynamically unstable patients, and Ketamine provides analgesia/sympathetic boost.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "includes",
        "to": "propofol"
      },
      {
        "type": "includes",
        "to": "etomidate"
      },
      {
        "type": "includes",
        "to": "ketamine"
      },
      {
        "type": "includes",
        "to": "thiopental"
      }
    ]
  },
  "intraventricular_hemorrhage": {
    "title": "Intraventricular Hemorrhage (Neonatal)",
    "primaryType": "disease",
    "tags": [
      "Pediatrics",
      "Neurology",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Cerebrovascular Disease",
      "Neonatal"
    ],
    "content": {
      "definition": "<p><b>Neonatal Intraventricular Hemorrhage (IVH)</b> is a bleeding into the brain's ventricular system originating from the fragile <u>germinal matrix</u>, predominantly affecting premature and low-birth-weight infants.</p>",
      "atAGlance": "<ul><li><b>Origin:</b> <b>Germinal Matrix</b> (highly vascularized area in subventricular zone, involutes by term). Fragile vessels rupture due to hypoxia/BP fluctuations.</li><li><b>Risk Factors:</b> <b>Prematurity</b> (<32 weeks), Low Birth Weight (<1500g), RDS.</li><li><b>Clinical Presentation:</b> Hypotonia, seizures, bulging fontanelle, anemia, apnea. Can be asymptomatic.</li><li><b>Complications:</b> Post-hemorrhagic <b>[[hydrocephalus]]</b> (clot obstructs CSF flow), Cerebral Palsy.</li><li><b>Screening:</b> Cranial Ultrasound.</li><li><b>USMLE Tip:</b> Look for a preemie with sudden drop in hematocrit and altered mental status.</li></ul>",
      "takeAway": "<p><b>Intraventricular Hemorrhage</b> is a complication of prematurity caused by the rupture of the fragile germinal matrix capillaries, potentially leading to hydrocephalus and neurodevelopmental delay.</p>",
      "mermaid": "graph TD; A[Prematurity] --> B[Fragile Germinal Matrix]; B --> C[Hypoxia/Hemodynamic Stress]; C --> D[Capillary Rupture]; D --> E[Bleeding into Ventricles]; E --> F[Hydrocephalus];"
    },
    "connections": [
      {
        "type": "originates_in",
        "to": "germinal_matrix"
      },
      {
        "type": "associated_with",
        "to": "prematurity"
      },
      {
        "type": "can_cause",
        "to": "hydrocephalus"
      }
    ]
  },
  "iritis": {
    "title": "Iritis (Anterior Uveitis)",
    "primaryType": "disease",
    "tags": [
      "Ophthalmology",
      "Pathology",
      "Inflammation",
      "USMLE"
    ],
    "classificationPath": [
      "Ophthalmology",
      "Uveitis",
      "Anterior"
    ],
    "content": {
      "definition": "<p><b>Iritis</b> (Anterior Uveitis) is the inflammation of the iris and anterior ciliary body, characterized by eye pain, photophobia, redness (ciliary flush), and the presence of leukocytes in the anterior chamber.</p>",
      "atAGlance": "<ul><li><b>Clinical Features:</b><br> - Pain, Photophobia, Redness (perilimbal injection).<br> - <b>[[hypopyon]]</b> (pus in anterior chamber).<br> - Irregular pupil (synechiae - adhesions between iris and lens/cornea).</li><li><b>Associations:</b><br> - <b>[[hla_b27]] Spondyloarthropathies:</b> Ankylosing Spondylitis, Reactive Arthritis, Psoriatic Arthritis, IBD.<br> - <b>Systemic:</b> Sarcoidosis, Syphilis, Tuberculosis, Juvenile Idiopathic Arthritis (pauciarticular).</li><li><b>Treatment:</b> Topical corticosteroids, Cycloplegics (reduce pain/synechiae).</li></ul>",
      "takeAway": "<p><b>Iritis</b> presents with a painful red eye and photophobia; it is a key ocular manifestation of HLA-B27 spondyloarthropathies and sarcoidosis.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "associated_with",
        "to": "hla_b27"
      },
      {
        "type": "manifests_as",
        "to": "hypopyon"
      },
      {
        "type": "is_a_type_of",
        "to": "uveitis"
      }
    ]
  },
  "iron": {
    "title": "Iron",
    "primaryType": "substance",
    "tags": [
      "Hematology",
      "Biochemistry",
      "Nutrition",
      "USMLE"
    ],
    "classificationPath": [
      "Biochemistry",
      "Micronutrients",
      "Minerals"
    ],
    "content": {
      "definition": "<p><b>Iron</b> is an essential mineral required for the synthesis of hemoglobin, myoglobin, and cytochromes, with its metabolism tightly regulated by absorption in the duodenum and storage as ferritin.</p>",
      "atAGlance": "<ul><li><b>Absorption:</b> Duodenum (as Fe<sup>2+</sup>). Enhanced by Vitamin C; Inhibited by tannins/tea. Regulated by <b>Hepcidin</b> (blocks ferroportin).</li><li><b>Transport:</b> <b>Transferrin</b> (transports Fe<sup>3+</sup> in blood).</li><li><b>Storage:</b> <b>Ferritin</b> (primary), Hemosiderin (macrophage degradation product).</li><li><b>Pathology:</b><br> - <b>Deficiency:</b> [[iron_deficiency_anemia]] (Microcytic, Low Ferritin, High TIBC).<br> - <b>Overload:</b> [[hemochromatosis]] (Bronze diabetes, cirrhosis, cardiomyopathy).<br> - <b>Toxicity:</b> Acute poisoning (GI bleeding, metabolic acidosis). Treat with [[deferoxamine]].</li><li><b>USMLE Tip:</b> \"Iron OUT\" (High TIBC/Transferrin) in deficiency. \"Iron IN\" (Low TIBC) in chronic disease/overload.</li></ul>",
      "takeAway": "<p><b>Iron</b> is critical for oxygen transport; deficiency leads to microcytic anemia, while overload (Hemochromatosis) causes multiorgan damage due to free radical generation.</p>",
      "mermaid": "graph TD; A[Dietary Iron] --> B[Absorption in Duodenum]; B --> C[Transferrin Transport]; C --> D[Bone Marrow (Heme Synthesis)]; C --> E[Storage (Ferritin)]; F[Hepcidin] --x|Blocks| B;"
    },
    "connections": [
      {
        "type": "deficiency_causes",
        "to": "iron_deficiency_anemia"
      },
      {
        "type": "excess_causes",
        "to": "hemochromatosis"
      },
      {
        "type": "regulated_by",
        "to": "hepcidin"
      },
      {
        "type": "toxicity_treated_by",
        "to": "deferoxamine"
      }
    ]
  },
  "ischemic_stroke": {
    "title": "Ischemic Stroke",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Vascular",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Cerebrovascular Disease",
      "Ischemic Stroke"
    ],
    "content": {
      "definition": "<p><b>Ischemic Stroke</b> is the acute loss of neurologic function due to compromised blood flow to the brain, leading to tissue infarction via thrombotic, embolic, or hypoxic mechanisms.</p>",
      "atAGlance": "<ul><li><b>Etiologies:</b><br> - <b>Thrombotic:</b> Clot forms <i>in situ</i> (e.g., atherosclerosis). Stuttering onset.<br> - <b>Embolic:</b> Clot from elsewhere (e.g., A-fib, Carotids). Sudden onset.<br> - <b>Hypoxic:</b> Global hypoperfusion (e.g., Shock). Affects [[watershed_zones]].</li><li><b>Histology Timeline:</b><br> - <i>12-24h:</i> <b>Red Neurons</b> (eosinophilic cytoplasm, pyknotic nuclei).<br> - <i>1-3 days:</i> Neutrophils + Necrosis.<br> - <i>3-7 days:</i> <b>Macrophages</b> (microglia).<br> - <i>1-2 weeks:</i> Reactive Gliosis + Vascular proliferation.<br> - <i>>2 weeks:</i> Glial Scar (cystic cavity).</li><li><b>Treatment:</b> tPA (if <3-4.5h), Thrombectomy, Aspirin.</li><li><b>USMLE Tip:</b> Diffusion-Weighted MRI (DWI) detects ischemia within minutes (bright signal). CT is to rule out hemorrhage.</li></ul>",
      "takeAway": "<p><b>Ischemic Stroke</b> causes liquefactive necrosis of brain tissue, evolving from Red Neurons to a fluid-filled cystic space walled off by gliosis.</p>",
      "mermaid": "graph TD; A[Vascular Occlusion] --> B[Ischemia]; B --> C[ATP Depletion]; C --> D[Cytotoxic Edema]; B --> E[Red Neurons (12h)]; E --> F[Neutrophils (1-3d)]; F --> G[Macrophages (3-7d)]; G --> H[Glial Scar];"
    },
    "connections": [
      {
        "type": "includes",
        "to": "thrombotic_stroke"
      },
      {
        "type": "includes",
        "to": "embolic_stroke"
      },
      {
        "type": "includes",
        "to": "hypoxic_stroke"
      },
      {
        "type": "results_in",
        "to": "liquefactive_necrosis"
      }
    ]
  },
  "isoflurane": {
    "title": "Isoflurane",
    "primaryType": "substance",
    "tags": [
      "Pharmacology",
      "Anesthesiology",
      "USMLE"
    ],
    "classificationPath": [
      "Pharmacology",
      "Anesthetics",
      "Inhaled"
    ],
    "content": {
      "definition": "<p><b>Isoflurane</b> is a halogenated ether <i>inhaled anesthetic</i> commonly used for maintenance of general anesthesia, characterized by a pungent odor and intermediate solubility.</p>",
      "atAGlance": "<ul><li><b>Properties:</b> Pungent odor (limits use for induction). Intermediate blood/gas solubility.</li><li><b>Mechanism:</b> Potentiates GABA<sub>A</sub> receptors.</li><li><b>Adverse Effects:</b> Airway irritation (coughing/breath holding), Respiratory depression, Hypotension (vasodilation), Increased intracranial pressure.</li><li><b>Class Effect:</b> Can trigger <b>[[malignant_hyperthermia]]</b> in susceptible individuals (Ryanodine receptor mutation).</li><li><b>USMLE Tip:</b> Halogenated anesthetics (ending in -flurane) + Succinylcholine are the triggers for Malignant Hyperthermia.</li></ul>",
      "takeAway": "<p><b>Isoflurane</b> is a standard maintenance anesthetic that shares the class risk of triggering malignant hyperthermia.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_a_type_of",
        "to": "inhaled_anesthetics"
      },
      {
        "type": "can_cause",
        "to": "malignant_hyperthermia"
      },
      {
        "type": "is_related_to",
        "to": "desflurane"
      }
    ]
  },
  "jc_virus": {
    "title": "JC Virus",
    "primaryType": "organism",
    "tags": [
      "Microbiology",
      "Virology",
      "Neurology",
      "USMLE"
    ],
    "classificationPath": [
      "Microbiology",
      "Viruses",
      "Polyomaviruses"
    ],
    "content": {
      "definition": "<p><b>JC Virus (John Cunningham Virus)</b> is a Polyomavirus (dsDNA, non-enveloped) that is ubiquitous and latent in most adults but reactivates in <u>immunocompromised</u> states (AIDS CD4 < 200) to cause <b>[[progressive_multifocal_leukoencephalopathy]]</b>.</p>",
      "atAGlance": "<ul><li><b>Pathogenesis:</b> Reactivation &rarr; Infection/Lysis of <b>[[oligodendrocytes]]</b> &rarr; Demyelination.</li><li><b>Disease:</b> <b>Progressive Multifocal Leukoencephalopathy (PML)</b>.</li><li><b>Clinical:</b> Rapidly progressive focal neurologic deficits (weakness, visual field defects, ataxia, dementia). Usually fatal.</li><li><b>Imaging:</b> MRI shows multifocal, non-enhancing white matter lesions (no mass effect).</li><li><b>USMLE Tip:</b> \"JC\" = <b>J</b>unky <b>C</b>erebrum (Demyelination). Don't confuse with BK virus (<b>B</b>ad <b>K</b>idney - transplant nephropathy).</li></ul>",
      "takeAway": "<p><b>JC Virus</b> targets oligodendrocytes in immunosuppressed patients, causing the fatal demyelinating disease PML.</p>",
      "mermaid": "graph TD; A[Immunosuppression] --> B[JC Virus Reactivation]; B --> C[Infection of Oligodendrocytes]; C --> D[Demyelination]; D --> E[Progressive Multifocal Leukoencephalopathy];"
    },
    "connections": [
      {
        "type": "causes",
        "to": "progressive_multifocal_leukoencephalopathy"
      },
      {
        "type": "destroys",
        "to": "oligodendrocytes"
      },
      {
        "type": "reactivates_in",
        "to": "aids"
      }
    ]
  },
  "jaw_jerk_reflex": {
    "title": "Jaw Jerk Reflex",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Physical Exam",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology",
      "Neurologic Examination",
      "Brainstem Reflexes"
    ],
    "content": {
      "definition": "<p>The <b>Jaw Jerk Reflex</b> is a monosynaptic stretch reflex of the masseter muscle, mediated by the <u>Trigeminal Nerve (CN V3)</u>; it is normally absent or minimal, and its presence/hyperactivity indicates an <b>Upper Motor Neuron lesion</b> above the mid-pons.</p>",
      "atAGlance": "<ul><li><b>Afferent Limb:</b> Sensory V3 (Muscle spindles in Masseter) &rarr; Mesencephalic Nucleus of V.</li><li><b>Efferent Limb:</b> Motor V3 &rarr; Masseter contraction.</li><li><b>Testing:</b> Tap on chin with mouth slightly open.</li><li><b>Significance:</b> <b>Hyperactive</b> (brisk closure) suggests bilateral supranuclear (UMN) pathology (e.g., [[pseudobulbar_palsy]], ALS).</li><li><b>USMLE Tip:</b> A brisk jaw jerk differentiates ALS (UMN bulbar signs) from simple bulbar palsy (LMN only).</li></ul>",
      "takeAway": "<p>The <b>Jaw Jerk Reflex</b> evaluates the trigeminal nerve and brainstem; hyperactivity serves as a sign of upper motor neuron dysfunction affecting the corticobulbar tracts.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "mediated_by",
        "to": "trigeminal_nerve"
      },
      {
        "type": "indicates",
        "to": "upper_motor_neuron_lesion"
      },
      {
        "type": "is_sign_of",
        "to": "pseudobulbar_palsy"
      }
    ]
  },
  "joints": {
    "title": "Joints",
    "primaryType": "structure",
    "tags": [
      "Index Stub"
    ],
    "classificationPath": [
      "Musculoskeletal",
      "Anatomy"
    ],
    "content": {
      "definition": "<p><i>(Placeholder)</i> Anatomical structures facilitating movement between bones, susceptible to inflammatory, degenerative, and neuropathic pathologies.</p>",
      "atAGlance": "<ul><li>See [[osteoarthritis]], [[rheumatoid_arthritis]], [[charcot_joint]], [[septic_arthritis]], [[gout]].</li></ul>",
      "takeAway": "",
      "mermaid": ""
    },
    "connections": []
  },
  "intraocular_pressure": {
    "title": "Intraocular Pressure (IOP)",
    "primaryType": "concept",
    "tags": [
      "Ophthalmology",
      "Physiology",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Ophthalmology",
      "Physiology"
    ],
    "content": {
      "definition": "<p><b>Intraocular Pressure (IOP)</b> is the fluid pressure inside the eye, determined by the balance between aqueous humor production (ciliary body) and drainage (trabecular meshwork/uveoscleral outflow), serving as the primary modifiable risk factor for [[glaucoma]].</p>",
      "atAGlance": "<ul><li><b>Normal Range:</b> 10-21 mmHg.</li><li><b>Regulation:</b> <br> - <i>Production:</i> Carbonic anhydrase, Beta-receptors.<br> - <i>Outflow:</i> Trabecular meshwork (M3 receptors open it), Uveoscleral pathway (Prostaglandins).</li><li><b>Pathology:</b> Elevated IOP compresses the optic nerve head &rarr; Glaucomatous optic neuropathy.</li><li><b>Pharmacology:</b> Targeted by Beta-blockers, Alpha-agonists, CAIs (decrease production) and Prostaglandins, Cholinomimetics (increase outflow).</li></ul>",
      "takeAway": "<p><b>Intraocular Pressure</b> dynamics underpin the pathophysiology and treatment of glaucoma; therapies aim to lower IOP to prevent optic nerve damage.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "regulated_by",
        "to": "aqueous_humor_pathway"
      },
      {
        "type": "elevation_causes",
        "to": "glaucoma"
      },
      {
        "type": "decreased_by",
        "to": "timolol"
      }
    ]
  }
}
```